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DDE 
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REACH Registration, Evaluation and 
Authorization of Chemicals 
TEB  Terminal end bud 
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TG  Transverse growth of mammary 
glands 
TotalMix  Mixture of estrogenic and anti-
androgenic chemicals (Emix, 
Amix and paracetamol 
combined) 
USL  Urethral slit length 
WM  Whole mount 
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Summary 
BACKGROUND: Endocrine disrupting chemicals (EDCs) may contribute to reproductive changes 
in boys in the Western world, however, less is known about influence of EDCs in women. The 
incidence of precocious breast development is increasing in USA and Europe and mammary gland 
development has been suggested as particularly sensitive to endocrine disruption. Mammary gland 
examination in toxicological studies may be useful for improving knowledge on possible influences 
of EDCs on human mammary glands and also be useful for detection of endocrine disrupting effects 
of chemicals as part of safety testing. To improve knowledge on possible influences of endocrine 
disrupters on female reproductive system, the effects of EDCs on genital malformations in females 
and the development of mammary glands were studied in the present project.  
 
AIMS: The aims for the studies on male and female mammary gland development and female 
genital malformations were (i) to investigate the effects of EDCs with estrogenic or anti-androgenic 
mode of action, (ii) to develop methods for evaluation of the effects of EDCs in offspring exposed 
during foetal and postnatal development until weaning and (iii) to investigate the sensitivity of these 
methods by examining the effects of perinatal exposure to different environmentally relevant EDCs 
in offspring.  
 
METHODS: Rat studies were used as a model for humans. Rat dams were exposed to EDCs during 
pregnancy and the lactation period. Female and male offspring were examined for changes in 
mammary gland development before puberty in whole mounted mammary glands and in adults in 
histological sections of the mammary glands. Moreover, female offspring were evaluated for 
external genital malformations. The EDCs studied for mammary gland effects were the estrogenic 
compounds ethinyl estradiol and genistein, a mixture of phytoestrogens, and a mixture of 
environmentally relevant estrogenic EDCs of various origins. Moreover, mixtures of anti-
androgenic chemicals were investigated. These include a mixture of pesticides and a mixture of 
environmentally relevant anti-androgenic EDCs of various origins. Finally, a mixture with 
environmentally relevant EDCs with dissimilar modes of action was studied.  Female genital 
malformations were investigated for the compounds ethinyl estradiol, bisphenol A and 
epoxiconazole as well as the mixtures of environmentally relevant EDCs.  
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RESULTS: Mammary glands in rats were sensitive to EDCs. EDCs with estrogenic mode of action 
appeared to increase mammary outgrowth in prepubertal female rats and a potent model compound, 
ethinyl estradiol, increased the density in females and males and the number of terminal end buds in 
male rats. Histological examination showed changes in epithelial morphology in male (hypertrophic 
epithelium) and female (lobuloalveolar morphology) mammary glands in adult rats exposed to 
phytoestrogens. Anti-androgenic chemicals showed signs of feminisation of adult male mammary 
glands. No effects of anti-androgens were observed in female mammary glands. The histological 
changes observed in adult female and male mammary glands were not present consistently in the 
groups of estrogenic or anti-androgenic chemicals and may be due to other modes of action of the 
chemicals. Female genital malformations were affected by the potent estrogenic chemical ethinyl 
estradiol, only. 
In studies on exposure to anti-androgens, other endpoints, such as nipple retention showed effects in 
male rats at dose levels where no effects were observed in male or female mammary glands or 
female external genitals. However, in studies on estrogenic chemicals, marked effects on 
prepubertal female rat mammary glands were observed at lower levels than those affecting other 
endpoints studied.  
CONCLUSION: The present findings in rats suggest that EDCs may affect mammary gland 
development in women and men, although risk assessment including comparison with exposure is 
necessary to draw conclusion on this. Histological examination of mammary glands are included in 
the extended one-generation OECD guideline studies, however, risk assessment of estrogenic 
chemicals may overlook the effects on mammary glands if outgrowth in females PD22 is not 
investigated. Further studies are necessary to confirm the high sensitivity of the distance to the 
lymph node in female mammary gland whole mounts and to validate this endpoint.  
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Resumé (summary in Danish) 
 
BAGGRUND: Det har vist sig, at hormonforstyrrende stoffer kan bidrage til nogle af de 
forandringer, man i dag ser i drenges reproduktionssystem i den vestlige verden. Man ved imidlertid 
mindre om hormonforstyrrende stoffers betydning i kvinder. I USA og Europa er der en stigende 
forekomst af piger, der udvikler bryster i en tidlig alder, og studier har vist, at brystudviklingen kan 
være følsom for hormonforstyrrende stoffer. For at øge vores viden om de mulige effekter af 
hormonforstyrrende stoffer på menneskers brystudvikling, kan undersøgelse af brystudviklingen i 
toksikologiske studier være vigtig. Sådanne studier er også vigtige for at opdage 
hormonforstyrrende effekter som et led i risikovurderingen af kemikalier. For at lære mere om 
hormonforstyrrende stoffers påvirkning af hunners reproduktionssystem, blev effekterne af 
hormonforstyrrende stoffer på udviklingen af de ydre hunkønsorganer og brystvævet i både hunner 
og hanner undersøgt i rotter i dette projekt. 
 
FORMÅL: Formålet med studierne på brystvævet og de ydre hunkønsorganer var: 
1) at undersøge effekterne af østrogene og anti-androgene hormonforstyrrende stoffer. 
2) at udvikle metoder til at vurdere effekterne af hormonforstyrrende stoffer i afkom, der har 
været eksponeret under fosterudviklingen og under diegivningsperioden. 
3) at vurdere følsomheden af metoderne ved at undersøge effekterne af perinatal eksponering 
for hormonforstyrrende stoffer. 
 
METODER: Rotter blev brugt som model for mennesket. Hunrotter blev udsat for 
hormonforstyrrende stoffer under drægtighed og efter fødsel, indtil ungerne blev fravænnet. 
Brystudviklingen i hun- og hanungerne blev undersøgt i brystvævet i sin helhed (whole mounts), i 
unge dyr inden de gik i pubertet (præpubertalt) og i histologiske snit af brystvævet efter 
kønsmodning. Hunungerne blev også undersøgt for misdannelser af de ydre kønsorganer. 
Effekterne på brystvævet blev undersøgt for de østrogene stoffer ethinyløstradiol og genistein, en 
blanding af fytoøstrogener og en blanding af miljørelevante østrogene hormonforstyrrende stoffer. 
Derudover blev effekterne af nogle blandinger af antiandrogener undersøgt. Disse indbefattede en 
blanding af pesticider og en blanding af miljørelevante antiandrogene kemikalier. Endelig blev en 
blanding af hormonforstyrrende stoffer med forskellige virkningsmekanismer undersøgt for effekter 
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i brystvævet. Effekter på de ydre hunkønsorganer blev undersøgt for ethinyløstradiol, bisphenol A, 
epoxiconazol og for de tre forskellige blandinger af miljørelevante hormonforstyrrende stoffer.  
 
RESULTATER: Brystudviklingen var følsom for hormonforstyrrende stoffer. Østrogene 
hormonforstyrrende stoffer gav en øget udvækst af de præpubertale hunners brystvæv, og det 
potente modelstof, ethinyløstradiol, gav en øget densitet i hunner og hanner samt flere ”terminal end 
buds” i hanner. Histologisk vurdering af brystvæv fra voksne rotter viste forandringer i morfologien 
af epithelet i hanner (hypertrofisk epithel) og hunner (lobuloalveolær morfologi) efter fytoøstrogen 
eksponering. Antiandrogener så ikke ud til at påvirke hunnernes brystudvikling, hvorimod voksne 
hanners brystvæv viste tegn på feminisering. Der tegnede sig ikke noget mønster for de histologiske 
forandringer i de voksne dyr eksponeret for østrogene eller antiandrogene kemikalier perinatalt. 
Dette kan muligvis skyldes andre virkningsmekanismer eller forskellige dosisniveauer af de enkelte 
kemikalier. De ydre hunkønsorganer blev kun påvirket af det potente østrogene stof, 
ethinyløstradiol.  
I studierne med antiandrogener blev der påvist effekter i andre endpoints, såsom ”nipple retention” 
(tilbageholdelse af brystvorter) i hanner, ved doser, hvor der ikke blev påvist forandringer i 
brystvæv fra hunner eller hanner eller i de ydre hunkønsorganer. Til gengæld blev der i studierne 
med østrogene stoffer påvist effekter i hunrotters brystvæv ved doser, hvor ingen effekter blev 
påvist i andre endpoints. 
 
KONKLUSION: Disse fund i rottestudierne peger på, at hormonforstyrrende stoffer kan påvirke 
brystvævets udvikling i mænd og kvinder. Risikovurdering med sammenligning af 
eksponeringsniveau er dog nødvendig for at kunne drage konklusioner på dette område. Histologisk 
vurdering af brystvæv er med i ”extended one-generation” OECD guideline studierne. Men effekter 
på brystvævet i præpubertale rotter vil blive overset, hvis der foretages risikovurdering af østrogene 
stoffer på basis af et sådant studie, hvor kun de voksne dyrs brystvæv bliver undersøgt. Flere studier 
er dog nødvendige for at bekræfte følsomheden af afstanden til lymfeknuden i whole mounts af 
præpubertale hunner og for at kunne validere dette endpoint. 
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1. Introduction  
 
Endocrine disrupting chemicals (EDCs) are chemicals that agonise or antagonise the effects of 
hormones in the mammalian body. EDCs affecting the sexual hormones may be classified as 
estrogenic or anti-androgenic, although a compound may have multiple modes of action. Increased 
prevalences of poor semen quality, hypospadias and testis cancer in Danish men have been reported 
in the last two decades as reviewed by Skakkebæk et al. (2006). Such adverse changes may 
decrease fertility in men and increased exposure to EDCs may contribute to the changes observed 
[Skakkebaek et al. 2006]. However, EDCs may also affect women. During the last two decades a 
decrease in the age of onset of puberty and breast development in girls has been reported in USA 
and Europe [Sorensen et al. 2012]. Precocious puberty can lead to psychosocial problems for the 
young girls and increase the risk for developing breast cancer later in life [Golub et al. 2008; 
Medina 2005]. Studies in rodents have shown a link between estrogenic EDCs and enhanced 
mammary development [Cotroneo et al. 2002; Murrill et al. 1996], suggesting that estrogenic EDCs 
play an important role in precocious breast development in girls [Aksglaede et al. 2009; Wohlfahrt-
Veje et al. 2012]. In vitro and in vivo studies on chemicals humans are exposed to in our daily life 
have been shown to be endocrine disrupting, and this may contribute to the high prevalence of 
breast cancer in women.  
 
In the European Union, chemicals present on the market in large quantities are regulated by 
authorities. Manufacturers and importers must demonstrate human safety of the chemicals by 
supplying experimental data on the chemicals. The OECD guidelines describe approved methods 
for toxicological and reproductive toxicity studies in vitro and in vivo. In the in vivo guidelines, 
several endpoints sensitive to EDCs are described, and these have been found to be sensitive to anti-
androgens. However, less is known about estrogen-sensitive endpoints, although estrogenic 
compounds are suspected of interfering with both male and female reproductive development. 
Endpoints evaluated in females are either difficult to assess due to changes in reproductive organs 
throughout the estrous cycle or due to data being evaluated as scoring data (e.g., sexual maturation 
and estrous cyclicity) with low statistical power. Therefore, estrogen-sensitive endpoints and 
endpoints easy to assess in female rodent studies are desirable in the toxicological studies for the 
risk assessment of chemicals.  
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This project focuses on the investigation of endpoints sensitive to estrogenic chemicals as well as 
development of endpoints in female rats. Few studies have investigated genital malformations in 
female rodents and have shown an increased incidence after perinatal exposure to EDCs [Vilela et 
al. 2007; Wolf et al. 1999b]. In the present PhD project, a rat model was applied to evaluate the 
effects of perinatal exposure to estrogenic and anti-androgenic chemicals on mammary gland 
development in both sexes and the effects on female genital malformations. Mammary glands were 
examined for changes in morphologic development and the female external genital malformations 
were evaluated for measurable changes. The endpoints were evaluated as a model to investigate the 
effects of EDCs on human mammary development and to determine the usefulness of the endpoints 
in studying EDCs in reproductive toxicological studies. 
 
 
The aims of this PhD project were:  
- To investigate the effects of EDCs with estrogenic or anti-androgenic mode of action. 
- To develop methods for evaluation of the effects of EDCs in offspring exposed during foetal 
and postnatal development until weaning.  
- To investigate the sensitivity of these methods by investigating the effects of perinatal 
exposure to EDCs in offspring.  
The aims are applied to the following two endpoints: mammary glands in females and males and 
female external genital malformations. Moreover, the endpoints are evaluated in relation to human 
risk assessment of EDCs.  
 
The following hypotheses were formulated for each endpoint:  
- Exposure to EDCs during foetal and prepubertal development affects mammary gland 
development in rats  
- Female external genital development in rats is altered by EDCs  
- Changes in female or male mammary glands or female genital malformations may be good 
predictors for endocrine disrupting effects of a chemical. 
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2. Background  
 
2.1. Endocrine disrupting chemicals (EDCs) 
Endocrine disrupters are defined by the World Health Organization (WHO) as “an exogenous 
substance or mixture that alters function(s) of the endocrine system and consequently causes 
adverse health effects in an intact organism, or its progeny, or (sub)populations” [WHO 2002]. 
Endocrine disrupters can act via a variety of mechanisms, either directly receptor mediated 
mechanisms (agonistic or antagonistic) or indirectly by affecting synthesis, transport or metabolism 
of the endogenous hormones [WHO 2002].  
In sexually mature females, estrogen is an important sex hormone playing an essential role in the 
estrous cycle and the physiological changes related to the estrous cycle. Androgens are male sex 
hormones important for the male sex characteristics. The androgen testosterone plays a key role in 
spermatogenesis and in the foetal development of male sexual organs and the organisation of the 
male brain.  
Several endocrine disrupting chemicals (EDCs) affecting sexual hormones may have an estrogenic 
or anti-androgenic mode of action. Estrogenic EDCs are compounds mimicking estrogens, e.g., by 
activating estrogen receptors or increasing the level of estrogen, whereas anti-androgenic 
compounds antagonize androgens, e.g., by blocking the androgen receptor or the level of androgens. 
Other modes of action may also influence reproductive development. 
Several compounds have been shown to have endocrine disrupting properties. Soy products 
containing the estrogenic compounds such as genistein, plastic toys and food containers containing 
the anti-androgenic phthalates, and the fungicides epoxiconazole and procymidone are examples of 
such EDCs in our daily environment [Boberg et al. 2011; Ostby et al. 1999; Taxvig et al. 2007]. 
Although these compounds are classified as “estrogenic” or “anti-androgenic” here in the literature, 
it is important to note that these and most other compounds often exhibit several different modes of 
actions simultaneously. 
 
 
  
13 
 
2.2. EDCs and reproductive development 
During foetal development, sexual hormones are crucial for the sexual differentiation, although 
hormones are only present at low levels [Apter 1997; Forest 1979]. Chemicals with estrogenic or 
anti-androgenic mode of action can perturb the hormonal balance during critical periods in 
development and may have implications later in life in the offspring even at low levels of EDCs. An 
increased incidence of men with undescended testes, low semen quality and testis cancer has been 
reported in Denmark and an increased exposure to EDCs in the environment may be related to the 
changes observed [Skakkebaek et al. 2006]. Indeed, EDCs have been shown to affect the 
development of genital organs in male rats. Changes such as increased incidence of hypospadias 
and cryptorchidism and decreased sperm count have been reported in rats exposed perinatally to 
EDCs [Axelstad et al. 2011; Christiansen et al. 2008; Kim et al. 2010]. The majority of effects of 
EDCs have been observed in male rodent studies on anti-androgens and little is known about the 
effects in females and effects of compounds with estrogenic mode of action.  
Reproductive changes have also been observed in females. An increase in the prevalence of 
precocious puberty in girls, defined as breast development or appearance of pubic hair before the 
age of 8 years, has been reported in the USA and Europe during the last 2 decades, as reviewed by 
Sørensen et al. [Sorensen et al. 2012]. The mean age of onset of breast development in girls has 
dropped 1 year during a 15-years period in Denmark, reaching a mean age of 9.86 in 2006 
[Aksglaede et al. 2009]. Precocious puberty may give rise to psycho-social and social 
consequences, e.g., a poor self-image, increased risk for eating disorders or drug abuse, as reviewed 
by Golub et al. (2008) and Patton and Viner (2007) [Golub et al. 2008; Patton and Viner 2007]. 
Early puberty onset may lead to a longer reproductive period, a period characterized by high 
estrogen levels and this has been associated with an increased risk for developing breast cancer later 
in life [Henderson et al. 1991; Medina 2005; Pike et al. 1981; Rudel et al. 2011]. Breast cancer is 
the most common type of cancer in women in Denmark (4944 women, corresponding to 22.8% of 
all women with cancer) (Cancerregisteret 2012, Sundhedsstyrelsen), a disease also seen in men 
(increased with 0.4% from 2006 to 2010 in Scandinavia) (NORDCAN) [Hodgson et al. 2004]. 
Breast development is observed in some men (gynecomastia) and breast cancer in men is usually 
more fatal than in women, as breast cancer in men is often detected at a much later stage. 
 
The mechanisms responsible for precocious breast development are yet unknown. Hormonal 
measurements indicate that early breast development is not associated with early activation of the 
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pituitary-gonadal axis (leading to high gonadotropin or estradiol concentrations) neither can body 
mass index explain the early breast development [Aksglaede et al. 2009; Wohlfahrt-Veje et al. 
2012]. Precocious puberty, early breast development and high incidence in breast cancer in women 
may be explained by increased exposure to EDCs in the environment. In a study investigating the 
breast development in girls from mothers working in greenhouses during early pregnancy, prenatal 
exposure to pesticides could be associated with breast development 1-1.5 years earlier compared to 
non-exposed girls [Wohlfahrt-Veje et al. 2012]. Several pesticides such as tebuconazole, 
epoxiconazole and prochloraz have been shown to be endocrine disrupting  [Taxvig et al. 2007; 
Vinggaard et al. 2002] and the early breast development observed may be explained by the 
endocrine disrupting activity of the pesticides. In fact, various EDCs have been shown to affect 
mammary gland development in rodent studies and especially estrogenic compounds, such as 
phytoestrogens (estrogenic compounds from plants), have been reported to increase growth of 
mammary glands in females [Cotroneo et al. 2002; Delclos et al. 2001; Murrill et al. 1996]. 
Estrogenic EDCs have also been shown to induce neoplastic transformation in vitro and exposure to 
estrogenic compounds during early development increased the susceptibility to carcinogen-induced 
mammary tumors in rats [Fernandez and Russo 2010; Khan et al. 2007; Tan et al. 2004; Ward et al. 
2000]. Thus estrogenic EDCs may affect mammary gland development and contribute to the 
precocious breast development seen in girls in the Western world and may contribute to the high 
prevalence of breast cancer in women. However, disagreement on the roles of estrogenic 
compounds in breast cancer has risen, as some studies have shown protective effects of estrogens 
against mammary cancer [Chen et al. 2003; Tou and Thompson 1999]. Focus on male breast cancer 
is lacking in in vivo studies, although a few studies have suggested that male mammary glands may 
be more sensitive to EDCs than female mammary glands [Latendresse et al. 2009; You et al. 2002], 
and other studies have suggested that some idiopathic gynecomastia may be related to EDC 
exposure [Henley et al. 2007].  
 
 
2.3. Mammary gland development 
Mammary glands are a common feature for mammals, however, the number, shape and size vary 
between species. Despite these differences, the embryologic development of the mammary glands is 
comparable between species [Cowie 1974; Hovey et al. 2002].  
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In rats, mammary gland development starts at gestation day (GD) 11, where the milk line is formed 
ventrolaterally from the cervical to the inguinal region. Between GD12 and GD13, mammary buds 
are formed in the milk line. When testosterone levels start rising in male fetuses between GD 13 and 
15 (peak at GD19) mammary glands are sensitive to testosterone, and differentiation to either 
female or male mammary glands occurs [Borellini and Oka 1989; Kratochwil 1977]. At GD15, cells 
proliferate and form the mammary cord from which branching occurs before birth [Borellini and 
Oka 1989]. After birth, the development of the mammary glands continues. From the age of 14 
days, 12 nipples are visible in female offspring (Figure 1), whereas male rats are born with a 
rudiment of the mammary gland and nipples are not present. In humans, the mammary glands 
follow similar developmental pattern but the milk line regresses in the caudal region, and mammary 
buds are formed in the thoracic region only. The embryonic mammary development in humans 
starts in the first trimester on embryonic week 10 and ends before birth on embryonic week 32 
[Fenton 2006] (Figure 2).  
After birth, the rat mammary gland undergoes two phases of development. Until weaning (22-23 
days old) the growth of the glands follows the growth of the body weight (isometric growth). After 
weaning and until puberty, the mammary gland grows approximately three-fold faster than the body 
weight (allometric growth) (reviewed by Borellini and Oka 1989). Until sexual maturation, 
mammary glands of males and females are morphologically comparable but not identical [Cardy 
1991; Ceriani 1970; You et al. 2002]. After sexual maturation rat mammary glands develop 
differently according to gender. Female mammary glands grow extensively (allometric growth) 
[Borellini and Oka 1989] passing the lymph node and filling out the mammary fat pad. In 
histological slides virgin female rat mammary glands are recognizable by a tubuloalveolar pattern; 
this typical female morphology is characterized by ducts and alveoli with distinct lumina and lined 
by a single layer of cuboidal epithelium [Cardy 1991; Wang et al. 2006]. Male rat mammary glands 
are smaller than female mammary glands and characterized by a lobuloalveolar pattern described as 
large lobular groups of cells arranged into alveoli with indistinct lumina and aboundant, eosinofilic 
and vacuoled epithelium [Cardy 1991; Wang et al. 2006]. The hormonal balance in sexually mature 
females varies according to the estrous cycle, which seems to have implications on the mammary 
glands. Lobules are further developed with each estrous cycle and full differentiation of female 
mammary glands is only reached at pregnancy [Russo and Russo 1978; Russo et al. 1990]. An 
increased proliferative index has been shown in females in metestrous, leading to a lobular 
morphology (type 2 with 11-25 acini or type 3 with more than 25 acini) of the adult mammary 
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glands in metestrous and early diestrous compared to small lobules with 10 or fewer acini (type 1) 
in late diestrous and proestrous [Hvid et al. 2010; Schedin et al. 2000], although Schedin et al. 
(2000) describes a large variation in the morphological appearance within each stage of estrous 
cycle [Schedin et al. 2000]. 
 
 
  
Figure 1. Female rat mammary glands. (A) Ventral view of a sexually mature female rat. Twelve nipples 
(Npl) are present, aligned by pairs from the cervical region (nipple pair nr. 1) to the inguinal region (nipples 
5 and 6). The genital papilla (GP) is situated anterior to the vaginal opening (VO). (B) Mammary gland 
(MG) whole mount from 22 days old female rats scanned on a flatbed scanner (4200 dpi). (C) Zones A, B 
and C defining areas of most to least differentiated parts of the mammary glands. Ln= lymph nodes. (Figures 
by Karen Riiber Mandrup). 
A 
B 
C 
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Figure 2. Timing of mammary development in rats and humans. EW: embryonic week. PND: post natal 
day. GD: gestation day. (Figure by Karen Mandrup) 
 
A number of differences between rat and human mammary gland development are present. In rats, 
ducts grow into the fat pad whereas human ducts grow along connective tissue septa and the lobular 
structures do not grow into the fat tissue [Russo et al. 1990]. Moreover, rat mammary gland can be 
divided into zones from a well differentiated area close to the nipple (zone A) and the least 
differentiated zone furthest away from the nipple (zone C) (Figure 1); such systematic gradient in 
development is not found in humans where the growth is more labyrinthic and varying degree of 
differentiation is found in the breast [Russo et al. 1990]. Additionally, a good correlation between 
age and gland development can be found in rats, of which none is found in humans where different 
degrees of development is observed in breasts of same aged women [Russo et al. 1990].  
 
Hormones play a crucial role in mammary gland development during fetal development in males 
and during puberty and adulthood in females [Neville et al. 2002]. In male mice and rats mammary 
gland development is controlled by androgens during fetal development, blocking the formation of 
nipples [Goldman et al. 1976; Kratochwil 1977; Raynaud and Frilley 1947]. After birth several 
hormones are involved in the development of the female mammary gland, however the mechanisms 
are not fully understood. In general, studies in rodents have found estrogen, progesterone and 
androgens to be important for mammary gland development. Estrogen is responsible for ductal 
elongation and branching, but seems to act in combination with growth hormone or prolactin 
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[Borellini and Oka 1989; Sourla et al. 1998]. Progesterone causes side branching and alveolar 
formation [Brisken 2002; Sourla et al. 1998]. Androgens are responsible for the male-like 
development of the mammary glands. In adult males androgens give rise to lobuloalveolar growth 
with a profuse growth of lobular units present around 2 months of age and multilayered epithelium 
in ducts and alveoli from the age of 3 months [Ahren and Etienne 1957; Sourla et al. 1998]. In 
humans, estrogen induces cell proliferation leading to ductal growth and progesterone enhances 
differentiation of the gland by developing acini [Borellini and Oka 1989].  
Despite differences between human and rat mammary glands, the development of the glands has 
many similarities. The rat mammary gland appears to be a good model for human mammary gland 
development and useful to study the effects of chemicals on the gland development. 
 
 
2.4. Methods for evaluation of mammary gland effects 
Three periods in the mammary development have been identified as sensitive periods for exposure 
to EDCs: the prenatal phase, the prepubertal phase and pregnancy [Fenton 2006]. Exposure to 
chemicals during both the prenatal and prepubertal phase (in utero and during lactation) especially 
appears to affect mammary gland development [Rayner et al. 2005] and may have adverse effects 
later in life, e.g. an increased risk of developing mammary cancer [Knight and Sorensen 2001] 
(Figure 3). Rat mammary glands can be evaluated in whole mounts or in histological slides, each 
method with different purposes. Evaluation of mammary gland growth as a marker for early or 
delayed mammary development in prepubertal rats can be done in whole mounted mammary 
glands. For whole mounting, dissected rat mammary glands are spread and fixed as a whole on a 
glass slide. After processing and staining, the mammary gland is macroscopically visible in its fat 
pad. This is called a whole mount of a mammary gland (Figure 1). Compared to histological 
sections of mammary glands, the whole mammary gland can be examined in whole mounts and 
give an overall picture of the stage of development or morphological changes of the gland. For the 
evaluation of differentiation and persistent epithelial as well as morphological effects on adult 
mammary glands, histological slides of mammary glands can be assessed. Histological examination 
of the mammary glands can include investigation of the presence of receptors, proliferation, 
apoptosis etc. with immunohistochemical staining. Moreover, both whole mounts and histological 
slides can be used to investigate the effects on terminal end buds (TEBs). In rats, TEBs are 
undifferentiated tear-drop shaped structures in the zone C of the mammary gland (Figure 1). TEBs 
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are the site of extensive proliferation both responsible for the elongation and branching of ducts 
[Brisken 2002]. Neoplastic transformation occurs primarily in the TEBs of rats [Russo et al. 1990]. 
In humans, the virginal lobules called terminal ductal lobular units (TDLUs) (or lobules type 1) 
seem to represent an undifferentiated stage where neoplastic transformation can occur. The TEBs in 
rats are thus considered to be the equivalent to TDLUs in humans [Russo et al. 1990]. In rats, the 
number of TEBs peak before puberty at 21 days of age [Russo and Russo 1978], and an increase in 
the number of TEBs in rats represents an increased risk of developing mammary cancer. 
 
 
Figure 3. Timeline highlighting the critical periods of female mammary gland development most likely 
to be altered by EDCs and the correlating potential health effects of these exposures. Three time periods 
are suggested from rodent model literature. LA: lobuloalveolar. TEBs: terminal end buds. (from Fenton 
2006) 
 
Whole mounting is optimal for small mammary glands that have not yet reached the boundaries of 
the fat pad, e.g. prepubertal mammary glands. Growth parameters can be difficult to evaluate when 
mammary glands have occupied the fat pad and the limits between two neighbouring mammary 
glands can be challenging to distinguish.  
Mammary whole mounts are most commonly evaluated for outgrowth (area, ductal elongation or 
the distance to the 5th gland) (Figure 4), gland differentiation (number of terminal end buds, alveolar 
development/ types of lobules present) and the density (branching and budding) of the mammary 
glands [Hovey et al. 2005; Moon et al. 2007; Thomsen et al. 2006; You et al. 2002].  
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Figure 4. Example of parameters for evaluation of mammary glands in whole mounts. Measurements 
for ductal outgrowth are depicted. MG: mammary gland. LG: longitudinal growth. TG: transverse growth. 
DL: distance to the lymph nodes. Ln: lymph node. 
 
Adult mammary glands are more easily evaluated in histological sections, where other 
morphological changes - cellular and epithelial changes - can be evaluated in hematoxylin and eosin 
(H&E) stained slides. Sectioning of the mammary gland should be done in a horizontal section, i.e. 
parallel to the skin [Hvid et al. 2011]. 
 
 
2.5. Abnormal mammary development following EDC exposure 
Estrogenic chemicals such as genistein, estradiol benzoate and secoisolariciresinol diglucoside have 
been shown to enhance mammary development and differentiation in rats. In whole mounts, 
evaluation of mammary glands have revealed an increased outgrowth of mammary glands (e.g. 
increased area) [Murrill et al. 1996] and an increased number of TEBs [Cotroneo et al. 2002; Tan et 
al. 2004] in prepubertal female rats and an enhanced differentiation (increased prevalence of lobules 
type 2) [Murrill et al. 1996; Ward et al. 2000] in adult female rats after perinatal exposure. 
Bisphenol A has also been shown to increase the number of TEBs [Moral et al. 2008]. However, 
these findings are not consistent among studies [Fritz et al. 1998; You et al. 2002]. In male rats 
comparable changes have been reported. Estrogenic chemicals have been shown to increase 
branching in prepubertal male rats and increase the area and density of the mammary glands in adult 
male rats [Wang et al. 2006; You et al. 2002].  
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Studies evaluating the effects of EDCs on adult mammary histology have reported effects in both 
male and female mammary glands. Estrogenic chemicals have been shown to lead to lobular 
hyperplasia [Takagi et al. 2004] and increased secretion in virgin females observed as dilated 
secretion-filled ducts [Biegel et al. 1998]. Moreover, a shift in the dominating lobuloalveolar pattern 
in males to larger areas with tubuloalveolar pattern [Biegel et al. 1998] and hypertrophy of 
mammary epithelium, have been reported [Delclos et al. 2001]. Other EDCs like genistein, with 
both estrogenic and anti-androgenic modes of action, have shown to affect female mammary glands 
to a shift from the tubuloalveolar pattern to a more lobuloalveolar-like pattern [Delclos et al. 2001].  
Few studies have investigated the effects of anti-androgens on mammary glands. Changes have 
been observed in pubertal or older rats. Saad et al. (2011) showed increased branching and ductal 
hyperplasia (multi-layered epithelium) in pubertal female rat mammary glands after perinatal 
exposure to vinclozolin [Saad et al. 2011]. Moreover, vacuolar degeneration and alveolar atrophy 
was reported in adult males exposed to di-n-butyl phthalate [Lee et al. 2004]. Thus, female and 
male mammary glands may be affected by EDCs with estrogenic or anti-androgenic modes of 
action with a wide range of possible changes observable in whole mounts and histological slides.  
 
 
2.6. Female external genital malformations 
The proper development of the female external genitals is important for female reproduction at 
mating and birth but also in the everyday life at urination and as a barrier for the external world. 
Hence, it is important to make sure that the development of the external genitals is not impaired. 
The development of the external genitals in foetal life of females or males is controlled by the lack 
or presence, respectively, of the hormone testosterone [O'Connor and Chapin 2003]. The female 
genitals are said to be the “default” form of the external genitals. The mechanisms controlling the 
development of the female external genitals are unknown, yet, it is probable that these mechanisms 
can be disturbed by the exposure to EDCs and this should be investigated.  
In female rats, the external genitals are represented by a genital papilla, anterior to the vaginal 
opening (Figure 1). At the tip of the papilla where the urethra ends, is a small cleft, the urethral slit. 
A deep urethral slit may be referred to as a clefted genital papilla (Figure 5). In the literature, the 
female external genitals have been evaluated in different ways: by registering the absence or 
presence of a vaginal thread, by measuring the depth of the urethral slit (urethral slit length), by 
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determining a clefted papilla as deeper than control urethral slits or by measuring the distance 
between the cleft and the vaginal opening (urethral-vaginal distance). 
 
Figure 5. Malformations of female external genitals. A, A normal genital papilla from a control animal. B, 
A clefted genital papilla with a deep urethral slit. Female exposed to ethinyl estradiol. C, Sketch of picture B 
illustrating the measurement of the urethral slit length. (Figures by Karen Riiber Mandrup) 
 
Deep urethral slits or clefted genital papillas have been demonstrated in females exposed to EDCs 
or endocrine disrupting model compounds with different modes of action (Table 1). Presence of a 
clefted papilla or increase in the urethral slit length has been described in adult rats after prenatal 
exposure to 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD), tamoxifen and testosterone propionate 
[Flaws et al. 1997; Gray et al. 1997; Gray and Ostby 1995; Wolf et al. 2002; Yamasaki et al. 2005]. 
Perinatal exposure to ethinyl estradiol showed an increase in the urethral slit length [Sawaki et al. 
2003a; Sawaki et al. 2003b]. Wolf et al. (1999) also showed a decrease in the urethral-vaginal 
distance in hamsters exposed to TCDD [Wolf et al. 1999a]. These findings are evidences of external 
genital malformations in females after exposure to EDCs. Thus, it is of interest to investigate the 
female external genitals for malformations and determine if (i) the development of female external 
genitals is sensitive to EDCs, if (ii) there is a specific sensitive method for evaluation of the female 
genital malformations sensitive to EDCs and, thus, if (iii) the development of female genital 
malformations could be used as a marker for endocrine disruption in foetal development.  
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Table 1: Literature presenting results on female genital malformations after perinatal exposure to endocrine 
disrupting compounds. Different means of measurement: urethral slit length (USL) and prevalence of 
females with a clefted genital papilla (CP).  
Paper Chemical Pre-/postnatal 
dosing 
Animal Changes Age at 
evaluation 
Gray & Ostby 
1995 
TCDD +/- 
GD8-15 
Long Evans 
rat 
USL↑ at 1 µg/kg Adult 
Gray et al. 
1997 
TCDD +/- 
GD15 
Long Evans 
rat 
CP↑ at 0.8 µg/kg 
USL↑ at 0.2 µg/kg 
Adult 
Flaws et al. 
1997 
TCDD +/- 
GD11,15 or 18 
Sprague-
Dawley rat 
CP↑  
at 1 µg/kg 
Pubertal  
Wolf, Ostby 
& Gray 1999 
TCDD +/- 
GD11.5 
Hamster Urethral-vaginal 
distance ↓  
at 2 µg/kg 
Adult 
Yamasaki et 
al. 2005 
Tamoxifen +/+ 
GD6-PND21 
Sprague-
Dawley rat 
CP↑ 
at 0.6 µg/kg 
Adult 
Wolf et al. 
2002 
Testosterone 
propionate 
+/- 
GD14-19 
Sprague-
Dawley rat 
CP↑ at 0.5mg,  
but not at 1 mg 
Adult 
Sawaki et al. 
2003a 
Ethinyl 
estradiol 
+/+ 
GD7-PND18 
Sprague-
Dawley rat 
USL↑ 
at 50 µg/kg 
Adult 
Sawaki et al. 
2003b 
Ethinyl 
estradiol 
+/+ 
GD7-PND18 
Sprague-
Dawley rat 
USL↑ at 50 µg/kg,  
CP ↑ (15/16) 
Adult 
TCDD: 2,3,7,8-tetrachlordibenzo-p-dioxin. Arrows: parameters reported to be increased or decreased. 
 
 
2.7. Regulatory considerations  
To secure human safety, the European Parliament has implemented legislation regulating chemicals 
used in the European Union, a legislation called REACH (Registration, Evaluation and 
Authorization of Chemicals). In Europe, all chemicals produced or imported in amounts exceeding 
1 ton per year must be registered to ECHA (European Chemical Agency) [European Parliament and 
Council of Europe 2006]. To be approved for the European market, such chemicals must be tested 
and the results have to be reported to ECHA. The studies required on a compound depend on the 
amounts produced or imported per year. Higher amounts of the chemical on the market require 
more data and more complex toxicological studies. The studies include in vitro and in vivo studies, 
e.g. studies for mutagenicity, acute toxicity and reproductive toxicity. The OECD test guidelines 
24 
 
describe study methods used for the testing according to REACH. Chemicals with endocrine 
disrupting activities may be detected in the 2-generation study, mandatory for chemicals exceeding 
1000 tons per year. In this study, some sensitive endpoints for endocrine disrupting effects on 
males, known to be sensitive to anti-androgens, are included [OECD 2001]. However, effects of 
estrogenic chemicals may be difficult to detect. The extended one-generation study includes 
histological examination of mammary glands and the relevance of the young mammary gland as a 
sensitive endpoint to estrogens is mentioned in a footnote [OECD 2010b]. This endpoint is yet to be 
validated, before inclusion in the extended one-generation study. This type of study is presently 
only included in testing requirements for pesticides and biocides, whereas effects on mammary 
glands are not tested for REACH chemicals. 
Most toxicological studies investigate the effects of single compounds and risk assessment of 
chemicals is usually done also for single compounds. However, the combination of several 
chemicals is more representative for human exposure. Tinwell and Ashby (2004) showed effects of 
a mixture that consisted of estrogenic chemicals, at doses where no effects were observed for single 
compounds [Tinwell and Ashby 2004]. Thus, EDCs may lead to toxicological effects if combined 
with other chemicals with similar modes of action, although exposure of each compound is below 
the no observed adverse effect level (NOAEL). Although the exact mechanisms of action of a 
compound are seldomly known, prediction of the mixture effects of some EDCs is possible. Dose-
addition appears to be useful to predict the mixture effects observed when compounds with similar 
modes of action are mixed [Christiansen et al. 2012; Orton et al. 2012; Tinwell and Ashby 2004]. 
However, mixture effects of chemicals with different modes of action (e.g. anti-androgens and 
estrogens) may be more difficult to predict.  
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3. Experimental design and methods 
 
To answer the aims of the PhD thesis, effects of perinatal exposure to EDCs on mammary gland 
development evaluated in whole mounts on PD21-22 and in histological slides in adult offspring 
were investigated. Moreover, the effects on female external genital malformations were 
investigated. 
Overall, the goal was to determine morphological parameters in female or male rat mammary 
glands sensitive to EDCs. Single compounds or mixtures of chemicals were investigated in vivo. 
Firstly, a positive control chemical, a potent estrogenic compound, ethinyl estradiol, was studied 
(papers 1 and 2). Secondly estrogenic compounds from food products or environmentally relevant 
estrogenic chemicals were studied as single compounds (genistein) or in mixtures of several 
compounds (phytoestrogens or various environmentally relevant estrogenic chemicals (Emix)) 
(papers 3 and 5). Finally, the endpoints were investigated in offspring exposed to mixtures of anti-
androgens (pesticides or chemicals with various origins (Amix)), or chemicals with dissimilar 
modes of action (TotalMix) or to the medicament paracetamol (papers 4 and 5). The sensitivity of 
female external genital malformations in Wistar rats were evaluated in the study with the positive 
control compound, ethinyl estradiol (paper 2), and secondly in studies with other single compounds 
of EDCs (bisphenol A, epoxiconazole and paracetamol) or mixtures of environmentally relevant 
EDCs (Emix, Amix, TotalMix) (Appendix 2). The effects were analysed to better understand how 
estrogenic and anti-androgenic chemicals may affect mammary glands or the female genital 
malformations in combination with other chemicals with similar or dissimilar modes of action. 
Ethinyl estradiol, genistein, the mixture with phytoestrogens and the mixture called Emix were 
expected to have estrogenic modes of action, and changes reflecting an enhanced mammary 
development were expected. The study on ethinyl estradiol was designed with mammary gland 
examination as primary aim, whereas the other studies were primarily designed for optimal 
evaluation of other specific endpoints and mammary tissues were dissected when possible. Thus, 
the papers in the present thesis include other endpoints that are not part of the results of this PhD 
but will be discussed in relation to the effects observed in mammary glands and female external 
genital malformations. An overview of the endpoints investigated in the studies performed in each 
paper is presented in table 2, and the compounds and dose levels investigated are presented in table 
3.  
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The following experimental goals were defined for papers 1-5: 
Paper 1: The aim was to identify sensitive parameters to a potent estrogenic compound, ethinyl 
estradiol, for analysis of female and male rat mammary gland whole mounts pup day (PD) 21-22. 
Several parameters covering the evaluation of the outgrowth, differentiation and the density of the 
mammary glands were evaluated. 
Paper 2: The aim was to identify sensitive parameters to a potent estrogenic chemical, ethinyl 
estradiol, for analysis of female and male rat mammary glands from adult offspring at PD50-55 and 
PD90 in histological slides. Furthermore, the sensitivity of female external genital malformations to 
ethinyl estradiol was evaluated. 
Paper 3: The aim was to study the mammary gland endpoints in whole mounts and histological 
sections in female and male rat offspring exposed to a xenoestrogen, genistein, or a mixture of 
dietary phytoestrogens. All chemicals studied are suggested to have an estrogenic mode of action. 
Paper 4: The aim was to study the mammary gland endpoints in whole mounts and histological 
sections in female and male rat offspring exposed perinatally to an environmentally relevant 
mixture of pesticides suggested to be anti-androgenic. 
Paper 5: The aim was to study the mammary gland endpoints in whole mounts and histological 
sections in female and male rat offspring exposed to various environmentally relevant mixtures of 
chemicals, covering both estrogenic (Emix) and anti-androgenic (Amix) chemicals as well as a 
mixture of both types of EDCs and paracetamol (TotalMix). Additionally, the medical compound, 
paracetamol, was studied.  
Appendix 1: The aim was to investigate the variation in control values for some parameters 
evaluated in whole mounts of mammary glands from the Wistar rat strain routinely used in our 
laboratory and study the differences between strains (Wistar and Sprague-Dawley) and sub-strains 
(from another supplier) used in some of our studies. 
Appendix 2 The aim was to identify the most sensitive method for evaluation of female genital 
malformations in rats and to study the sensitivity of this endpoint to environmentally relevant 
chemicals. Several parameters for evaluation of the genital malformations were evaluated to decide 
the most reliable and sensitive method to a potent estrogenic compound, ethinyl estradiol. 
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Moreover, several single compounds and mixtures of EDCs were investigated for their effects on 
the parameter. 
 
 
3.1. Study design 
In general, all studies performed in the present thesis were designed in a comparable way. Pregnant 
rat dams were exposed by gavage from 4 days after arrival (GD7) until the day before expected 
delivery. The day of expected delivery was called PD0. Exposure was resumed the day after 
delivery until PD13, 16 or PD22 (Table 3). Necropsy of offspring was performed on PD21-22, 
PD50-55 and PD90 or older. At necropsy, evaluation of female external genital malformations was 
performed measuring the urethral slit length. The 4th mammary gland was dissected for whole 
mounting (PD21-22) and in paper 1 and 5, part of the 5th mammary gland was dissected with the 4th 
mammary gland for supplementing measurements in whole mounts (Figure 1 and 4). For histology, 
the 4th mammary gland was dissected (PD50, 90 and/ or older); however, when the 4th mammary 
glands were dissected for other purposes, the 2nd mammary gland was dissected for histology. 
Details on the experimental design of the studies are described in papers 1-5. 
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Table 2: Overview of the endpoints evaluated in the papers and manuscripts included in the present thesis.  
Paper 
(P), 
Appen-
dix (A) 
Strain Chemical(s) Whole 
mounts 
(WMs) and 
genders 
evaluated 
PD21/22 
Histology of 
mammary 
glands and age 
at evaluation 
Female 
genital 
malfor-
mations 
and age at 
evaluation 
N 
(litter) 
P1 Wistar  Ethinyl estradiol Female and 
male WMs  
- - 6-9 
P2 Wistar  Ethinyl estradiol 
 
- Female and male 
mammary glands 
PD50/55 and 90 
PD22, 50, 
90 
6-9 
P3 Sprague-
Dawley 
Genistein 213 mg/kg or 
a mixture of 
phytoestrogens  
 
Female WMs  Male mammary 
glands PND150. 
Female mammary 
glands PND135 
- 14-15 
P4 Wistar Mixture of pesticides  
 
Female and 
male WMs  
Female and male 
mammary glands 
PD50 
- 9-17 
P5 Wistar Amix, Emix 
paracetamol or 
TotalMix 
 
Female and 
male WMs  
Male and female 
mammary glands 
10 and 13 months 
old, respectively 
PD22, 50, 
13 months 
16-20 
A1 Sprague-
Dawley  and 
Danish and 
Swedish 
Wistar 
Control values from 
studies performed in 
papers 1-5 and historical 
studies 
Female and 
male WMs  
- - 7-17 
A2 Wistar Ethinyl estradiol, 
Bisphenol A, 
Epoxiconazole, Emix, 
Amix, TotalMix or 
paracetamol 
- - PD22, 
PD50, 
PD90 
6-20 
Emix: mixture of estrogenic chemicals, Amix: mixture of anti-androgenic chemicals, TotalMix: mixture of chemicals 
with various modes of action. PD: pup day. PND: post natal day. N: number of litters on PD1. 
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Table 3: Overview of chemicals and doses used in the studies performed in the papers and manuscripts 
included in the present thesis. 
Paper (P)/ 
Appendix (A) 
Chemical(s) Doses Exposure 
period 
Origin of chemicals 
P1 Ethinyl estradiol 0, 5, 15 and 50 
µg/kg bw/day 
GD7-PD22 Contraceptive pills 
P2 Ethinyl estradiol 0, 5, 15 and 50 
µg/kg bw/day 
GD7-PD22 Contraceptive pills 
P3 Genistein 213 mg/kg bw/day GD7-PND13 Soy products 
Phytoestrogens (SECO, 
daidzeine, genistein, equol, 
formononetin, biochanin, 
enterodiol, coumestrol, 
enterolactone, matairesinol, 
lariciresinol and pinoresinol) 
Mixture doses were 
high human dietary 
intake x1, x10, 
x100 
GD7-PND13 Soy, nuts and other plant 
products 
P4 Mixture of pesticides 
(epoxiconazole, mancozeb, 
prochloraz, tebuconazole and 
procymidone) 
Doses were 8.3%, 
17% or 25% of 
NOAEL, 
correspondding to 
14.6, 29.2 or 43.8 
mg/kg bw/day of 
the mixture 
GD7-PD16 Pesticides – fruits and 
vegetables 
P5 Amix: DBP, DEHP, 
vinclozolin, prochloraz, 
procymidone, linuron, 
epoxiconazole and p,p’-DDE 
Mixture ratios were 
based on “high 
human intake” 
estimates x200 and 
x450 
GD7-PD22 Plasticizer in wrapping 
and food containers (DBP 
and DEHP), pesticides 
(vinclozolin, prochloraz, 
procymidone, linuron and 
epoxiconazole) and 
pesticide metabolite (p,p’-
DDE) 
Emix: 4-MBC, OMC, 
Bisphenol A and butyl 
paraben 
Mixture ratios were 
based on “high 
human intake” 
estimates x200 and 
x450 
GD7-PD22 UV filters (4-MBC, 
OMC), polycarbonate 
plastics and epoxy resin 
(Bisphenol A), cosmetics 
(BP)  
Paracetamol Based on “high 
human intake” 
estimates. 360 
mg/kg bw/day 
GD13-19 
and  
PD1-22 
Analgesic and antipyretic 
medicine 
TotalMix: Amix + Emix + 
paracetamol) 
Mixture ratios were 
based on “high 
human intake” 
estimates x100, 
x200, x450 
GD7-PD22 As for Amix, Emix and 
paracetamol 
A1 Controls – no exposure - - - 
A2 Ethinyl estradiol (from P1 and 
P2) and Amix, Emix, 
TotalMix and paracetamol 
(from P5) 
As in P1, P2 and P5 GD7-PD22 As for P1, P2 and P5 
Bisphenol A 0.025, 0.25, 5, 50 
mg/kg bw/day 
GD7-PD22 Polycarbonate plastics and 
epoxy resin 
Epoxiconazole 15, 30 mg/kg 
bw/day 
GD7-GD17 Pesticide – fruits and 
vegetables 
SECO: secoisolarici resinol. DBP: di-n-butyl phthalate, DEHP: di-(2-ethylhexyl) phthalate, P,p’-DDE: pesticide 
metabolite. 4-MBC: 4-methyl-benzylidene camphor, OMC: Octyl methoxycinnamate. GD: gestation day, PD: pup day. 
PND: post natal day. NOAEL: no observed adverse effect level.  
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3.2. Methods applied for mammary gland examination 
Mammary glands in whole mounts and histological slides were examined for effects of different 
EDCs to study which parameters may be expected to be affected by EDCs.  
In the present studies, mammary glands were spread on glass slides and pressed with clamps and 
stained with alum carmine. In general, whole mounts of prepubertal glands were evaluated for 
ductal outgrowth, density and differentiation. The ductal outgrowth was evaluated by measuring the 
area covered by the mammary gland, longitudinal growth, transverse growth, distance to the lymph 
node and distance to the 5th gland (Figure 4). The longitudinal growth was defined as the longest 
distance covered by the gland in the longitudinal axis of the animal. The transverse growth was 
defined as the longest growth perpendicular to the longitudinal growth. The distance to the lymph 
node was defined as the shortest distance between the mammary gland and the lymph node. The 
distance to the 5th mammary gland was defined as the shortest distance between the 4th and the 5th 
mammary glands. An example of the measurement of the outgrowth parameters evaluated in the 
studies described in the present project can be found in figure 4. The density was given a score (1-5) 
according to the extension of branching and budding, with 5 being the most dense gland. The 
scoring scale was adjusted for gender, as male mammary glands generally are less developed 
compared to female mammary glands. The differentiation was evaluated by the number of TEBs.   
Adult female and male mammary glands were evaluated in H&E stained histological slides at 
different ages in post pubertal offspring. In general, female mammary glands were evaluated in a 
specific stage of the estrous cycle and were evaluated for the extent of lobular development. 
However, for the studies with phytoestrogens, genistein and the mixture of pesticides (papers 3 and 
4) females were sacrificed regardless of estrous cycle.  The evaluation of lobuloalveolar pattern was 
distinguishable from the normal lobular changes due to the estrous cycle and was evaluated 
although females were not in the same stage of the estrous cycle. Male mammary glands were 
evaluated for tubuloalveolar pattern, secretory activity (vacuolated epithelium and secretory 
material in ducts and alveoli) and hypertrophy of mammary epithelium and the presence of 
apocrine-like changes in most of the studies. 
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The measurements of whole mounts and female urethral slit lengths were performed by Karen 
Riiber Mandrup or by other persons under supervision of Karen Riiber Mandrup. Histological 
examination was performed by Karen Riiber Mandrup. 
 
 
3.3. Methods applied for female external genital malformation examination 
In the literature, various methods for evaluation of female external genital malformations have been 
described. Appendix 2 describes how several parameters were measured in female external genitals 
exposed to a potent estrogenic chemical, ethinyl estradiol, to evaluate the most useful and sensitive 
parameter for evaluation of female external genital malformations. In further studies on 
environmentally relevant EDCs, external genital malformations in female offspring were evaluated 
measuring only the urethral slit length. The external genitals were evaluated in female offspring 
exposed perinatally to a potent estrogenic chemical, ethinyl estradiol, single compounds of the 
environmentally relevant chemicals bisphenol A, epoxiconazole or paracetamol or mixtures of 
environmentally relevant chemicals with Emix, Amix or TotalMix. 
  
32 
 
4. Results 
 
In the following, an overview of the results and conclusions on whole mounts of mammary glands, 
histological slides of mammary glands and female genital malformations is described for each 
paper. Results from papers 1-5 are summarized in tables 4-8 according to the endpoints 
investigated. Results on whole mounts from PD21-22 are summarized in table 4 (females) and 5 
(males). Results from histology of adult mammary glands are summarized in table 6 (females) and 7 
(males). Results of female external genital malformations are summarized in table 8.  
Paper 1: The aim was to identify sensitive parameters to a potent estrogenic chemical, ethinyl 
estradiol, for analysis of mammary gland whole mounts PD21-22. Twelve different parameters 
were evaluated in the whole mounts, covering parameters for ductal outgrowth, density and 
differentiation. Changes were seen from 15 µg/kg in females: a decrease in the relative distance to 
the lymph node and the distance to the 5th gland and an increase in the density were observed. In 
males, the number of TEBs and the density were increased at 50 µg/kg. Together, these changes 
confirm that the estrogenic chemical increases the growth of mammary glands and progresses the 
development of female and male mammary glands before puberty. The parameters sensitive to 
exposure to ethinyl estradiol PD22 were the distance to the lymph node, the distance to the 5th gland 
and the density in females, and in males PD21 the density and the number of TEBs. 
Paper 2: The aim was to identify sensitive parameters to a potent estrogenic chemical, ethinyl 
estradiol, for analysis of mammary glands from adult offspring at PD50-55 and PD90 in 
histological H&E stained slides. Furthermore, the endpoint “female external genital malformations” 
was evaluated. No statistically significant changes were found in adult mammary glands, however, 
trends were observed in the same direction as effects reported in other studies. This lack of 
statistical significant changes may be due to a low power of scoring data and/or a shorter dosing 
period compared to other studies. An effect was, however, found on genital malformations in 
females. An increased prevalence of females had deep urethral slit length in the highest dose group 
(50 µg/kg) compared to controls PD50 and the urethral slit length was increased PD90 in the 
highest dose group.  
Paper 3: The aim was to study the endpoints in rat mammary glands in whole mounts of 
prepubertal female offspring and in histological slides of adult female and male offspring after 
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perinatal exposure to “high human intake” of estrogenic chemicals originating from plant products 
(phytoestrogens) (Table 3). Genistein and a mixture of phytoestrogens showed no effects on the 
parameters evaluated in female whole mounts (area, longitudinal growth, transverse growth, 
density). Adult mammary glands showed an increased prevalence of hypertrophy of mammary 
epithelium in males PND150 exposed to phytoestrogens or genistein compared to controls. This 
increase was statistically significant in the highest dose of phytoestrogens. Moreover, an increase in 
vacuolated mammary epithelium and in the presence of secretory material in alveoli was observed 
in males and may be a sign of feminisation of the mammary glands, although not statistically 
significant (p=0.06). Females PND135 showed an increase in the prevalence of animals showing a 
lobuloalveolar pattern, indicating a masculinisation of the mammary glands, however, this increase 
was not statistically significant.  
Paper 4: The aim was to study the endpoints in rat mammary glands in whole mounts of 
prepubertal offspring and histological slides of adult offspring after perinatal exposure to 
environmentally relevant anti-androgenic EDCs. A mixture of pesticides with suggested anti-
androgenic mode of action (Table 3) showed no effects on the parameters investigated in whole 
mounts PD22 (area, longitudinal growth, transverse growth, density and number of TEBs). 
Histological evaluation of male mammary glands showed an increased prevalence of mammary 
glands with secretory activity (increased secretory material in alveoli and vacuolated mammary 
epithelium), suggesting a feminisation of the male mammary glands. Lobuloalveolar morphology of 
adult female mammary glands was observed in the exposed groups, however, this change was not 
statistically significantly different from controls.  
Paper 5: The aim was to study the endpoints in whole mounts of prepubertal and histological slides 
of adult mammary glands of offspring exposed perinatally to three different mixtures of EDCs, 
Emix, Amix and TotalMix or to paracetamol (Table 3). A decrease in the distance to the lymph 
node was observed in females from the Emix and TotalMix groups. No effects were observed in 
offspring exposed to Amix or paracetamol. An effect on hypertrophy of male mammary epithelium 
may be present in the Emix group, however, a high prevalence was also seen in the control group 
and may be due to age-related changes and mask a possible dose-related effect. Females that had 
reached one year of age showed changes of extensive secretory activity and lobular development in 
the TotalMix group, suggesting an increased prevalence of prolactin producing pituitary tumors. 
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In the following, results for whole mounts of prepubertal mammary glands and histological 
evaluation of adult mammary glands, respectively, will be summarised, evaluating the results across 
papers 1-5 and appendix 1 and 2.   
 
 
4.1. Whole mounts of prepubertal mammary glands 
In whole mounts, female mammary glands PD22 were evaluated for ductal outgrowth (e.g. area, 
longitudinal growth, and distance to lymph node), density and differentiation (number of TEBs). 
Overall, estrogenic chemicals seemed to decrease the distance to the lymph node in females. Both 
the potent estrogen, ethinyl estradiol, the mixture of environmentally relevant estrogens (Emix) and 
the TotalMix (also containing estrogenic chemicals) affected the distance to the lymph node. It 
should be noted that the distance to the lymph node was not evaluated in offspring exposed to the 
mixture of phytoestrogens; and for ethinyl estradiol, the distance to the lymph node was evaluated 
as the growth towards the lymph node relative to the total distance between the nipple and the 
lymph node, but not as an absolute distance. Moreover, a decrease in the distance to the 5th gland in 
offspring exposed to ethinyl estradiol confirmed the observed increase in outgrowth in this study. 
Ethinyl estradiol – as the only chemical studied – also increased the density of the female mammary 
glands. Anti-androgens, however, did not affect the parameters evaluated in whole mounts of 
female prepubertal mammary glands. Yet, the distance to the lymph node was not evaluated for the 
mixture of pesticides. 
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Table 4. Summary of results from paper 1-5 on whole mounts from female offspring PD22 exposed to 
endocrine disrupting chemicals perinatally.  
PD22 females Area LG TG Distance 
to lnn 
Distance 
to 5th 
gland 
Density TEBs Paper 
Ethinyl 
estradiol 
5 µg/kg/day - - - - - - -  
1 15 µg/kg/day - - - ↓ ↓ ↑ - 
50 µg/kg/day - - - - ↓ - - 
Genistein 213 mg/kg/day - - -   -  3 
Phytoestrogens 1x - - -   -  3 
10x - - -   -  
100x - - -   -  
Emix 200x - - - ↓ - -  5 
450x - - - ↓ - - - 
Pesticides 14.6 mg/kg/day - - -   - - 4 
29.2 mg/kg/day - - -   - - 
43.8 mg/kg/day - - -   - - 
Amix 450x - - - - - - - 5 
TotalMix 450x - - - ↓# - - - 5 
Paracetamol 360 mg/kg/day - - - - - - - 5 
x: fold human intake. LG: longitudinal growth. TG: transverse growth. lnn: lymph nodes. TEBs: terminal end buds. 
Emix: mixture of estrogenic chemicals. Amix: mixture of anti-androgenic chemicals. TotalMix: mixture of estrogenic 
and anti-androgenic chemicals and paracetamol. Pesticides: mixture of pesticides with proposed anti-androgenic effects. 
Grey areas represent parameters not evaluated for the chemical. Arrows: statistically significant increase or decrease 
compared to controls. #: statistically significant decrease when two similar studies were pooled. -: no statistically 
significant changes. 
 
In male mammary glands, outgrowth was not affected by the EDCs studied. However, the density 
and the number of TEBs were increased by ethinyl estradiol. Thus, an increased branching and 
budding as well as a sign of increased proliferation were observed in male mammary glands after 
exposure to a potent estrogenic chemical. Overall, only ethinyl estradiol was able to affect male 
mammary glands in prepubertal whole mounts. 
 
  
36 
 
Table 5. Summary of results on whole mounts from male offspring PD22 exposed to endocrine disrupting 
chemicals perinatally.  
PD22 males Area LG TG Distance 
to lnn 
Distance 
to 5th 
gland 
Density TEBs Paper 
Ethinyl 
estradiol 
5µg/kg/day - - - -  - -  
1 15µg/kg/day - - - -  - - 
50µg/kg/day - - - -  ↑ ↑ 
Emix 200x - - - - - - - 5 
450x - - - - - - - 
Pesticides 14.6mg/kg/day - - -   - - 4 
29.2mg/kg/day - - -   - - 
43.8mg/kg/day - - -   - - 
Amix 450x - - - - - - - 5 
TotalMix 450x - - - - - - - 5 
Paracetamol 360 mg/kg/day - - - - - - - 5 
x: fold human intake. LG: longitudinal growth. TG: transverse growth. lnn: lymph nodes. TEBs: terminal end buds. 
Emix: mixture of estrogenic chemicals. Amix: mixture of anti-androgenic chemicals. TotalMix: mixture of estrogenic 
and anti-androgenic chemicals and paracetamol. Pesticides: mixture of pesticides with proposed anti-androgenic effects. 
Grey areas represent parameters not evaluated for the chemical. Arrows: statistically significant increase or decrease 
compared to controls. -: no statistically significant changes 
 
 
4.2. Rat strain differences in mammary whole mounts 
Results from control data on area, distance to the lymph node, density and number of TEBs in 
female and male mammary whole mounts are shown in appendix 1. Statistically significant 
differences in whole mount parameters were observed between strains but also between sub-strains 
and within the same sub-strain of Wistar rats. Control data from whole mounts of female and male 
mammary glands PD21-22 showed that Sprague-Dawley female rats have larger mammary glands 
compared to female Wistar rats. Wistar rats from different suppliers (different sub-strains) showed 
differences in the number of TEBs in females and males and in the mean density in males. 
Moreover, offspring from Wistar dams from the same sub-strain routinely used in our lab showed 
differences in area, density and number of TEBs.  
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4.3. Histology of adult mammary glands 
An overview of the results of histological examination of adult mammary glands is shown in table 6 
(females) and 7 (males). In females, no statistically significant changes were found. Lobuloalveolar 
pattern of the mammary glands is observed in rare cases. Such changes were only observed in 
exposed animals in the study with the mixture of pesticides and an increased prevalence was also 
seen after exposure to phytoestrogens. In those two studies only one control female showed 
lobuloalveolar pattern of the mammary glands. Moreover, enhanced lobular development was 
observed after perinatal exposure to ethinyl estradiol, a change not observed in the other studies. 
Lobule development is important for assessment of differentiation of the mammary glands. 
However, lobule development was not assessed for the studies with genistein, phytoestrogens and 
pesticides as females were killed at different stages of the estrous cycle in these studies. 
 
 
Table 6. Histological findings in adult female mammary glands.  
Study Lobuloalveolar pattern Lobules Estrous cycle n Paper 
Ethinyl estradiol PD90 - (↑) Diestrous 5-9 2 
Genistein PND135 -  Varying 11-13 3 
Phytoestrogens PND135 (↑)  Varying 11-15 3 
Emix 13 months old - - Estrous 11-16 5 
Amix 13 months old - - Estrous 13-16 5 
Pesticides PD50 (↑)  Varying 9-14 4 
Paracetamol 13 months old - - Estrous 13-16 5 
TotalMix 13 months old - -  Estrous 12-16 5 
n: number of animals examined. PD: pup day. PND: post natal day. Emix: mixture of estrogenic EDCs. Amix: mixture 
of anti-androgenic EDCs. TotalMix: mixture of Emix, Amix and paracetamol. Parameters not evaluated a specific study 
are marked with grey cells. ↑: statistically significantly increase compared to controls (p<0.05). (↑): changes described 
and discussed in papers 2-5, although not statistically significantly different from controls  
 
 
In males, an increased prevalence of hypertrophy was observed after exposure to estrogenic 
chemicals in offspring 90 days old or older. This was the only change observed in adult male 
mammary glands that was statistically significantly different from controls. In 10 months old males, 
a high prevalence of hypertrophic epithelium was present in controls. Secretory activity appeared to 
be increased by phytoestrogens and pesticides. Thus, both estrogenic and anti-androgenic chemicals 
may affect male mammary glands towards feminisation of the glands, although these changes are 
not consistent in all studies with estrogenic and anti-androgenic chemicals.  
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Table 7. Histological findings in adult male mammary glands.  
Study vacuoles secretion Hypertrophy Apocrine-like 
changes 
n Paper 
Ethinyl estradiol PD50 - - - - 5-8 2 
Ethinyl estradiol PD90 - - (↑) - 8-10 2 
Phytoestrogens PND150 (↑) (↑) ↑ (↑) 12-15 3 
Genistein PND 150 - - (↑) - 12-13 3 
Emix 10 months old - - - - 16 5 
Amix 10 months old - - - - 15-16 5 
Pesticides PND50 (↑) (↑)   6-9 4 
Paracetamol 10 months old - - - - 12-16 5 
TotalMix 10 months old - - - - 13-16 5 
n: number of animals examined. PD: pup day. PND: post natal day. Emix, Amix, TotalMix: as for table 6. Parameters 
not evaluated a specific study are marked with grey cells. ↑: statistically significantly increase compared to controls.  
(↑): changes described and discussed in papers 2-5, although not statistically significantly different from controls 
 
 
 
4.4. Female genital malformations 
As described in appendix 2, the urethral slit length was evaluated to be the most reliable parameter 
to investigate female external genital malformations after perinatal exposure to EDCs and this 
endpoint was sensitive in adult females PD90 exposed perinatally to a potent estrogen, ethinyl 
estradiol. The urethral slit length measured in offspring exposed perinatally to environmentally 
relevant chemicals showed no statistical significant changes. A summary of the results for urethral 
slit length from the present work is presented in table 8.  
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Table 8. Results on female external genital malformations.  
Chemical Doses PD22 PD50 PD90 PD400 
Ethinyl 
estradiol 
5 μg/kg/day - - -  
15 μg/kg/day - - -  
50 μg/kg/day - ↑ ↑  
Bisphenole A 0.025 mg/kg/day -  -  
0.25 mg/kg/day -  -  
5 mg/kg/day -  -  
50 mg/kg/day -  -  
Epoxiconazole 15 mg/kg/day -  -  
30 mg/kg/day -  -  
Emix 200x - -  - 
450x - -  - 
Amix 200x - -  - 
450x - -  - 
TotalMix 100x - -  - 
200x - -  - 
450x - -  - 
Paracetamol 360 mg/kg/day - -  - 
x: fold “high human intake”. Emix: mixture of estrogenic chemicals. Amix: mixture of anti-androgenic chemicals. 
TotalMix: mixture of estrogenic and anti-androgenic chemicals and paracetamol. Ages not evaluated for a specific 
exposure are marked with grey cells. ↑: Statistically significant increase in the urethral slit length (p<0.05).  
- : no statistically significant changes in the urethral slit length. 
 
 
4.5. Comparison with other EDC-sensitive endpoints  
Other endpoints than mammary glands and female genital malformations may be more sensitive to 
EDCs, and other endpoints were evaluated in several of the studies described in the present PhD 
thesis. The low observed effect level (LOEL) for known estrogen- or anti-androgen-sensitive 
endpoints were compared with the LOEL for the endpoints studied in the present project. 
 
Ano-genital distance (AGD) and nipple retention are endpoints known to be sensitive to anti-
androgenic chemicals. Nipple retention was increased in male offspring in the studies on anti-
androgenic pesticides, Amix and TotalMix [Christiansen et al. 2012; Hass et al. 2012]. Mammary 
gland effects of these mixtures were found in prepubertal females showing a decreased distance to 
the lymph node in the highest TotalMix dose. However, this effect was observed at a higher dose 
(TotalMix-450, i.e. 450 fold human exposure) than nipple retention (TotalMix-150, i.e. 150 fold 
human exposure) and the mammary gland effect may be contributable to the estrogenic chemicals 
in the mixture. Female genital malformations were evaluated for Amix and TotalMix, but no 
40 
 
changes were found. Thus, nipple retention was the most sensitive endpoint in the studies 
investigating the effects of anti-androgenic chemicals (Table 9). 
 
Estrogen-sensitive female endpoints like sexual maturation and regularity of the estrous cycle were 
also evaluated. No statistically significantly effects of ethinyl estradiol, genistein, phytoestrogens or 
mixture of pesticides were found on these endpoints (papers 2, 3 and 4). Statistically significant 
effects on mammary glands were observed in offspring exposed to ethinyl estradiol or 
phytoestrogens. Female genital malformations were observed in the study with ethinyl estradiol. 
Thus, mammary glands and female genital malformations are female endpoints that appear to be 
affected by estrogenic chemicals and detect statistically significant effects when traditional female 
endpoints do not, although the number of animals studied was similar for all endpoints across a 
study.  
The estrogenic chemicals ethinyl estradiol, genistein and the phytoestrogen mixture also showed 
effects on AGD in the highest dose-groups (papers 2, 3 and Christiansen et al., 2012). Data on 
nipple retention were present for ethinyl estradiol, only, and showed an increased number of nipples 
in females in the highest dose-group. However, mammary effects were observed at lower dose-
levels than effects in AGD and nipple retention (Table 9). Mammary whole mounts showed 
increased outgrowth of female mammary glands defined by a decrease in the distance to the lymph 
node and distance to the 5th gland at 15 µg/kg ethinyl estradiol and a decreased distance to the 
lymph node at Emix-200. The distance to the lymph node and the distance to the 5th gland were not 
evaluated in the study with phytoestrogens and genistein. However, in that study, female mammary 
glands showed increased lobuloalveolar morphology in all phytoestrogen dose-groups, although not 
statistically significant. Moreover, hypertrophy of male mammary glands and female genital 
malformations were observed at the same dose levels as AGD and nipple retention in the study on 
phytoestrogens and ethinyl estradiol, respectively. Thus, outgrowth parameters, such as the distance 
to the lymph node, measured in mammary whole mounts in female offspring PD22 appears to 
detect effects of estrogenic chemicals at lower levels than AGD and nipple retention. However, 
AGD and nipple retention are more sensitive to anti-androgens than female genital malformations 
evaluated by the urethral slit length and mammary gland endpoints in whole mounts and 
histological examination. 
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Table 9. Statistical significant low observed effect level (LOEL) observed for each of the endocrine-
sensitive endpoints mammary whole mounts, mammary histology, ano-genital distance index (AGDi) and 
nipple retention (NR) in the studies investigated in the present PhD thesis.  
 Mammary whole 
mounts 
Mammary histology Female genital 
malformations 
AGDi or NR 
Ethinyl 
estradiol 
15µg/kg: female 
distance to lnn, distance 
to 5th gland, density. 
50µg/kg: male density 
and number of TEBs. 
- 50µg/kg PD50 and 
PD90 
50µg/kg: AGDi and 
number of nipples 
increased in females 
Genistein - 
(distance to lnn not 
determined) 
-  AGDi decreased in 
males.  
(NR not determined)   
Phyto-
estrogens 
- 
(distance to lnn not 
determined) 
x100: Hypertrophy in 
males.  
 x100: AGDi 
decreased in males. 
(NR not determined) 
Emix x200: distance to lnn 
decreased in females 
- - - 
Pesticides - -  14.6 mg/kg: NR 
increased in males 
29.2 mg/kg: AGDi 
increased in females 
(1) 
Amix - - - x450: NR increased 
in males (2) 
TotalMix TotalMix-450: distance 
to lnn decreased in 
females 
- - x150: NR increased 
in males (2) 
x: fold high human intake estimates. lnn: lymph nodes. TEBs: terminal end buds. Emix: mixture of estrogenic 
chemicals. Amix: mixture of anti-androgenic chemicals. TotalMix: mixture of endocrine disrupting chemicals with 
dissimilar modes of action. Endpoints not determined for a specific exposure are marked with grey cells. The lowest 
dose with an observed effect (LOEL) for the compound or mixture is marked in bold red. 1: [Hass et al. 2012], 2: 
[Christiansen et al. 2012]. -: no statistically significant effects observed. 
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5. Discussion 
 
Environmental EDCs were found to affect mammary gland development in female and male rats, 
with effects also detectable in adulthood. This stresses the possible influence of environmental 
chemicals on breast development in humans. In contrast, only a model compound, ethinyl estradiol, 
showed effects on female external genitals.  
 
 
5.1. Effects of EDCs on mammary gland whole mounts 
Investigation of mammary gland effects may be conducted in whole mounts or histological slides, 
in females or males, before or after puberty, in mice or rats. Mammary gland morphology has been 
widely studied at different ages in whole mounts from mice [Hilakivi-Clarke et al. 1997; Thomsen 
et al. 2006], Sprague-Dawley rats [Cotroneo et al. 2002; Fritz et al. 1998] and Long Evans rats 
[Hovey et al. 2010; Moon et al. 2007]. However, studies on whole mounts in Wistar rats are sparse, 
although Wistar rats are commonly used in toxicological studies. As reviewed by Rudmann et al. 
(2012), differences in susceptibility to neoplastic lesions are common between strains of rats 
[Rudmann et al. 2012]. Thus, differences may be expected between strains in the morphology of 
mammary glands and is important to investigate if mammary glands should be included in standard 
toxicological studies. In the present studies, differences between strains and sub-strains were 
present in prepubertal mammary gland morphology. However, effects of EDCs are detectable in 
mammary glands of rats in all strains investigated. 
In the present studies, female mammary glands were affected by estrogenic chemicals, leading to 
increased density and increased outgrowth (decreased distance to the lymph node and for ethinyl 
estradiol a decreased distance to the 5th gland), although changes in outgrowth were not detectable 
in the measurement of area, longitudinal growth or transverse growth. This is in accordance with 
previous studies showing altered mammary gland development after perinatal exposure to 
estrogenic chemicals. Increased outgrowth (increased area) [Murrill et al. 1996] and an increased 
number of TEBs [Cotroneo et al. 2002] were shown in prepubertal female rat offspring exposed to 
genistein postnatally. However, other studies with perinatal or postnatal exposure to estrogenic 
chemicals have not shown statistically significant effects in whole mounts of female prepubertal 
43 
 
rats or mice [Cabanes et al. 2004; Muñoz-de-Toro et al. 2005; You et al. 2002]. Thus, findings on 
estrogenic compounds are not consistent among studies. This may be due to the different 
parameters investigated and the different methods used to examine the parameters in whole mounts. 
Moreover, it may be due to the chemicals studied. A difference in potency of the compounds may 
be present and EDCs classified as estrogenic may also have other modes of action influencing the 
changes observed in mammary glands. 
Few studies have investigated the effects of estrogenic chemicals in prepubertal male mammary 
glands, and male mammary glands have been reported to be more sensitive to EDCs compared to 
females [You et al. 2002]. You et al. (2002) showed statistically significant effects of genistein in 
whole mounts of male mammary glands PD22 and no effects in females [You et al. 2002]. In the 
studies performed in this PhD project, an increase in the density and the number of TEBs was found 
in male offspring after exposure to ethinyl estradiol but not to other estrogenic compounds. The 
increased density reflects an increase branching and budding of the glands and this finding is thus in 
accordance with the findings reported by You et al.. The number of TEBs was not changed in 
females and it was hypothesized that the number of TEBs in males may be more sensitive to 
estrogenic chemicals compared to females.  
One study only could be found describing the effects of developmental exposure to an anti-
androgenic chemical on the whole mounted mammary glands of pubertal rats. Saad et al. (2011) 
observed increased branching in whole mounts of pubertal (post natal day 35) female mammary 
glands following perinatal exposure to 1 mg/kg/day of the anti-androgenic pesticide vinclozolin 
[Saad et al. 2011]. No changes in outgrowth were reported in other studies investigating the effects 
of anti-androgens on whole mounts of pubertal mouse mammary glands [Peters et al. 2011; Skarda 
2003]. In female mice, peripubertal exposure (week 5-12) to the anti-androgenic medicament 
flutamide did not show effects on ductal growth or branching [Peters et al. 2011]. In male mice, 
prepubertal exposure to the anti-androgenic medicaments flutamide, bicalutamide (Casodex) or 
chlormadinone acetate did not show effects on the area of the mammary glands [Skarda 2003]. In 
accordance with these findings, no change in outgrowth was observed in either male or female 
offspring PD22 exposed perinatally to anti-androgenic chemical mixtures (paper 4 and 5). The 
density was not changed with exposure, reflecting no observed effects on branching and budding 
PD22. The increased branching observed by Saad et al. (2011) may be explained by the higher dose 
or other modes of action of the chemical studied. Collectively, it appears that perinatal exposure to 
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anti-androgens does not affect mammary gland morphology prepubertally. However, anti-
androgens may possibly cause other changes in mammary glands prepubertally, and morphological 
changes may be observable later in life as discussed later. 
In prepubertal mammary glands of Wistar rats, no parameters appeared affected by anti-androgens, 
yet some parameters were identified to be sensitive to estrogenic chemicals. In females, the density 
of the female mammary glands was increased by ethinyl estradiol, indicating an increased 
branching and budding of the mammary gland. However, this effect was not found with other EDCs 
studied in this PhD project. This may be due to the potency of ethinyl estradiol compared to the 
EDCs studied. The distance to the lymph node and the distance to the 5th gland were outgrowth 
parameters that appeared sensitive to estrogenic chemicals although the area was not changed by 
exposure. The distance to the lymph node was decreased by ethinyl estradiol and Emix, whereas the 
distance to the 5th gland was only decreased by ethinyl estradiol. Thus, the distance to the lymph 
node appeared to be more sensitive to environmentally relevant estrogenic compounds compared to 
the distance to the 5th gland and area measurements. Vandenberg et al. (2007) showed that 
outgrowth parameters in mice may be influenced by the position of the foetus in utero. The gender 
of the sibling lying next to the offspring examined appears to affect branching, area and ductal 
elongation [Vandenberg et al. 2007]. A female offspring positioned between two females had less 
developed mammary glands (smaller area, ductal extension and fewer TEBs) compared to females 
positioned between two males [Vandenberg et al. 2007]. This may lead to a large variation in these 
parameters and thus a low power. A large variation in the area may explain why changes were not 
observed for this parameter when changes were seen in the distance to the lymph node. The same 
parameter – distance to the lymph node – was statistically significantly decreased in several groups 
of females exposed to estrogenic compounds: 50 µg/kg ethinyl estradiol, Emix-200 and Emix-450. 
Thus, the decrease in the distance to the lymph node may not be a Type I error (false positive effect 
due to ) but may be a change due to exposure to estrogenic compounds. The decrease in this 
parameter indicates an increased growth of the female mammary glands towards the lymph nodes. 
Evaluation of whole mounts revealed that mammary glands in general grow primarily towards the 
lymph nodes (Figure 6) and ducts furthest away from the lymph nodes are poorly developed. Other 
parameters evaluated did not specifically determine the growth towards the lymph nodes and this 
may explain why other parameters like the transverse growth and area did not show significant 
changes, although the distance to the lymph node was significantly decreased. The ductal 
elongation from the nipple towards the lymph node may be possible to measure instead of the 
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distance between the edge of the mammary gland and the lymph node and may also be a parameter 
sensitive to estrogenic chemicals. However, this would decrease the number of measurements 
possible to perform, as the nipple is not always present in whole mounts and thus the power of the 
parameter would decrease. The positioning and size of the lymph nodes may differ between 
individuals and may influence the parameter. Knowledge on this aspect is necessary to investigate 
to determine the relevance of a changed distance to the lymph node. The sensitivity of the distance 
to the lymph node to estrogenic chemicals needs to be further investigated.
 
 
 
 
 
 
 
 
 
 
Figure 6. Growth of ducts in prepubertal 
female mammary glands. Mammary gland 
whole mount from a 22 days old control female 
rat. Ducts appear to grow primarily towards the 
lymph nodes (Ln) (a single duct is marked in 
black). Ducts furthest away from the lymph nodes 
are poorly developed (a single duct marked in 
white).  
Npl: nipple.   
 
In males, the density and the number of TEBs PD21 were parameters sensitive to the potent 
estrogenic chemical, ethinyl estradiol. The findings indicated a feminisation of the male mammary 
gland through an increased growth determined by an increased branching and budding of the gland, 
and an increased growth potential (TEBs) with an increased risk of development of mammary 
cancer. These changes were seen at 50 µg/kg, whereas changes in female whole mounts were 
observed from 15 µg/kg. Moreover, effects seen in males exposed to ethinyl estradiol were not 
found for other estrogenic EDCs studied. Thus female mammary glands appear to be more sensitive 
to estrogenic chemicals than male mammary glands when evaluating mammary glands in whole 
mounts. This is in contrast to histological examination of mammary glands as will be discussed 
later. 
46 
 
Overall, developmental exposure to estrogenic but not anti-androgenic chemicals appeared to have 
effects on the outgrowth and density in female mammary glands and on the density and number of 
TEBs in male mammary glands prepubertally. Evaluation of prepubertal mammary glands whole 
mount from pups exposed perinatally to potential EDCs should include the distance to the lymph 
node, the distance to the 5th gland and the density in females and the density and the number of 
TEBs in males. Further insights into effects on mammary glands of compounds with other modes of 
action are needed. 
 
 
5.2. Strain differences in mammary gland whole mounts 
As shown in appendix 1, difference in mammary gland morphology was present between Wistar 
sub-strains from different suppliers and between strains (Wistar and Sprague-Dawley) and care 
should be taken in comparing crude numbers between studies using different strains or sub-strains. 
However, a difference in control values between sub-strains and strains of rats may not indicate a 
lower sensitivity of the endpoint. Other endpoints in rats are known to differ in control values 
between strains but are sensitive endpoints used in toxicological studies, e.g., litter size and body 
weight. In mammary glands, it is well known that some strains are more prone to develop mammary 
tumors than other strains as reviewed by Rudmann et al. (2012) [Rudmann et al. 2012]. For 
toxicological studies it is important to be aware of such differences. Mammary glands may be 
sensitive to endocrine disruption even though differences between strains and sub-strains exist. 
Although no effects were observed in prepubertal mammary glands of Sprague-Dawley rats 
exposed to phytoestrogens (paper 3), other studies with Sprague-Dawley rats have shown effects of 
EDCs in whole mounts around PD22. Several studies have shown statistically significant more 
TEBs in 21 days old females exposed postnatally to estrogenic compounds like bisphenol A, 
genistein, estradiol benzoate or flaxseed [Cotroneo et al. 2002; Moral et al. 2008; Tan et al. 2004]. 
Additionally, effects of EDCs on mammary gland morphology have been reported in Long Evans 
rats. Atrazine, an anti-androgenic compound, was shown to delay the migration to the lymph node 
and fewer primary branches were observed in mammary glands of 22 days old female offspring 
[Moon et al. 2007]. Wistar offspring have also been shown to be sensitive to EDCs. Ethinyl 
estradiol increased the density in females and males, decreased the distance to the lymph node in 
females and increased the number of TEBs in males (paper 1). Moreover, a decreased distance to 
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the lymph node was found in females exposed to a mixture of environmentally relevant estrogenic 
chemicals (Emix) (paper 5). Overall, the migration to the lymph node, density and number of TEBs 
are parameters that have been shown to be affected by EDCs. To my knowledge, a difference in 
sensitivity of whole mount examination between strains and sub-strains has not been investigated in 
the literature, and further studies may elaborate on this point.  
 
 
5.3. EDC effects on mammary gland histology 
In the present studies, changes in adult mammary glands were observed in offspring exposed to 
estrogenic chemicals. Adult females exposed to ethinyl estradiol showed increased lobular 
hyperplasia compared to controls and the mixture of phytoestrogens increased the prevalence of 
lobuloalveolar pattern. In adult males exposed to the estrogenic chemicals ethinyl estradiol, 
phytoestrogens or genistein, an increase in the prevalence of animals with hypertrophic mammary 
epithelium was observed in the present studies. These findings are in accordance with the findings 
reported by others [Delclos et al. 2001; Masutomi et al. 2004; Takagi et al. 2004]. Moreover, signs 
of increased secretory activity were seen in males. Secretory vacuoles and dilated ducts have also 
been reported in adult male mammary glands exposed to estrogenic chemicals [Biegel et al. 1998; 
Latendresse et al. 2009]. Secretory activity is a feature specific for female mammary glands, and 
may reflect a feminisation of the gland. Estrogenic feminisation of male mammary glands showing 
increased tubuloalveolar pattern has been reported previously for ethinyl estradiol and 17β-estradiol 
[Andrews et al. 2002; Biegel et al. 1998]. Tubuloalveolar morphology is the typical morphology in 
female mammary glands and the appearance of tubuloalveolar morphology in males is also 
perceived as a sign of feminisation of the male mammary glands.  
Developmental exposure to a mixture of anti-androgenic pesticides (paper 4) also showed signs of 
increased secretory activity of adult male mammary glands. However, no changes were observed in 
the adult mammary glands in the study investigating the effects of environmentally relevant anti-
androgens of various origins (Amix) (paper 5). Adult female offspring exposed to the mixture of 
anti-androgenic pesticides showed lobuloalveolar pattern in 3 exposed animals compared to none in 
the control group (paper 4). Although few animals showed such changes they may be exposure-
related as discussed later. To my knowledge, only one study has investigated the effects of an anti-
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androgenic chemical on the histology of adult mammary glands. Lee et al. (2004) observed 
increased incidence of vacuolar degeneration in alveolar cells and alveolar atrophy in the mammary 
glands of adult males (PD50) exposed perinatally to the anti-androgenic chemical di-n-butyl 
phthalate [Lee et al. 2004]. Thus, it can be hypothesized that anti-androgens affect adult male 
mammary glands. Androgens contribute to male differentiation of mammary glands to a 
lobuloalveolar pattern and it may be hypothesized that perinatal exposure to anti-androgens changes 
the responsiveness of male mammary glands to androgens later in life. Changes observed in females 
exposed to pesticides were similar to changes observed in females exposed to phytoestrogens and 
may be due to other modes of action of the chemicals.  
Most of the changes described in the present studies were not statistically significant. The only 
histological finding that was statistically significantly changed compared to controls was the 
increase in hypertrophy in male mammary glands in the study with phytoestrogens (paper 3). 
However, other changes may be related to exposure, although not statistically significant. 
Lobuloalveolar pattern of the female mammary gland PD90 and 135 is a rare finding in control 
animals. Only one control female among 33 control females examined before the age of 1 year 
showed a lobuloalveolar pattern in the present studies. In the study with phytoestrogens, 
lobuloalveolar pattern was observed in 11 of the exposed females. Such findings in exposed groups 
may be an important sign of change due to exposure, although not statistically significant. In 
general, histological evaluation has low power compared to quantitative data, as the data from such 
analyses are scoring data or dichotomous in nature [OECD 2010a]. Low power of histological 
scoring data calls for a large number of animals to detect statistical significant changes. The small 
number of animals studied in some of the present papers, may thus be responsible for the lack of 
significant effects and trends in histological findings investigated.  
None of the changes observed were possible to determine as attributable to a specific group of 
chemicals with similar modes of action. EDCs often have combined modes of action and the EDCs 
studied do not have purely estrogenic or purely anti-androgenic modes of action. The differences in 
effects observed may be explained by the different properties of the compounds studied, but also by 
a difference in age at evaluation of the mammary glands. In the study with mixtures of 
environmentally relevant chemicals (paper 5), mammary glands were evaluated approximately at 
PD300 (males 10 months old) and PND400 (females 13 months old). Around this age some control 
female rats are beginning to achieve reproductive senescence and pituitary tumors arise 
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spontaneously in some rats. As a result, evaluation of female mammary glands at this age may show 
various changes reflecting changes either related to hormonal changes due to reproductive 
senescence or pituitary tumors. Such changes may mask changes related to exposure. Examination 
of exposure-related morphological changes in female rat mammary glands should thus preferably be 
evaluated before age-related changes occur in controls. However, other changes, e.g., neoplastic 
transformation and tumors, may be relevant to study after reproductive senescence. Age is also an 
important consideration to keep in mind for examination of male mammary glands, in which 
differentiation and maturation occurs after sexual maturation. In the present studies, a change in 
hypertrophy of the epithelial cells was only apparent in male mammary glands PD 90 and 150 
(paper 2 and 3). However, in 10 months old males, the prevalence of males with hypertrophic 
epithelium in offspring exposed to the estrogenic chemicals (Emix) was at the same level (81%) as 
in the younger males (88% of males PD90 exposed to ethinyl estradiol and 80% of males PD150 
exposed to phytoestrogens), but with a higher control-level of hypertrophy (60%) at 10 months of 
age. Thus, 10 months old males may demonstrate the same morphology as young males exposed to 
estrogenic chemicals. However, in 10 months old males hypertrophic mammary epithelium was 
more common in controls (paper 5) and a change in exposed animals compared to controls was not 
detectable. Hypertrophy may be a change naturally occurring with age in male mammary 
epithelium. Estrogenic chemicals may accelerate this change. It is encouraged to evaluate female 
and male mammary glands before signs of aging appear in controls, but the exact age when signs of 
aging show up in controls, has not been determined. Moreover, in accordance with findings 
reported by others [Ahren and Etienne 1957; Sourla et al. 1998], male mammary glands PD50 had 
not yet fully differentiated to lobuloalveolar pattern in the present studies. Changes like 
feminisation of the male mammary glands reflected by tubuloalveolar morphology or secretory 
activity is more evident in males where male differentiation has occurred and the typical male 
mammary architecture is present. Rat mammary glands are preferably evaluated after gender-
specific differentiation and before signs of aging has occurred.  
Overall, perinatal exposure to EDCs affects mammary gland development in female and male 
offspring and changes are observable histologically in adults. Female mammary glands may show 
changes in lobuloalveolar pattern and lobular hyperplasia. Male mammary glands may show 
changes in hypertrophy of mammary epithelium and signs of feminisation, such as secretory 
activity or tubuloalveolar morphology. Trends in histological changes are important to investigate 
for parameters like the lobuloalveolar pattern that seldom appear in controls. Rat mammary glands 
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should be evaluated after sex-specific morphological differentiation has occurred and before age-
related changes may occur. Strain differences may also be present in the timing of maturation of 
mammary glands. According to the present studies, Wistar rats should in general be evaluated 
around PD90, but further studies are necessary to determine the best time-points for Wistar rats as 
well as for other stains. Other mammary changes such as neoplastic transformation and tumors may 
be relevant to study in older rats. 
  
 
5.4. Sensitivity of mammary gland endpoints 
In the present project, mammary glands were examined in prepubertal and sexually mature female 
and male rats. Evaluation of whole mounts of prepubertal mammary glands can show effects on 
outgrowth and differentiation before puberty and give a good overview of the gland in toto. In 
contrast, histological evaluation of adult mammary glands can show epithelial changes as well as 
differentiation of the gland. Estrogenic chemicals have been shown to affect both prepubertal and 
adult mammary glands. The present study on ethinyl estradiol (paper 1 and 2) showed statistically 
significant effects in whole mounts of prepubertal mammary glands and no statistically significant 
effects in adult mammary glands. In accordance, two papers reported results in mammary glands of 
male offspring exposed prepubertally to genistein. In those studies, statistically significant effects 
were found in parameters evaluated in whole mounts whereas no statistical results were reported for 
the histological changes observed [Wang et al. 2006; You et al. 2002]. Evaluation of prepubertal 
mammary glands in whole mounts appeared more sensitive to detect statistically significant effects 
of developmental exposure to estrogenic chemicals compared to the evaluation of histological 
sections of adult mammary glands. Only trends to dose-dependent histological changes were shown 
in histological examination of the adult glands. In contrast, the study on phytoestrogens (paper 3) 
showed statistically significant changes in histology of adult male mammary glands, yet, no 
changes were observed in the mammary whole mounts of prepubertal offspring. Thus, histological 
examination of adult male mammary glands appeared more sensitive to detect changes from 
phytoestrogens than evaluating whole mounts prepubertally. This difference in detectability of 
effects of estrogenic chemicals may be due to different properties of chemicals. As noted, 
statistically significant effects may in general be more easily detected in whole mounts compared to 
histological evaluation of the mammary glands due to low power of histological data. However, 
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changes that are not statistically significant should not be ignored and quantitative methods for 
histological examination could be useful.  
 
Gender-specific differences in sensitivity were observed in prepubertal as well as adult mammary 
glands. Morphological analysis of whole mounts of prepubertal mammary glands in the study on 
ethinyl estradiol (paper 1) showed a statistically significant increase in the number of TEBs PD21 in 
male mammary glands at 50µg/kg. No effect in the number of TEBs in females was observed, 
suggesting that the number of TEBs is a parameter more sensitive to estrogenic chemicals in male 
mammary glands than in females. In accordance with these findings, You et al. (2002) showed more 
marked effects in branching in whole mounts of 22 days old male mammary glands than in females 
[You et al. 2002]. However, in the present study, female mammary gland whole mounts showed a 
statistically significant change in outgrowth not seen in males. A decrease in the distance to the 5th 
gland was seen at 15µg/kg in offspring exposed to ethinyl estradiol and the distance to the lymph 
node was decreased in female offspring exposed to ethinyl estradiol or the Emix (paper 1 and 5). 
However, the distance to the 5th gland was not changed in females in other studies with estrogenic 
compounds and the decrease found in the study with ethinyl estradiol may be a chance finding. 
Nevertheless, the outgrowth (distance to the lymph node) appeared more sensitive in females than 
in males and may be a parameter more sensitive than the number of TEBs to estrogenic chemicals. 
However, it should be noted that the distance to the 5th gland was not possible to measure in males 
and it is not known whether female and male mammary glands differ in sensitivity regarding this 
endpoint. 
In histological examination of adult mammary glands, a more marked effect was observed in male 
mammary glands as compared to females. In the study with phytoestrogens (paper 3), male 
mammary histology showed statistically significant changes in the highest mixture dose-group 
whereas no statistically significant changes were observed in female mammary histology in adult 
offspring. Other studies have shown a similar difference between male and female mammary gland 
sensitivity to exposure to EDCs. In studies with perinatal exposure to genistein, histopathological 
examination of mammary glands showed hyperplasia in male mammary glands at a lower dose than 
changes observed in female mammary glands [Delclos et al. 2001]. Similarly, other studies on 
genistein or ethinyl estradiol showed hyperplasia of male mammary glands when no histological 
changes were reported in females [Andrews et al. 2002; Wang et al. 2006]. This may point to a 
higher sensitivity of male than female mammary glands. Males are known to have lower levels of 
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estrogen compared to females and male mammary glands may thus be more sensitive to small 
changes in the estrogen levels, e.g., caused by low levels of estrogenic EDCs. 
Collectively, this may indicate that male mammary glands are more sensitive to EDCs than female 
mammary glands in respect to the development of TEBs and histological changes, whereas female 
outgrowth of prepubertal mammary glands is more sensitive to estrogenic compounds compared to 
male outgrowth. In the case of the study with phytoestrogens, a lower NOAEL for mammary gland 
effects was seen when not only female, but also male mammary glands were evaluated. Thus, it is 
important to include evaluation of male mammary glands in addition to females, as also reflected in 
recent updates of OECD guidelines for reproductive toxicity [OECD 2010b].  
 
Overall, histological examination of mammary glands may show changes that should not be 
neglected, although not statistically significant. Moreover, male mammary glands appear sensitive 
to EDCs and should be included in the investigation of effects of EDCs in vivo. 
 
 
5.5. Female external genital malformations 
As described in appendix 2, several methods for evaluation of female external genital 
malformations were investigated in a study with ethinyl estradiol. The distance to the vaginal 
opening was technically difficult to assess. Thus, the urethral-vaginal distance and the relative 
urethral slit length were not reliable measurements unless the person performing the measurement is 
well trained and experienced in the procedure. The urethral slit length and the evaluation of the 
presence of a clefted genital papilla were sensitive measurements that were the most reliable.  
Two studies by Sawaki et al. (2003a and b) showed an increased urethral slit length in adult female 
offspring exposed perinatally to 50 µg/kg ethinyl estradiol. Accordingly, the present study showed 
increased urethral slit length in females PD90 exposed to 50 µg/kg ethinyl estradiol. However, 
offspring PD22 and 50 did not show changes in the urethral slit length, suggesting that changes in 
the urethral slit length are not as marked in young animals. This is in contrast to Flaws et al. (1997) 
reporting macroscopically visible clefts at the time of vaginal opening (PND28-40) [Flaws et al. 
1997]. This may be due to a difference in the compound studied. Flaws et al. (1997) investigated the 
effects of 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD), an endocrine disrupting compound with 
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other modes of action, and may be more potent than ethinyl estradiol on influencing the 
development of female external genitals [Heiden et al. 2008]. 
Effects on female genital malformations have been reported for different compounds, such as 
TCDD, ethinyl estradiol, tamoxifen and testosterone propionate, with various endocrine disrupting 
modes of action, suggesting effects of a wide range of EDCs on female external genitals [Flaws et 
al. 1997; Gray et al. 1997; Gray and Ostby 1995; Wolf et al. 1999a; Wolf et al. 2002; Yamasaki et 
al. 2005]. However, in the present studies on environmentally relevant EDCs, no changes in the 
urethral slit length were shown. No genital malformations in females exposed perinatally to the 
Emix were observed, although changes were seen in females exposed to the potent estrogenic 
compound, ethinyl estradiol. This may be due to a difference of potency and the dose level of Emix 
selected.  
 
 
5.6. Human relevance of EDC effects on mammary glands and female 
external genitals 
Estrogenic compounds were shown to increase outgrowth of rat mammary glands, suggesting an 
early breast development in girls exposed to estrogenic chemicals during foetal development and 
the lactation period. As noted, precocious puberty and breast development may increase the risk for 
breast cancer later in life [Pike et al. 1981]. Thus, perinatal exposure to EDCs with estrogenic mode 
of action may indirectly lead to breast cancer in women. It should be noted that dose-levels used in 
some of the studies are very different from human exposures. High doses were used in the studies 
on ethinyl estradiol and pesticides (papers 1, 2 and 4), whereas the studies on phytoestrogens and 
contaminants (papers 3 and 5) used doses with a lower safety margin. Further risk assessment is 
required for further determination of human risk, but this is out of scope of this thesis.  
Developmental exposure to EDCs led to feminisation and hypertrophy of male adult mammary 
glands. Other studies have shown feminisation of sexually mature male mammary glands by EDCs 
[Andrews et al. 2002; Biegel et al. 1998]. Such changes may suggest development of gynecomastia 
in men after puberty. However, this relation is yet to be verified.  
An increased number of TEBs in male mammary glands and female genital malformations were 
observed in offspring exposed to a potent estrogen, but not in other studies with environmentally 
relevant EDCs. These changes may suggest an increase in the risk for mammary cancer and a 
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disturbed development of the external genitals in females by potent estrogens. Human exposure to 
the mixtures of EDCs in the environment does not appear to be at levels with risk for such changes. 
 
 
5.7. Regulatory relevance  
Mammary gland development and genital malformations in female rats were investigated to 
determine if these female endpoints were affected by the selected EDCs. The endpoints were 
evaluated to determine if they were able to detect effects of EDCs.  
 
As described in section 4.5, AGD and nipple retention were endpoints more sensitive to anti-
androgens than female genital malformations evaluated by the urethral slit length and mammary 
gland endpoints in whole mounts and histological examination. However, prepubertal female 
mammary glands detected effects at lower levels of perinatal exposure to estrogenic chemicals than 
other endpoints sensitive to EDCs. The distance to the lymph node measured in mammary whole 
mounts in female offspring PD22 detected effects when other estrogen-sensitive endpoints, such as 
sexual maturation and irregularity of estrous cycles, did not. Moreover, the distance to the lymph 
node was affected by estrogenic chemicals at lower levels than AGD and nipple retention.  
Male mammary glands also showed effects of estrogenic chemicals. The number of TEBs PD21 
and hypertrophy of the mammary epithelium were affected in adult male rats (Table 9), effects not 
detected in female rats. These effects may reflect changes of importance for the risk for mammary 
cancer or possibly gynecomastia in men. However, the observed effects may also be relevant for 
female mammary glands, but appeared to be more sensitive parameters in male rat mammary glands 
compared to female rats.  
 
Histological examination of adult but not prepubertal mammary glands is included in the extended 
one-generation studies [OECD 2010b]. This type of study is used for approval of pesticides and 
biocides in the European Union, but not for other types of chemicals. The two-generation study is 
the reproductive study used for other chemicals and mammary gland examination is not included in 
this study [OECD 2001]. Thus, only pesticides and biocides are investigated for mammary gland 
effects.  
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Inclusion of prepubertal female and male rat mammary glands in toxicological studies is important 
as effects of EDCs may go undetected if only adult rat mammary glands are studied. Some features 
of prepubertal rats make examination of such mammary glands easier compared to histological 
examination of adult mammary glands, and evaluation of male mammary whole mounts is 
somewhat easier than the evaluation of female mammary glands. In adults, evaluation of mammary 
glands of females is dependent on estrous cycle for some parameters [Schedin et al. 2000]. The lack 
of an estrous cycle in prepubertal females facilitates the timing of necropsy and the evaluation of 
the gland. Male mammary glands are less developed than female mammary glands and have fewer 
TEBs than females. Thus, counting of TEBs PD21 may be faster in male mammary glands 
compared to females.  
 
Adverse effects of chemicals on mammary glands may be overlooked and estrogenic effects 
detectable in mammary glands may not be observed when prepubertal and adult mammary glands 
are not investigated in the guideline studies.   
 
 
5.8. Further studies 
Scoring data are known to have low power and although changes may be present, a statistical 
analysis may not necessarily detect a change. Quantitative measurements are more sensitive than 
scoring data and quantitative methods are preferable to use. Computerised methods may help to 
quantitate morphological features such as the density in whole mounts, lobular development or 
hypertrophy in histological slides. For example, the number of branch points or the number of 
terminal ends in mammary gland whole mounts may be determined by an image analysis 
programme. In histological slides, the area of the most developed lobules may be possible to 
measure as well as the area or intensity of the staining of cells and nuclei. Such parameters may 
give a quantitative measure for the density in whole mounts and for the differentiation (lobular 
development) or hypertrophy in adult mammary glands. Few studies have described advanced 
methods for quantitative image analysis of rodent mammary glands [Fernandez-Gonzalez et al. 
2004; McGinley and Thompson 2011], but more simple techniques should be developed to facilitate 
the implementation of the endpoints in guideline studies.  
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Histological examination of male mammary glands in the studies on phytoestrogens and 
environmental relevant EDCs (paper 3 and 5) showed hypertrophic changes resembling apocrine 
changes described in humans [Fuehrer et al. 2012]. In humans, malignant and benign apocrine 
changes can be distinguished by immunohistochemical staining for androgen receptors (AR), 
estrogen receptors (ER) and progesterone receptors (PR) [Gatalica 1997; O'Malley 2004]. In the 
present studies apocrine-like changes were observed in controls and exposed rats (papers 3 and 5) 
and the biological relevance of these changes in rodents is unknown. Further studies may clarify if 
the apocrine-like changes observed in rodents are comparable to the human apocrine changes and if 
it is possible to distinguish between benign and malignant types by using immunohistochemical 
staining as in humans. Moreover, other effects in the mammary glands may be relevant to 
investigate by immunohistochemical staining (for example staining for proliferation or apoptosis) or 
gene expression of the mammary glands. 
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6. Conclusions 
 
The present project aimed at verifying the hypothesis that (i) exposure to EDCs during foetal and 
prepubertal development affects mammary gland development in rats, (ii) female external genital 
development in rats is altered by EDCs and (iii) changes in female or male mammary glands or 
female genital malformations may be good predictors for endocrine disrupting effects of a chemical. 
Mammary gland development in rats was affected by perinatal exposure to EDCs. Although 
differences in whole mounts of control mammary glands were present in Sprague-Dawley and 
Scanbur Wistar rats compared to Taconic Wistar rats, the parameters were sensitive to EDCs. EDCs 
with estrogenic mode of action appeared to increase mammary outgrowth in prepubertal female rats 
and a potent model compound, ethinyl estradiol, increased the density in females and males and the 
number of TEBs in male rats. Moreover, phytoestrogens showed changes in epithelial morphology 
in male (hypertrophic epithelium) and female (lobuloalveolar morphology) mammary glands in 
adult rats. Anti-androgenic chemicals showed signs of feminisation of adult male mammary glands. 
No effects of anti-androgens were observed in female mammary glands.  
Female external genitals in rats were affected by a potent estrogenic model compound, ethinyl 
estradiol, however, no effects were found in females exposed to the environmentally relevant 
estrogenic chemicals bisphenol A, epoxiconazole or compounds in the Emix. No effects of anti-
androgens were observed in female external genitals. Estrogenic compounds may perturb 
development of female genitals, however, this was not seen for the EDCs and dose levels studied in 
the present project.  
Overall, female and male mammary glands were affected by a model compound (ethinyl estradiol) 
or environmentally relevant EDCs in the commonly used Wistar rats as known for other strains of 
rats. The changes observed in mammary glands and female external genitals may be of importance 
for human health. The present findings suggest that perinatal exposure to estrogenic EDCs may lead 
to precocious breast development in girls exposed to estrogenic compounds perinatally if exposure 
levels to these compounds are sufficiently high. Moreover, EDCs may lead to changes in adult male 
mammary glands, and this may indicate a role of EDCs in development of gynecomastia in men.  
Ethinyl estradiol showed effects in female external genitals indicating a failure in the fusion of the 
urogenital folds and suggests a disturbance of the foetal development. Such disturbance may affect 
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other aspects in foetal development and is also of concern for humans and wild animals if exposure 
to potent estrogenic chemicals is present.   
Outgrowth of prepubertal female mammary glands measured as the distance to the lymph node was 
observed at lower dose-levels of estrogenic chemicals compared to other endpoints known to be 
sensitive to EDCs. However, further studies are needed to confirm the sensitivity of the distance to 
the lymph node in whole mounts of female mammary glands to estrogenic compounds. Estrogenic 
effects on the number of TEBs in males and the density in females and males PD21-22 also appear 
to be relevant to investigate further.  
The extended one-generation reproductive toxicity study described in the OECD guidelines for 
testing of chemicals (TG 443) includes sacrifice of female and male rats around PD90 [OECD 
2010b]. At this age, histological mammary gland examination is included. Evaluation of female 
external genital malformations described in the present studies, can be performed, but may not be 
affected by estrogenic EDCs. However, in such a study, risk assessment of estrogenic chemicals 
may overlook the effects on mammary glands if outgrowth in females PD22 is not investigated. 
Thus, for evaluation of the effects of chemicals suspected to have endocrine disrupting effects, 
mammary glands of both male and female offspring may be relevant to evaluate, both prepubertally 
and in adults, using whole mounts and histology.    
  
59 
 
 
Reference List 
 
Ahren, K and Etienne, M. 1957. The Development of the Mammary Gland in Normal and Castrated 
Male Rats After the Age of 21 Days. Acta Physiologica Scandinavica 41(2-3): 283-300. 
Aksglaede, L, Sorensen, K, Petersen, J H, Skakkebaek, N E, and Juul, A. 2009. Recent Decline in 
Age at Breast Development: The Copenhagen Puberty Study. Pediatrics 123(5): e932-e939. 
Andrews, P, Freyberger, A, Hartmann, E, Eiben, R, Loof, I, Schmidt, U, Temerowski, M, Folkerts, 
A, Stahl, B, and Kayser, M. 2002. Sensitive Detection of the Endocrine Effects of the Estrogen 
Analogue Ethinylestradiol Using a Modified Enhanced Subacute Rat Study Protocol (OECD Test 
Guideline No. 407). Archives of Toxicology 76(4): 194-202. 
Apter, D. 1997. Development of the Hypothalamic-Pituitary-Ovarian Axis. Annals of the New York 
Academy of Sciences 816: 9-21. 
Axelstad, M, Boberg, J, Hougaard, K S r, Christiansen, S, Jacobsen, P R, Mandrup, K R, 
Nellemann, C, Lund, S r P, and Hass, U. 2011. Effects of Pre- and Postnatal Exposure to the UV-
Filter Octyl Methoxycinnamate (OMC) on the Reproductive, Auditory and Neurological 
Development of Rat Offspring. Toxicology and Applied Pharmacology 250(3): 278-290. 
Biegel, L B, Flaws, J A, Hirshfield, A N, O'Connor, J C, Elliott, G S, Ladics, G S, Silbergeld, E K, 
Van Pelt, C S, Hurtt, M E, Cook, J C, and Frame, S R. 1998. 90-Day Feeding and One-Generation 
Reproduction Study in Crl:CD BR Rats With 17[Beta]-Estradiol. Toxicological Sciences 44(2): 
116-142. 
Boberg, J, Christiansen, S, Axelstad, M, Kledal, T S, Vinggaard, A M, Dalgaard, M, Nellemann, C, 
and Hass, U. 2011. Reproductive and Behavioral Effects of Diisononyl Phthalate (DINP) in 
Perinatally Exposed Rats. Reproductive Toxicology 31(2): 200-209. 
Borellini, F and Oka, T. 1989. Growth Control and Differentiation in Mammary Epithelial Cells. 
Environmental Health Perspectives 80: 85-99. 
Brisken, C. 2002. Hormonal Control of Alveolar Development and Its Implications for Breast 
Carcinogenesis. Journal of Mammary Gland Biology and Neoplasia 7(1): 39-48. 
Cabanes, A, Wang, M, Olivo, S, DeAssis, S, Gustafsson, J A, Khan, G, and Hilakivi-Clarke, L. 
2004. Prepubertal Estradiol and Genistein Exposures Up-Regulate BRCA1 MRNA and Reduce 
Mammary Tumorigenesis. Carcinogenesis 25(5): 741-748. 
Cardy, R H. 1991. Sexual Dimorphism of the Normal Rat Mammary Gland. Veterinary Pathology 
28(2): 139-145. 
Ceriani, R L. 1970. Fetal Mammary Gland Differentiation in Vitro in Response to Hormones - I. 
Morphological Findings. Developmental Biology 21(4): 506-529. 
60 
 
Chen, J, Tan, K P, Ward, W E, and Thompson, L U. 2003. Exposure to Flaxseed or Its Purified 
Lignan During Suckling Inhibits Chemically Induced Rat Mammary Tumorigenesis. Experimental 
Biology and Medicine (Maywood) 228(8): 951-958. 
Christiansen, S, Kortenkamp, A, Axelstad, M, Boberg, J, Scholze, M, Jacobsen, P R, Faust, M, 
Lichtensteiger, W, Schlumpf, M, Burdorf, A, and Hass, U. 2012. Mixtures of Endocrine Disrupting 
Contaminants Modelled on Human High End Exposures: an Exploratory Study in Rats. 
International Journal of Andrology 35(3): 303-316. 
Christiansen, S, Scholze, M, Axelstad, M, Boberg, J, Kortenkamp, A, and Hass, U. 2008. Combined 
Exposure to Anti-Androgens Causes Markedly Increased Frequencies of Hypospadias in the Rat. 
International Journal of Andrology 31(2): 241-248. 
Cotroneo, M S, Wang, J, Fritz, W A, Eltoum, I E, and Lamartiniere, C A. 2002. Genistein Action in 
the Prepubertal Mammary Gland in a Chemoprevention Model. Carcinogenesis 23(9): 1467-1474. 
Cowie, A T. 1974. Proceedings: Overview of the Mammary Gland. The Journal of Investigative 
Dermatology 63(1): 2-9. 
Delclos, K B, Bucci, T J, Lomax, L G, Latendresse, J R, Warbritton, A, Weis, C C, and Newbold, R 
R. 2001. Effects of Dietary Genistein Exposure During Development on Male and Female CD 
(Sprague-Dawley) Rats. Reproductive Toxicology 15(6): 647-663. 
European Parliament and Council of Europe. 2006. Regulation (EC) No 1907/2006 of the European 
Parliament and of the Council. 1907/2006: 1-849. 
Fenton, S E. 2006. Endocrine-Disrupting Compounds and Mammary Gland Development: Early 
Exposure and Later Life Consequences. Endocrinology 147(6): s18-s24. 
Fernandez, S V and Russo, J. 2010. Estrogen and Xenoestrogens in Breast Cancer. Toxicologic 
Pathology 38(1): 110-122. 
Fernandez-Gonzalez, R, Barcellos-Hoff, M H, and Ortiz-De-Solorzano, C. 2004. Quantitative 
Image Analysis in Mammary Gland Biology. Journal of Mammary Gland Biology and Neoplasia 
9(4): 343-359. 
Flaws, J A, Sommer, R J, Silbergeld, E K, Peterson, R E, and Hirshfield, A N. 1997. In Uteroand 
Lactational Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Induces Genital 
Dysmorphogenesis in the Female Rat. Toxicology and Applied Pharmacology 147(2): 351-362. 
Forest, M G. 1979. Plasma Androgens (Testosterone and 4-Androstenedione) and 17-
Hydroxyprogesterone in the Neonatal, Prepubertal and Peripubertal Periods in the Human and the 
Rat: Differences Between Species. Journal of Steroid Biochemistry 11(1, Part 2): 543-548. 
Fritz, W A, Coward, L, Wang, J, and Lamartiniere, C A. 1998. Dietary Genistein: Perinatal 
Mammary Cancer Prevention, Bioavailability and Toxicity Testing in the Rat. Carcinogenesis 
19(12): 2151-2158. 
61 
 
Fuehrer, N, Hartmann, L, Degnim, A, Allers, T, Vierkant, R, Frost, M, and Visscher, D. 2012. 
Atypical Apocrine Adenosis of the Breast: Long-Term Follow-Up in 37 Patients. Archives of 
Pathology & Laboratory Medicine 136(2): 179-182. 
Gatalica, Z. 1997. Immunohistochemical Analysis of Apocrine Breast Lesions: Consistent Over-
Expression of Androgen Receptor Accompanied by the Loss of Estrogen and Progesterone 
Receptors in Apocrine Metaplasia and Apocrine Carcinoma in Situ. Pathology - Research and 
Practice 193(11-12): 753-758. 
Goldman, A S, Shapiro, B H, and Neumann, F. 1976. Role of Testosterone and its Metabolies in 
Differentiation of Mammary Gland in Rats. Endocrinology 99(6): 1490-1495. 
Golub, M S, Collman, G W, Foster, P M D, Kimmel, C A, Rajpert-De Meyts, E, Reiter, E O, 
Sharpe, R M, Skakkebaek, N E, and Toppari, J. 2008. Public Health Implications of Altered 
Puberty Timing. Pediatrics 121 Suppl 3: S218-S230. 
Gray, L E and Ostby, J S. 1995. In Utero 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Alters 
Reproductive Morphology and Function in Female Rat Offspring. Toxicology and Applied 
Pharmacology 133(2): 285-294. 
Gray, L E, Wolf, C, Mann, P, and Ostby, J S. 1997. In Utero Exposure to Low Doses of 2,3,7,8-
Tetrachlorodibenzo-p-Dioxin Alters Reproductive Development of Female Long Evans Hooded Rat 
Offspring. Toxicology and Applied Pharmacology 146(2): 237-244. 
Hass, U, Boberg, J, Christiansen, S, Jacobsen, P R, Vinggaard, A M, Taxvig, C, Poulsen, M E, 
Herrmann, S S, Jensen, B H, Petersen, A, Clemmensen, L H, and Axelstad, M. 2012. Adverse 
Effects on Sexual Development in Rat Offspring After Low Dose Exposure to a Mixture of 
Endocrine Disrupting Pesticides. Reproductive Toxicology 34(2): 261-274. 
Heiden, T C K, Struble, C A, Rise, M L, Hessner, M J, Hutz, R J, and Carvan III, M J. 2008. 
Molecular Targets of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Within the Zebrafish Ovary: 
Insights into TCDD-Induced Endocrine Disruption and Reproductive Toxicity. Reproductive 
Toxicology 25(1): 47-57. 
Henderson, B E, Ross, R K, and Pike, M C. 1991. Toward the Primary Prevention of Cancer. 
Science (New York, N Y ) 254(5035): 1131-1138. 
Henley, D V, Lipson, N, and Korach, K S. 2007. Prepubertal Gynecomastia Linked to Lavender and 
Tea Tree Oils. New England Journal of Medicine 356(5): 479-485. 
Hilakivi-Clarke, L, Cho, E, Raygada, M, and Kenney, N. 1997. Alterations in Mammary Gland 
Development Following Neonatal Exposure to Estradiol, Transforming Growth Factor Alpha, and 
Estrogen Receptor Antagonist ICI 182,780. Journal of Cellular Physiology 170(3): 279-289. 
Hodgson, N C F, Button, J H, Franceschi, D, Moffat, F L, and Livingstone, A S. 2004. Male Breast 
Cancer: Is the Incidence Increasing? Annals of Surgical Oncology 11(8): 751-755. 
Hovey, R C, Coder, P S, Wolf, J C, Sielken, R L, Jr., Tisdel, M O, and Breckenridge, C B. 2010. 
Quantitative Assessment of Mammary Gland Development in Female Long Evans Rats Following 
in Utero Exposure to Atrazine. Toxicological Sciences 119(2): 380-390. 
62 
 
Hovey, R C, sai-Sato, M, Warri, A, Terry-Koroma, B, Colyn, N, Ginsburg, E, and Vonderhaar, B 
K. 2005. Effects of Neonatal Exposure to Diethylstilbestrol, Tamoxifen, and Toremifene on the 
BALB/c Mouse Mammary Gland. Biology of Reproduction 72(2): 423-435. 
Hovey, R C, Trott, J F, and Vonderhaar, B K. 2002. Establishing a Framework for the Functional 
Mammary Gland: From Endocrinology to Morphology. Journal of Mammary Gland Biology and 
Neoplasia 7(1): 17-38. 
Hvid, H, Thorup, I, Sjogren, I, Oleksiewicz, M B, and Jensen, H E. 2010. Mammary Gland 
Proliferation in Female Rats: Effects of the Estrous Cycle, Pseudo-Pregnancy and Age. 
Experimental and Toxicologic Pathology 64(4): 321-332.  
Hvid, H, Thorup, I, Oleksiewicz, M B, Sjogren, I, and Jensen, H E. 2011. An Alternative Method 
for Preparation of Tissue Sections From the Rat Mammary Gland. Experimental and Toxicologic 
Pathology 63(4): 317-324. 
Khan, G, Penttinen, P, Cabanes, A, Foxworth, A, Chezek, A, Mastropole, K, Yu, B, Smeds, A, 
Halttunen, T, Good, C, Makela, S, and Hilakivi-Clarke, L. 2007. Maternal Flaxseed Diet During 
Pregnancy or Lactation Increases Female Rat Offspring's Susceptibility to Carcinogen-Induced 
Mammary Tumorigenesis. Reproductive Toxicology 23(3): 397-406. 
Kim, T S, Jung, K K, Kim, S S, Kang, I H, Baek, J H, Nam, H S, Hong, S K, Lee, B M, Hong, J T, 
Oh, K W, Kim, H S, Han, S Y, and Kang, T S. 2010. Effects of in Utero Exposure to DI(n-Butyl) 
Phthalate on Development of Male Reproductive Tracts in Sprague-Dawley Rats. Journal of 
Toxicology and Environmental Health, Part A 73(21-22): 1544-1559. 
Knight, C H and Sorensen, A. 2001. Windows in Early Mammary Development: Critical or Not? 
Reproduction (Cambridge) 122(3): 337-345. 
Kratochwil, K. 1977. Development and Loss of Androgen Responsiveness in the Embryonic 
Rudiment of the Mouse Mammary Gland. Developmental Biology 61(2): 358-365. 
Latendresse, J R, Bucci, T J, Olson, G, Mellick, P, Weis, C C, Thorn, B, Newbold, R R, and 
Delclos, K B. 2009. Genistein and Ethinyl Estradiol Dietary Exposure in Multigenerational and 
Chronic Studies Induce Similar Proliferative Lesions in Mammary Gland of Male Sprague-Dawley 
Rats. Reproductive Toxicology 28(3): 342-353. 
Lee, K Y, Shibutani, M, Takagi, H, Kato, N, Takigami, S, Uneyama, C, and Hirose, M. 2004. 
Diverse Developmental Toxicity of Di-n-Butyl Phthalate in Both Sexes of Rat Offspring After 
Maternal Exposure During the Period From Late Gestation Through Lactation. Toxicology 203(1-
3): 221-238. 
Masutomi, N, Shibutani, M, Takagi, H, Uneyama, C, and Hirose, M. 2004. Dietary Influence on the 
Impact of Ethinylestradiol-Induced Alterations in the Endocrine/Reproductive System With 
Perinatal Maternal Exposure. Reproductive Toxicology 18(1): 23-33. 
McGinley, J and Thompson, H. 2011. Quantitative Assessment of Mammary Gland Density in 
Rodents Using Digital Image Analysis. Biological Procedures Online 13(1): 4 
63 
 
Medina, D. 2005. Mammary Developmental Fate and Breast Cancer Risk. Endocrine-Related 
Cancer 12(3): 483-495. 
Moon, H J, Han, S Y, Shin, J H, Kang, I H, Kim, T S, HONG, J H, Kim, H S, and Fenton, S E. 
2007. Gestational Exposure to Nonylphenol Causes Precocious Mammary Gland Development in 
Female Rat Offspring. The Journal of Reproduction and Development 53(2): 333-344. 
Moral, R, Wang, R, Russo, I H, Lamartiniere, C A, Pereira, J, and Russo, J. 2008. Effect of Prenatal 
Exposure to the Endocrine Disruptor Bisphenol A on Mammary Gland Morphology and Gene 
Expression Signature. Journal of Endocrinology 196(1): 101-112. 
Muñoz-de-Toro, M, Markey, C M, Wadia, P R, Luque, E H, Rubin, B S, Sonnenschein, C, and 
Soto, A M. 2005. Perinatal Exposure to Bisphenol-A Alters Peripubertal Mammary Gland 
Development in Mice. Endocrinology 146(9): 4138-4147. 
Murrill, W B, Brown, N M, Zhang, J X, Manzolillo, P A, Barnes, S, and Lamartiniere, C A. 1996. 
Molecular Epidemiology and Cancer Prevention: Prepubertal Genistein Exposure Suppresses 
Mammary Cancer and Enhances Gland Differentiation in Rats. Carcinogenesis 17(7): 1451-1457. 
Neville, M C, McFadden, T B, and Forsyth, I. 2002. Hormonal Regulation of Mammary 
Differentiation and Milk Secretion. Journal of Mammary Gland Biology and Neoplasia 7(1): 49-66. 
O'Connor, J C and Chapin, R E. 2003. Critical Evaluation of Observed Adverse Effects of 
Endocrine Active Substances on Reproduction and Development, the Immune System, and the 
Nervous System. Pure and Applied Chemistry 75(11-12): 2099-2123. 
O'Malley, F P. 2004. Non-Invasive Apocrine Lesions of the Breast. Current Diagnostic Pathology 
10(3): 211-219. 
OECD. 2001. Test No. 416: Two-Generation Reproduction Toxicity. 416: 1-13. 
OECD. 2010a. Guidance Document No. 125: Guidance Document on Hitopathology for Inhalation 
Toxicity Studies, Supporting TG 412 and TG 413.  1-52. 
OECD. 2010b. Test No. 443: Extended One-Generation Reproductive Toxicity Study. 1-125. 
Orton, F, Rosivatz, E, Scholze, M, and Kortenkamp, A. 2012. Competitive Androgen Receptor 
Antagonism As a Factor Determining the Predictability of Cumulative Antiandrogenic Effects of 
Widely Used Pesticides. Environmental Health Perspectives 120(11): 1578-1584. 
Ostby, J, Kelce, W R, Lambright, C, Wolf, C J, Mann, P, and Gray, L E, Jr. 1999. The Fungicide 
Procymidone Alters Sexual Differentiation in the Male Rat by Acting As an Androgen-Receptor 
Antagonist in Vivo and in Vitro. Toxicology and Industrial Health 15(1-2): 80-93. 
Patton, G C and Viner, R. 2007. Pubertal Transitions in Health. The Lancet 369(9567): 1130-1139. 
Peters, A A, Ingman, W V, Tilley, W D, and Butler, L M. 2011. Differential Effects of Exogenous 
Androgen and an Androgen Receptor Antagonist in the Peri- and Postpubertal Murine Mammary 
Gland. Endocrinology 152(10): 3728-3737. 
64 
 
Pike, M C, Henderson, B E, Casagrande, J T, Rosario, I, and Gray, G E. 1981. Oral Contraceptive 
Use and Early Abortion As Risk Factors for Breast Cancer in Young Women. British Journal of 
Cancer 43(1): 72-76. 
Raynaud, A and Frilley, M. 1947. *Embryologie Experimentale - Etat de Développement des 
Ebauches Mammaires et du Cordon Vaginal Chez les Foetus Males et Femelles de Souris, dont les 
Ebauches des Glandes Genitales ont été Détruites par une Irradiation au Moyen des Rayons-X, à l' 
age de Treize Jours. Comptes Rendus Hebdomadaires des Seances de l' Académie des Sciences 
225(25): 1380-1382. 
Rayner, J L, Enoch, R R, and Fenton, S E. 2005. Adverse Effects of Prenatal Exposure to Atrazine 
During a Critical Period of Mammary Gland Growth. Toxicological Sciences 87(1): 255-266. 
Rudel, R A, Fenton, S E, Ackerman, J M, Euling, S Y, and Makris, S L. 2011. Environmental 
Exposures and Mammary Gland Development: State of the Science, Public Health Implications, 
and Research Recommendations. Environmental Health Perspectives 119(8): 1053-1061. 
Rudmann, D, Cardiff, R, Chouinard, L, Goodman, D, Kuttler, K, Marxfeld, H, Molinolo, A, 
Treumann, S, Yoshizawa, K, and For the INHAND Mammary, Z P a C G O W G. 2012. 
Proliferative and Nonproliferative Lesions of the Rat and Mouse Mammary, Zymbal's, Preputial, 
and Clitoral Glands. Toxicologic Pathology 40(6 suppl): 7S-39S. 
Russo, I H and Russo, J. 1978. Developmental Stage of the Rat Mammary Gland As Determinant of 
Its Susceptibility to 7,12-Dimethylbenz[a]Anthracene. Journal of the National Cancer Institute 
61(6): 1439-1449. 
Russo, J, Gusterson, B A, Rogers, A E, Russo, I H, Wellings, S R, and van Zwieten, M J. 1990. 
Comparative Study of Human and Rat Mammary Tumorigenesis. Laboratory Investigation; a 
Journal of Technical Methods and Pathology 62(3): 244-278. 
Saad, H E S, Meduri, G, Phrakonkham, P, Berg+¿s, R, Vacher, S, Djallali, M, Auger, J, Canivenc-
Lavier, M C, and Perrot-Applanat, M. 2011. Abnormal Peripubertal Development of the Rat 
Mammary Gland Following Exposure in Utero and During Lactation to a Mixture of Genistein and 
the Food Contaminant Vinclozolin. Reproductive Toxicology 32(1): 15-25. 
Sawaki, M, Noda, S, Muroi, T, Mitoma, H, Takakura, S, Sakamoto, S, and Yamasaki, K. 2003a. 
Evaluation of an in Utero Through Lactational Exposure Protocol for Detection of Estrogenic 
Effects of Ethinyl Estradiol on the Offspring of Rats: Preliminary Trial. Reproductive Toxicology 
17(3): 335-343. 
Sawaki, M, Noda, S, Muroi, T, Mitoma, H, Takakura, S, Sakamoto, S, and Yamasaki, K. 2003b. In 
Utero Through Lactational Exposure to Ethinyl Estradiol Induces Cleft Phallus and Delayed 
Ovarian Dysfunction in the Offspring. Toxicological Sciences 75(2): 402-411. 
Schedin, P, Mitrenga, T, and Kaeck, M. 2000. Estrous Cycle Regulation of Mammary Epithelial 
Cell Proliferation, Differentiation, and Death in the Sprague-Dawley Rat: A Model for Investigating 
the Role of Estrous Cycling in Mammary Carcinogenesis. Journal of Mammary Gland Biology and 
Neoplasia 5(2): 211-225. 
65 
 
Skakkebaek, N E, Jorgensen, N, Main, K M, Meyts, E R-D, Leffers, H, Andersson, A M, Juul, A, 
Carlsen, E, Mortensen, G K, Jensen, T K, and Toppari, J. 2006. Is Human Fecundity Declining? 
International Journal of Andrology 29(1): 2-11. 
Skarda, J. 2003. Bioassay of Steroid Hormone Agonist and Antagonist Activities of Anti-
Androgens on Mammary Gland, Seminal Vesicles and Spleen of Male Mice. Journal of Veterinary 
Medicine Series A 50(4): 204-212. 
Sorensen, K, Mouritsen, A, Aksglaede, L, Hagen, C P, Mogensen, S S, and Juul, A. 2012. Recent 
Secular Trends in Pubertal Timing: Implications for Evaluation and Diagnosis of Precocious 
Puberty. Hormone Research in Paediatrics 77(3): 137-145. 
Sourla, A, Martel, C, Labrie, C, and Labrie, F. 1998. Almost Exclusive Androgenic Action of 
Dehydroepiandrosterone in the Rat Mammary Gland. Endocrinology 139(2): 753-764. 
Takagi, H, Shibutani, M, Lee, K Y, Lee, H C, Nishihara, M, Uneyama, C, Takigami, S, Mitsumori, 
K, and Hirose, M. 2004. Lack of Modifying Effects of Genistein on Disruption of the Reproductive 
System by Perinatal Dietary Exposure to Ethinylestradiol in Rats. Reproductive Toxicology 18(5): 
687-700. 
Tan, K P, Chen, J, Ward, W E, and Thompson, L U. 2004. Mammary Gland Morphogenesis Is 
Enhanced by Exposure to Flaxseed or Its Major Lignan During Suckling in Rats. Experimental 
Biology and Medicine 229(2): 147-157. 
Taxvig, C, Hass, U, Axelstad, M, Dalgaard, M, Boberg, J, Andeasen, H R, and Vinggaard, A M. 
2007. Endocrine-Disrupting Activities In Vivo of the Fungicides Tebuconazole and Epoxiconazole. 
Toxicological Sciences 100(2): 464-473. 
Thomsen, A R, Almstrup, K, Nielsen, J E, Sørensen, I K, Petersen, O W, Leffers, H, and Breinholt, 
V M. 2006. Estrogenic Effect of Soy Isoflavones on Mammary Gland Morphogenesis and Gene 
Expression Profile. Toxicological Sciences 93(2): 357-368. 
Tinwell and Ashby. 2004. Sensitivity of the Immature Rat Uterotrophic Assay to Mixtures of 
Estrogens. Environmental Health Perspectives 112(PART 5): 575-582. 
Tou, J C L and Thompson, L U. 1999. Exposure to Flaxseed or Its Lignan Component During 
Different Developmental Stages Influences Rat Mammary Gland Structures. Carcinogenesis 
(Oxford) 20(9): 1831-1835. 
Vandenberg, L N, Maffini, M V, Wadia, P R, Sonnenschein, C, Rubin, B S, and Soto, A M. 2007. 
Exposure to Environmentally Relevant Doses of the Xenoestrogen Bisphenol-A Alters 
Development of the Fetal Mouse Mammary Gland. Endocrinology 148(1): 116-127. 
Vilela, M L B, Willingham, E, Buckley, J, Liu, B C, Agras, K, Shiroyanagi, Y, and Baskin, L S. 
2007. Endocrine Disruptors and Hypospadias: Role of Genistein and the Fungicide Vinclozolin. 
Urology 70(3): 618-621. 
Vinggaard, A M, Nellemann, C, Dalgaard, M, Jorgensen, E B, and Andersen, H R. 2002. 
Antiandrogenic Effects in Vitro and in Vivo of the Fungicide Prochloraz. Toxicological Sciences 
69(2): 344-353. 
66 
 
Wang, X J, Bartolucci-Page, E, Fenton, S E, and You, L. 2006. Altered Mammary Gland 
Development in Male Rats Exposed to Genistein and Methoxychlor. Toxicological Sciences 91(1): 
93-103. 
Ward, W E, Jiang, F O, and Thompson, L U. 2000. Exposure to Flaxseed or Purified Lignan During 
Lactation Influences Rat Mammary Gland Structures. Nutrition and Cancer 37(2): 187-192. 
WHO. 2002. Global Assessment of the State-of-the-Science of Endocrine Disruptors.  1-133. 
Wohlfahrt-Veje, C, Andersen, H R, Schmidt, I M, Aksglaede, L, Sorensen, K, Juul, A, Jensen, T K, 
Grandjean, P, Skakkebaek, N E, and Main, K M. 2012. Early Breast Development in Girls After 
Prenatal Exposure to Non-Persistent Pesticides. International Journal of Andrology 35(3): 273-282. 
Wolf, C J, Ostby, J S, and Gray, L E. 1999a. Gestational Exposure to 2,3,7,8-Tetrachlorodibenzo-p-
Dioxin (TCDD) Severely Alters Reproductive Function of Female Hamster Offspring. 
Toxicological Sciences 51(2): 259-264. 
Wolf, C, Lambright, C, Mann, P, Price, M, Cooper, R L, Ostby, J, and Gray, L E, Jr. 1999b. 
Administration of Potentially Antiandrogenic Pesticides (Procymidone, Linuron, Iprodione, 
Chlozolinate, P,p'-DDE, and Ketoconazole) and Toxic Substances (Dibutyl- and Diethylhexyl 
Phthalate, PCB 169, and Ethane Dimethane Sulphonate) During Sexual Differentiation Produces 
Diverse Profiles of Reproductive Malformations in the Male Rat. Toxicology and Industrial Health 
15(1-2): 94-118. 
Wolf, C J, Hotchkiss, A, Ostby, J S, LeBlanc, G A, and Gray, L E. 2002. Effects of Prenatal 
Testosterone Propionate on the Sexual Development of Male and Female Rats: A Dose-Response 
Study. Toxicological Sciences 65(1): 71-86. 
Yamasaki, K, Noda, S, Muroi, T, Mitoma, H, Takakura, S, and Sakamoto, S. 2005. Effects of in 
Utero and Lactational Exposure to Tamoxifen in SD Rats. Toxicology Letters 156(2): 289-296. 
You, L, Sar, M, Bartolucci, E J, McIntyre, B S, and Sriperumbudur, R. 2002. Modulation of 
Mammary Gland Development in Prepubertal Male Rats Exposed to Genistein and Methoxychlor. 
Toxicological Sciences 66(2): 216-225. 
 
NORDCAN http://www-dep.iarc.fr/NORDCAN/DK/frame.asp 15th of april 2013 
 
PAPER 1 
 
Karen Riiber Mandrup, Ulla Hass, Sofie Christiansen, Julie Boberg. 
Perinatal ethinyl estradiol alters mammary gland development in male and female 
Wistar rats. 
International Journal of Andrology 2012, 35: 385-39. 
 
ORIGINAL ARTICLE
Perinatal ethinyl oestradiol alters mammary gland
development in male and female Wistar rats
K. R. Mandrup, U. Hass, S. Christiansen and J. Boberg
Division of Toxicology and Risk Assessment, National Food Institute, Technical University of Denmark, Søborg, Denmark
Introduction
In the USA and Europe, the mean age of puberty onset
in girls has decreased over the last decades, including
early development of breasts (Mouritsen et al., 2010).
Early puberty onset increases the risk for breast cancer
(Pike et al., 1981; Medina, 2005; Rudel et al., 2011), rais-
ing the concern for this decrease in age of puberty in the
western world. Exposure to endocrine disrupting chemi-
cals (EDCs) are suspected to be involved in the changes
in puberty onset and breast development, and more
attention is being paid to the effects of EDCs on pregnant
women and their offspring, including the effects on mam-
mary glands.
In rats, exposure to certain EDCs has been shown to
alter both the timing of sexual maturation and the devel-
opment of mammary glands (Hilakivi-Clarke et al., 1997;
Goldman et al., 2000; Cotroneo et al., 2002; Hovey et al.,
2005; Thomsen et al., 2006). These changes are seen when
rats are exposed prenatally, postnatally or both pre- and
postnatally, showing that the mammary glands are sensi-
tive to EDCs during a wide time span of the development
of the animal. The mammary glands continue developing
throughout life, and studies have shown that the glands
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Summary
Increased attention is being paid to human mammary gland development
because of concerns for environmental influences on puberty onset and breast
cancer development. Studies in rodents have showed a variety of changes in
the mammary glands after perinatal exposure to endocrine disrupting chemi-
cals, indicating progressed development of mammary glands when exposed to
oestrogens early in life. However, laboratories use different parameters to evalu-
ate the development of mammary glands, making studies difficult to compare.
Moreover, studies of whole mounts in Wistar rats are lacking. In the present
study, Wistar rats were exposed to 0, 5, 15 or 50 lg ⁄ kg of ethinyl oestradiol
per day during gestation and lactation. A wide range of morphological parame-
ters were evaluated in whole mounts of mammary glands from male and
female offspring PD21–22. This study showed that in both male and female
pre-pubertal Wistar rats, mammary gland development was accelerated after
perinatal oestrogen exposure with increase in size, density and number of
terminal end buds (TEBs). In female rats, the most sensitive parameters were
the distance to the fifth gland, the relative growth towards the lymph node and
the overall density. The sensitive endpoints in male rats were TEB numbers,
both in the whole gland and in the zone C, the overall- and the highest den-
sity. The overall density was sensitive in both male and female rats and was
considered a good representative of both branching and budding of the gland.
The number of TEBs in zone C was representative of the number of TEBs in
the whole gland. Further studies in older Wistar rats and with weak oestrogenic
compounds could be performed to validate mammary gland examination as an
endpoint in reproductive toxicity studies and to examine how early life envi-
ronmental exposures may alter mammary gland development, disrupt lactation
and alter susceptibility to breast cancer.
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are especially sensitive to exposure around three phases
where development is extensive in females. The first phase
is the prenatal period where the mammary epithelial
sprout is developed and the primary ducts grow into the
fat pad. The second period is the pre-pubertal period
where the mammary glands grow extensively with the
outgrowth of several secondary and tertiary branches,
occupying an increasing area of the fat pad, including
growing of buds. The third period is during pregnancy,
where the glands develop lobules and turn into milk
producing glands (Fenton, 2006). Studies are still being
performed trying to discern the specific time of develop-
ment sensitive to EDCs in utero (Rayner et al., 2005).
In the reproductive stage of life between puberty and
menopause (excluding lactation), the mammary gland is a
dynamic structure changing with the female cycle (Ander-
son et al., 1998; Schedin et al., 2000; Hvid et al., 2010). In
women, proliferation of the breast tissue is elevated in the
mid-luteal phase of the menstrual cycle when the level of
oestradiol peaks together with progesterone (Anderson
et al., 1998). Overall, several studies suggest that the
hormone being the main mitogen in the breast tissue in
both humans and rodents is oestradiol, possibly in combi-
nation with progesterone (Anderson et al., 1998; Cotroneo
et al., 2002; Clarke, 2003; Gompel et al., 2010). This
encourages the theory that EDCs with oestrogenic proper-
ties can affect mammary glands and enhance mammary
development and that exposure to EDCs may be involved
in changes linked to early breast development. Exposure
to EDCs before puberty may also affect the mammary
glands and give rise to permanent changes and alter their
susceptibility to environmental influences later in life. Fos-
ter et al. showed that although mammary glands did not
show histopathological changes after exposure to EDCs
in utero, an increased sensitivity to a repeated exposure to
EDCs postnatally resulted in histopathological changes in
mammary glands of the adult rat (Foster et al., 2004).
Although several laboratories have examined changes in
mammary glands in humans, rats and mice, no standard
evaluation techniques have been agreed. Different struc-
tures are being evaluated and many different measure-
ments are being performed (Brody et al., 2011; Rudel
et al., 2011). Grossly, mammary glands of rodents are
either evaluated in whole mounts or histologically. Labo-
ratories evaluating whole mounts look at (i) the ductal
development, for example by counting the number of pri-
mary ducts, measuring the ductal elongation, the length
of the ductal tree along its longitudinal axis, the migra-
tion of the mammary epithelium towards the lymph
node, area occupied by the parenchyma or the outermost
edges of the epithelial tree or the distance between neigh-
bouring glands; (ii) the gland differentiation and alveolar
development by counting or giving a score for the
amount of structures like terminal end buds (TEBs),
terminal ducts and alveolar buds and lobules and (iii) the
density of the mammary tissue by scoring the extension
of development according to criteria relevant for the
specific age and gender (Fielden et al., 2002; Rayner et al.,
2004; Mun˜oz-de-Toro et al., 2005; Moon et al., 2007;
Moral et al., 2008; Hovey et al., 2010). Moreover, mam-
mary gland whole mounts are evaluated at different time
points of development, including juvenile mammary
glands before puberty and adult glands (Hilakivi-Clarke
et al., 1997; Hovey et al., 2005; Thomsen et al., 2006).
These different measurements represent effects on differ-
ent developmental processes: longitudinal growth of the
ducts, increased branching, growth of buds and lobules
or a combination. Mammary gland development is
dependent on TEBs, undifferentiated structures at the end
of the ducts, most distant to the nipple. They have a high
proliferation rate, and are responsible for ductal out-
growth and give birth to new ducts and alveoli. The
number of TEBs reaches a peak around post-natal day
(PND) 20 and decreases at older age (Russo et al., 1979).
TEBs are the structures sensitive to carcinogens and give
rise to mammary cancer (Russo et al., 1979; Russo &
Russo, 1996b; Fenton, 2006). Hence, chemically induced
increase in the number of TEBs could be linked to an
increased risk of mammary cancer (Fenton, 2006) and
thus, TEBs are the main structure investigated in studies
of mammary glands. As the TEBs are located at the end
of the ducts, they are to be found in high numbers in the
area of the gland furthest away from the nipple, called
the zone C (Russo & Russo, 1996a). Yet, the rat mam-
mary gland is a three-dimensional structure and TEBs
could also be found in the other areas of the gland. Thus,
it is of interest to investigate if TEBs should preferably be
counted in the whole mammary gland of rats.
Oestrogenic chemicals have been shown to accelerate
the development of female mammary glands. For exam-
ple, studies with pups exposed during lactation with
oestrogenic compounds in female mice showed increased
branching, ductal criss-crossing and number of TEBs with
17b-oestradiol (Hilakivi-Clarke et al., 1997; Thomsen
et al., 2006) and increased ductal outgrowth with diethyl-
stilbestrol (DES) (Hovey et al., 2005). In female pups of
Sprague–Dawley (S–D) rats, similar changes were found
with increased branching and number of TEBs when
exposed to genistein, oestradiol benzoate or DES during
the lactational period (Cotroneo et al., 2002; Ninomiya
et al., 2007). In contrast, anti-oestrogenic compounds
were found to have the opposite effect with fewer TEBs
in offspring of dams exposed during lactation (Cotroneo
et al., 2002).
Few laboratories have studied the effects of EDCs in
male mammary glands. Nonetheless, male mammary
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glands from S–D rats are also sensitive to oestrogenic
chemicals like genistein and ethinyl oestradiol (You et al.,
2002; Latendresse et al., 2009). Later in life, even more
prominent changes can be observed in male mammary
glands (Wang et al., 2006). Some chemicals may not have
adverse effects on female mammary glands, but lead to
developmental changes in male mammary glands (You
et al., 2002). It is desirable to detect these changes, as the
incidence of breast cancer in men has been rising over
the last decades in the US and UK (Hodgson et al., 2004;
Speirs & Shaaban, 2009). Moreover, changes seen in male
rat mammary glands exposed to EDCs may reflect
changes connected to breast cancer in men. Furthermore,
an effect of EDCs on male mammary gland development
may serve as a marker of endocrine disruption.
Several laboratories study the effects of oestrogenic
chemicals on mammary gland whole mounts in mice
(Hilakivi-Clarke et al., 1997; Hovey et al., 2005; Thomsen
et al., 2006), Sprague-Dawley (Cotroneo et al., 2002;
Ninomiya et al., 2007) or Long-Evans rats (Moon et al.,
2007), but to our knowledge, investigation of the mor-
phology of mammary glands in whole mounts in Wistar
rats exposed to oestrogens is lacking. However, Wistar rats
are widely used in toxicological studies, hence more
knowledge about mammary gland changes in Wistar rats
is desirable. In the current study, we hypothesize that
Wistar rat mammary gland development is sensitive to
oestrogenic chemicals and shows similar effects to those
seen in mice and other strains of rats. The aim of this
study was to investigate which endpoints in mammary
gland whole mount analysis are sensitive to perinatal
exposure to an oestrogenic model compound, ethinyl oes-
tradiol. Several studies have shown histological changes
such as hyperplasia of the mammary epithelium in S–D
offspring 50 days old or older after maternal exposure to
50 ppb (approximately equivalent to 5 lg ⁄ kg) and
50 lg ⁄ kg of ethinyl oestradiol during gestation and after
birth (Masutomi et al., 2001; Takagi et al., 2004; Laten-
dresse et al., 2009). However, other studies have shown
increased foetal ⁄neonatal morbidity in Long-Evans
Hooded rats after exposure to 50 lg ⁄ kg ⁄day of ethinyl
oestradiol (Howdeshell et al., 2008). Hence, 50 lg ⁄ kg ⁄day
was chosen as the highest dose in the present study and
the lower dose levels of 5 and 15 lg ⁄ kg ⁄day were chosen
to gain knowledge of the dose–response curve. The whole
mount method was evaluated in 21–22 days old male and
female Wistar rats. To cover a wide span of sensitive peri-
ods in the development of mammary glands sensitive to
EDCs, rats in this study were exposed during the majority
of pregnancy (GD7–21) and from birth to necropsy on
pup day (PD) 21–22. Sinha et al. showed that TEBs reach
the maximum number from the third week of age up to
PND 35, and many laboratories have found effects of
EDCs on mammary glands PD 21 (Sinha et al., 1983).
Mammary glands from pre-pubertal female and male off-
spring were mounted as whole mounts and evaluated to
reveal possible gender specific differences in sensitivity to
oestrogenic-acting chemicals perinatally. A wide range of
parameters were evaluated to compare different parame-
ters for measuring changes in the mammary gland devel-
opment and to find the most sensitive endpoints
representing each of the three developmental types, (i) duc-
tal development, (ii) gland differentiation and (iii) density.
Materials and methods
Experimental design
In this study, 40 time-mated nulliparous young adult
Wistar rats (HanTac:WH, Taconic Europe, Ejby, Den-
mark) were supplied at gestation day (GD) 3 of pregnancy.
On the day after arrival (GD 4), the dams were distributed
into four groups of ten animals to obtain similar weight
distributions in each group. The animals were housed in
pairs until GD 18 and alone thereafter under standard con-
ditions in semi-transparent polycarbonate cages (15 · 27 ·
43 cm) with Aspen bedding (Tapvei; Brogaarden, Gentofte,
Denmark) situated in an animal room with controlled
environmental conditions (12 h light-dark cycles with light
starting at 9 p.m., light intensity 500 lux, temperature
21 ± 2 C, humidity 50 ± 5%, ventilation eight air changes
per h). A complete rodent diet for growing animals
Altromin 1314 (Soy- and alfalfa-free; Altromin GmbH,
Lage, Germany) and acidified tap water was provided ad
libitum. The dams were dosed by gavage from GD 7 to the
day before expected birth (GD 21) and from PD 1 until PD
21 or 22. The control group was dosed with vehicle (corn
oil; Sigma, Brøndby, Denmark) and the exposure groups
were given 5, 15 or 50 lg ⁄ kg bw ⁄day of ethinyl oestradiol
(CAS 57-63-6 from Steraloids, nr. E1550-000). The
expected day of delivery, GD 23, was designated PD 1. The
animal studies were performed under conditions approved
by the Danish Agency for Protection of Experimental Ani-
mals and by the in-house Animal Welfare Committee of
the National Food Institute at the Technical University of
Denmark.
Mammary gland whole mounts
A total of 1–3 pups per gender per litter were weighed,
anaesthetized and decapitated for necropsy. Male pups
were necropsied on PD21 and female pups on PD22. The
fourth abdominal mammary glands were dissected at nec-
ropsy including the nipple and the lymph node. The tissue
was spread onto glass slides and covered with parafilm
while drying for minimum 2 h, then fixed, stained with
alum carmine, dehydrated and mounted.
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Whole mounts were scanned in a flatbed scanner
(4800 dpi) and measurements were performed on the dig-
ital images in Image Pro Plus 7.0 software (Media Cyber-
netics, Bethesda, MD, USA). Spatial calibration was
performed for each picture before measurements were
made, and data produced were exported to a Microsoft
Excel spreadsheet. The glandular densities were scored by
visual inspection of the digital images. The number of
TEBs was determined by evaluation of the whole mounts
under a light microscope at 5–10 times magnification.
Buds were determined as TEBs if they had a diameter
‡100 lm as described by Brown et al. (Brown et al.,
1998). The single experimenter doing the morphometric
analyses was blinded to the dose-groups. A parameter was
not measured on the whole mount if the part of the
gland important for the parameter was missing.
Several measurements were performed for each mam-
mary gland. First, seven different parameters were mea-
sured representing the (i) ductal outgrowth: (1) number
of primary ducts, (2) longitudinal growth (mm), (3)
transverse growth (mm), (4) area occupied by the epithe-
lial tree (mm2), (5) outline area (mm2) determined by
the outline of the mammary gland, (6) when the fifth
mammary gland was present, the distance between the
fourth and fifth mammary gland was measured and (7)
relative growth to the lymph node assessed as the
percentage of the total distance from the nipple to the
lymph node covered by mammary tissue. Next, three dif-
ferent parameters were measured representing the (ii)
gland differentiation: (8) score of number of lateral buds
(1–5), (9) number of TEBs in zone C, (10) number of
TEBs in the whole gland. Finally, two different densities
were achieved taking into account the evaluation of both
budding and branching development with a score from
1 to 5, with 1 representing few branches and buds, and 5
representing highly branched glands with many buds:
(11) overall density defined as an average of the density
of the whole gland, (12) highest density in the gland
assessed as the highest density present in the gland
(Fig. 1). Most of these parameters are used in other
A B
C D
Figure 1 Female mammary gland whole mounts PD22. (A) Mammary gland with overall density score 3 and highest density 4 (box). (B) Mammary
gland with zone C outlined. (C) Mammary gland with the parameters ‘outline area’ (white polygon), ‘longitudinal growth’ (black dotted line) and
‘transverse growth’ (white dotted line) depicted. The black box is enlarged in d. (D) Mammary gland viewed in a microscope with magnification
5·. TEBs are shown (arrows). Bars in the lower left corner of each picture represent 1 mm. The dark areas in the lower right corner of pictures a,
b and c are lymph nodes.
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laboratories to evaluate mammary gland whole mounts.
However, the relative growth to the lymph node is a new
alternative to measure the ductal outgrowth taking into
account the size of the animal without using the body-
weight (bw). Studies have shown that ethinyl oestradiol
decreases offspring neonatal bw and weight gain until
PND 21 (Masutomi et al., 2001; Takagi et al., 2004).
Thus, a measurement independent of the bw is desirable.
The two means of counting TEBs were performed to
compare the relationship between the number of TEBs in
the most distant part of the gland (zone C) (Fig. 1) and
the TEBs in the whole gland. The measurement 12, ‘high-
est density’, is an alternative to the overall density scoring
as some glands are unequally dense, and it may be of
interest to discern if a mammary gland is affected with
higher density in any part of the gland (Fig. 1). As mam-
mary glands from control female and male rats are
slightly different, a different scale for density scoring was
used for male and female mammary glands to be able to
differentiate even small changes in the male mammary
glands.
Statistics
For all analyses, the alpha level was set at 0.05 and the
litter was the statistical unit. Statistical analysis of variance
(anova) was performed using sas Enterprise Guide 3.0
statistical software (SAS Institute Inc, Cary, NC, USA).
Correlation and linear regression analysis were performed
in Graph Pad Prism 5. Discrete data were analysed with a
one-way anova (Mixed Models) with bw as a covariate
and litter as a random factor. However the bw was
analysed without a covariate. The relative growth to the
lymph node is a measure taking into account the size of
the animal, and the statistical analysis was consequently
performed without bw as a covariate. The litter means of
the mammary gland densities were evaluated for treat-
ment effects using a one-way anova with heterogeneous
variance. Residuals were verified for homogeneity of
variance and normal distribution before performing the
statistical tests. The number of TEBs in zone C and in the
whole gland in male mammary glands varied from 0 to 2,
except for few animals with more TEBs. Therefore, a sup-
plementary Fisher’s exact test was performed for the male
TEBs. The TEBs in zone C and TEBs in the whole gland
were tested for correlation within each dose group with a
two-tailed Pearson analysis.
Results
In this study, some of the time-mated animals were not
pregnant. Thus, the number of litters in the control and
the two highest dose groups varied between seven and
nine, and the lowest dose group had six litters. All control
dams gave birth on GD23. One dam in the lowest dose-
group and five of eight pregnant dams in the highest
dose-group gave birth on GD24.
Female mammary glands
Mammary gland whole mounts in Wistar rats exposed
to ethinyl oestradiol perinatally were evaluated for (i)
ductal development, (ii) gland differentiation and (iii)
density using several different measurements (Tables 1
and 2). In the female rats, the ductal development
showed no significant changes in any group for number
Table 1 Female mammary gland evaluation PD 22 after in utero and lactational exposure to 0, 5, 15 or 50 lg ⁄ kg ⁄ day of ethinyl oestradiol.
Mean of litter ± SD
Female PD22 Control 5 lg ⁄ kg 15 lg ⁄ kg 50 lg ⁄ kg
Body weight (g) 42.3 ± 4.5 39.0 ± 2.2 37.6 ± 4.3 38.0 ± 5.7
Number of primary ducts 2.5 ± 0.5 2.7 ± 0.6 2.7 ± 0.7 2.61 ± 0.5
Longitudinal growth (mm) 11.0 ± 1.2 10.6 ± 0.9 11.0 ± 1.6 10.7 ± 1.1
Transverse growth (mm) 6.0 ± 1.2 6.2 ± 1.1 6.2 ± 1.1 6.9 ± 1.5
Tree area (mm2) 26.4 ± 12.6 27.8 ± 4.7 31.1 ± 5.3 34.2 ± 8.9
Outline area (mm2) 40.9 ± 13.2 46.9 ± 8.5 47.1 ± 9.3 46.1 ± 9.7
Distance to fifth gland (mm) 10.3 ± 0.7 10.6 ± 1.3 7.8 ± 1.2a 7.6 ± 1.0a
Relative growth to the lymph node (%) 83.8 ± 7.8 87.8 ± 7.6 96.1 ± 6.5a 88.1 ± 9.4
Bud density (score) 3.0 ± 0.7 3.0 ± 0.7 3.3 ± 0.7 3.5 ± 1.1
TEBs in whole gland 23.6 ± 16.7 14.9 ± 19.4 32.1 ± 17.7 26.7 ± 12.4
TEBs in zone C 10.1 ± 10.7 7.0 ± 10.1 13.4 ± 9.6 12.9 ± 5.8
Overall density (score) 2.6 ± 1.1 2.5 ± 1.1 3.6 ± 0.7a 3.4 ± 1.1
Highest density (score) 3.1 ± 0.7 3.0 ± 1.0 3.8 ± 0.7 3.5 ± 1.0
aStatistically significantly different from controls, alpha level at p < 0.05. N = 4–8 litters, 1–3 pups per litter.
PD, pup day; TEBs, terminal end buds.
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of primary ducts, longitudinal growth and transverse
growth (Table 1). The measurements of the area occu-
pied by the mammary gland were increased with dosing,
yet not statistically significant for either the outline of
the glandular area or the tree area. The distance to the
fifth gland was significantly shorter than controls in the
two highest dose-groups. An attempt was made to make
measurements independent of the bw using the relative
growth to the lymph node. This measurement was sig-
nificantly higher than controls for rats given 15 lg ⁄ kg
ethinyl oestradiol. The gland differentiation showed a
trend of an increased number of TEBs, however no sta-
tistically significant differences in the bud density, the
number of TEBs in zone C (TEBC) or TEBs in the
whole gland (TEBall) were present. When comparing
TEBC and TEBall, the number of TEBC increased with
the number of TEBall (Fig. 2). Data showed a clear cor-
relation in all the dose-groups (r2 > 0.8). The overall
density and highest density of the glands appeared
increased by oestradiol exposure, but this was only sta-
tistically significant for the overall density in the group
dosed with 15 lg ⁄kg ethinyl oestradiol (Table 1, Fig. 3).
The bw of the female offspring PD22 appeared slightly
decreased with dosing, but this was not statistically
significant.
The measurements tree area and the number of TEBs
in the zone C had a high variation in the controls, with
standard deviations (SD) equal to the half of the mean or
more (Table 1). The high variation was because of a
single animal in the control group with more than five
times more TEBs (34) compared with the mean of the
rest of the controls (6.1 ± 2.2). Similarly, the mean and
variation of the tree area was also increased because of
this animal, which can be considered an outlier within
normal biological variation.
Male mammary glands
Male mammary glands PD 21 were evaluated for the
same endpoints as the female mammary glands (Table 2).
Table 2 Male mammary gland evaluation PD 21 after in utero and lactational exposure to 0, 5, 15 or 50 lg ⁄ kg ⁄ day of ethinyl oestradiol. Mean
of litter ± SD
Male PD21 Control 5 lg ⁄ kg 15 lg ⁄ kg 50 lg ⁄ kg
Body weight (g) 39.4 ± 4.2 39.5 ± 5.5 36.8 ± 5.3 34.4 ± 4.8
Number of primary ducts 2.1 ± 0.7 2.0 ± 0.0 1.9 ± 0.5 2.0 ± 0.0
Longitudinal growth (mm) 10.2 ± 1.3 10.6 ± 1.3 9.4 ± 1.5 9.6 ± 2.0
Transverse growth (mm) 5.2 ± 0.9 5.6 ± 0.2 5.2 ± 0.9 5.2 ± 0.9
Tree area (mm2) 14.5 ± 4.4 18.1 ± 4.7 12.4 ± 6.6 14.3 ± 6.1
Outline area (mm2) 46.0 ± 8.6 45.9 ± 7.9 37.3 ± 15.8 37.0 ± 14.3
Relative growth to the lymph node (%) 77.4 ± 6.8 75.3 ± 10.9 83.3 ± 10.9 86.2 ± 10.3
Bud density (score) 1.6 ± 0.7 1.8 ± 0.3 1.9 ± 0.7 2.8 ± 1.6
TEBs in whole gland 0.7 ± 0.4 0.6 ± 0.9 1.2 ± 1.5 7.2 ± 7.3a
TEBs in zone C 0.6 ± 0.4 0.6 ± 0.9 0.9 ± 1.2 3.8 ± 4.0a
Overall density (score) 1.9 ± 0.6 1.9 ± 0.2 2.2 ± 0.7 2.8 ± 1.0a
Highest density (score) 2.3 ± 0.5 2.1 ± 0.5 2.6 ± 0.7 3.3 ± 1.1a
aStatistically significantly different from controls, alpha level at p < 0.05. N = 4–9 litters, 1–3 pups per litter.
PD, pup day; TEBs, terminal end buds.
Figure 2 Correlation between the number of TEBs in the zone C and in the whole mammary gland in female and male Wistar rats PD21–22
after exposure to ethinyl oestradiol perinatally. Each data point represents the mean number of TEBs of a litter. The axes are broken in the figure
for the male TEBs to make the correlations of the three lowest dose–groups visible.
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The fifth mammary gland was only present in five of the
whole mounts; hence this parameter is not shown. When
examining the other measurements for ductal develop-
ment, no statistical significant changes were seen in the
mammary glands. For the gland differentiation, a statisti-
cally significant increase was only found for both the
number of TEBs in the whole gland and the number of
TEBs in the zone C at 50 lg ⁄kg compared with control
(Fig. 4). The number of TEBs varied from 0 to 2 in con-
trols and rats exposed to 5 lg ⁄ kg ⁄day of ethinyl oestra-
diol, independently of the zones (Fig. 2). TEBC and
TEBall correlated well in all dose groups (r2 > 0.7)
(Fig. 2). With regard to the densities, both density mea-
surements were significantly higher in the highest dose
group (Fig. 4). The decrease in bw of male pups PD21
was not statistically significant.
Discussion
Pups in this study were exposed to ethinyl oestradiol
perinatally to evaluate whether mammary gland examina-
tion in prepuberty, which is known to be sensitive to
oestrogenic compounds in mice and certain strains of
rats, is also sensitive to a potent oestrogen in Wistar rats.
Female mammary gland whole mounts PD22 revealed
increased branching and budding expressed by an
increased overall density of the mammary glands in
animals exposed to 15 lg ⁄kg ⁄day of ethinyl oestradiol
perinatally. Increased growth of branches was also shown
by increased relative growth towards the lymph node at
15 lg ⁄kg ⁄day and a decreased distance to the neighbour-
ing fifth gland at the doses 15 and 50 lg ⁄ kg ⁄day.
In male mammary glands, the current study showed a
statistically significant increase in TEB numbers and density
in rats exposed to 50 lg ⁄kg ⁄day of ethinyl oestradiol com-
pared with controls. This confirms the expectations that
perinatal exposure to oestrogenic compounds progresses
prepubertal development of mammary glands in males and
females (Cotroneo et al., 2002; You et al., 2002).
Based on the present findings, the most sensitive end-
points in pre-pubertal female Wistar rats exposed to ethi-
nyl oestradiol perinatally seem to be: the distance to the
fifth gland, the relative growth to the lymph node and the
overall density of the gland. In comparison, endpoints
A B
C D
Figure 3 Female mammary gland density and terminal end bud (TEB) number PD22.(A) Mammary gland of control rat with density score 2.
(B) Mammary gland of female rat exposed to 15 lg ⁄ kg of ethinyl oestradiol with density score 4. (C) TEB number in female mammary glands.
Number of TEBs was increased with dosing, but the increase was not statistically significant. (D) Mean densities ± SD. Each point represents the
mean density of a litter. Density was statistically significantly increased in females exposed to 15 lg ⁄ kg of ethinyl oestradiol (p < 0.05) (*). Bars in
pictures a and b represent 1 mm.
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most sensitive in male Wistar rats seem to be: the num-
ber of TEBs in the whole gland, the number of TEBs in
the zone C and the two means of measuring the density
of branches and buds. Regarding the TEBs, the correla-
tion between TEBC and TEBall, show that TEBC increases
similarly when TEBall increases in both male and female
Wistar rats. Hence, TEBC is a good parameter represent-
ing the number of TEBall, making this endpoint fast and
easy to achieve. In female rats, a tendency to increased
TEB numbers (in whole gland or region C) was not sta-
tistically significant. For females, data for the tree area
and the number of TEBs in zone C showed a high varia-
tion in all groups. The control group had a mean number
of TEBs in zone C of 10 and a SD of 11 [coefficient of
variance (CV) = 110%]. A single animal in the control
group was responsible for the high variation. Thus,
changes in the tree area and the number of TEBs in zone
C may have been more difficult to detect in the present
study because of this animal. In a study by Moral et al.
(2008) the number of TEBs in zone C in control animals
is approximately 30 ± 5 (mean ± SEM) (read-out from
graph in Fig. 1, Moral et al., 2008), leading to a SD of 15
(n = 9) and a CV of 50% (Moral et al., 2008). Other
studies on S–D rats showed a similar variation in the
number of TEBs PND 21. Cotroneo et al., 2002 and Tan
et al., 2004 showed 34 ± 3 and 43 ± 5 (mean TEBs ±
SEM), respectively, leading to a CV of 26.6% for Tan
et al., 2004 (Cotroneo et al., 2002; Tan et al., 2004). Thus,
the variation in the number of TEBs in zone C in female
rats is expected to be high, and the variation in the pres-
ent study is further increased because of one animal.
TEBall and TEBC numbers varied between zero and
two in most male mammary glands. For the TEBall, only
2 of 14 and 4 of 11 animals had more than two TEBs in
the groups treated with 15 lg ⁄kg and 50 lg ⁄ kg of ethinyl
oestradiol respectively. Hence, a Fisher’s exact test was
run. However, some animals in the group exposed to
50 lg ⁄ kg of ethinyl oestradiol had noticeable more TEBs
(more than 10). This number of TEBall was increased
more than fivefold, and it was considered important to
take this into account in the statistical test together with
the litter. Thus, an anova with bw as a covariate and
litter as a random factor was run in addition to the Fish-
er’s exact test. Both the anova and the Fisher’s exact test
A B
C D
Figure 4 Male mammary gland density and terminal end bud (TEB) number PD21. (A) Mammary gland of control rat with density score 2.
(B) Mammary gland of male rat exposed to 50 lg ⁄ kg of ethinyl oestradiol with density score 3. Notice the presence of more buds in picture B
than A. (C) TEB number in male mammary glands. Number of TEBs was statistically significantly increased in rats exposed to 50 lg ⁄ kg of ethinyl
oestradiol (p < 0.05) (*). (D) Mean overall densities + SD. Each point represents the mean overall density of a litter. Overall density was statistically
significantly increased in males exposed to 50 lg ⁄ kg of ethinyl oestradiol (p < 0.05) (*). Bars represent 1 mm.
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showed the same result for TEBall, i.e. a statistically
significant increase in the group exposed to 50 lg ⁄ kg of
ethinyl oestradiol. It should be noted that with this heter-
ogeneous type of data, it is important to select appropri-
ate statistical analyses.
As the variation in the number of TEBs in female rats
is high, only major changes in the number of TEBs can
be detected. However, a low variation is observed in the
number of TEBs in male mammary glands. Hence, this
endpoint is more sensitive in male mammary glands.
These findings are in accordance with a study by You
et al., 2002 (You et al., 2002). In that study, mammary
glands were evaluated from male and female pups of
dams exposed via feed to the oestrogenic compounds
genistein or methoxychlor at 300 or 800 ppm (equally to
15–30 and 40–80 mg ⁄ kg) in the diet throughout preg-
nancy and lactation until necropsy at PND 22. Similar to
the current study, You et al. found an increase in the
number of TEBs in male mammary glands, but not in
female mammary glands. These findings suggest that male
mammary glands indeed are more sensitive to oestrogen
than female mammary glands regarding the number of
TEBs. On the other hand, results from the present study
suggest that the relative growth to the lymph node is a
more sensitive endpoint to oestrogenic chemicals in
female rat mammary glands than in males.
In the present study, the statistical tests for the area and
distance to the fifth gland, includes bw measurements to
take the size of the animal into account. However, the bw
may reflect both the size of the animal but also the condi-
tion of the animal being either thin or overweight. Mea-
surements independent of the bw are desirable, and other
laboratories have also tried to make such measurements
using the outline tree area relative to the fat pad area (Mu-
n˜oz-de-Toro et al., 2005). Laboratories have also measured
the distance to the lymph node, but they have made the
measurement in mm or given a score (Mun˜oz-de-Toro
et al., 2005; Moon et al., 2007). In the current study, the
distance is assessed as the migration towards the lymph
node as a percentage of the total distance from the nipple
to the lymph node. Hereby, this measurement is also inde-
pendent of the bw. Further studies on this endpoint may be
needed to validate this endpoint and resolve whether this is
indeed more sensitive in female rats than male rats.
As mentioned earlier, mammary glands are sensitive to
EDC exposure during several and long periods of the devel-
opment of the animal. In the current study, animals were
exposed to ethinyl oestradiol during most of the uterine life
(GD 7–21), including the period shown by Rayner et al. to
be the most sensitive period in utero for mammary glands
(GD 17–19), and during their post-natal life from birth
until necropsy PD 21–22 (Rayner et al., 2005). As follows,
offspring in the current study were exposed during all time
points critical for pre-pubertal mammary gland develop-
ment. An important developmental stage for the mammary
glands is puberty, where the glands undergo extensive pro-
liferation. Some studies have shown that male and female
mammary glands may only show extensive changes to
exposure after puberty, with no or barely prominent
changes before puberty (Brown et al., 1998; You et al.,
2002; Wang et al., 2006). As a consequence, it is desirable
to evaluate the status of the mammary glands post-puberty
and compare with the results from PD21–22 to obtain an
overview of the developmental effects of ethinyl oestradiol
pre- and post-natally on the mammary glands before and
after this developmental stage.
Latendresse et al. revealed histological changes seen as
hyperplasia in mammary glands of male 90-day-old S–D
rats chronically exposed to ethinyl oestradiol in low con-
centrations close to 0.2 lg ⁄ kg ⁄day in the diet during
pregnancy, lactation and adult life (Latendresse et al.,
2009). However, this was the only age and exposure
group where hyperplasia was observed at this low expo-
sure to ethinyl oestradiol. In 50 days old male rats, mam-
mary hyperplasia was only seen at 5 lg ⁄ kg. Male rats
exposed from conception to weaning also showed mam-
mary gland hyperplasia on PND 50 at 5 lg ⁄ kg. Thus,
perinatal exposure to ethinyl oestradiol does affect mam-
mary glands, but a chronic exposure continuing in adult
life may affect mammary glands at lower doses. In the
present study, no statistically significant changes were
seen in males at 5 and 15 lg ⁄ kg ⁄day of ethinyl oestradiol.
This may reflect the difference in strain, the differences in
dosing by gavage compared with dosing in the diet lead-
ing to a different internal dose or it may reflect that
effects are only seen at high doses at this age. Another
possibility is that histological sections may be able to
show further changes at lower concentrations of ethinyl
oestradiol compared with whole mount evaluation.
In female whole mounts, the current study showed
statistically significant changes in two morphological analy-
ses at 15 lg ⁄ kg ethinyl oestradiol, but not at 50 lg ⁄ kg. This
may be because of a large variation in the measurements or
a smaller group size in the highest dose group compared
with the group exposed to 15 lg ⁄ kg ⁄day of ethinyl oestra-
diol for these endpoints (Table 1, Fig. 3). As some parame-
ters were not possible to measure in all specimens, the
group size varied between 4 and 7 litters for female rats in
the highest dose-group and between 6 and 8 litters for the
dose group exposed to 15 lg ⁄ kg ⁄day. Another possibility is
suggested by Vandenberg et al., showing a non-monoto-
nous dose–response curve for morphological analysis in
whole mounts in female mice PND 35 mammary glands in
response to increasing doses of 17b-oestradiol ranging
from 0.25 to 50 lg ⁄ kg ⁄day from PND 25–35, with a maxi-
mal effect at 5 lg ⁄ kg ⁄day (Vandenberg et al., 2006). It is
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possible that the presence of endogenous oestrogen in
female rats cause this non-monotonous dose–response in
female rats and not in male rats. Ethinyl oestradiol may act
as an oestrogenic agonist at low doses, but higher doses of
ethinyl oestradiol may inhibit the actions of endogenous
oestrogen by competitive binding to the oestrogen recep-
tor, as discussed for EDCs by Meyers et al. (Myers et al.,
2009). In addition, Vandenberg et al. suggest that oestro-
gen can have proliferative as well as apoptotic effects in the
mammary glands, and these opposing effects may lead
to differences in response at low and high dose levels
(Vandenberg et al., 2006). However, the possibility of
non-monotonous dose–response relationships for ethinyl
oestradiol is yet to be verified.
To our knowledge, no studies have been published
examining mammary whole mounts from rat pups
exposed to ethinyl oestradiol, yet many other oestrogenic
compounds have been studied in whole mounts of mam-
mary glands at PD 22. The results from the present study
confirm the changes found by Cotroneo et al. (2002)
showing increased branching and alveolar structures PND
21 in female S–D rats exposed pre-pubertally to oestradiol
benzoate (Cotroneo et al., 2002).
Taken together, this study shows that perinatal exposure
to strong oestrogen enhances male and female Wistar rat
mammary gland development PD21–22. Moreover, the
most sensitive endpoints at PD21–22 in Wistar rats after
exposure to oestrogenic-acting chemicals in morphological
analysis of mammary glands in whole mounts differ
between male and female rats, except for the overall den-
sity. Hence, the overall density is a good representative for
branching and budding for both genders. In female rats,
the ductal outgrowth may be represented by the distance
between fourth and fifth gland, or by the relative growth to
the lymph node. The gland differentiation may be evalu-
ated by counting the number of TEBs in zone C.
There is an evident interest in studying the development
of mammary glands, and a validation process with more
method development and extensive evaluation of the mam-
mary gland samples is important to obtain data that facili-
tates further considerations on inclusion of male and
female rat mammary gland investigation as an endpoint
e.g. OECD test guidelines for Reproductive Toxicity. It is
desirable to find the most sensitive endpoints to standard-
ize the study of mammary gland whole mounts and recom-
mendations for enhancing mammary gland evaluation in
guideline toxicology studies have been proposed (Makris,
2010). Moreover, a review by Rudel et al. (2011) showed
that early life environmental exposures can alter mammary
gland development, disrupt lactation and increase suscepti-
bility to breast cancer. They concluded that assessment of
mammary gland development should be incorporated in
chemical test guidelines and risk assessment (Rudel et al.,
2011). Specified outgrowth parameters and developed
criteria for density scoring may be useful for development
of guidance for evaluation of the rat mammary gland as an
endocrine sensitive endpoint. We recommend including
mammary gland development as a novel endpoint in
OECD Test Guidelines including TG 443 Extended
One-Generation Reproductive Toxicity Study. In our fur-
ther studies, we plan to continue the method development
in general and provide data on the relevance and sensitivity
of mammary gland development as a novel endpoint in
OECD test guidelines. Further studies in post-pubertal and
adult Wistar rats and exposure to weak oestrogenic com-
pounds can be used to further validate the mammary gland
as an endpoint in reproductive toxicity studies, and to
elucidate how early life environmental exposures may alter
mammary gland development, disrupt lactation and alter
susceptibility to breast cancer.
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Panel discussion
Toine Bovee (Wageringen, Netherlands):
You used ethinyl oestradiol (EE2) as a gold standard for a
compound with oestrogenic activity, but it is not a pure
oestrogen receptor (ER) agonist because it is also an
androgen receptor (AR) agonist and an AR antagonist. Its
antiandrogenicity might be the cause of the effects seen
on the male prostate gland. EE2, therefore, is probably
not a good reference compound for ER agonists. When
pesticides are being characterized as oestrogenic or anti-
androgenic, it is important to know their mode of action.
Dienestrol is a synthetic oestrogen and is a pure ER ago-
nist: this might be a better reference compound and it
would be useful to compare outcomes caused by dienes-
trol with EE2. EE2 might be a good reference compound
for pesticides which have both oestrogenic and antiandro-
genic activities.
Julie Boberg (Søborg, Denmark):
Studying the effects of EE2 is relevant to the other
endocrine disrupters in the environment all of which
have different types of effects, and it is difficult to dis-
criminate between pure oestrogenic effects and pure
antiandrogenic effects. We have ongoing studies asses-
sing mixtures of several different environmental chemi-
cals each characterized as putative oestrogens or
putative antiandrogens, including known pesticides and
phthalates. We are looking at the mammary effects of
so-called oestrogens and so-called antiandrogens com-
pared to controls.
Ana Soto (Boston, USA):
A ‘‘round robin’’ examination organized by Susan Fenton
has shown quantitatively similar results in rats and mice
when assessing endocrine effects on mammary glands.
The mouse mammary gland is monoplanar, more sensi-
tive and easier to work with. Why do you use rats rather
than mice?
Julie Boberg:
The rat mammary gland is three dimensional which
causes difficulties, and it may be easier to work with
mice. However, male mice only have rudimentary breast
tissue, and it has been shown that mammary glands of
male rats are particularly sensitive to endocrine disrupting
chemicals. Also, rats are often used for regulatory studies
and it is essential to get information on the sensitivity to
mammary gland changes in rat strains used for regulatory
studies.
Ana Soto:
The presence of male breast tissue in mice is strain speci-
fic, and we have seen effects of bisphenol A (BPA) in
male mammary glandular tissue in mice.
Anna-Maria Andersson (Copenhagen, Denmark):
You see gross morphological changes in the breasts of rats
exposed to oestrogens during fetal life, and you alluded
to the increased risk of breast cancer. Do you think that
prenatal exposure might make the breast tissue more sen-
sitive to exposure to carcinogens or hormonal changes in
later life?
Julie Boberg:
There are many studies indicating that prenatal exposure to
endocrine disrupters alters the susceptibility to carcinogen-
esis and tumour induction later in life. It is also possible
that responses to hormonal challenges are influenced by
early exposure to endocrine disrupters but only a few stu-
dies have been performed and more research is required.
Anna-Maria Andersson:
Rat and human breast tissues are similar in many ways
but there is one important difference. Humans are the
only species with breasts outside of the lactating period
and develop breasts at puberty. The sensitivity of breast
tissue outside of pregnancy and lactation might be speci-
fic to humans.
Julie Boberg:
Rats also develop breast tissue at puberty.
Shanna Swan (New York, USA):
You stated that pregnant women are not exposed to ethi-
nyl oestradiol (EE2) during pregnancy because they stop
taking the oral contraceptive pill in order to become
pregnant. But that is not entirely true because some
breakthrough pregnancies occur when women are not
taking the pill properly. They do not realize that they are
pregnant until later in gestation when they are still taking
the pill resulting in exposure of the human fetus to EE2.
A few years ago Fred vom Saal suggested studying this
aspect of human prenatal exposure to oestrogens and it is
a survey which must be performed because of the magni-
tude of the exposure. Although only a small percentage of
pregnant mothers continue to take the pill, overall there
are a substantial number of fetuses exposed, and the
effects will be missed if we do not look for them.
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Perinatal exposure to endocrine disrupting chemicals with estrogenic activity can 4 
adversely affect reproductive development, but few studies evaluating estrogen-5 
sensitive endpoints have been performed in Wistar rats. Therefore, time-mated Wistar 6 
rats (n=10) were gavaged during gestation and lactation with 0, 5, 15 or 50 μg/kg 7 
bw/day of ethinyl estradiol. 8 
Increased anogenital distance, urethral slit length and number of nipples was observed 9 
in female offspring. Prostate mRNA levels were affected prepubertally. For male and 10 
female mammary gland and prostate histology the expected differences were weak or 11 
absent, possibly due to termination of exposure at weaning.  12 
In conclusion, ethinyl estradiol affected offspring before puberty and gave rise to 13 
persistant genital malformations following withdrawal of ethinyl estradiol exposure. 14 
Female external sexual characteristics and changes in prostates and male and female 15 
mammary glands should be in focus of future studies on estrogenic environmental 16 
chemicals.   17 
 3 
Introduction  1 
 2 
In humans, prenatal exposure to estrogenic chemicals such as diethylstilbestrol 3 
(DES), has been shown to adversely affect the reproductive development [1;2] and is 4 
furthermore associated with an increased risk of cancer in adulthood [1;3;4]. In 5 
toxicological in vivo studies, several endocrine disrupting compounds with an 6 
estrogenic mode of action have also been shown to adversely affect offspring after 7 
perinatal exposure. These include synthetic estrogens like ethinyl estradiol and 17β–8 
estradiol, as well as phytoestrogens, butyl- and propylparaben (used as preservatives 9 
in cosmetics), bisphenol A (used in polycarbonate plastics), and some UV-filters 10 
(used in sunscreens and packaging) [5-10]. These are all compounds to which humans 11 
are exposed, and it is therefore important to obtain more knowledge on endpoints that 12 
in toxicological studies are sensitive to estrogenic action.  13 
 14 
The present study aimed at exposing pregnant Wistar rat dams to ethinyl estradiol as a 15 
positive control compound for estrogenic chemicals. The chosen dose levels were 16 
expected to affect reproductive parameters while avoiding foetal/neonatal morbidity 17 
[11-14]. In humans, ethinyl estradiol is used in contraceptive pills which contain 20-18 
50µg ethinyl estradiol, corresponding to 0.2-0.7µg/kg bw/day, and thus the doses 19 
selected in the present study (5, 15 and 50 µg/kg) were approximately 10 to 100 times 20 
higher than exposure of women taking contraceptive pills. It may be noted that 21 
endocrine-disrupting effects of estrogenic compounds have been observed at lower 22 
doses in some studies, but based on the traditional expectations of increasing 23 
responses at increasing doses, the selected doses were relatively high in order to 24 
increase the possibility of detecting reproductive effects. Increasing knowledge on 25 
low-dose effects have made it clear that non-monotonous dose response curves can be 26 
seen for various endpoints [15;16], but this was not addressed by the current dose 27 
selection. 28 
Previous studies examining the developmental effects of ethinyl estradiol as a model 29 
for estrogenic activity have mostly used Sprague-Dawley (SD) and Long-Evans (LE) 30 
rats, and strain differences have been reported for sensitivity to effects of estrogenic 31 
compounds [17-19]. The present study was conducted in outbred Wistar rats in order 32 
to investigate whether this rat strain is sensitive to a potent estrogen. The examination 33 
of endocrine sensitive endpoints in Wistar rats is particularly important in a regulatory 34 
perspective, as a large proportion of toxicological studies are performed in Wistar 35 
rats. Furthermore, some endpoints that have not previously been investigated 36 
thoroughly after perinatal ethinyl estradiol exposure, including malformations of 37 
female genitalia and changes in male mammary glands, were included in the present 38 
study.  39 
 40 
Two commonly used endpoints in reproductive toxicity studies examining endocrine 41 
disrupting effects are anogenital distance (AGD) and nipple retention. These 42 
endpoints are very sensitive to antiandrogenic action in male offspring [20-22], 43 
whereas perinatal ethinyl estradiol exposure has not previously been shown to affect 44 
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AGD or nipple retention in males [11;23]. In female offspring, AGDs have been 1 
shown to be affected by ethinyl estradiol, although findings are not consistent among 2 
studies [24-29]. In the few studies investigating nipple retention in females, no 3 
significant effects of estrogenic compounds were seen  [5;28].  4 
 5 
Estrogenic compounds are known to enhance female mammary development and 6 
ethinyl estradiol has been shown to cause lobular hyperplasia in adult females [13;14]. 7 
Little is still known about effects of perinatal exposure to estrogenic chemicals on 8 
male mammary glands, whereas a shift to a female-like morphology in male 9 
mammary glands has been shown after exposure to estrogenic compounds in 10 
adulthood [12;30-33]. Data on early mammary development were presented in 11 
Mandrup et al (2012) [34], and showed that ethinyl estradiol affected the density of 12 
mammary whole mounts at pup day (PD) 21-22 in both males and females caused 13 
increased number of terminal end buds in males and increased outgrowth in females. 14 
In the present paper, elaborated examinations of female and male mammary glands in 15 
whole mounts at PD50 and in histological sections at PD50 and 90 are presented. 16 
 17 
Other reproductive parameters that have previously been shown to be sensitive to 18 
perinatal estrogen exposure include timing of sexual maturation, regularity of the 19 
estrous cycles, external genital malformations, male reproductive organ weight and 20 
prostate development. Several estrogenic compounds, including ethinyl estradiol, 21 
17β-estradiol and bisphenol A have been show to advance puberty in female rats 22 
[28;35-37], whereas exposure to estrogenic compounds seems to delay sexual 23 
maturation in SD and LE males [14;38-40]. Ethinyl estradiol, genistein and bisphenol 24 
A, have also been shown to cause more animals to cycle irregularly [27;41;42], and 25 
studies investigating the effects on external genital malformations in females have 26 
shown an increase in the urethral slit length in SD rats exposed to ethinyl estradiol 27 
[29;43]. Prostate development is known to be affected by estrogenic compounds, as 28 
an increased incidence of prostatic lesions including hyperplasia and inflammatory 29 
cell infiltration has been shown in young adult rats after perinatal or neonatal 30 
exposure to estrogenic compounds [44;45]. These changes may be related to a 31 
decreased prostate weights seen before puberty [11] and altered expression of 32 
estrogen-sensitive genes. The current study therefore included histological 33 
examination of adult prostates and analysis of the mRNA expression for estrogen 34 
receptors (ER)α and ERβ and estrogen-regulated genes insulin-like growth factor 1 35 
(IGF-1), ornithine decarboxylase (ODC) and Complement-C3 in the prepubertal 36 
prostate. As the prostate is profoundly regulated by androgen receptors, changes in 37 
mRNA levels of the androgen receptor (AR) and the AR regulated genes TRPM-2 38 
and PBPC3 were also investigated in prepubertal prostates. 39 
 40 
 41 
Collectively, the current study examined an array of endocrine-sensitive endpoints to 42 
examine the sensitivity of Wistar rats to the expected estrogenic effects previously 43 
investigated by others in SD or LE rats, and to investigate further the influence of 44 
 5 
ethinyl estradiol on AGD, nipple retention and changes in mammary glands. The 1 
study was designed to investigate effects of ethinyl estradiol both following a period 2 
with full exposure of the dams to ethinyl estradiol (up to PD day 22) and a subsequent 3 
period where ethinyl estradiol was withdrawn (up to PD 90). This was done to 4 
investigate whether ethinyl estradiol leaves a footprint in the rats to cause 5 
(semi)permanent changes to rat physiology. 6 
 7 
 8 
Materials and methods 9 
 10 
Animals and study design 11 
40 time-mated nulliparous female Wistar rats (HanTac:WH, Taconic Europe, Ejby, 12 
Denmark) arrived on gestation day (GD) 3. The day after arrival (GD4), the dams 13 
were assigned to four groups of 10 animals with similar weight distributions in all 14 
groups. The animals were housed in pairs until GD17 and alone thereafter until birth 15 
in semi-transparent polycarbonate cages (15x27x43 cm) with Aspen bedding (Tapvei, 16 
Brogaarden, Gentofte, Denmark). They were housed under the following controlled 17 
environmental conditions: 12h light/dark cycle with dark at 9AM to 9PM, 22°C ± 18 
1°C, humidity of 55% ± 5 and 8 air changes per hour. A diet for growing rodents 19 
Altromin 1314 (soy- and alfalfa-free, Altromin GmBH, Lage Germany) and acidified 20 
tap water was provided ad libitum.   21 
The dams were dosed by gavage from GD7 to GD21and from pup day (PD) 2 to PD 22 
22 with 0, 5, 15 or 50μg per kg body weight (bw) per day of ethinyl estradiol (CAS 23 
57-63-6 from Steraloids, nr. E1550-000). Independently of actual day of delivery, the 24 
expected day of delivery, GD23, was designated PD1. Thereby, the age of the pups 25 
was related to the time of conception, but was rather similar to postnatal age. From 26 
PD 23 to PD 90 the offspring were not exposed to ethinyl estradiol. The control group 27 
was dosed with vehicle (corn oil, Sigma, Brøndby, Denmark, nr. C8267-2.5L). The 28 
animal studies were performed under conditions approved by the Danish Animal 29 
Experiments Inspectorate and by the in-house Animal Welfare Committee of the 30 
National Food Institute at the Technical University of Denmark.  31 
 32 
 33 
Evaluation of dams and offspring 34 
Dams were distributed equally into four dose group on GD4, according to body 35 
weight, and body weight gain of the dams was registered daily from GD7 to GD21 36 
and during lactation from the day after birth to PD22. Day of delivery was registered 37 
together with the weight and the distribution of male and female pups, and all live 38 
offspring were weighed again on PD6, 14, 22, 50/55, 76 and 90.  39 
All examined endpoints are listed in Table 1 by age and gender. 40 
Evaluation of endocrine sensitive endpoints in live offspring after delivery 41 
After delivery the weights of dams and individual pups were recorded and the pups 42 
were counted, sexed, checked for anomalies and anogenital distance (AGD) was 43 
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measured using a stereomicroscope. Additionally, anogenital index (AGDI), i.e. 1 
AGD/cubic root of body weight was calculated for all offspring. Pups found dead 2 
were macroscopically investigated for changes when possible. On PD14, all male and 3 
female offspring were examined for the presence of areolas/nipples, as described in 4 
Jacobsen et al [47].  5 
 6 
Necropsy PD21, 22 and 27 7 
On PD21 one to two male pups per litter and on PD22 one to two female pups per 8 
litter were randomly selected for necropsy. The pups were decapitated in CO2/O2 9 
anaesthesia. Liver, testis, ventral prostate, epididymis, seminal vesicle, levator 10 
ani/bulbocavernosus muscle (LABC), bulbourethral glands, and uterus were dissected 11 
from one male and one female per litter and weighed. Ovaries were dissected and 12 
weighed from 2 females per litter. Thyroids from female pups were excised from the 13 
thyroid cartilage and weighed, and thyroids from male pups were excised together 14 
with the thyroid cartilage and fixed in formalin for histological examination. Prostates 15 
were transferred to RNAlater for mRNA level analyses. 16 
On PD27, two males and two females per litter were weaned for assessment of 17 
puberty onset, testing of motor activity levels and later sacrifice on PD50/55 and 90. 18 
The rest of the pups were sacrificed on PD22. Dams were anaesthetised in CO2/O2 19 
and decapitated on PD27 and the number of implantations in the uterus was counted.  20 
 21 
Onset of puberty  22 
Onset of puberty was registered in all weaned male and female offspring. In female 23 
offspring sexual maturity was assessed by determining the day of vaginal opening 24 
(VO) as described by Goldman et al (2000) [48] and in male offspring puberty onset 25 
was assessed as time of preputial separation (PPS) [40;49]. Females were examined 26 
daily from PD27 and males from PD34. The age and weight at VO or PPS were 27 
recorded.  28 
 29 
Estrous cyclicity 30 
Vaginal smears were collected from PD75 between 8 and 10 AM in the beginning of 31 
the dark period for the animals, vaginal cells were transferred to a glass slide using a 32 
moistened swab. The smears were fixed in 96% ethanol and stained with Gill’s 33 
hematoxylin, Orange G6 and eosin-azure 50 (provided by VWR, Gentofte, Denmark) 34 
according to the adapted Papanicolaou (PAP stain) procedure reported by [51]. The 35 
stained smears were examined blindly to exposure group and stages were classified as 36 
Estrus (E), Metestrus (M), Diestrus (D) or Proestrus (P) or transitions between stages. 37 
These stages were recognized by the presence, absence or proportional numbers of 38 
epithelial cells, cornified cells and leucocytes as described in OECD guidance 39 
document 106 and by Goldman and coworkers (2007) [52;53].  40 
 41 
Necropsy PD50 and 55  42 
On PD50 (females) or 55(males) offspring one male and one female per litter were 43 
anesthetised in CO2/O2 and decapitated. On PD50 vaginal smear was performed after 44 
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sacrifice and stained with PAP stain to evaluate the specific stage of cycle. Ovaries 1 
and uterus were dissected and weighed and ovaries were fixed in formalin for 2 
histological examination. The uterus was weighed when intact as well as after 3 
draining. Abdominal (4th) mammary glands from male and female pups were 4 
dissected for whole mount and fixed in formalin for histology. 5 
Necropsy PD 90 6 
On PD90 the remaining one female and one male per litter were anesthetised in 7 
CO2/O2 and decapitated. Female pups were sacrificed in diestrous, evaluated by 8 
unstained vaginal smear. The vaginal smear was stained according to the same 9 
protocol for PAP staining and re-evaluated to confirm the stage of cycle. The 10 
following organs were excised and weighed from females: Liver, ovaries and uterus. 11 
The uterus was weighed when intact as well as after draining. From males, the 12 
following organs were excised and weighed: Liver, testis, epididymis, ventral 13 
prostate, seminal vesicle, levator ani/bulbocavernosus muscle (LABC), and 14 
bulbourethral glands, 4th mammary glands were excised from both males and females. 15 
Epididymis, ventral prostate, ovaries, uterus and mammary glands were fixed in 16 
formalin for histology. One testis was placed in Bouin’s fixative for histological 17 
examination.  18 
 19 
 20 
Genital malformations 21 
Males were evaluated for testicular descent, external genital malformations and loss 22 
of hair as described by Christiansen et al (2008) [54] at necropsy on PD21, 55 and 90. 23 
On PD55 all live males were similarly evaluated for genital malformations.  24 
Additionally, female pups were evaluated for malformations of the external genitalia 25 
at necropsy on PD22, 50 and 90. The urethral slit length was measured using a 26 
stereomicroscope with a scale (Figure 1), and a threshold for normal urethral slit 27 
length was set according to the deepest slit measured in controls.  28 
 29 
 30 
Mammary gland whole mounts and histology 31 
Whole mounts from PD50 females and PD55 males were scanned on a flatbed 32 
scanner (4800 dpi), and evaluation of the glands was performed using Image-Pro Plus 33 
7.0 software (Media Cybernetics, Bethesda, MD, USA). For male whole mounts 34 
PD55 the following parameters were measured: longitudinal growth, transverse 35 
growth, and the area (smallest polygon enclosing the mammary gland). The growth 36 
towards the lymph node was given a score (1-2 describing if the gland had reached 37 
the lymph nodes or not), and the density of the mammary glands was scored from 1 to 38 
5 with 5 being a gland with high branching and budding. Female whole mounts PD50 39 
were evaluated for the presence of beaded ducts as described by Vandenberg et al 40 
(2008) [55] and the density (score 1-5) in a standardised area between the nipple and 41 
the lymph nodes. The density scores for males and females were not comparable, as 42 
the scoring criteria were adjusted for the normal gender differences at this age. 43 
Additionally, the development of lobules was evaluated in the female mammary 44 
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glands PD50, both for predominant type of lobules present and the most developed 1 
type of lobule present in the gland (lobules type 1 to 3, as described by Russo et al 2 
1988) [56].  3 
Mammary glands for histology were routinely processed for paraffin embedding and 4 
stained with haematoxylin and eosin (H&E). At PD50, female mammary glands were 5 
evaluated in controls and in the highest dose group for lobule development (no lobular 6 
development, type 1 or type 2 lobules) and alveolar epithelium (single- or multi-7 
layered). Female mammary glands were evaluated bearing the stage of estrous cycle 8 
in mind, as verified by stained smear and uterus histology. At PD90, female 9 
mammary glands were evaluated for lobuloalveolar pattern, lobule development, 10 
amount of fibrous tissue in the stroma, secretory material and dilation of ducts. Only 11 
mammary glands from females confirmed to be in diestrous or metestrous after 12 
staining of the smears and confirmed by histology of uteri and ovaries were used for 13 
statistical evaluation of the histological findings PD90. Male mammary glands PD55 14 
were evaluated in controls and the highest dose group for vacuolation, secretory 15 
material in the ducts and tubuloalveolar pattern. Male mammary glands PD90 were 16 
evaluated in all dose groups for hypertrophy, epithelial vacuolisation and secretory 17 
material in the ducts. Additionally, male mammary glands were stained with periodic 18 
acid Schiff (PAS) and mucicarmine (Diagnostic BioSystems, Hague, Netherlands). 19 
PAS-stained mammary glands were evaluated for PAS positive secretory material and 20 
PAS positive granula in the cells. Mucicarmine stained mammary glands were 21 
evaluated for mucin positive secretory material.  22 
 23 
 24 
Histology of reproductive organs and thyroids 25 
Tissue samples for histological examination were routinely processed, embedded in 26 
paraffin, sectioned, stained with H&E and examined blinded to treatment groups.  27 
Thyroids from male pups PD21 were examined. 28 
Uteri and ovaries PD90 and uterus PD50 were evaluated for determination of stage of 29 
the estrous cycle. Ventral prostates PD90 were evaluated and were classified 30 
according to the dominating appearance of acini as regular (acini without or with 31 
minimal epithelial infoldings) or papillary (acini with folded epithelium) and 32 
according to the dominating epithelial type (simple squamous, cuboidal, columnar or 33 
high columnar). Additionally, the following were scored: Epithelial hyperplasia (score 34 
0-4 depending on the precence of acini with areas of hyperplastic epithelium; no acini 35 
(0); few foci with ≤3 acini (1); multifocal foci with ≤3 acini (2); multifocal foci with 36 
> 3 acini (3); all acini (4)), epithelial atrophy (score 0-3 according to the proportion of 37 
acini lined by flattened epithelium), and interstitial, intraluminal and total 38 
inflammation (score 0-4 relative to severity of inflammation).    39 
Adult testes were examined with emphasis on effects that may be related to endocrine 40 
disruption: a) spermatid retention, b) tubular dilation, c) degeneration of germ cells at 41 
specific stages, d) Leydig cell hyperplasia or adenoma. In the epididymal caput, 42 
examination focused on a) presence of sloughed testicular cells in epididymal lumen, 43 
b) amount of spermatids c) vacuolization and degeneration in epithelium of main 44 
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caput segment, d) disorganization of epithelium in initial segment, and e) interstitial 1 
inflammation. 2 
 3 
Measurement of mRNA levels in prepubertal prostate 4 
For mRNA level analyses, mRNA was isolated by use of the RNAeasy Mini Kit 5 
(Qiagen, Hilden, Germany) from samples stored in RNAlater. cDNA was next 6 
synthesised by use of the Omniscript RT kit (Life Technologies Europe BV, Naerum, 7 
Denmark) according to the description by the manufacturers. mRNA levels were then 8 
assessed by quantitative (q)PCR using TaqMan probes in combination with specific 9 
primer pairs. The investigated genes were: Insulin-like growth factor-1 (IGF-1), 10 
androgen receptor (AR), Transient receptor potential cation channel, Subfamily M, 11 
member 2 (TRPM-2), actin, Complement C3, Peroxisome proliferator-activated 12 
receptor (PPAR) α and γ, Estrogen receptor (ER)-α and β, Ornithine decarboxylase 13 
(ODC), and Prostate specific binding protein polypeptide C3 (PBP C3) in the ventral 14 
prostate of PND 21 males. Furthermore, the housekeeping genes 18s rRNA and β-15 
actin were evaluated. Primer and probe sequences are described in [57]. Primers and 16 
probes were mixed with TaqMan Fast Universal PCR Master Mix (Life Technologies 17 
Europe BV, Naerum, Denmark) and run on a Taqman 7900 HT qPCR apparatus 18 
(Applied Biosystems). The Ct value is the cycle number at which the amplified target 19 
reaches a defined threshold. First this value was determined for the raw qPCR data. 20 
Normalization was next done by subtracting the Ct value of the housekeeping gene 21 
18s rRNA from the Ct value of the target gene. This is the delta Ct value (dCt). Then 22 
2-dCt values representing arbitrary values of mRNA copy numbers were used for 23 
graphs and statistical analysis to test for differences between treatment groups.  24 
 25 
Statistics 26 
For all statistical tests was used SAS Enterprise Guide 3.0 statistical software (SAS 27 
Institute Inc, Cary, NC, USA) or GraphPad Prism (GraphPad Software, Inc., La Jolla, 28 
CA, USA). The level of significance was set at 0.05. Data with normal distribution 29 
and homogeneity of variance were analysed using analysis of variance (ANOVA). 30 
When more than one pup from each litter was examined, statistical analyses were 31 
adjusted using litter as an independent, random and nested factor in ANOVA, or 32 
analysis were done on litter means. Body weight and number of pups in a litter was 33 
included as a covariate in analyses when relevant. A Dunnett post hoc test was used to 34 
correct for multiple comparisons. In cases where normal distribution and homogeneity 35 
of variance could not be obtained by data transformation, a non-parametric Kruskall-36 
Wallis test was used, followed by a Wilcoxon test for pair wise comparisons. Discrete 37 
data were analysed using a one-way analysis of variance (ANOVA) with body weight 38 
(bw) as a covariate.   39 
The number of nipple/areolas was assumed to follow a binomial-distribution with a 40 
response range between 0 and θmax, with θmax being equal to the biologically 41 
possible maximal number of nipples in rats, either 12 or 13. The choice of θmax was 42 
decided by considering the global fit (information criterion of Schwarz). Litter effects 43 
on number of nipples and over-dispersion in the data were accounted by using 44 
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Generalized Estimating Equations. Statistical significance were assessed using 1 
multiple contrast tests (Dunnett contrasts, global error rate α = 5%, two-sided) [58]. 2 
These tests were chosen as they are already implemented in the SAS procedure PROC 3 
GENMOD. Estrous cyclicity data were analysed using logistic regression and tested 4 
for over dispersion with Deviance and Pearson Goodness-of-Fit tests and correction 5 
for over dispersion due to litter effects were used when appropriate. 6 
Histological data were analysed using a Fisher’s exact test with two to four scores.  7 Regarding gene expression, -2dCt values were tested for normal distribution and 8 analyzed by one-way ANOVA with post-test for linear slope and with Dunnett's 9 test. For all genes the correlation between prostate weight and mRNA level was 10 
analyzed by use of Pearson correlation calculation (Graph Pad Prism). 11 
 12 
 13 
Results 14 
 15 
Reproductive parameters 16 
The weight gain of dams from GD7 to GD21 was decreased in a dose-dependent 17 
manner with a statistically significant decrease at 50 µg/kg (p<0.001) (Table 2). 18 
Additionally, at 50 µg/kg, the gestation length was increased (p<0.001) (Table 2). 19 
There were no statistically significant effects on the number of implantations or 20 
perinatal loss of pups. No statistically significant difference in the distribution of 21 
females and males in the litters of dosed animals compared to controls was observed. 22 
At delivery, the weight of female pups was not affected. In contrast, the weight of 23 
male pups was decreased at delivery at 50 µg/kg (p<0.05).  24 
 25 
AGD, nipple retention and body weight gain after delivery 26 
In male offspring no statistically significant effects were observed in AGD or nipple 27 
retention. Female offspring from the high dose group had a significantly longer AGD 28 
and AGDI (p<0.01 for both) (Figure 2) and more nipples were present in offspring 29 
from group 4 (50 µg/kg) than in controls and this effect was statistically significant 30 
(p<0.01) (Figure 3). 31 
After delivery, no effect on weight gain of dams was observed (Table 2). Body 32 
weights of offspring at necropsy are shown in Table 3 and 4. In general, pups were 33 
smaller and had decreased growth when exposed to high doses of ethinyl estradiol. 34 
Growth in the exposed groups was decreased leading to smaller male pups PD6 at 50 35 
µg/kg and at 15 and 50 µg/kg ethinyl estradiol when the animals reached PD14. 36 
Female pups were not statistically significantly smaller in any of the exposed groups 37 
at delivery, but growth was delayed leading to smaller pups in the highest dose-group 38 
at PD6, PD14 and PD22. On PD50-55 and PD90 no statistically significant 39 
differences were seen in the body weights.  40 
 41 
Onset of puberty and estrous cycle determination 42 
No statistically significant effects were observed on onset of puberty in male or 43 
female offspring compared to control (data not shown). In females, 5 of 16 animals 44 
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(31%) representing 3 litters in the high dose (50 µg/kg) were scored as already having 1 
developed VO on the first day of VO registration (PD27). At 15 µg/kg, 2 out of 18 2 
animals (11%), both belonging to the same litter, already showed VO on the first day 3 
of registration. No control animals or those receiving 5 µg/kg were scored as having 4 
VO on PD27. 5 
No statistically significant effects were observed on estrous cyclicity although 6 
irregularly cycling animals were only observed in exposed groups. None of the 7 7 
animals in the control group had irregular cycles, 2/8 (5 litters) in the group treated 8 
with 5 µg/kg, 3/10 (9 litters) in the group treated with 15 µg/kg and 2/8 (7 litters) in 9 
the highest exposure group, respectively. 10 
 11 
 12 
Organ weights 13 
At PD21, the ventral prostate weights were significantly decreased in the group 14 
exposed to 15 µg/kg (p<0.05; Table 3). Interestingly, also other androgen-dependent 15 
male reproductive organs appeared smaller at 15 µg/kg than at 50µg/kg, although no 16 
statistically significant differences were observed (epididymides p=0.07, seminal 17 
vesicle p=0.5) (Table 3). No organs were weighed from males PD55. No statistically 18 
significant changes were found in organ weights of males PD90 (Table 4). 19 
At PD22, weights of ovaries were statistically significantly decreased in the highest 20 
dose group (p<0.05) for both the ANOVA with body weight as a covariate and for 21 
relative ovary weights (Table 3) (data not shown for relative organ weights). On 22 
PD50 and 90, no changes in the weights of ovaries and uterus were found (Table 4). 23 
On PD90, one female in the lowest dose-group was distinctively smaller in terms of 24 
body weight than other females PD90 and was perceived as an outlier and thus 25 
removed from the dataset.  26 
 27 
 28 
Genital malformations 29 
In female pups, genital malformations were observed as a statistically significant 30 
increase in the urethral slit length was measured PD90 in females exposed to 50 µg/kg 31 
of ethinyl estradiol (p<0.05) (Figure 1). Similarly, on PD50 the mean urethral slit 32 
length showed a trend towards increased slit length, and a statistical significant 33 
increase was seen in the number of animals at 50 µg/kg showing larger clefts (long 34 
slit length) than controls (p<0.05) (Figure 1). No changes were observed in the 35 
urethral slit length on PD22. Upon examination of the female genitalia on PD22, two 36 
pups from the same litter in the highest dose-group showed starting development of 37 
VO. The same animals had an enlarged uterus with a markedly increased uterus 38 
weight compared to the rest of the female pups. 39 
No genital malformations were observed in males at necropsy on PD21 or 90. On 40 
PD55, examination of live males showed two animals, one from each of the two 41 
highest dose groups, with unilateral cryptorchidism. At necropsy on PD55, three 42 
animals (one at 15 µg/kg and two at 50µg/kg) were found to have a mildly split penis 43 
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and one animal had unilateral cryptorchidism. There were no statistically significant 1 
differences between groups. 2 
 3 
      4 
Mammary glands 5 
Overall, females PD50 were mainly presenting no lobular development or type 1 6 
lobules as the predominant lobule development in the whole mounts of mammary 7 
glands. However, an increase in the type of the most developed lobule was observed. 8 
All but one control animal had lobules type 1 as the most developed type of lobule. 9 
One of 7 control animals, 2 out of 8 in each of the lowest dose-groups and 4 of 8 10 
females from the highest dose group had lobules type 2 as the most developed lobules 11 
present (Figure 4A). However, this apparent shift from lobule type 1 to lobule type 2 12 
as the most developed type of lobule in the high dose group was not statistically 13 
significant. No beads were found in the ducts of the mammary glands in the whole 14 
mounts. One control female PD50 had prolonged diestrous, thus showing different 15 
morphology in both whole mounts and histology and was not included in the statistics 16 
and the data presented. 17 
 18 
Histological examination of controls and high-dose female mammary glands PD50 19 
showed a higher frequency of high-dose females with multi-layered alveolar 20 
epithelium, however, this was not statistically significant (Figure 4B). Female 21 
mammary glands PD90 were evaluated, but statistics were restricted to females in 22 
diestrous or metestrous. Few animals were in another estrous stage (2 controls, 2 low 23 
dose, 0 middle dose and 3 high dose animals). All 10 females in the 15 µg/kg dose 24 
group were in diestrous. The evaluation of the female mammary histology PD90 25 
showed no difference in the number of animals with regard to lobular development 26 
(lobules type 1 or 2) (data not shown). The number of dilated ducts appeared 27 
increased in the 15 µg/kg dose group, but this was not statistically significant (Figure 28 
4C). No treatment-related differences were found in the distribution or the amounts of 29 
secretory material in the mammary glands and the dilated ducts were not associated 30 
with secretion of the mammary glands. 31 
 32 
Mammary gland whole mounts from high dose male offspring PD55 showed no 33 
statistically significant changes in the longitudinal growth, transverse growth, area or 34 
density. However, a trend to an increased number of animals with mammary glands 35 
reaching the lymph node was observed (Figure 5A) and an increase in the number of 36 
animals with a high density score (score 5) was observed at 50 µg/kg (data not 37 
shown). Yet, no changes in male whole mounts were statistically significant. Due to 38 
technical difficulties in sectioning the mammary glands for histology, the number of 39 
controls PD55 was reduced to 5 and trends for histological changes were difficult to 40 
interpret. Consequently, data from histology of male mammary glands PD55 were 41 
omitted.  42 
On PD90 the number of males with hypertrophic mammary epithelium appeared 43 
increased (Figure 5B), but this was not statistically significant. No changes in 44 
 13 
tubuloalveolar pattern, vacuolisation of mammary epithelium or distribution of 1 
secretion filled ducts in the glands were observed (data not shown). PAS positive 2 
granula were found more often and were more abundant in the highest dose group 3 
compared with controls, however, no statistically significant differences between the 4 
groups was found for mucin-positive or PAS-positive secretion or granula (data not 5 
shown).  6 
 7 
Histology of reproductive organs and thyroid gland  8 
Histological examination showed no effects of dosing in male thyroid glands PD21 or 9 
testes and epididymides PD 90. Moreover, ventral prostates showed no statistically 10 
significant differences, although an increased prevalence of epithelial hyperplasia 11 
score 3, papillary epithelial infoldings and high columnar epithelium was observed at 12 
5 and 15 µg/kg (Table 5). Histological appearance of prostates of the high dose group 13 
was comparable to controls. Interstitial and intraluminal infiltration with 14 
predominantly mononuclear inflammatory cells was found in all groups, but 15 
moderately severe inflammation was only seen in groups exposed to ethinyl estradiol 16 
(Table 5). Reactive hyperplasia was observed in prostates from all males with 17 
moderately severe inflammation (Table 5). 18 
 19 
The stage of estrous cycle of females at necropsy on PD50 and PD90 was confirmed 20 
by vaginal smear and histologic examination of uterus PD50 and for PD90 with 21 
histology of uterus and ovaries. One control PD50 and one female in the highest dose-22 
group PD90 were acyclic and were omitted from the data of mammary glands.  23 
 24 
Gene expression 25 
For prostate isolated on PD21, ODC and actin mRNA levels were increased by 26 
ethinyl estradiol as evaluated by post test for linear trend in connection with ANOVA 27 
(Figure 6). Regarding mRNA levels, there were no effects of ethinyl estradiol on AR, 28 
TRPM2, IGF-1, complement C3, PPARα, PPARγ, ERα (p=0.06 by post test for linear 29 
trend) and β, or PBPC3. By correlation analysis it was found that the prostate weight 30 
in the individual animal was correlated to the mRNA level of PBPC3 (p<0.01, data 31 
not shown). 32 
 33 
 34 
 35 
Discussion  36 
Several studies have examined reproductive effects of ethinyl estradiol in SD and LE 37 
rats, and in the current study we examined effects in Wistar rats, which are commonly 38 
used in regulatory toxicology studies. The study included endpoints that have not 39 
previously been thoroughly investigatedand revealed developmental effects in female 40 
offspring, in which an increased AGD, an increased number of nipples, and an 41 
increased urethral slit length were observed. In males, perinatal exposure to ethinyl 42 
estradiol affected mainly mammary glands and prostate.  43 
  44 
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Effects on dams and pup growth 1 
The lower maternal weight gain during gestation in high dose dams is in accordance 2 
with findings in other studies with perinatal exposure to ethinyl estradiol [11;13;14]. 3 
Gestational length was increased in the highest dose-group, and to our knowledge this 4 
has not been reported for ethinyl estradiol before [27;28;43], but a prolonged 5 
gestational length has been reported for dietylstilbestrol (DES) [59;60]. 6 
In general, pup weight gain from delivery and onwards was decreased at 50µg/kg 7 
while dosing was on-going, confirming several other studies [13;14;29]. However, at 8 
weaning, this effect was smaller and only apparent in female offspring. This delayed 9 
growth of offspring may be a sign of toxicity, but could also reflect a decreased 10 
lactation in high-dose dams especially affecting the offspring in the earliest period of 11 
lactation when supplementary intake of other food is absent.  12 
 13 
Changes in female external sexual characteristics  14 
Female pups exposed perinatally to ethinyl estradiol showed an increased AGD and 15 
AGDi, an increased number of nipples and an increased urethral slit length; effects 16 
that are not thoroughly investigated in the literature or are not consistent among 17 
studies.  18 
The observed increased AGD in females treated with 50 µg/kg ethinyl estradiol is in 19 
agreement with previous findings of increased AGD in female Long Evans rats at the 20 
same dose level and dosing period (GD7 to PND18) [28]. However, one study with 21 
similar exposure and dosing period found no effects of treatment in SD rats [29], and 22 
a multi-generation study in SD rats showed no changes in female AGD in F1 23 
offspring at comparable doses [25;27]. It may be speculated that strain-specific 24 
differences are present with SD rats being less sensitive than LE or Wistar rats 25 
regarding estrogen-induced influences on female AGD.  26 
There are only few reports describing effects on the number of nipples in females in 27 
the open literature, however, not with estrogenic exposure. In the National 28 
Toxicology Program (NTP) study hypertrophy of the nipples was found as an effect 29 
of ethinyl estradiol exposure [27], whereas Ryan et al (2010) did not observe 30 
increased number of nipples in female offspring in LE rats following ethinyl estradiol 31 
exposure at doses and dosing period comparable to the present study [28].  32 
The increased urethral slit length at PD50 and PD90 is in accordance with Sawaki et 33 
al showing an increase in the urethral slit length and an increased number of adult 34 
animals having a deep urethral slit after perinatal exposure to 50 µg/kg ethinyl 35 
estradiol [29;43]. Overall, ethinyl estradiol seemed to affect female external genital 36 
development. Changes in female external genitals were seen in neonates (increased 37 
AGD) as well as adults (increased urethral slit length), suggesting that effects on the 38 
genitals are persistant and present after withdrawal of the exposure. 39 
 40 
Male and female mammary glands 41 
In adult mammary glands, no statistically significant changes were found, but in adult 42 
female mammary glands, a trend to increased lobular development was observed, 43 
indicating advanced differentiation. Although this was not statistically significant 44 
 15 
these trends may reflect persistent effects of ethinyl estradiol on mammary glands. As 1 
a small number of glands were evaluated the power to detect statistically significant 2 
changes on score measures is low, and it is considered important to pay attention to 3 
trends and findings that may suggest an effect of exposure, as stressed in OECD 4 
guidance documents for histological evaluation [61]. 5 
 6 
Changes in both female and male adult mammary glands were expected as lobular 7 
development (lobular hyperplasia) and increased secretory activity in females and 8 
feminization of male mammary glands have been described previously for SD rats 9 
[13;14;31]. Takagi et al (2004) found increased lobular hyperplasia in adult female 10 
mammary glands after perinatal exposure to ethinyl estradiol and Murrill and co-11 
workers (1996) observed a significant increase in  lobules type 2 in 50 days old 12 
female SD rats exposed postnatally to genistein [14;62]. Dilated ducts were observed 13 
in ethinyl estradiol exposed females in the present study at PD90, but this did not 14 
correlate to an increased secretory activity of the mammary glands of exposed adult 15 
females, as was expected based on the increased secretory dilation of alveoli seen in 16 
adult female SD rats after perinatal exposure to 17β-estradiol [31]. In that study, pups 17 
were exposed continuously through the diet until the day of necropsy, and as the same 18 
changes were found in adults exposed exclusively in adulthood [31], increased 19 
secretory activity may be expected only for adult estrogen exposure.   20 
 21 
No clear indications of histological changes in male mammary glands were found, 22 
although epithelial hypertrophy was expected based on previous studies on estrogenic 23 
compounds. Our previous study on male SD rats exposed to a mixture of 24 
phytoestrogens showed a significantly higher incidence of hypertrophy in adulthood 25 
after exposure from GD 7 to PND 21 [57]. Another study on male SD rats exposed 26 
perinatally and after weaning to genistein showed increased alveolar hypertrophy and 27 
hyperplasia of male mammary glands PND50 [63]. In the current study, histological 28 
examination showed a tendency towards a higher prevalence of adult males with 29 
hypertrophic mammary epithelium, but this was not statistically significant, and 30 
hypertrophy was common in controls (50%).  31 
No signs of feminization of the male mammary glands were present, as no increase in 32 
secretion or changes in tubuloalveolar pattern were observed. This is in accordance 33 
with the lack of feminization with tubuloalveolar growth in adult male mammary 34 
glands after dietary exposure of SD rats to 50 ppb ethinyl estradiol (approximately 35 
equal to 5 µg/kg) from conception until adulthood [12]. In contrast, adult exposure to 36 
high doses of estrogens (500 to 2500 µg/kg) has been shown to feminize mammary 37 
glands [31], and it has been hypothesized that feminization of the mammary gland is 38 
likely caused by hyperprolactinemia [64]. 39 
Although male mammary gland development was altered at PD 22 [34], persistent 40 
effects are likely more marked with continued exposure than perinatal exposure only. 41 
Further studies on cancer development in aging rats may determine whether these 42 
early changes in male mammary gland development can lead to persistent or delayed 43 
adverse effects.  44 
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 4 
Our previous study on prepubertal offspring from the same litters showed advanced 5 
development of mammary glands [34]. Whole mounts of mammary glands PD21-22 6 
showed an enhanced development of female and male mammary glands represented 7 
by statistically significant differences in the outgrowth, density and number of 8 
terminal end buds [34]. Thus, prepubertal mammary glands seem to be more 9 
markedly affected by ethinyl estradiol compared to adult mammary glands, which 10 
could be interpreted as transient effects in prepubertal animals, but could also reflect a 11 
low power for detection of persistent effects in adults due to the low number of 12 
animals examined. 13 
Reproductive endpoints in female offspring 14 
An earlier VO was expected in this study, as other studies have reported an earlier age 15 
of sexual maturation following perinatal exposure to ethinyl estradiol [27;28]. 16 
Although 11% and 31% of female offspring exposed to the two highest doses of 17 
ethinyl estradiol were in puberty at the first day of registration, effects were not 18 
statistically significant.. It is unknown at what age the few animals in puberty at the 19 
first day of registration had attained VO, and the registration of VO from PD27 may 20 
thus result in a weaker statistical result. Another reason for the lack of statistical 21 
significance is group size, as a report from ILSI 1999 estimated that a group size of 20 22 
litters should be used when measuring effects on PPS and VO [67]. In comparison, 23 
our group size was 5-9 litters. 24 
 25 
No statistically significant effects on estrous cyclicity were observed. However, 26 
irregularly cycling females were observed only in ethinyl estradiol exposed groups (7 27 
of 26 exposed females). An increased incidence of abnormal estrous cyclicity was 28 
expected, as others have shown an increased length of cycles, an increased number of 29 
abnormal cycles or changes charachterized by persistent estrous in rats following 30 
exposure to ethinyl estradiol [27] [68] [25].  In the present study, no statistically 31 
significant effects on estrous cyclicity were observed, although irregularly cycling 32 
females were observed only in ethinyl estradiol exposed groups (7 of 26 exposed 33 
females). The lack of significant effects may be due the small group size and to the 34 
short dosing period terminating at weaning in contrast to the studies reported in the 35 
literature.  36 
 37 
Reproductive endpoints in male offspring 38 
Changes in prepubertal prostate weights and gene expression were the only male 39 
endpoints investigated in the present study that were significantly affected by 40 
perinatal ethinyl estradiol exposure. In prepubertal males, ethinyl estradiol reduced 41 
prostate weight at 15 µg/kg, but not at 50 µg/kg, and not in adulthood. Marked effects 42 
on adult male reproductive organ weights have been observed in other studies on 43 
perinatal exposure to comparable doses of ethinyl estradiol. Statistically significant 44 
 17 
reductions of testes and seminal vesicle weights and slight reduction of prostate 1 
weights were seen at 5 µg/kg, and statistically significant reduction of prostate, LABC 2 
and glans penis weights were seen at 50 µg/kg of ethinyl estradiol in adult LE rats 3 
exposed from GD7 to PND18 [11]. Although mean weights of testes, epididymides, 4 
seminal vesicle, bulboutrethal gland and LABC did appear reduced in the current 5 
study, these changes were not statistically significant and were seen in prepubertal but 6 
not in adult males. As no trends to decreasing adult male reproductive organ weights 7 
were seen in this study, it may be proposed that strain differences in sensitivity may 8 
explain these conflicting findings. Wistar rats have previously been found to be less 9 
sensitive than Fisher 344 rats to changes in male reproductive weights and histology 10 
[17], but no direct comparison with LE rats has been presented.  11 
Histological changes in testes and epididymides were not observed but have been 12 
described in previous studies at higher dose levels or with adult exposure to ethinyl 13 
estradiol [69-71]. In a comparable study on subcutaneous exposure of SD rats to 14 
ethinyl estradiol in the neonatal period, only doses above 100 µg/kg induced 15 
histological changes in epididymis and testes, and the lack of histological changes in 16 
the current study were thus expected. 17 
Prostate weight has previously been found to be affected by estrogenic compounds in 18 
a non-monotonous manner, but in those studies the opposite pattern was observed, i.e. 19 
increased prostate weight at low levels (0.015 µg/kg of estradiol benzoate) and 20 
decreased prostate weight at high doses (1.5 and 15 mg/kg bw) [18]. Comparable 21 
patterns have been reported in mice exposed to estrogenic compounds [72;73]. Our 22 
observation of reduced prostate weight at 15 µg/kg was thus expected, but the lack of 23 
effect at 50 µg/kg cannot be readily explained. 24 
 25 
Estrogenic compounds may alter expression of ER responsive genes such as IGF-1 26 
[74], Compl C3 or ODC. In addition, reduced ERα mRNA and protein levels have 27 
been found in adult rat prostates following perinatal soy exposure [75]. The current 28 
study showed an increased mRNA level of ODC in ventral prostates of prepubertal 29 
rats. In addition, ethinyl estradiol was found to increase actin mRNA levels. Actin has 30 
previously been described to increase in rat uterus upon estrogen exposure [76], and 31 
other lines ef evidence suggest a role for estradiol in the control of the actin skeleton 32 
supporting that actin is an estradiol regulated protein [77]. Prostate weight was 33 
correlated to the PBPC3 mRNA level. Such a correlation has been described 34 
previously for flutamide [78]. Thus, the current data support that the weight of the 35 
prostate is important for the expression of this gene or vice versa.  36 
 37 
These early changes in prostate gene expression induced by ethinyl estradiol appear to 38 
be followed by persistent effects on prostate histology. Howdeshell et al (2008) 39 
observed ventral prostate hyperplasia PND150 in 2 of 29 rats at 5 µg/kg ethinyl 40 
estradiol and in 11 of 24 rats at 50 µg/kg ethinyl estradiol after perinatal exposure, 41 
while this was not seen in 31 control rats [11]. Likewise, an increased incidence of 42 
prostatic lesions including hyperplasia and inflammatory cell infiltration has been 43 
shown in young adult rats after perinatal or neonatal exposure to other estrogenic 44 
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compounds [44;45]. In the current study more prominent epithelial hyperplasia was 1 
indicated in ventral prostate in young adults in the low and middle dose groups and 2 
moderately severe inflammation was observed in all dosed groups, but not in controls. 3 
The lack of hyperplastic response in the high dose group cannot readily be explained. 4 
However, other studies with perinatal dietary exposure of SD rats to 0.5 ppm (27-63 5 
µg/kg) ethinyl estradiol did not show significant histopathological changes in prostate 6 
in young adults [13;14]. Although not consistently reported [79] non-monotonic dose-7 
response patterns on prostate development have been described for natural and 8 
synthetic estrogens administered prenatally or neonatally to mice and rats [18;73].  9 
 10 
Unexpectedly, no significant effects were seen on the weight or timing of onset of 11 
puberty in the male offspring. Several studies report a delayed PPS following 12 
perinatal exposure to ethinyl estradiol (27-63 µg/kg in the diet) [13;14] or other 13 
estrogenic compounds [8;38;80]. In a multi-generation study conducted by the NTP, 14 
delayed PPS was seen at the highest group of 50 ppb (approximately 4 ug/kg) but 15 
only in the F2 generation. In contrast, their range-finding study indicated accelerated 16 
PPS at 5 and 25 ppb (approximately 1.1 and 5.5 µg/kg , respectively) but not at higher 17 
doses [27]. The lack of effects on PPS in the current study may be due to the short 18 
dosing period compared to other studies showing delayed PPS following perinatal 19 
exposure to ethinyl estradiol [13;14] or other estrogenic compounds [8;38;80].. 20 
 21 
 22 
 23 
Refinement of reproductive toxicity studiesWhen planning animal studies, the number 24 
of animals should be appropriate, and too high or too low numbers of animals should 25 
be avoided. When evaluating studies in the published scientific literature it becomes 26 
clear that in many biological disciplines, a study of ten mated dams per group as in 27 
the current study may be considered a large study. This study (and a vast amount of 28 
evidence from toxicological studies) shows that for several reproductive endpoints 29 
including endpoints of a dichotomous nature, moderately sized studies are not 30 
sufficient to demonstrate presence or absence of effects [67]. Several classical 31 
estrogen-sensitive endpoints such as sexual maturation, estrous cyclicity and 32 
mammary gland histology are evaluated as score measures and thus, the statistical 33 
power is low and may result in false negative conclusions compared to quantitative 34 
endpoints (e.g. organ weights and gene expression). Hence, a large number of animals 35 
is needed to see a difference between the dosed groups and the controls such 36 
endpoints, even in the present case of a potent estrogenic chemical. 37 
 38 
Also selection of appropriate exposure periods and rat strains is necessary to ensure a 39 
high sensitivity of the selected endpoints. For some endpoints, studies with continued 40 
exposure to estrogenic chemicals appeared to show more marked effects than seen in 41 
this study with exposure until weaning. For other endpoints, variations in 42 
susceptibility of different rat strains is known, as e.g. SD rats are more susceptible to 43 
develop spontaneous and carcinogen induced mammary tumours compared to other 44 
 19 
rat strains as reviewed by Rudmann et al [81]. Most studies on e.g. mammary gland 1 
morphology and histology is, to our knowledge, studied in SD or LE rats, and more 2 
knowledge on estrogen sensitive endpoints in Wistar rats is important for evaluation 3 
of e.g. regulatory toxicological studies, which are often performed in this rat strain.  4 
AGD and the number of nipples are not score measures and are evaluated in a large 5 
number of animals (i.e. all offspring) and were shown to be sensitive endpoints for the 6 
effects of ethinyl estradiol in developing females. Further refinement of reproductive 7 
toxicity studies could be obtained by developing sensitive and preferably quantitative 8 
measurements to supplement the currently used endpoints known to be affected by 9 
estrogens, e.g. mammary gland morphology, may facilitate the detection of adverse 10 
effects of estrogenic compounds. Concomitantly, this would reduce the present need 11 
for a high number of experimental animals in reproductive toxicity studies. 12 
 13 
 14 
 15 
Conclusions  16 
The present study investigated endocrine-sensitive endpoints in male and female 17 
Wistar rats following perinatal ethinyl estradiol exposure. This potent estrogenic 18 
compound was found to induce an increased number of nipples in female offspring 19 
and an increase in malformations of external female genitalia, which seemed to be 20 
permanently affected after withdrawal of exposure. Malformations of female genitals 21 
were found in young as well as adult offspring appearing as an increased AGD at 22 
birth and a deeper urethral slit length in adulthood. In prepubertal male offspring, 23 
estrogen-regulated gene expression was increased dose-dependently and a decreased 24 
ventral prostate weight was seen at 15 µg/kg. Changes in mammary gland histology, 25 
timing of sexual maturation and estrous cyclicity were not statistically significant, but 26 
showed similar trends as observed in SD and LE rats. The lack of clear effects on 27 
these endpoints may be due to the short dosing period terminating at weaning in 28 
contrast to other studies with continued exposures after weaning. Additionally, the 29 
low power when dealing with data of a dichotomous nature should be should be 30 
carried in mind when evaluating or planning studies on possible endocrine disrupters.  31 
We conclude that perinatal ethinyl estradiol exposure of Wistar rats predominantly 32 
affect the morphology of the female reproductive system and prostate endpoints in 33 
males. Prepubertal male and female mammary glands also revealed marked changes 34 
and these endpoints should be in focus of future studies on estrogenic environmental 35 
chemicals, as potential chemical perturbation of mammary, prostate and female 36 
reproductive organ development during fetal life may have severe consequences later 37 
in life. Moreover, continued exposure after weaning should be considered in 38 
toxicological testing of potential estrogenic compounds, and future development of 39 
sensitive and preferably quantitative endpoints is encouraged.  40 
 41 
 42 
 43 
 44 
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Figure 1. Female external genital malformations (cleft phallus). A, control animal with a shallow cleft. B, 
female from high dose group with a deep cleft/ large urethral slit length. C, schematic drawing of female B 
showing how the urethral slit length was measured. D, Prevalence of females with deep clefts (large urethral 
slit length) in females PD50. E, Mean urethral slit length PD90 (in units of the scale). 
 
 
 
Figure 2. Ano-genital distance index (AGDI). Ano-genital distance adjusted for body weight for male and 
female offspring PD14.  
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Figure 3. Number of nipples in female offspring PD14.   
 
 
 
     
Figure 4: Adult female mammary glands. A, Most developed type of lobule in female whole mounts 
PD50. B, Histological evaluation of alveolar epithelium PD50. C, Histological evaluation of dilatation of 
mammary ducts PD90.  
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Figure 5: Adult male mammary glands. A, male mammary glands reaching the lymph node, evaluated in 
whole mounts PD55. B, Hypertrophy of mammary epithelium evaluated in histologic sections PD90.  
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Table 1 Examined endpoints  
Age  Gender Endpoint 
PD 1 Male/female AGD 
PD 14 Male/female  Nipple retention 
PD 21 Male Organ weights (testis, ventral prostate, epididymis, seminal vesicle, LABC, 
bulbourethral gland, liver) 
Mammary gland whole mounts 
Thyroid histology 
Prostate gene expression (IGF-1, AR, TRPM-2, actin, Complement C3, PPAR α 
PPARγ, ER-α, ERβ, ODC, PBP C3, 18s, β-actin) 
PD 22 Female Organ weights (uterus, ovary, liver, thyroid) 
Mammary gland whole mounts  
PD 27-41 Female Puberty onset (vaginal opening) 
PD 34-48 Male Puberty onset (preputial separation) 
PD 75-90 Female Estrous cyclicity 
PD 50 Female Mammary gland whole mounts 
Mammary gland histology 
Organ weights (uterus, ovary) 
PD55 Male Mammary gland whole mounts  
Mammary gland histology 
PD 90 Female  Organ weights (uterus, ovary, liver) 
Histology of mammary gland, uterus, ovary 
PD 90 Male Organ weights (testis, epididymis, ventral prostate, seminal vesicle, levator 
ani/bulbocavernosus muscle (LABC), bulbourethral glands, 4th mammary gland) 
Histology of mammary gland, ventral prostate, testis, epididymis 
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Table 2. Pregnancy and litter data. Data represent group means based on litter means ± SD. *p<0.05, ** 
p<0.01, ***p<0.001. AGD is analyzed with birth weight as a covariate. # male birth weight in group 3 seems 
to be decreased but it is not significant when bw and number af pups per litter as covariates in the statistical 
analysis. EE2: ethinyl estradiol.  
 1: Control 2:EE2 5 µg/kg/bw 3:EE2 15 
µg/kg/bw 
 4: EE2 50 
µg/kg/bw 
No. Of dams ( litters) 10 (8) 10 (6) 10 (9) 10 (8) 
Maternal weight gain 
GD7-GD21 70.4 ± 7.8 64.8 ± 14.7 65.7 ± 12 41.0 ± 16.5*** 
Maternal weight gain 
GD7-PD1 14.2 ± 7.7 13.6 ± 5.9 9.4 ± 8.6 -3.7 ± 6.3 *** 
Maternal weight gain 
PD1-22 4.6 ± 10 1.7 ± 11.7 1.6 ± 10.3 7.6 ± 7.5 
Gestation length 
(days) 23 ± 0.0 23.2 ± 0.41 23 ± 0.0 23.7 ± 0.46*** 
% post-implantation 
loss 2.2  ± 4.3 8.2  ± 7.5 4.5  ± 9.2 2.1  ± 5.9 
% perinatal loss   
8.0  ± 8.6 11.0  ± 6.9 7.9  ± 13.0 5.7  ± 12.0 
Born alive per. Litter 
10.4 ± 1.9 9.7 ± 2.9 11.1 ± 2.7 9.1 ± 3.9 
% Postnatal death 8.4 ± 9.5 8.9 ± 9.0 3.4 ± 4.9 4.1 ± 7.8 
% Males 57.6 ± 14.0 48.3 ± 18.9 48.5 ± 16.8 53.0 ± 17.0 
Birth weight male 
offspring 6.2 ± 0.3 6.4 ± 0.4 6.0 ± 0.2# 6.0 ± 0.5* 
Birth weight female 
offspring 5.9 ± 0.3 5.9 ± 0.3 5.6 ± 0.2 5.7 ± 0.5 
AGD males 21.3 ± 0.7 21.5 ± 0.7 21.2 ± 0.8 21.9 ± 0.8 
AGD females 10.9 ± 0.7 11.0 ± 0.5 11.1 ± 0.3 11.9 ± 0.9** 
AGDi males 11.6 ± 0.5 11.6 ± 0.3 11.7 ± 0.4 12.1 ± 0.4 
AGDi females 6.1 ± 0.4 6.1 ± 0.4 6.3 ± 0.2 6.7 ± 0.3*** 
No. nipples males 0.05 ± 0.09 0.00 0,02 ± 0.06 0.02 ± 0.05 
No. nipples females 12.28 ± 0.24 12.31 ± 0.16 12.27 ± 0.20 12.78 ± 0.49** 
Males bw PD6  13.0 ± 1.2 12.6 ± 1. 12.0 ± 1.2 10.9 ± 1.1*** 
Females bw PD6 12.5 ± 1.0 11.7 ± 1.1 11.6 ± 1.1 10.5 ± 1.1*** 
Males bw PD14  
27.6 ± 2.6 26.2 ± 2.8 24.8 ± 3.0* 23.5 ± 3.2*** 
Females bw PD14 26.4 ± 2.2 24.6 ± 1.9 24.2 ± 2.9 22.8 ± 2.8*** 
Males bw PD21 39.6 ± 5.1 39.2 ± 4.9 36.8 ± 5.1 36.1 ± 5.9* 
Females bw PD22 42.4 ± 3.5 38.8 ± 3.1 39.1 ± 5.7 38.1 ± 5.3*** 
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Table 3. Female and male prepubertal organ weights (PD21-22). Body weights are for the necropsied 
animals only. Mean ±SD. * Indicates a statistically significant difference from controls in a Dunnett’s test 
(p<0.05).  
 Control 5µg/kg 15µg/kg 50µg/kg 
Female PND22 (n=7) (n=5) (n=8) (n=7) 
Body weight (g) 42.3±4.5 39.0±2.2 37.6±4.3* 38.0±5.7* 
Liver (mg) 1528±207 1379±144 1360±197 1393±205 
Thyroid gland (mg) 8,0±4.01 5.2±1.55 6.7±3.59 5.8±2.57 
Uterus (mg) 26,7±3.7 25.2±5.3 25.6±6.0 27.2±10.5 
Ovaries (mg) 15,1±3.4 14.5±2.9 14.1±1.5 10.4±3.6* 
Male PD21 (n=8) (n=5) (n=9) (n=7) 
Body weight 39.4±4.3 38.2±5.0 36.6±5.2 33.7±3.9 
Liver (mg) 1333.2±168.5 1367±156.3 1236,0±232.2 1132,6±240.6 
Testis (mg) 196.1±21.5 194.9±17.0 183,1±24.9 172.5±24.4 
Epididymides 35.8±5.2 32.0±3.5 29.6±5.4 32.0±5.6 
Prostate (mg) 25.5±5.3 22.4±4.4 18.7±5.1* 23.8±2.6 
Seminal vesicle (mg) 20.4±5.2 18.8±4.2 17.0±4.5 19.5±4.1 
Bulbourethral glands 2.3±0.6 2.4±0.3 2.0±0.9 1.9±0.4 
LABC (mg) 35.7±5.9 33.5±4.7 29.3±5.9 26.8±6.2 
Prostate (g) 0.45±0.1 0.43±0.1 0.44±0.1 0.50±0.1 
Vesicula seminalis 
(g) 
1.25±0.3 1.31±0.2 1.22±0.2 1.27±0.2 
gl. Bulbourethralis 
(g) 
0.09±0.04 0.10±0.03 0.10±0.02 0.10±0.02 
M. levator ani (g) 0.95±0.2 0.83±0.1 0.96±0.1 0.92±0.1 
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Table 4. Postpubertal female and male organ weights. *Indicates a statistically significant different from 
controls (p<0.05) in ANOVA with body weight as a covariate.  
 Control 5µg/kg 15µg/kg 50µg/kg 
Female PD50 (n=8) (n=8) (n=8) (n=8) 
Body weight 143±8 141±14 140±8 136±8 
Uterus (g) 0.64±0.33 0.41±0.20 0.47±0.25 0.44±0.22 
Uterus drained (g) 0.30±0.12 0.24±0.04 0.32±0.09 0.29±0.07 
Ovaries (mg) 62.8±7.9 58.5±13.3 66.1±9.8 61.7±10.7 
Female PD90 (n=8) (n=7) (n=10) (n=8) 
Body weight (g) 209±8 205±3 208±21 203±1 
Liver (g) 6.7±0.4 7.3±0.65* 6.8±0.8 6.9±0.6 
Uterus (g) 0.42±0.09 0.44±0.15 0.38±0.07 0.40±0.09 
Uterus drained (g) 0.41±0.08 0.40±0.08 0.37±0.07 0.38±0.08 
Ovaries (mg) 95.1±9.2 91.6±13.4 86.7±8.8 90.3±13.3 
Male PD55 (n=8) (n=10) (n=10) (n=8) 
Body weight 214±18 206±15 212±20 197±8 
Male PD90 (n=8) (n=8) (n=10) (n=8) 
Body weight 351±34 354±17 347±38 354±16 
Liver (g) 11.8±1.4 11.6±0.6 11.2±1.5 11.5±0.6 
Testis (g) 3.5±0.3 3.5±0.2 3.5±0.3 3.4±0.2 
Epididymides (g) 0.57±0.05 0.58±0.03 0.56±0.05 0.55±0.05 
Prostate (g) 0.45±0.1 0.43±0.1 0.44±0.1 0.50±0.1 
Vesicula seminalis (g) 1.25±0.3 1.31±0.2 1.22±0.2 1.27±0.2 
gl. Bulbourethralis (g) 0.09±0.04 0.10±0.03 0.10±0.02 0.10±0.02 
M. levator ani (g) 0.95±0.2 0.83±0.1 0.96±0.1 0.92±0.1 
 
  
41 
 
Table 5: Number and prevalence of males with a given histological findings in 
ventral prostate PD90 
  Control 5µg/kg 15µg/kg 50µg/kg 
Dominating 
appearance of 
acini 
Regular  7/8 (88%) 3/8 (38%) 4/10 (40%) 6/8 (75%) 
Papillary 1/8 (13%) 5/8 (63%) 6/10 (60%) 2/8 (25%) 
Dominating 
epithelia type  
Cuboidal 0/8 (0%) 0/8 (0%) 0/10 (0%) 1/8 (13%) 
Columnar 5/8 (63%) 3/8 (38%) 4/10 (40%) 5/8 (63%) 
High columnar 3/8 (38%) 5/8 (63) 6/10 (60) 2/8 (25%) 
Epithelial 
atrophy 
Score 0 3/8 (38%) 3/8 (38%) 6/10 (60%) 3/8 (38%) 
Score 1 3/8 (38%) 5/8 (63%) 3/10 (30%) 4/8 (50%) 
Score 2 2/8 (25%) 0/8 (0%) 1/10 (10%) 1/8 (13%) 
Epithelial 
hyperplasia  
Score 2 6/8 (75%) 4/8 (50%) 4/10 (40%) 5/8 (63%) 
Score 3 2/8 (25%) 4/8 (50%) 6/10 (60%) 3/8 (38%) 
Reactive 
epithelial 
hyperplasia   2/8 (25%) 4/8 (50%) 3/8 (30%) 2/8 (25%) 
Total 
inflammation 
Score 0 1/8 (13%) 0/8 (0%) 2/10 (20%) 1/8 (13%) 
Score 1 4/8 (50%) 4/8 (50%) 5/10 (50%) 4/8 (50%) 
Score 2 3/8 (38%) 2/8 (25%) 0/10 (0%) 2/8 (25%) 
Score 3 0/8 (0%) 2/8 (25%) 3/10 (30) 1/8 (13%) 
 
 
 
PAPER 3 
 
Julie Boberg, Karen Riiber Mandrup, Pernille Rosenskjold Jacobsen, Louise Krag 
Isling, Niels Hadrup, Line Berthelsen, Anders Elleby, Maria Kiersgaard, Anne Marie 
Vinggaard, Ulla Hass, Christina Nellemann. 
 
Endocrine disrupting effects in rats perinatally exposed to a dietary relevant mixture 
of phytoestrogens. 
 
Submitted to Reproductive Toxicology, 2013. 
 
 
1 
 
Title: Endocrine disrupting effects in rats perinatally exposed to a dietary relevant mixture of 
phytoestrogens  
 
Running title: Endocrine disruption by phytoestrogen mixture  
 
Authors: Julie Boberg*, Karen Riiber Mandrup, Pernille R. Jacobsen, Louise Krag Isling, 
Niels Hadrup, Line Berthelsen, Anders Elleby, Maria Kiersgaard, Anne Marie Vinggaard, 
Ulla Hass, and Christine Nellemann. 
 
Division of Toxicology and Risk Assessment, National Food Institute, Technical University of 
Denmark, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark 
 
*Corresponding author.  Tel +45 3588 7560; e-mail: jubo@food.dtu.dk 
 
 
 
  
 
 
 
2 
 
Abstract  
Dietary phytoestrogens may prevent certain human diseases, but endocrine activity has been 
reported in animal studies. Sprague-Dawley rats were exposed perinatally to a 1-, 10- or 100-fold 
“high human dietary intake” mixture of 12 phytoestrogens consisting of mainly the lignan 
secoisolarici resinol and the isoflavones genistein and daidzein.  
This mixture induced persistent adverse effects, as male mammary glands showed hypertrophic 
growth. In young pups, no effects on reproductive organ weights were seen, but a reduced 
anogenital distance in newborn male pups exposed to the mixture indicated an anti-androgenic 
mode of action. Decreased serum estradiol was seen in genistein-exposed dams.  This study 
indicated adverse effects at high intake levels in rats, but does not provide evidence for risk of 
phytoestrogen-mediated endocrine disruption at normal human dietary consumption levels. Further 
studies are warranted to increase the knowledge upon which risk assessment on dietary 
phytoestrogen exposure during pregnancy and infancy is based.  
 
Highlights (3-5 bullets, optional) 
- High doses of a dietary relevant mixture of phytoestrogens induced endocrine disruption in 
rats 
- Mammary gland histology was altered in adult males after perinatal exposure 
- Anti-androgenic effects on anogenital distance were present in young males 
- An excessive human intake of phytoestrogens from dietary supplements or special dietary 
habits may contribute to endocrine disruption following exposure during fetal life 
 
Keywords: mammary, histology, daidzein, genistein, secoisolarici resinol, lignans, diet, anti-
androgenic 
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1. Introduction  
Phytoestrogens, i.e. naturally occurring plant compounds with estrogenic actions, are believed to 
have chemopreventive effects on a variety of human diseases including cancers, through the 
ingestion of soy-based foods [1]. Concern has been raised, however, of potential adverse effects due 
to the estrogenic and other endocrine activities of these compounds.   
Isoflavones such as daidzein and genistein are found in soy beans and other plant products, and 
humans are commonly exposed to these compounds through soy milk, tofu and other soy containing 
products [2]. Lignans including secoisolarici resinol (SECO) are found mainly in flax seeds, but 
also in sunflower, sesame, and pumpkin seeds, and a high intake is seen in populations with a high 
consumption of e.g. rye bread containing these seeds [3].  Rat studies on daidzein, genistein, SECO 
and SECO metabolites enterolactone and enterodiol have shown adverse developmental and 
reproductive effects in males and females [1;4-6]. Among these effects, changes in mammary gland 
morphology and tumor incidence have been reported in reproductive studies on SECO and genistein 
[1;7]. Postnatal exposure of rats to 10% dietary flaxseed or SECO diglucoside reduced incidence 
and numbers of tumors induced by 7,12-Dimethylbenz(a)anthracene (DMBA) [8]. Other studies 
have shown that exposure to flax seed containing SECO during early development enhances 
mammary growth [9] and increases the susceptibility to carcinogen-induced mammary tumors [10], 
and it appears that the possible protective effects of these compounds are highly dependent on the 
time window of exposure. 
For genistein, developmental and reproductive toxicity in rats is known, as evidenced by transient 
decreased offspring body weight at doses from 7 mg/kg bw/day, decreased anogenital distance in 
male and female pups, reduced litter size, reduced pregnancy rate, altered estrous cyclicity, altered 
ovarian and prostate histology and accelerated vaginal opening at 35 to 44 mg/kg bw/day [5]. A 
National Toxicology Program expert panel considered adverse reproductive or developmental 
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effects unlikely for human adults with exposures up to 0.43 mg/kg bw/day, and negligible concern 
for neonates and infants consuming 0.01-0.08 mg/kg bw/day of genistein in soy formula. 
However, the combined exposure to endocrine active compounds in human diet needs to be 
considered to determine whether human phytoestrogen intake may have harmful effects. In the 
current study, we examined the endocrine disrupting effects in rats of a mixture of phytoestrogens. 
The mixture composition was based on the composition of phytoestrogens in human diet in order to 
address the shortcoming controversy of doing risk assessment based on single compound exposure, 
whereas real-life human exposure is to a mixture of compounds with different endocrine effects. 
The mixture composition is listed in Table 1 and based on the upper range of exposures determined 
by Hedelin et al., 2006 [11]. This mixture was administered by gavage in order to control the exact 
exposure in doses that were 1-fold, 10-fold or 100-fold of “high human dietary intake”. As 
indicated in Table 1, the main components of the mixture are secoisolarici resinol, genistein and 
daidzein with a smaller content of other resinols and a very low content of isoflavonoids, SECO 
metabolites and coumestrol. Hedelin et al. calculated daily phytoestrogen exposure levels for 
humans based on a food frequency questionnaire distributed to Swedish prostate cancer cases and 
corresponding controls (mean age 68 years), combined with analytical data on content of 
phytoestrogens in food products [11]. These data were used as surrogate data for “high human 
dietary intake” of pregnant women, although there may be differences in diets of elderly men and 
young pregnant women. To control background exposure to phytoestrogens, a soy-free rat chow 
was used as a background diet. This diet as well as the ambient environment may contain other 
estrogenic compounds, and this study was thus performed with a background exposure to estrogenic 
compounds, as also experienced by humans. 
In vitro studies on the 12 compounds carried out in our lab showed that genistein inhibited 
testosterone production and that genistein, daidzein and a mixture of lignans including SECO could 
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increase estradiol production in a human adrenal steroid producing cell line [12]. None of the 
phytoestrogen mixtures tested acted as antagonists of the androgen receptor in vitro, but a mixture 
of lignans was found to be an aromatase inducer [12]. Another study in adrenal cells has shown a 
general inhibitory effect of lignan metabolites on steroid synthesis in adrenal cells, an effect that 
could in turn contribute to an anti-androgenic mode of action [13]. In vivo studies on SECO or flax 
seed containing SECO have indicated adverse reproductive effects, as altered anogenital distance, 
altered estrus cyclicity and altered ventral prostate weights were observed in rats exposed to 
flaxseed in the diet [6;14-16]. Decreased male and female AGD at PND 3, altered estrus cyclicity, 
and increased uterus (prepubertal), ovary (adult) and prostate (adult) weights were observed in rats 
exposed in utero and via lactation to 10% flax seed corresponding to 12 mg/kg bw/day of SECO 
[16]. In our study, the middle and high dose included 17.4 mg/kg bw/day and 174 mg/kg bw/day of 
SECO, respectively, i.e. higher doses than the effective doses in the study on dietary flax seed 
exposure.  
The genistein dose (19.4 mg/kg bw/day) contained in the highest mixture dose  was lower than 
those being effective in studies on perinatal exposure (35-44 mg/kg bw/day) [5]. It is thus expected 
that SECO contributes markedly to the possible reproductive effects of the current phytoestrogen 
mixture. 
Daidzein is metabolized to equol, which has been shown to have anti-androgenic effects in adult 
rats by reducing prostate and epididymal weights through binding of dihydrotestosterone and 
thereby preventing it from activating the androgen receptor [4]. Formononetin and biochanin A 
were potent inhibitors of testosterone production and inducers of estradiol production in vitro [12], 
and the weak estrogen receptor agonist coumestrol is known to reduce sex hormone levels in young 
male rats at doses far above those applied in the current study [17]. Little is known about the effects 
of resinols other than SECO on estrogenic or anti-androgenic endpoints. 
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This paper describes effects of a human relevant mixture of phytoestrogens on hormone sensitive 
endpoints including anogenital distance (AGD), nipple retention, mammary development and 
chemically induced mammary tumor incidence in rat offspring exposed during pregnancy and 
lactation.  
 
2. Materials & Methods 
2.1 Test compounds 
Genistein (CAS 446-72-0), daidzein (CAS 486-66-8), equol (CAS 66036-38-2), formononetin 
(CAS 485-72-3), biochanin A (CAS 491-80-5), enterodiol (CAS 80226-00-2), and coumestrol 
(CAS 479-13-0) were all purchased from Sigma-Aldrich (Milwaukee, WI, USA). Enterolactone 
(CAS 78473-71-9), secoisolarici resinol (CAS 29288-59-8), matairesinol (CAS 580-72-3), 
lariciresinol (CAS 27003-73-2), and pinoresinol (CAS 487-36-5) were purchased from Arbo-Nova 
(Turku, Finland). N-methyl-N-nitrosourea (MNU, CAS 684-93-5) was purchased from Sigma-
Aldrich (Milwaukee, WI, USA).  
 
2.2 Animals and dosing 
The animal studies were performed under conditions approved by the Danish Agency for Protection 
of Experimental Animals and by the in-house Animal Welfare Committee of the National Food 
Institute at the Technical University of Denmark. 80 time-mated Sprague-Dawley rats (Taconic 
M&B, Denmark, bodyweight approx. 230 g) were supplied at day 3 of pregnancy. The study was 
performed in 3 blocks separated by one week and with equal distribution of dose groups. The dams 
were randomized into 5 groups of 16 with similar body weight distributions and housed in pairs 
under standard conditions. Semi-transparent plastic cages with Tapvei aspen bedding were situated 
in an animal room with controlled environmental conditions (12 h light-dark cycles with light 
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starting at 9 p.m., light intensity 500 lux, temperature 21 ± 2°C, humidity 50% ± 5%, ventilation 8 
air changes per h). Food (Soy free Altromin 1314) and tap water were provided ad libitum. Dams 
were dosed daily by gavage from gestation day (GD) 7 to postnatal day (PND) 13 with either 
vehicle (corn oil), a mixture of 12 phytoestrogens (both lignans and isoflavonoids) or genistein 
alone. Doses were selected from “high human dietary intake” determined by Hedelin et al., 2006, in 
a Swedish population (Table 1). Control group: corn oil only. “Mix 2” group: 1 x “high human 
dietary intake” phytoestrogen mix (total of 2.13 mg/kg bw/day). “Mix 21” group: 10 x “high human 
dietary intake” phytoestrogen mix (total of 21.3 mg/kg bw/day). “Mix 213” group: 100 x “high 
human dietary intake” phytoestrogen mix (total of 213 mg/kg bw/day). “Genistein 213” group: 
genistein 213 mg/kg bw/day.  
Anogenital distance (AGD) was measured in male and female pups on the day of birth using a 
dissecting scope with an ocular reticle. AGDi was calculated as the AGD divided by the third root 
of birth weight. At PND 13 all pups were weighed and examined for the presence of 
nipples/areolas, described as a dark focal area (with or without a nipple bud) located where nipples 
are normally present in female offspring. The nipples were counted and no distinction was made 
between the retention of an areola or a nipple. However, a technical error was identified, as areolas 
(dark coloration of skin) were only assessed in the last of the 3 blocks. The number of nipples in 
female rats is normally 12-13 versus zero in males. AGD and nipple retention was recorded by the 
same technician skilled in these measurements and blinded to exposure group. 
On PND 13, one male and one female pup per litter were randomly selected for autopsy and 
mammary analyses. On PND 22, one female pup per litter were randomly selected for autopsy and 
mammary analyses, and one male per litter and two females per litter were weaned and kept for 
examinations in adulthood. Remaining pups were sacrificed and blood was collected for hormone 
analyses. Weaned rats were caged in pairs of same sex and exposure. Age at sexual maturation was 
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investigated in all weaned rats by recording the day of vaginal opening in the females and cleavage 
of the balano-preputial skinfold in the males. The latter was done by observing when the prepuce, 
which is fused to the glans penis until the onset of puberty, could be fully retracted. The day sexual 
maturation was observed, the weight of the animals was registered. 
At PND 50, one randomly selected female per litter (MNU-females) was exposed to 50 mg/kg bw 
of N-Nitroso-N-methylurea (MNU) in a 2% solution in isotonic saline as an intraperitoneal injection 
of a total amount of 2.5 ml per kg bw. MNU acts as a mammary tumor inducer in rats [18]. Rats 
were palpated for tumors twice a week from PND 64 onwards, and age of mammary tumor 
detection was noted. 
 
2.3 Autopsies 
On PND 13 one male and one female per litter were sacrificed by decapitation and blood was 
collected for hormone analyses. From females the 4th mammary glands were excised for whole 
mount preparation and gene expression, respectively. From males, the 4th mammary glands were 
excised for whole mount preparation. Ventral prostate was weighed and placed in RNAlater (Life 
Technologies Europe BV, Naerum, Denmark) for gene expression analysis. Testes were weighed 
and one testis was placed in Bouin’s fixative for later histological examination, and the other was 
placed in an empty tube and snap-frozen in liquid nitrogen for measurement of testicular 
testosterone content. Livers from males and females were weighed and placed in RNAlater for gene 
expression analysis.  
On PND 22, one female per litter was sacrificed by decapitation after CO2/O2 anesthesia and blood 
was collected for hormone analysis. The 4th mammary glands were excised for whole mount 
preparation and gene expression, respectively, and the uterus and one ovary were weighed and fixed 
in formalin for histological examination.  
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Adult males were sacrificed by decapitation after CO2/O2 anesthesia at PND 150 and the 4th 
mammary glands were excised and fixed in formalin for histological examination and whole mount, 
respectively. One testis and the ventral prostate were weighed and placed in RNAlater for gene 
expression analysis. The other testis was fixed in Bouin’s fixative for histological examination.  
Females exposed to MNU on PND 50 (one per litter) were sacrificed by decapitation after CO2/O2 
anesthesia when tumor size approximated 20 mm in accordance with in-house ethical guidelines. 
Rats were examined, tumor number and sizes were recorded, and tumors were excised and fixed in 
formalin for histological examination. When mammary tumors were detected in 50% of controls, 
the remaining MNU-females were sacrificed (PND 132). 
Females not exposed to MNU were sacrificed by decapitation after CO2/O2 anesthesia at PND 135-
150 in CO2/O2 anaesthesia, blood was collected for hormone analysis, and a vaginal smear was 
collected for determination of estrous cycle stage and stained by the adapted Papanicolau procedure 
[19] (Gill’s hematoxylin, Orange G6 and eosin-azure 50, provided by VWR, Gentofte, Denmark). It 
was the aim to sacrifice animals in proestrous, which was determined by measurement of the 
electrical impedance of the epithelial cell layer of vaginal mucosa by inserting a Vaginal Impedance 
Checker (VIC, Model MK-10C, Muromachi, Japan) into the vagina. If the measured value was 3 
kΩ of impedance or above, the animal was considered to be in proestrous. As this measurement was 
somewhat variable, the accurate stage of estrous cycle was determined by evaluation of vaginal 
smears together with histological evaluation of uterus and ovary. A few animals were in anestrous 
and were omitted from the histological evaluation of mammary glands, ovaries and uteri, and 
evaluations of the remaining animals were performed bearing the stage of the estrous cycle in mind. 
From each female one of the 4th mammary glands was excised for whole mount preparation and the 
2nd mammary gland, uterus and one ovary were excised, weighed and fixed in formalin for 
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histological examination. The other ovary was weighed and placed in RNAlater for gene expression 
analysis.  
 
2.4 Histology 
Tissue samples for histological examination were routinely processed, embedded in paraffin, and 
sectioned. All sections were evaluated blinded to treatment groups in adult males and females. 
Hematoxylin and eosin (HE) stained sections from adult female mammary glands were evaluated 
for vacuolisation and lobuloalveolar pattern defined as mammary epithelium forming lobular units 
with no alveolar structures (no lumen, no one-layered alveolar epithelium, e.g. loss of female 
alveolar architecture). HE stained sections from adult male mammary glands were evaluated for 
hypertrophy and vacuolisation of mammary epithelium and secretory material in alveoles and ducts. 
Additionally, adult male mammary glands were stained with periodic acid Schiff (PAS) and 
mucicarmine. PAS stained sections were evaluated for PAS-positive secretion. Mucicarmine stained 
sections were evaluated for mucin-positive secretion.  
One HE stained section of each tumor were examined and classified according to the dominating 
histopathological type [20]. A semi-quantitative analysis was made for stromal (desmoplastic) 
reaction: No stromal reaction (0), mild stromal reaction (1), moderate stromal reaction (2), severe 
stromal reaction (3), and for stromal inflammation (infiltration with inflammatory cells in the 
stroma): No infiltration (0), mild = focal or few multifocal areas with low cell density (1), moderate 
= multifocal areas with low to moderate cell density (2), severe = multifocal areas with high cell 
density (3).  
One HE stained section of each testis (PND 13 and adult) were evaluated histologically. Prepubertal 
testes were examined for lumen formation and developmental stage. Adult testes were examined for 
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degenerative changes and abnormal development. Apoptosis assessment by TUNEL staining of 
testes was performed in one section per testis as described in [21].   
In one HE stained section of PND 22 ovaries, the number of multioocyte follicles per section was 
determined. From adult females, one HE stained section of the uterus and one HE stained section of 
the ovary from all rats were examined histologically. The accurate stage of the estrous cycle was 
determined by evaluation of uterine and ovarian histology as well as vaginal smear evaluation. 
Lumen size, epithelial folding and epithelial height were evaluated in uterine sections. The number 
of corpus lutei, nonatretic and atretic antral follicles, follicular cysts and granulosa cell hyperplasia 
(none, few nests, several nests and multiple nests/diffuse scored as 0,1,2,3 respectively) were 
evaluated in ovarian sections.  
 
2.5 Whole mounts 
Mammary glands for whole mount preparation were excised with the adjacent lymph node and 
spread on a glass slide. The tissue was covered with a coverslip and compressed for 1-2 hours 
before fixation in formalin overnight. Further processing was performed as described by Mandrup 
et al., 2012 [22]. 
Whole mounts were evaluated by an examiner blinded to treatment groups. Mammary development 
was examined by evaluating mammary whole mounts from 13 and 22-day old rats using a 1-4 score 
for density of the tissue and by measurement of the longitudinal and transversal expansion and the 
area of the mammary tissue. Whole mounts of adult males and females were evaluated for 
mammary development using a 1-5 density score. Density scores were given according to the 
extension of branching and budding of the gland, adjusted for age and gender. Moreover, the 
number of terminal end buds (TEBs) were counted in male and female mammary glands at PND 13 
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and were defined as tear-drop shaped structures with a diameter larger than 100μm as described by 
[23]. It was not possible to evaluate all parameters in some whole mounts due to missing parts.  
 
2.6 Hormone levels 
Trunk blood was centrifuged at 4000 g for 10 min at 4˚C, and kept at -80ºC until analysis of 
testosterone concentration. Steroids were extracted from plasma by solid-phase extraction using IST 
Isolute C18 SPE columns of 100 mg. The testosterone concentration was measured with a Delfia 
time-resolved fluoroimmunoassay (PerkinElmer, Wallac Oy, Turku, Finland). The detection limit of 
the assay is 0.3 nM and intra-assay variability is reported to 5.5-6% by the supplier. Values below 
the limit of detection were set to the same value as the detection limit. 
 
2.7 Gene expression  
mRNA was purified from RNAlater stored samples by use of the RNAeasy Mini Kit (Qiagen, 
Hilden, Germany) and cDNA was synthesised by use of the Omniscript RT kit (Life Technologies 
Europe BV, Naerum, Denmark). Both procedures were done according to the descriptions by the 
manufacturers. mRNA levels were evaluated by quantitative (q)PCR  using TAQ man probes in 
combination with specific primer pairs (Sequences  are given in Supplementary Materials, Table 
S1). These were mixed withTaq Man Fast Universal PCR Master Mix (Life Technologies Europe 
BV, Naerum, Denmark) and then run on a Taqman 7900 HT qPCR apparatus (Applied 
Biosystems). Two methods were used to evaluate the results. Quantitation by use of standard curves 
as described previously [24] using beta actin values for normalization was used for the following 
genes: Insulin-like growth factor-1 (IGF-1),  androgen receptor (AR), Transient receptor potential 
cation channel, Subfamily M, member 2 (TRPM-2) and Prostate specific binding protein 
polypeptide C3 (PBP C3) in the ventral prostate of PND 13 males, and PBP C3 and IGF-1 in 
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ventral prostate of adult males. Quantification by the comparative threshold cycle (CT) method 
(without a standard curve) was employed for of the following genes: IGF-1, Estrogen receptor-α 
(ERα) and ERβ in female mammary glands PND 13 and PND 22, ERα in the ventral prostate of 
PND 13 males, ERα and AR in ventral prostate of adult males; AR and ERα in testes of adult 
males. The Ct value is the cycle number at which the amplified target reaches a defined threshold. 
First this value was determined for the raw qPCR data. Normalization was next done by subtracting 
the Ct value of the housekeeping gene 18s rRNA from the Ct value of the target gene. This is the 
delta Ct value (dCt). The 2-dCt values were then used for statistical analysis to test for differences 
between treatment groups.  
 
2.8 Statistics 
Non-processed, logarithmically transformed and square root transformed data were examined for 
normal distribution and homogeneity of variance. Normally distributed data were analyzed by 
ANOVA using single animal data. For datasets including more than one animal per litter, the litter 
was the statistical unit and included in the analysis of variance as an independent, random factor. 
AGD and AGDi data were analyzed for males and females separately, and with bodyweight as a 
covariate. Additionally, AGD and AGDi data from the genistein-exposed group were compared to 
controls by comparing differences of LS means. Organ weights and outgrowth measures on 
mammary whole mounts were analyzed using body weight as a covariate. Data that could not obtain 
variance homogeneity or normal distribution with transformation were examined in a non-
parametric Kruskall-Wallis test followed by Dunn’s test for multiple comparisons. Asterisks 
indicate a statistically significant difference compared to controls *: p<0.05; **: p<0.01; 
***:p<0.001.  
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The number of nipple/areolas was assumed to follow a binomial-distribution with a response range 
between 0 and θmax, with θmax being equal to the biologically possible maximal number of nipples in 
rats, either 12 or 13. The choice of θmax was decided on considering the global fit (information 
criterion of Schwarz). To account for litter effects on nipple retention, correlation structures 
between number of nipple/areolas and litter were modeled by the Generalized Estimating Equations 
method[25]. All statistical analyses were performed using the SAS procedure PROC GENMOD 
(SAS Institute Inc, Cary, NC, USA). SAS statistical software was used for the analyses (SAS 
Institute Inc, Cary, NC, USA).  
Histological data were analyzed by Fisher exact test using SAS Enterprise 9.1. Exposed groups 
were only compared with controls separately in cases with overall statistically significant results. 
Data on tumor incidence were analyzed by Peto test (proc lifetest) for analysis of differences 
between groups in age of occurrence of first tumor and by Fisher exact test for comparison of tumor 
numbers at a fixed age at which more than 50% of controls had palpable tumors (PND 132). 
Mammary histology was analysed in GraphPad Prism 5 with a Fisher exact test. 
Regarding gene expression, dCT values were tested for normal distribution by the D’Agostino and 
Pearson omnibus normality test. Normal distributed data were analyzed by one-way ANOVA with 
post-test for linear slope or with Dunnet's test for control vs. phyto groups, as well as a t-test of 
control vs. genistein. Data that were not normal distributed were analyzed using a Kruskall-Wallis 
test followed by Dunn’s test for multiple comparisons for control vs. mixture groups, as well as a 
Mann-Whitney test of control vs. Genistein. 
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3. Results  
3.1 Perinatal development 
AGD was assessed in offspring to evaluate anti-androgenic effects of the phytoestrogen mixture. A 
dose-related trend to decreasing AGDs at birth was seen in males exposed to the mixture, and  
significantly reduced AGD and AGDi at birth were seen in the highest mixture group compared to 
controls (Fig. 1A). For genistein exposed animals, AGD and AGDi were not significantly different 
from controls in Dunnett’s post hoc test (p=0.11 and p=0.13). A high outlier from an abnormal litter 
with only one male and one female pup likely influenced the lack of statistical significance for the 
genistein group. Reductions in AGD and AGDi were statistically significant in genistein exposed 
male pups when comparing differences of LS means, i.e. a pairwise comparison of genistein and 
controls (p=0.03 and P=0.04, respectively). No changes in AGD were seen for females. 
 
Data on nipple/areola retention were omitted due to an identified technical error, as areolas (dark 
coloration of skin) were only assessed in the last of the 3 blocks.  
No changes in maternal weight gain, gestation length, post-implantation or perinatal loss, postnatal 
deaths, sex ratio, birth weights or body weights of offspring were observed (Table 2). No alterations 
of puberty onset were observed (data not shown). 
 
3.2 Hormone levels and organ weights 
Organ weights were unaffected by treatment at PND 13 (ventral prostate, testis, liver) or 22 (ovary, 
uterus) or in adulthood (ventral prostate, testis, ovary, uterus) (Table 3).  
Reduced serum estradiol levels were seen in dams from the genistein group compared to controls, 
whereas the phytoestrogen mixture did not affect estradiol levels (Fig. 2A). A trend towards 
reduced plasma estradiol levels in female offspring was not statistically significant (Fig. 2B). 
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Males exposed to genistein had a statistically significant reduction in serum testosterone level 
compared to controls at PND 13 (Fig. 2C). The analyzed samples were pools of serum from 2-4 
pups from the same litter, and the observed reduction was due to 3 out of 5 pooled serum samples 
from genistein exposed males having testosterone levels below the limit of detection, whereas all 
control samples had testosterone levels above the detection limit. At PND 22 (Fig. 2D) and in 
adulthood no statistically significant effect on testosterone was found. Testicular testosterone 
concentration was not changed by the phytoestrogen administration (Table 3).  
 
3.3 Mammary whole mounts 
Mammary development was evaluated in whole mounts of the 4th mammary gland of offspring at 
PND 13 (females and males) and PND 22 (females). No statistically significant differences between 
groups were observed for the area (Supplementary materials, Table S2), the longitudinal- or the 
transverse growth of the breast tissue at PND 13 or PND 22 (data not shown). A statistically 
significant reduction in density scores was observed at PND 13 in females from the lowest mixture 
dose group compared to controls, but no statistically significant differences in density scores were 
seen for PND 13 males or PND 22 females (Supplementary materials, Table S2).  When including 
body weight as a covariate in the analysis of density scores of PND 13 females, there were no 
statistically significant differences between groups. No statistically significant differences between 
groups were found in the number of TEBs. In adult females and males no statistically significant 
differences in density score were seen between the groups. Areas with female-like branches were 
observed sporadically in male mammary glands PND 150 in all groups.  
 
3.4 Mammary histology 
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Histopathology of mammary glands was evaluated in females PND 135 and males PND 150. In 
males, a dose-related increase in hypertrophy was observed and was statistically significant at the 
highest phytoestrogen mixture dose. An elevated number of males with hypertrophy was also seen 
in the genistein group, but this was not statistically significant. Among the 40 male mammary 
glands with hypertrophic epithelium, 11 were found to show a similar morphology to the apocrine 
changes seen in some human breast cancers [26] (Fig. 3C and 3F). These apocrine-like changes 
were defined as cells with abundant eosinophilic cytoplasm containing small eosinophilic  granules 
and round to oval lightly stained nuclei as described by Durham and Fechner, 2000 [27]. 
Additionally, vacuolated mammary epithelium and secretory material in alveoli was observed more 
frequently in animals exposed to phytoestrogens than in controls, but this was not statistically 
significant (Fisher exact test for secretory material in alveoli in high dose mixture group: p=0.06) 
(Fig. 3D). In females, histological examination was performed on cycling animals. Four animals in 
the phytoestrogen mixture groups were in anoestrous and were not included for statistical analysis 
nor shown in Fig. 4. In females exposed to the phytoestrogen mixture, an increase in the prevalence 
of animals with lobuloalveolar pattern was seen, yet this was not statistically significant (Fig. 4B 
and 4C). No increase in vacuolization of the epithelium was observed with dosing. Vacuolated 
epithelium was not specific for a certain stage of estrous cycle, and the lobuloalveolar pattern 
observed was distinguishable from the typical lobules with tubuloalveolar pattern of animals in 
diestrous and metestrous [28]. PAS and mucicarmine stained male mammary glands showed no 
differences between the groups for PAS-positive and mucin-positive secretion.  
 
3.5 Mammary tumors 
Tumor latency after MNU exposure was not different between dose groups (Fig. 5). Animals were 
sacrificed at different ages for ethical reasons. Due to these age differences, tumor multiplicity data 
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were not considered relevant for statistical examination, but a qualitative data examination was 
performed and showed no apparent differences between groups. Histological examination of tumors 
showed that all tumors were malignant adenocarcinomas of variable size. A cribriform pattern was 
dominating at all doses, while in some exposed animals the papillary and comedo patterns were the 
dominating histopathological types. These differences between groups in dominating 
histopathological types were not statistically significant (Supplementary materials, Table S2). No 
differences between groups were observed with respect to stromal reactions or inflammation. 
 
3.6 Histology of other organs 
No group differences in testis histology were apparent at PND 13 and in adulthood. Apoptosis 
assessment by TUNEL staining of adult testes showed no treatment-related effects (data not 
shown).  
Staging of vaginal smears, uteri and ovaries showed that not all animals were in proestrous (P) as 
intended, but several animals had entered estrous (E) and a smaller number of animals were in 
diestrous (D) or metestrous (M). All groups except controls had 1- 3 animals evaluated as being in 
anestrous as listed below: 
Controls: 10 animals in P or E, 4 animals in D or M, 0 animals in anestrous. Mix 2: 12 animals in P 
or E, 3 animals in D or M, 1 animal in anestrous.Mix 21: 10 animals in P or E, 1 animal in D or M, 
3 animals in anestrous. Mix 213: 14 animals in P or E, 1 animal in D or M, 1 animal in anestrous. 
Geni 213: 9 animals in P or E, 2 animals in D or M, 3 animals in anestrous. 
Although anestrous appeared more frequently among exposed animals than controls, this was not 
statistically significant and may be a sign of pseudopregnancy, which could be induced by the use 
of vaginal impedance measurement.  
Histological examination of uterus and ovary showed no dose-related changes.  
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3.7 Gene expression 
Gene expression in female mammary glands showed no statistically significant changes in the 
expression of mRNA for IGF-1, ERα or ERβ on PND 13 or 22 (data not shown). Gene expression 
analysis of PND 13 ventral prostates showed no statistically significant differences between 
controls and exposed groups in the expression of IGF-1, AR, PBP C3, TRPM-2 or ERα (data not 
shown). In adult ventral prostate, ERα expression was very low and no differences in IGF-1, 
PBPC3, AR or ERα expression were observed (data not shown). In adult testes, no changes in AR 
or ERα mRNA expression were observed (data not shown).  
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4. Discussion (1460 words excl references) 
In contrast to previous studies on SECO and genistein, the current study showed only few adverse 
effects on developing and adult male rats. Changes in female mammary glands and adverse changes 
in the male reproductive system were expected based on studies on genistein or SECO reported in 
the literature, but were not detected in the current study. However, this is the first study to describe 
reduced AGD in male pups and persistent adverse changes in male mammary glands following 
perinatal exposure to a phytoestrogen mixture containing mainly SECO and genistein. 
 
4.1 Early anti-androgenic effects 
Perinatal exposure to this phytoestrogen mixture induced anti-androgenic effects in young male 
rats, as a dose-related trend to decreased AGD was observed reaching statistical significance at the 
highest doseThe effect of the mixture was likely caused by the combined exposure to SECO, 
genistein and daidzein, as these were the main constituents of the mixture, and these compounds 
have all been associated with anti-androgenic effects [1;5;6]. Multiple modes of actions are known 
for the main constituent of the mixture, SECO, which can act as an estrogen, a steroid synthesis 
inhibitor, and an aromatase inducer and/or inhibitor [12;13].  
 
4.2 Mammary gland effects 
The phytoestrogen mixture affected male mammary glands, as an increase in the number of males 
with hypertrophic mammary epithelium was seen at the high mixture dose. Likewise, Delclos et al., 
2001, observed hypertrophy of the alveolar and ductal epithelium in male mammary glands PND 50 
after perinatal dietary exposure to genistein (from 25 ppm (approximately 2.5 mg/kg bw/day) and 
above) [29]. Comparable effects were seen in the animals exposed to genistein alone, but 
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unexpectedly, these were not statistically significant despite a high dose level of 213 mg/kg bw/day. 
One difference between these studies is dietary exposure versus exposure by gavage, but the 
apparently higher sensitivity in the dietary study may also reflect that exposure of offspring was 
continued until necropsy on PND 50 in that study. 
Among the animals with hypertrophic epithelium in the current study, several were found to be 
morphologically similar to the apocrine metaplasia seen in some human breast cancers [26]. To our 
knowledge, apocrine changes have not been previously described in rats, and the human relevance 
of these apocrine-like changes in rats may be of interest for further investigation.  
Moreover, presence of secretory material in alveoli of adult male mammary glands may be a sign of 
feminization and was observed more frequently in males exposed to phytoestrogens than in 
controls, but this was not statistically significant. As the power to detect statistically significant 
changes on binary measures is low, it is important to pay attention to trends and findings that, 
although not statistically significant, may suggest an effect of exposure to the test material, as 
stressed in OECD guidance documents for histological evaluation [30].  Similar effects were 
observed in a study with perinatal exposure to a mixture of pesticides with anti-androgenic 
properties [31], suggesting a feminization of the male mammary gland under the action of 
pesticides with anti-androgenic activity. Androgens are known to be responsible for masculinization 
of the mammary gland during pre- and postnatal development [32;33], but there are currently few 
studies on the actions of anti-androgenic compounds on the male mammary gland. Male rats appear 
to be particularly sensitive to endocrine disrupting compounds in this and other studies [7;29], and 
evaluation of male mammary gland histology is included in the recent OECD guideline for the 
extended one-generation study (OECD 443) [34]. 
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In adult female mammary glands, a trend to increasing frequencies of lobuloalveolar pattern was 
seen in mixture groups indicating a possible masculinization of the mammary gland. In a 
comparable study using perinatal dietary exposure to genistein, histopathology of female mammary 
glands PND 50 showed hyperplasia with proliferation of alveolar complexes into compact lobules, 
which was statistically significant from 250 ppm (approximately 25 mg/kg/day) following pre- and 
postnatal exposure until PND 50 [29]. In the current study, the highest mixture dose contained 19.4 
mg/kg bw/day of genistein, i.e. slightly lower levels than those effective in the dietary study. As for 
the males, the difference in sensitivity between the dietary study and the current findings may be 
due to different exposure routes or to higher sensitivity with continued exposure of pups in the 
dietary study.  
Generally, it is expected that perinatal exposure to estrogenic compounds will lead to earlier 
development and increased growth of the prepubertal mammary glands [22;29;35], but no 
indications of progressed prepubertal mammary development were seen following mixed 
phytoestrogen exposure. Reduced scores for density in PND 13 females in the lowest mixture dose 
group may be a chance finding as no other changes in prepubertal mammary development or in 
expression of estrogen responsive genes were observed for males or females.  
 
4.3 Mammary tumor latency 
In the current study, mixed phytoestrogen exposure did not appear to alter latency to mammary 
tumors induced by the carcinogen MNU or to affect the number of TEBs on PND13. It has 
previously been proposed that SECO and other lignans may reduce the mammary cancer risk [8], 
while other studies have shown that exposure to flax seed containing SECO during early 
development enhanced mammary growth [9], increased the susceptibility to carcinogen-induced 
mammary tumors [10], or reduced TEB numbers suggesting a protective effect against mammary 
24 
 
tumors [36]. The timing of exposure appears important for the observed effects of phytoestrogens, 
but also differences in the specific compound studied (SECO, SECO diglucoside, flax seed or 
mixed phytoestrogen exposure) may account for the different results obtained. In agreement with 
the lack of change in tumor latency in the current study, Fritz et al., 1998, found an increased 
number of tumors, but no change in tumor latency following perinatal genistein exposure of rats 
[37]. Other studies showed that neonatal, but not prepubertal exposure to genistein increased tumor 
latency [2].  
 
4.4 Male reproductive system 
Genistein exposure, but not mixed phytoestrogen exposure, appeared to alter plasma testosterone 
levels in prepuberty in this study. The finding of reduced plasma testosterone levels in the genistein 
group at PND 13 but not at PND 22 may be a transient effect disappearing after the end of dosing or 
a chance finding. The reduction of testosterone by genistein confirms findings by Akingbemi et al., 
2007, who found impaired testicular steroidogenesis in rats exposed perinatally to a soy-based diet 
containing genistein and daidzein [38]. They found that serum testosterone levels were decreased in 
pre-puberty and elevated in adulthood, possibly due to changes in Leydig cell numbers and 
function. In contrast, a rat study on perinatal exposure to soy beans showed increased Leydig cell 
numbers and increased testicular testosterone production in prepuberty [39]. No changes in adult 
serum testosterone levels were observed in the current study, and no changes in testicular histology 
were observed. As testosterone measurement is very variable, further examination such as 
quantitative examination of Leydig cells would be very relevant to include. 
 
Unexpectedly, no changes in prostate weights were seen for genistein or for the phytoestrogen 
mixture. In general, it is known that estrogenic compounds may increase or decrease prostate 
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weights depending on dose level and age of examination [40-42], and possibly depending on the 
selected strain of rats. Genistein may also induce histological changes in prostates, but this was not 
examined in the current study [5].  
 
Prostate development is known to be influenced by anti-androgens as well as estrogens [43]. 
Changes in mRNA levels of the AR regulated genes TRPM-2 and PBPC3 in ventral prostate have 
been observed following perinatal exposure to anti-androgenic chemicals in previous studies [44-
47], but in the current study no changes in mRNA levels of the AR or androgen-regulated genes 
(TRPM-2, PBPC3) were found in prepubertal or adult ventral prostates.  
Estrogenic compounds may alter expression of ER responsive genes such as IGF-1 [43], and  
reduced ERα mRNA and protein levels have been found in adult rat prostates following perinatal 
soy exposure [38], but no changes in IGF-1 or ERα mRNA expression of the prepubertal or adult 
ventral prostate were seen in this study. Another study in mice exposed to genistein in the neonatal 
period showed decreased ERα and AR levels (mRNA and protein) in adult testes [48], but no 
changes in these genes were observed in adult testes in the current study.  
 
The absence of effects on testicular and prostatic gene expression in genistein exposed animals in 
the current study may be due to differences in dose levels and dosing periods, but examination of 
e.g. prostate histology, semen quality or epididymal changes would be required to exempt the 
phytoestrogen mixture for adverse effects on male reproductive organs.  
 
4.5 Combination effects and human intake 
Genistein, daidzein and SECO were present at relatively high levels in the mixture (9, 5, and 82% 
of the mixture, respectively), and it is likely that the combined exposure to these three compounds 
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have caused the observed effects on mammary glands and AGD. Overall, steroid synthesis 
inhibition and aromatase induction by lignans appear to be a plausible mechanism behind the AGD 
reduction observed in the current study, and may also be involved in the tendencies towards low 
estradiol levels in dams and female offspring. 
Effects on AGD and male mammary hypertrophy were statistically significant at 100-fold “high 
human dietary intake” of phytoestrogens, while trends towards effects on these and other endpoints 
were seen also at 1x and 10x “high human dietary intake”. Large variations made it difficult to 
determine whether the 1x or the 10x “high human dietary intake” dose can be considered a no-effect 
level in rats. 
When considering the relevance for humans with an average phytoestrogen intake, it should be 
noted that the mean human dietary intake of phytoestrogens is far below the high dose level in this 
study. Furthermore, there may be differences between the study population of elderly men on which 
these “high human dietary intake” levels are based, and the pregnant women who are in focus when 
comparing with effects on reproductive development in perinatally exposed rats. Recent data on 
dietary phytoestrogen intake in German women (median age 63 years) [49] describe median intake 
levels 100-fold below median levels of the study population of Hedelin et al. [11], meaning that the 
lowest mixture dose (1x “high human dietary intake”) is approximately equal to 100-fold mean 
human dietary intake level in the German female study population. At the 1-fold mixture dose level, 
the calculated intake of SECO is 104 mg/day per person corresponding to 38 g flaxseed per day 
[50]. Intake above this level is not expected from dietary sources, but intake of dietary supplements 
containing SECO could potentially lead to higher intake levels. Genistein intake at this “high 
human dietary intake” is 12 mg/day per person corresponding to 24 g soy beans per day; an intake 
level that may be exceeded by some consumers as NTP uses a high genistein intake of 25.8 
mg/person per day [2].   
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The 10x “high human dietary intake” dose corresponding to 1000-fold “mean human exposure 
level” was a no-effect level in this study, and the safety margin can be considered sufficient for 
pregnant women with average phytoestrogen intakes. It should be noted that only a limited amount 
of data on phytoestrogen intake can be found in the literature, and that intake data for pregnant 
women are scarce. An excessive human intake of phytoestrogens may result from e.g. dietary 
supplements or special dietary habits. Such intakes may contribute to endocrine disruption 
particularly for sensitive subpopulations or for persons exposed in combination with other 
endocrine disrupting chemicals.  
 
Further studies on male and female mammary glands and on male nipple retention and AGD may 
be required to determine no-effect levels for particularly SECO. This study showed no effects on 
prostate or testicular weights and no changes in mRNA levels of steroid receptors and their target 
genes, but further studies on e.g. prostate histology, semen quality or epididymal changes would be 
beneficial. Experimental and epidemiological studies on the influences of the dietary sources of 
SECO (flax seed, rye bread) on reproductive development would also be very relevant.  
 
4.6 Conclusions  
Perinatal exposure to high doses of phytoestrogens can induce adverse mammary changes in rats, 
particularly in males. This is seen by increased hypertrophic growth and increased alveolar 
secretion as a sign of feminization. These changes are likely related to the endocrine disruption 
reflected by changes in male AGD.  
Flaxseed and rye bread are the main dietary sources of lignans including SECO [11], and although 
they are often associated with beneficial health effects it may be necessary to examine further 
whether realistic intakes of these dietary components also have adverse effects on male 
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reproductive development. This study indicated adverse effects at high intake levels in rats, but does 
not provide evidence for risk of phytoestrogen-mediated endocrine disruption at normal human 
dietary consumption levels. Further studies are warranted to increase the knowledge upon which 
risk assessment on dietary phytoestrogen exposure during pregnancy and infancy is based. 
However, an excessive human intake of phytoestrogens may result from e.g. dietary supplements or 
special dietary habits and may contribute to endocrine disruption, particularly for sensitive 
subpopulations or for persons exposed in combination with other endocrine disrupting chemicals.  
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Figure legends: 
 
Figure 1. Anogenital distance in male offspring of rats perinatally exposed to a mixture of 
phytoestrogens or genistein. Data points show litter means, horizontal lines are means of litter 
means ±SD. * Indicates statistically significant difference from controls (p<0.05, including all data 
points).  
 
Figure 2. Hormone levels in dams and offspring exposed to a mixture of phytoestrogens or 
genistein, mean±SEM. * indicates a statistically significant difference compared to controls in an 
ANOVA followed by Dunnett’s test.  
 
Figure 3. Histopathology of mammary glands of male rats perinatally exposed to a mixture of 
phytoestrogens. A, control mammary gland with absence of secretion in alveoli. B, hypertrophy in 
male mammary gland from the highest dose-group (Mix-213). C, apocrine-like changes and 
secretion filled alveoli (arrow) in male mammary gland from the highest dose-group (Mix-213). 
Prevalence of males with secretory material in alveoli (D), hypertrophy (E) or apocrine-like changes 
(F). *: p<0.05 compared to controls. Scale bar in lower left corner of pictures represents 50µm. 40x 
magnification.  
 
Figure 4. Histopathology of mammary glands of female rats perinatally exposed to a mixture of 
phytoestrogens. A, tubuloalveolar pattern in control female mammary gland. B, lobuloalveolar 
pattern in mammary gland of female from the highest dose-group (Mix-213). C, prevalence of 
females with lobuloalveolar pattern. Scale bar in the bottom right corner of photos represents 50µm. 
40x magnification. 
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Figure 5. Cumulated incidence of mammary tumors in rats exposed to a mixture of phytoestrogens 
or genistein (n=14-16). No statistically significant differences between controls and exposed groups 
were observed.  
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Tables 
 
Table 1. Composition of phytoestrogen mixture based on “high human dietary intake” from Hedelin 
et al.,2006 [11]. The gray-shaded row indicates the total intake in mg/kg bw/day for each dose 
groups and corresponds to the group names “Mix 2”, “Mix 21” and “Mix 213” 
 
1x high human 
dietary intake, 
µg/kg/day  
10x high human 
dietary intake, 
µg/kg/day 
100x high human 
dietary intake, 
µg/kg/day 
#Genistein  194  1940 19400 
#Daidzein  123  1230 12300 
#Equol  0.22  2.2 22 
#Formononetin  0.28 2.8 28 
#Biochanin A  0.28  2.8 28 
*Enterolactone  2.78  27.8 278 
*Enterodiol  0.01  0.1 1 
Coumestrol  0.08  0.8 8 
*Secoisolarici resinol  
(SECO) 
1739  17390 173900 
*Matairesinol  6.82  68.2 682 
*Lariciresinol  40.2  402 4020 
*Pinoresinol  19.07  190.7 1907 
Total (µg/kg/day) 2125.7 21257.4 212574 
Total (mg/kg/day) 2.13 21.3 212.6 
Total isoflavonoids 
and isoflavonoid 
metabolites (#) 
(mg/kg/day) 
0.3 3.2 31.8 
Total lignans and 
lignan metabolites (*) 
(mg/kg/day) 
1.8 18.1 180.8 
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Table 2. Pregnancy and litter data. Data represent group means based on litter means ± SD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Control Mix 2 
 
 
 
 
Mix 21 Mix 213 
 
Genistein 213 
No. of dams  
( litters) 
16 (14) 16 (15) 16 (14) 16 (14) 16 (14) 
Maternal 
weight gain 
GD7-GD21 92.0 ± 8.7 89.4 ± 17.8 98.8 ± 22.6 88.6 ± 11.0 83.1 ± 13.7 
Maternal 
weight gain 
GD7-PD1 14.4 ± 12.3 8.7 ± 18.1 14.6 ± 22.7 2.6 ± 18.0 2.5 ± 16.1 
Maternal 
weight gain 
PD1-22 6.4 ± 13.9 8.1 ± 14.4 13.2 ± 15.2 13.9 ± 18.5 18.8 ± 13.7 
Gestation 
length (days) 23.0 ± 0.1 22.9 ± 0.3 23.0 ± 0.0 22.9 ± 0.2 23.0 ± 0.3 
% post-
implantation 
loss 6.1 ± 8.5 2.3 ± 4.2 6.0 ± 7.5 5.2 ± 5.7 7.6 ± 14.8 
% perinatal 
loss   8.7 ± 10.0 6.6 ± 9.9 7.7 ± 8.5 10.4 ± 10.0 11.4 ± 18.8 
Live pups per 
litter 11.6 ± 1.9 13.1 ± 1.4 12.3 ± 1.7 12.6 ± 2.3 11.4 ± 3.2 
% Postnatal 
death 2.7 ± 6.5 4.5 ± 8.4 1.8 ± 3.6 5.4 ± 9.9 5.4 ± 9.9 
% Males 46.3 ± 11.2 47.5 ± 16.4 52.0 ± 18.5 48.0 ± 13.7 47.0 ± 14.5 
Birth weight 
male 
offspring 6.8 ± 0.3 6.6 ± 0.3 6.7 ± 0.4 6.5 ± 0.7 6.7 ± 0.5 
Birth weight 
female 
offspring 6.5 ± 0.2 6.0 ± 0.5 6.2 ± 0.4 6.0 ± 0.5 6.3 ± 0.4 
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Table 3. 
Reproductive organ weights (absolute and relative) and serum hormone levels in rat offspring 
exposed to a mixture of phytoestrogens or to genistein from GD 7 to PND 13. Mean ±SD 
  Control Mix 2 Mix 21 Mix 213 Genistein 
213 
PND 
13, 
males 
N (N prostate) 14 (9) 15 (13) 14 (12) 14 (13) 14 (12) 
Body weight, g 26.7±3.0 24.5±3.5 24.8±3.0 24.5±4.3 25.1±3.6 
Testes, mg 68.7±6.1 66.5±5.8 65.0±6.1 64.1±9.4 67.1±8.5 
Ventral prostate, mg 6.0±2.2 5.2±1.4 5.5±1.7 4.4±1.5 5.5±1.4 
Liver, mg 693±100 642.1±81.6 625±85 638±142 654±125 
Rel. testes, mg/g 2.60±0.26 2.75±0.36 2.64±0.19 2.63±0.20 2.68±0.17 
Rel. ventral prostate, 
mg/g 
0.15±0.12 0.18±0.09 0.19±0.10 0.17±0.08 0.19±0.09 
Rel. liver, mg/g 26.03±2.46 26.41±2.90 25.30±2.25 26.00±2.51 25.93±2.52 
Plasma testosterone#, 
pg/ml 
150±102 84±58 71±39 136±84 47±73* 
Testis testosterone, 
ng/testis 
0.78±0.45 0.47±0.59 0.70±0.71 0.65±0.43 0.49±0.37 
PND 
13, 
females 
N 14 13 15 14 14 
Body weight, g 25.8±3.2 22.9±3.3 23.7±2.7 24.4±4.2 24.4±3.4 
Liver, mg 673±89 612±103 628±92 641±149 622±126 
Rel. liver, mg/g 26.1±2.2 26.8±2.2 26.4±1.8 26.1±2.3 27.0±2.2 
Plasma estradiol# 9.5±3.6 9.1±2.5 7.4±5.0 6.7±2.1 6.3±3.2 
PND 
22, 
males 
N 14 14 13 13 12 
Plasma testosterone, 
pg/ml 
50.4±47.3 66.9±40.2 56.8±41.6 38. 5±28.6 47.5±55.7 
PND 
22, 
females 
N 14 14-15 10 13 13 
Body weight, g 50.1±6.0 46.4±5.1 46.7±4.1 46.8±7.1 48.6±7.7 
Uterus, mg 24.1±5.3 23.0±2.8 23.4±2.9 24.2±5.5 22.9±2.7 
Ovaries, mg 17.8±2.5 17.0±2.7 16.7±2.1 16.5±2.9 17.8±3.4 
Rel. uterus, mg/g 0.48±0.10 0.50±0.07 0.50±0.06 0.52±0.12 0.48±0.09 
Rel. ovaries, mg/g 0.36±0.04 0.37±0.05 0.36±0.04 0.35±0.04 0.37±0.05 
Plasma estradiol 
pg/ml 
15.9±4.1 17.8±3.3 18.3±3.3 17.6±4.2 17.1±3.8 
PND 
150, 
males 
N 14 15-16 15-16 16 13-14 
Body weight, g 460±28 454±37 464±36 436±35 448±36 
Testes, mg 3878±354 3775±260 3784±193 3708±372 3683±283 
Ventral prostate, mg 617±151 592±113 639±160 605±135 616±148 
Rel. testes, mg/g 8.4±0.7 8.3±0.7 8.0±1.2 8.5±0.6 8.3±0.6 
Rel. ventral prostate, 
mg/g 
1.3±0.3 1.3±0.3 1.4±0.4 1.4±0.3 1.3±0.5 
Plasma testosterone 
pg/ml 
2576±2360 1777±2673 1372±1102 1694±1720 1949±1692 
PND 
135 
females 
N (N proestrus/estrus) 
## 
10 (9) 16 (12) 14 (10) 16 (14) 14 (9) 
Body weight, g 244±16 249±14 251±22 250±22 252±22 
Uterus, mg 881±363 843±436 811±277 797±413 876±187 
Ovaries, mg 88±16 85±13 87±11 95±13 100±16 
Rel. uterus, mg/g 3.6±1.5 3.4±1.7 3.4±1.2 3.2±1.7 3.6±0.8 
Rel. ovaries, mg/g 0.36±0.08 0.34±0.05 0.36±0.04 0.38±0.05 0.41±0.06 
Plasma estradiol 
pg/ml 
15.2±7.9 26.6±16.1 21.0±12.6 26.5±13.5 21.8±9.5 
# at PND 13 samples for plasma hormone levels were pooled for 2-3 pups, n=4-7 for males and n=5 for females. ##In 
adult females, plasma estradiol levels, uterus and ovary weights were compared for animals in proestrous or estrous 
only. * indicates a statistically significant difference from controls in an ANOVA followed by Dunnett’s test.  
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Supplementary data description 
Supplementary data contain tables with information on probe/primer sequences for mRNA 
expression analyses (Table S1) and data on mammary whole mount evaluation and tumor histology 
(Table S2). 
 
 
Table S1. Information on probe/primer sequences 
Gene name Probe/primer sequences 
β-actin 
 
Probe (reporter-nucleotide sequence-quencher): 5′-FAM-TAT GGA ATC 
CTG TGG CAT CCA TGA AAC TAC A-TAMRA-3′ 
Forward:, 5′-ATG CCC CGA GGC TCT CTT-3′ 
Reverse: 5′-CAA CGT CAC ACT TCA TGA TGG A-3′ 
18s rRNA 
 
Probe: 5′-FAM-ACC GGC GCA AGA CGA ACC AGA G-TAMRA-3′ 
Forward:, 5′-GCC GCT AGA GGT GAA ATT CTT G-3′ 
Reverse: 5′-GAA AAC ATT CTT GGC AAA TGC TT-3′ 
TRPM-2 
 
Probe: 5′-FAM-AGT TTC TGA ACC AGA GCT CAC CCT TCT ACT 
TCT G-TAMRA-3′ 
Forward: 5′-CTG GTT GGT CGC CAG CTA GA-3′ 
Reverse: 5′-ATG CGG TCC CCG TTC AT-3′ 
IGF-1  
 
Probe: 5′-FAM-CAA CAC TCA TCC ACA ATG CCC GTC T-TAMRA-3′ 
Forward: 5′-GAC CAA GGG GCT TTT ACT TC-3′ 
Reverse: 5′-GCA GCG GAC ACA GTA CAT CT-3′ 
AR  
 
Probe: 5′-FAM-TCG CGA TTC TGG TAT GCT GCT GC-TAMRA3′ 
Forward: 5′-GAC ACT TGA GAT CCC GTC CT-3′ 
Reverse: 5′-GAG CGA GCG GAA AGT TGT AG-3′ 
PBP C3  
 
Probe: 5′-FAM-TCATCT AGA ATA CTG CAG CCA GAA CCA CTG G-
TAMRA-3′ 
Forward: 5′-CCA TCC CCA TTT GCT GCT AT-3′ 
Reverse: 5′-AGT CAC AGT TGA GTT AAT TGT ACC TCT AAT AAC-3′ 
ERα  
 
Probe: 5′-FAM-CCA CCC TGC TGG TTC A-MGB-3′ 
Forward: 5′-ATT CCT TCC TTC CGT CTT ACT GTC T-3′ 
Reverse: 5′-AGC CGC CGA GGT ACA GAT T-3′ 
ERβ  
 
 
Probe: 5′-FAM-CCA CTA AGC TTC CTC TTC AGT GTC TCT CTG TTT 
ACA-TAMRA-3′ 
Forward: 5′- TTG GTG TGA AGC AAG ATC ACT AGA G-3′ 
Reverse: 5′- AAC AGG GCT GGC ACA ACT G-3′ 
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 Table S2. Mammary gland changes in rats perinatally exposed to a mixture of phytoestrogens or to 
genistein including mammary tumor histology in rats exposed to MNU at PND 50. TEBs: terminal 
end buds. Values are mean ±SD for density scores, areas (mm2), and TEB number. For tumors, 
numbers are given as: affected animals/total number of animals (% affected animals in parentheses). 
*: statistically significant compared to controls with p<0.05. 
 
  Control Mix 2 Mix 21 Mix 213 Genistein 
213 
Mammary whole mounts 
Females PND 13 Density  2.8±0.6 2.0±0.6* 2.1±0.5 2.4±0.9 2.5±0.9 
Area 50±12 41±10 40±10 45±11 46±14 
TEBs 5.7±4.9 9.3±7.6 6.8±9.1 7.7±13.3 9.2±7.1 
Males PND 13 
 
Density 2.8±0.8 2.4±0.7 2.7±0.6 2.6±0.9 2.4±0.7 
Area 42±10 40±7 41±10 38±12 40±11 
TEBs 4.4±4.8 8.1±14.1 7.0±8.6 10.8±12.7 7.0±9.0 
Females PND22  Density 2.5±0.9 2.3±0.8 2.5±0.8 2.8±0.6 3.0±0.6 
Area 93±22 86±26 68±22 95±30 91±29 
Females PND135 Density 2.9±0.9 3.3±1.3 2.9±1.4 2.9±1.3 3.3±1.0 
Males PND150 Density 2.3±1.0 2.1±0.8 2.8±0.9 2.9±1.4 2.6±1.4 
Mammary tumors in MNU exposed females  
Dominating 
histopathological 
type  
Cribriform 9/9 (100%) 6/11 (55%) 4/7 (57%) 9/11 (82%) 6/7 (86%) 
Papillary 0/9 (0%) 5/11 (45%) 2/7 (29%) 2/11 (18%) 1/7 (14%) 
Comedo 0/9 (0%) 0/11 (0%) 1/7 (14%) 0/11 (0%) 0/7 (0%) 
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a b s t r a c t
There is growing concern of permanent damage to the endocrine and nervous systems after devel-
opmental exposure to endocrine disrupting chemicals. In this study the permanent reproductive and
neurobehavioral effects of combined exposure to ﬁve endocrine disrupting pesticides, epoxiconazole,
mancozeb, prochloraz, tebuconazole and procymidone, were examined. Pregnant and lactating rat dams
were dosed with a mixture of the ﬁve pesticides at three different doses, or with the individual pesticides
at one of two doses.
Adverse effects were observed in young and adult male offspring from the group exposed to the
highest dose of the mixture. These included reduced prostate and epididymis weights, increased testes
weights, altered prostate histopathology, increased density of mammary glands, reduced sperm counts,
and decreased spatial learning. As no signiﬁcant effects were seen following single compound exposure
at the doses included in the highest mixture dose, these results indicate cumulative adverse effects of
the pesticide mixture.
© 2012 Elsevier Inc. All rights reserved.
1. Introduction
Exposure to endocrine disrupting chemicals (EDCs) during early
life may cause long-term health effects, and can inﬂuence both the
sexual and neurological development of the offspring, even until it
reaches maturity or middle age [1–3]. In the Western world, ﬁnd-
ings of declining human semen quality and a high prevalence of
congenital malformations of reproductive organs and hormone-
dependent cancers [4–6], as well as a high prevalence of children
being diagnosed with ADHD and other neurological disorders [7,8]
are causing concern.
Previous research indicates that a wide range of pesticides may
act as endocrine disrupters. The azole fungicides prochloraz, tebu-
conazole and epoxiconazole have been shown to react through
∗ Corresponding author. Tel.: +45 35 88 75 41; fax: +45 35 88 70 01.
E-mail address: maap@food.dtu.dk (M. Axelstad).
1 Both authors contributed equally.
several endocrine disrupting mechanisms, and to induce various
endocrine disrupting effects [9–15]. Common features for the azole
fungicides are that they increase gestational length and affect
steroid hormone levels in fetuses and/or dams. In addition, stud-
ies indicate that prochloraz may also affect thyroid hormone levels
and cause effects on the sexually dimorphic development of the
brain [11]. Furthermore, it has been shown that procymidone com-
petitively antagonizes binding to the androgen receptor (AR), and
consequently affects the reproductive development in male off-
spring [16,17]. Mancozeb, a fungicide from the dithiocarbamate
group, mainly acts via disruption of the thyroid hormone system
and is therefore suspected of affecting brain development [18,19].
Although animal studies have shown that some pesticides can
disrupt male sexual differentiation during development, the indi-
vidual pesticides alone have so far not been shown to contribute to
adverse human effects at relevant exposure levels. However, ini-
tial observations in epidemiological studies [20–22] point in the
same direction as what has been seen in laboratory experiments
0890-6238/$ – see front matter © 2012 Elsevier Inc. All rights reserved.
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with endocrine disrupting chemicals, namely that substantial
mixture effects occur even though the individual chemicals are
present at low, ineffective doses [23–25]. Cumulative effects can
be seen when small and statistically insigniﬁcant effects of each
compound are added to induce statistically signiﬁcant effects
when these compounds are mixed. These ﬁndings have stimulated
interest in exploring the consequences of combined exposures to
environmentally relevant mixtures of endocrine disrupting pesti-
cides.
Currently, there are no data on the effects of combined devel-
opmental exposure to endocrine disrupting pesticides, which have
the potential for affecting both reproductive and brain develop-
ment. It is important to keep in mind that some pesticides may act
through both sex- and thyroid hormone related mechanisms. Fur-
thermore thyroid hormone disrupting pesticides may also affect
testicular development [26] while anti-androgenic pesticides may
disturb the sexually dimorphic development of the brain [11,27].
Consequently, it is relevant to study combined effects of pesti-
cides with such dissimilar modes of action. Therefore, this study
aimed at exploring whether combined developmental exposure
to endocrine disrupting pesticides at low doses, i.e. doses below
NOAEL for the single pesticides, would lead to adverse develop-
mental toxicity effects. In the present paper we report results on
thyroid and reproductive organs and behavioral endpoints from
pre-pubertal and adult animals that have been exposed pre- and
postnatally to amixture of the ﬁve endocrine disrupting pesticides;
procymidone, prochloraz, tebuconazole, epoxiconazole and man-
cozeb. Data on maternal endpoints, postnatal development and
genital malformation frequencies from this study as well as math-
ematical modeling of the mixture results and in vitro studies with
the same mixture of pesticides are presented in Hass et al. [28].
2. Materials and methods
2.1. Chemicals
Before initiating the study, the mixture ratio and dose levels of the individual
pesticides were chosen as presented in Hass et al. [28]. In summary, the mixture
ratio for the ﬁve pesticides was chosen based on the NOAEL for effects on increased
gestation length in dams and perinatal mortality in the offspring. Upon choosing
the mixture ratio, two range-ﬁnding studies were performed in order to test for
toxicity and endocrine disrupting effects of various mixture doses. The ﬁrst was in
non-pregnant animals while the second was in pregnant animals [29].
The 5 pesticides used were procymidone (CAS no. 32809-16-8, purity 99.5),
epoxiconazole (CAS no. 106325-08-8, purity 99.0), tebuconazole (CAS no. 107534-
96-3, purity 98.5), mancozeb (CAS no. 8018-01-7, purity 76.0) and prochloraz (CAS
no. 67747-09-5, purity 98.5). All chemicals were purchased in a technical quality
from VWR – Bie & Berntsen, Herlev, Denmark. Corn oil (Sigma–Aldrich, Brøndby,
Denmark) was used as vehicle.
2.2. Animals and exposure
The mixture study was performed under conditions approved by the Danish
Animal Experiments Inspectorate and by the in-house Animal Welfare Committee.
Animals received a complete rodent diet and acidiﬁed tap water ad libitum, and
were housed under standard conditions with 12h reverse light–dark cycle with
light starting at 9 p.m. and continuing throughout the night until 9 a.m. In this way
behavioral testing could be performed during the animals’ active period. For further
information on housing conditions please consult Hass et al. [28].
The study included 14 groups of animals, and was performed in 4 blocks with
a week between each block. The 14 groups were as equally as possible distributed
among the 4 blocks, and the animals used were 198 time-mated nulliparous, young
adult female Wistar rats (HanTac:WH, Taconic Europe, Ejby, Denmark). The animals
were observed twice daily for signs of toxicity andbodyweightswere recordeddaily
during the entire dosing period.
On the day after arrival at gestation day (GD) 4, the dams were distributed into
groups with similar body weight (bw) distributions. They were given 4 days after
arrival to adapt to the reversed light–dark cycle before beginning the exposure.
Dams were dosed daily by gavage, from GD 7 to pup day (PD) 16. For more detailed
information on dosing scheme please consult Hass et al. [28].
In Table 1 the composition of the pesticide mixture, the doses of the pesticides
administered individually and in mixture and the number of litters in each group
are shown. Four groups of 22 rat dams were given daily oral doses of 0, 14.6 (8.3%
of NOAEL), 29.2 (17% of NOAEL) or 43.8 (25% of NOAEL) mg/kg/day of the mixture
of the 5 pesticides, whereas ten groups of 10 or 12 time-mated rats were similarly
dosed with two doses of the individual pesticides. The lowest dose of each pesticide
was similar to the dose included in the highest mixture dose and the highest dose
of the single pesticides was 4 times higher, corresponding to 25% of NOAEL and
to NOAEL, respectively, for effects on gestation length and perinatal mortality. Due
to low pregnancy rate the number of litters in each dose group was unfortunately
somewhat lower (Table 1).
In Fig. 1 anoverviewof the studydesign is given.Results fromoffspring sacriﬁced
on PD16 and afterweaning are presented in the present paper,whereas results from
dams and the younger pups are presented in Hass et al. [28].
2.3. Sacriﬁce on PD 16
On PD 16, 1–3 male and 1–3 female pups per litter were randomly selected for
autopsy. Pups were weighed, decapitated and trunk blood was collected for hor-
mone analysis. Uterus, ovaries, thyroids and liver were dissected from one female
pup per litter. Uterus, ovaries and livers were weighed, whereas the thyroid was
excised on the thyroid cartilage in order to obtain optimal histological preservation.
Uterus, one ovary, alternately left and right, a section of the liver and the thyroid
were ﬁxed in formalin and processed for parafﬁn embedding.
Testes, epididymides, ventral prostate, seminal vesicle, levator
ani/bulbocavernosus muscle (LABC), bulbourethral glands, liver and thyroids
were dissected from one male pup per litter and weighed. One testis per male
(alternately left and right) was ﬁxed in Bouin’s ﬁxative and processed for parafﬁn
embedding. Epididymides, seminal vesicles and thyroids (cleared from the thyroid
cartilage) were ﬁxed in formalin and processed for parafﬁn embedding.
Histological evaluationwasmadeof testes, thyroids andof thoseorgans inwhich
statistically signiﬁcant changes in organ weights were seen. One section per organ
was stainedwith hematoxylin and eosin for histological evaluation, and for thyroids
only the mixture groups were evaluated.
2.4. Sacriﬁce on PD 22 and 50
On PD 22, 1–3 male and 1–3 female pups per litter were weaned. Dams were
decapitated in CO2/O2 anesthesia and the numbers of uterine implantation sites
was counted. Trunk blood was collected and used for hormone analysis. The male
and female pups which were not to be kept after weaning were decapitated on PD
22 in CO2/O2 anesthesia and blood samples were collected for hormone analyses.
On PD 50 1–2 males and females per litter from control and mixture groups were
decapitated in CO2/O2 anesthesia and blood samples were collected for hormonal
analyses.
2.5. Mammary glands
From controls and the three mixture groups (groups 1–4), one male and one
female per litter at PD 22 and 1–2 males and 1–2 females per litter at PND 50
were used for investigation of effects on mammary gland development. At both
ages, the 4th abdominal mammary gland was excised for whole mount prepara-
tion, and on PD 50 the contralateral 4th abdominal mammary gland from males and
females was excised for histological analysis. Alternately left and right glands were
used for each purpose. For histologic examination, mammary glands were ﬁxed in
formalin and stained with hematoxylin and eosin. Female mammary glands were
evaluated for tubuloalveolar and lobuloalveolarmorphology.Malemammaryglands
were evaluated for secretory material in the ducts and vacuolization of the epithe-
lium in controls and the highest mixture group. The mammary gland whole mounts
were ﬁxed in formalin, stained with alum carmine, dehydrated and mounted. The
mammary glands were scanned on a ﬂatbed scanner and outline area, longitudi-
nal growth, and transverse growth were measured using Image Pro Express (Media
Cybernetics). Thedensitywas scoredona scale from1 to5 (with5 representingmost
densemammary glands)with appropriate scoring criteria according to age and gen-
der. The number of terminal end buds (TEBs) was counted in the mammary glands
at PD 22. Whole mounts of females PD 50 were only evaluated for density due to
the large gland size and overlapping branches hampering outgrowthmeasurements
and TEB number assessment.
2.6. Onset of puberty
Onset of puberty was registered in all weaned male and female offspring. In
female offspring sexual maturity was assessed by determining day of vaginal open-
ing (VO) as described by Goldman et al. [30]. All weaned females were examined
daily from PD 30 to PD 42. In male offspring the onset of puberty was assessed as
time of preputial separation (PPS) [31,32]. Males were examined daily from PD 34
to PD 50. On the day of VO or PPS the age and weight of the animals were recorded.
2.7. Behavioral testing
The investigations were performed during the animals’ dark cycle, i.e. their
active period, from 9 a.m. to 4 p.m., in dimly lit rooms. The experimenter was kept
unaware as to which group an individual rat belonged, and exposed and control
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Table 1
Composition of pesticide mixture.
Group na Epoxiconazole Mancozeb Prochloraz Tebuconazole Procymidone Pesticide mixture
1: Control 22(15) – – – – – –
2: Pestimix-14.6 22(17) 1.25 2.08 2.92 4.17 4.17 14.6
3: Pestimix-29.2 22(9) 2.5 4.17 5.83 8.33 8.33 29.2
4: Pestimix-43.8 22(14) 3.75 6.25 8.75 12.5 12.5 43.8
5: Epoxi-3.75 12(8) 3.75 – – – –
6: Epoxi-15 10(4) 15 – – – –
7: Manz-6.25 12(5) – 6.25 – – –
8: Manz-25 10(7) – 25 – – –
9: Prchl-8.75 12(8) – – 8.75 – –
10: Prchl-35 10(4) – – 35 – –
11: Tebu-12.5 12(8) – – – 12.5 –
12: Tebu-50 10(6) – – – 50 –
13: Procy-12.5 12(7) – – – – 12.5
14: Procy-50 10(4) – – – – 50
The number of dosed dams (viable litters) in each group and the doses of the pesticides, that were administered individually and in mixture in mg/kg/day, are shown in the
table. Epoxiconazole (Epoxi), mancozeb (Manz), prochloraz (Prchl), tebuconazole (Tebu) or procymidone (Procy).
a The large difference between the number of dosed dams and viable litters was mainly due to very low pregnancy rate from the animal breeders, and not to high rates of
pre- and postnatal deaths in the offspring.
animals were tested alternately as were female and male animals. All statistics
on behavioral data were conducted on litter means, and therefore the presented
n-values describe the number of litters in each dose group.
2.7.1. Motor activity and habituation capability
In the tests of motor activity, all weaned offspring (140 males and 138 females)
were tested (n=9–17 for control and mixture groups and n=2–9 for single pesticide
groups). The offspring were tested on PD 28 and again at PD 59. The motor activity
of the animals was recorded in activity boxes with photocells for 10×3min (as
described in Axelstad et al. [33]). The total activity during the 30min was used as
a measure of general activity. In order to assess habituation capability, the 30min
was divided into two time periods of 15min.
2.7.2. Learning and memory (Morris Water Maze)
The number of animals used for the test of spatial learning, was somewhat
smaller than for activity testing, as 90 males and 90 females were used (n=9–10
for control and mixture groups and n=2–6 for single pesticide groups). The animals
were tested at age of 4–5 months in a maze with a diameter of 220 cm, ﬁlled with
water at room temperature, as described in [33,34]. A circular transparent platform
was situated on a solid support and submerged below the water surface. When the
rat swam to and climbed onto the platform, the trial was completed. If the animal
failed to locate the platform within 60 s, it was led to the platform. A video-tracking
device (Viewpoint video tracking system, Sandown Scientiﬁc, Middlesex, England)
was used to collect data about latencies to ﬁnd the platform, the path lengths and
swimming speeds of the animals.
Learning was tested with the platform situated at the center of the southwest
quadrant of the pool, and the animals were trained in 4 trials per day for 7 days
(ﬁve consecutive days, two day break and then two more days of training). Reversal
learningwas testedwith a newplatformposition, the day after the last learning day.
The animals were tested in a reversal procedure with the platform placed opposite
the original location, again with 4 trials a day, but only for two consecutive days, i.e.
days 8 and 9.
2.7.3. Mating behavior in male offspring
The males tested for mating behavior were the animals previously tested in the
MorrisMaze. For the assessment ofmalemating behavior, non-ovariectomized sex-
ually mature female Wistar rats (weight 170±20g) were purchased from Taconic
Europe. These female rats were treated with -oestradiol-3-benzoate (25g/rat)
48h before the mating and progesterone (500g/rat) 4h before mating to obtain
‘chemical estrus’. Both solutions were injected subcutaneously. The effects of pro-
gesterone dosing lasts for about 4h and the females could therefore be used several
times. Male rats need to be sexually experienced before a successful mating session
can take place [35]. Therefore the males were placed with a female in ‘chemical
estrus’ for 20min before the test trial. It was required that the female showed pro-
ceptive behavior (described below) otherwise it was replaced by another female rat.
The male rats had one training trial before the mating behavior test session, which
was scored as described below.
The mating test was performed between 12.00 and 16.00 (in the active period
of the animals) and the female rats were brought into ‘chemical estrus’ in relation to
that timepoint. Themale from the couplewas placed in a transparent polycarbonate
cage (59.5×38×20 cm (D×W×H)) with a ﬂat lid and with no bedding in an unlit
room. A female in “chemical estrus” was then introduced into the male cage and
allowed to stay for 20min. The same cage was used for all animals in the study. The
mating behavior was recorded from the side of the cage using a standard Phillips
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Fig. 1. Schematic overview of the design of the mixture study. Pregnant dams were dosed from gestation day 7 to postnatal day 16 with a mixture of pesticides, or the
individual chemicals. In the present paper the results from organ weights, histopathology, mammary glands, hormone levels, timing of sexual maturation, behavioral tests
and semen quality are presented (shown in italic in highlighted black boxes). The results from endpoints before PD 16 as well as malformation scores are presented in Hass
et al. [28].
240 P.R. Jacobsen et al. / Reproductive Toxicology 34 (2012) 237–250
CCD-MOS video camera (black and white) with sensitivity in the infra-red area
(800–950nm). The recordings were stored on a hard disk/DVD recorder (LVW-545
HDD+DVD recorder).
All mating behavior data were scored using a Psion Workabout (ProInfo) with
the softwarePocketObserver® (Noldus, TheNetherlands) installed. Thiswasdoneby
trained observers blind to experimental groups. The observer looked at the record-
ings of mating behavior on a computer and registered the behavioral elements
Mount, Intromission and Ejaculation.
2.8. Necropsy of adult female offspring
Female offspring were autopsied at approximately 6 months of age. Stage of
estrous cycle was determined using a rat Vaginal Impedance Checker (Model MK-
10C (Muromachi, Japan). When an impedance value was higher than 3, the female
was assumed to be in proestrus and was sacriﬁced. Animals were decapitated in
CO2/O2 anesthesia and trunk blood was collected for hormone analysis. Thyroids
(on the thyroid cartilage) were ﬁxed in formalin and later embedded in parafﬁn.
Histopathological evaluation was made of the thyroid. One section of the thyroid
from rats belonging to groups 1, 4, 7 and 8 was stained with hematoxylin and eosin
for histological evaluation by an examiner blinded to treatment groups.
2.9. Necropsy of adult male offspring
Sexually mature male offspring (261–280 days of age to around 9 months of
age) were weighed, anesthetized in CO2/O2 and decapitated, and trunk blood was
collected for hormone analysis.
Semen motility was analyzed in all dose groups, whereas sperm counts were
only performed in the control males and in the males from the highest mixture
dose group. For sperm motility analysis, spermatozoa were obtained from the distal
cauda epididymis (alternately left and right) and sperm samples were prepared and
analyzed by computer assisted sperm analysis (CASA) as described in Jarfelt et al.
[36]. For sperm count analysis, cauda epididymis was weighed and prepared as
described by Jarfelt et al. [36], and samples were analyzed using 10× UV ﬂuorescent
objective and IDENT OPTIONS. Ten ﬁelds were analyzed for each sample and three
counts were performed for each suspension. Counts were averaged and data are
presented as number of sperm per gram cauda.
The rats were further autopsied and macroscopically examined. The following
organs were excised and weighed: right and left testis, ventral prostrate, semi-
nal vesicles with seminal ﬂuid, epididymis, bulbourethral glands, LABC, liver and
thyroid.
The right or left testis (alternately)was ﬁxed in Bouin’s ﬁxative, parafﬁn embed-
ded and stained with hematoxylin and eosin. The epididymis not used for motility
analysis was excised and weighed.
The following organs were ﬁxed in formalin and subsequently embedded in
parafﬁn: caput epididymis, ventral prostrate, seminal vesicles and liver. One sec-
tion per organ was stained with hematoxylin and eosin for histological evaluation
byanexaminerblinded to treatmentgroups. Inventral prostate thedegreeof epithe-
lial atrophy, epithelial infolding and inﬂammation was scored in the following way:
Epithelial atrophy: Score 0: no or minimal epithelial atrophy (≤5 acini affected);
Score 1: moderate epithelial atrophy (>5% and <50% of the section affected); Score
2: marked epithelial atrophy (≥50% of the section affected). Papillary growth: Score
1: mild; Score 2: moderate; Score 3: marked. Inﬂammation: Score 1: no or very few
scattered interstitial mononuclear cells; Score 2: focal to few multifocal interstitial
accumulations of few mononuclear cells; Score 3: multifocal interstitial accumula-
tions of mononuclear cells; Score 4: diffuse interstitial inﬁltrations of mononuclear
cells. Additionally, prostates were evaluated for intraepithelial vacuolation, acini
with concretions in the lumen, presence of areas with multilayering of epithelial
cells, and focal acinar atrophy.
Ventral prostates from animals in dose groups 1 and 4 were further evaluated
with regard to acini with atypical hyperplasia: score 0: no acini; score 1: few acini
(<5% acini with atypical hyperplasia); score 2:moderate level (>5% and <50% of acini
with atypical hyperplasia); score 3:marked level (>50%aciniwith atypical hyperpla-
sia), acini with cribriform pattern: score 0: no acini; score 1: single acinus affected;
score2: 2–4acini affected; score3: >4acini affected, andaciniwith columnar epithe-
lium and papillary growth: score 0: no acini affected; score 1: <25% acini affected;
score 2: >25% and <50% acini affected; score 3: >50% and <75% acini affected; score
4: >75% acini affected.
2.10. Hormone analysis
Trunk blood for hormone analysis was collected in Na–heparine coated tubes
and centrifugated for 10min, 4000 rpm at 4 ◦C. Plasma samples were stored at
−20 ◦C. Progesterone, testosterone, and estradiol levels were analyzed in rat plasma
at PD 16, PD 50/51 and in the dams at PD 22. T4 was measured in male and female
pups at PD 50. The progesterone levels were analyzed in plasma from 1–5 male
and 1–3 female pups in 4–5 litters per dose group. Testosterone and estradiol were
analyzed in plasma from 1–3 male or 1–3 female pups in 3–5 litters, respectively.
Plasmasamples fromthepups ineach litterwerepooledby sex. Furthermore, testos-
terone and progesterone levels were analyzed in plasma from 9 months old male
and female offspring, respectively. Testosterone, estradiol, and progesterone were
extracted from the plasma on IST Isolute C18 SPE columns as previously described
[12] and samples were resuspended in heptanes. All hormones including T4 were
analyzed using Delﬁa time-resolved ﬂuorescence kits (PerkinElmer Life Sciences,
Turku, Finland), and measured by use of a Wallac Victor 1420 multilable counter
(PerkinElmer Life Sciences, Turku, Finland).
2.11. Statistics
For all analyses, the alpha level was set at 0.05 and the litter was the statisti-
cal unit. Data were examined for normal distribution and homogeneity of variance,
and if relevant, transformed. In cases where normal distribution and homogene-
ity of variance could not be obtained by data transformation, a non-parametric
Kruskall–Wallis test was used, followed by Wilcoxon’s test for pair wise compar-
isons. Data with normal distribution and homogeneity of variance were analyzed
using analysis of covariance (ANCOVA). When more than one pup from each litter
was examined, statistical analyses were adjusted using litter as an independent,
random and nested factor in ANOVA or litter means were used. Where an overall
signiﬁcant treatment effect was observed, two-tailed comparison was performed
using least square means.
Dunnett’s test corrects for multiple comparisons, but applying this test on a
studywith 14 groupsmay lead to over-compensation andmay lead to false negative
results. For the analysis of reproductive organ weights an alternative approach to
using a Dunnett’s post hoc test on each group of chemicals separately was applied
(i.e. separate analysis of controls and mixture groups 2–4, and separate analysis
of controls and the two doses of each of the single pesticides). This separation of
the study into one mixture study and ﬁve studies on single pesticides increases the
likelihood of ﬁnding statistically signiﬁcant differences, but also increases the risk
of false positive ﬁndings. Results of both approaches are evaluated bearing these
differences in mind.
A similar approach was taken in analysis of the behavioral data, however here
the statistical analysis of controls and the two doses of the individual compounds
were not performed, because of the low number of animals tested in these groups.
The statistics on the Morris Maze data (i.e. swim length, swim speed and latencies)
were calculated both for each separate test day, and for the combined total swim
length and total latency, as this equals a ‘repeated measures’ test of these endpoints
Data obtained from prostate- and thyroid histology were analyzed statistically
by Fisher’s exact test. Prostate data from each mixture groups as well as each single
compound groups were compared with the control group. If statistically signiﬁ-
cant differences (p<0.05) were observed when all scores for a given endpoint were
included, then individual scores were compared separately. For the densities of the
mammary glands a one-way ANOVA with heterogeneous variance was used. For
mammary gland densities PD 50, a threshold based on densities of control animals
was set andaFisher’s exact testwasused tomakegroupcomparisonsof thenumbers
of animals with densities above this threshold.
Asterisks in tables and ﬁgures, indicate a statistically signiﬁcant difference com-
pared to controls *: p≤0.05; **: p<0.01. ***: p<0.001. All analyses were performed
using SAS Enterprise Guide 3.0, SAS Institute Inc, Cary, NC, USA.
3. Results
3.1. Pregnancy, litter and offspring data
None of the applied exposures caused adverse effects on dam
body weight gain, litter size or pup mortality. For further informa-
tion regarding pregnancy and litter data please consult Hass et al.
[28].
3.2. Section PD 16, organ weights
Absolute weights of male reproductive organs are listed in
Table 2. In the comparisons of absolute organweights, bodyweight
was taken into consideration as this was included as a covariate in
the statistical analysis. Reduced absolute weights of epididymis,
prostate and seminal vesicle were seen in the highest mixture
dose group compared with controls, in a model using Dunnett’s
post hoc test on all 14 dose groups. Epididymis weight was dose-
dependently reduced in all three mixture groups compared with
controls, though this effect was only statistically signiﬁcant in the
low and high mixture groups due to fewer animals in the mid-
dle dose group. Additionally, a statistically signiﬁcant increase in
absolute prostate weight was seen in animals exposed to the high-
est dose of epoxiconazole. Possible differences in weights of LABC,
glandula bulbourethralis, liver and thyroid were not statistically
signiﬁcant in a Dunnett’s test on all 14 groups. Comparable effects
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Table 2
Absolute male organ weights on PD 16 and in adult male rats (PD 260–280) exposed to the pesticides singly or in mixture during fetal and neonatal life.
Absolute organ weights (mg) n Body weight (g) Testis (g) Epididymis (g) Prostate (g) Seminal vesicle (g) LABC (g) Bulbo (g) Liver (g) Thyroid (mg)
Male offspring PD 16
1: Control 15 30.8 ± 5.7 103 ± 15 23.3 ± 2.3 10.6 ± 2.5 10.4 ± 3.6 26.5 ± 5.8 1.7 ± 0.4 786 ± 128 4.4 ± 0.7
2: Pestimix-14.6 16 28.9 ± 2.8 101 ± 11 20.3 ± 2.5*,## 8.8 ± 1.7 8.0 ± 2.0 22.7 ± 3.8 1.5 ± 0.4 735 ± 68 4.0 ± 0.6
3: Pestimix-29.2 9 30.2 ± 3.9 109 ± 13# 20.8 ± 2.2# 8.5 ± 1.9# 8.6 ± 1.8 26.4 ± 6.7 1.5 ± 0.4 811 ± 120 4.4 ± 0.8
4: Pestimix-43.8 12 30.7 ± 4.5 110 ± 15# 19.4 ± 1.7***,### 7.1 ± 1.9***,### 7.2 ± 1.8**,## 24.3 ± 5.6 1.5 ± 0.6 811 ± 123 4.4 ± 1.6
5: Epoxi-3.75 6 30.9 ± 4.5 106 ± 7 22.3 ± 1.6 10.9 ± 1.7 9.5 ± 1.0 26.1 ± 15.5 2.2 ± 0.8 789 ± 135 4.8 ± 1.4
6: Epoxi-15 3 33.7 ± 4.0 120 ± 10 27.6 ± 0.9## 14.9 ± 2.7*,# 9.8 ± 3.0 25.1 ± 3.5 2.2 ± 0.6 902 ± 87 4.3 ± 1.0
7: Manz-6.25 5 28.5 ± 3.6 100 ± 8 21.0 ± 2.0 9.6 ± 1.0 10.6 ± 2.2 23.4 ± 2.8 1.7 ± 0.4 718 ± 99 4.4 ± 0.7
8: Manz-25 7 27.2 ± 1.1 97 ± 7 22.6 ± 1.5 9.8 ± 3.1 8.6 ± 2.2 25.7 ± 4.7 1.7 ± 0.3 690 ± 38 4.3 ± 0.9
9: Prchl-8.75 9 30.2 ± 2.0 108 ± 8 23.3 ± 2.5 11.4 ± 0.8 8.6 ± 2.0 25.7 ± 3.2 1.6 ± 0.4 765 ± 77 3.8 ± 0.6
10: Prchl-35 4 30.0 ± 3.5 107 ± 19 20.1 ± 2.6# 10.8 ± 2.4 7.8 ± 1.8 22.8 ± 2.5 1.5 ± 0.5 760 ± 130 3.4 ± 0.4#
11: Tebu-12.5 8 28.7 ± 3.8 104 ± 16 22.4 ± 2.4 12.0 ± 2.6 9.8 ± 3.2 25.0 ± 3.6 1.7 ± 0.4 746 ± 96 4.1 ± 1.2
12: Tebu-50 5 30.5 ± 2.8 105 ± 8 22.0 ± 2.7 9.8 ± 2.9 11.5 ± 2.2 24.5 ± 2.2 1.7 ± 0.3 839 ± 99## 5.3 ± 1.2
13: Procy-12.5 6 29.8 ± 1.0 112 ± 7*,## 22.3 ± 3.5 8.6 ± 1.5 7.6 ± 1.4 27.8 ± 6.3 1.5 ± 0.2 786 ± 46 4.3 ± 0.9
14: Procy-50 3 28.1 ± 4.6 102 ± 16 18.7 ± 3.0# 6.5 ± 0.7# 8.2 ± 1.0 18.5 ± 2.4 1.1 ± 0.4# 771 ± 194 4.2 ± 0.6
Adult male offspring
1: Control 16 497 ± 34 3.89 ± 0.31 0.70 ± 0.07 0.63 ± 0.15 1.91 ± 0.37 1.38 ± 0.19 0.22 ± 0.07 13.2 ± 1.4 22 ± 3
2: Pestimix-14.6 18 458 ± 29# 3.88 ± 0.24 0.69 ± 0.07 0.67 ± 0.17 1.94 ± 0.30 1.27 ± 0.17 0.24 ± 0.08 11.6 ± 0.9 24 ± 10
3: Pestimix-29.2 12 469 ± 50 4.03 ± 0.69 0.74 ± 0.11 0.63 ± 0.12 2.11 ± 0.40 1.28 ± 0.19 0.18 ± 0.07 12.0 ± 1.8 24 ± 4
4: Pestimix-43.8 16 457 ± 32 4.01 ± 0.26 0.69 ± 0.06 0.47 ± 0.19# 2.08 ± 0.38 1.15 ± 0.23*,# 0.21 ± 0.06 12.0 ± 1.2 20 ± 3
5: Epoxi-3.75 10 472 ± 41 4.00 ± 0.17 0.66 ± 0.07 0.63 ± 0.14 1.94 ± 0.35 1.24 ± 0.17 0.21 ± 0.05 11.9 ± 0.6 20 ± 2
6: Epoxi-15 2a 396 ± 31 4.06 ± 0.03 0.75 ± 0.001 0.64 ± 0.13 2.09 ± 0.001 1.28 ± 0.08 0.29 ± 0.06 11.4 ± 0.1 23 ± 1
7: Manz-6.25 8 464 ± 55 3.79 ± 0.27 0.69 ± 0.03 0.53 ± 0.25 1.82 ± 0.46 1.30 ± 0.28 0.22 ± 0.07 12.0 ± 1.6 30 ± 22
8: Manz-25 10 478 ± 36 3.89 ± 0.34 0.72 ± 0.08 0.61 ± 0.14 1.90 ± 0.43 1.23 ± 0.09 0.21 ± 0.07 12.9 ± 1.1 29 ± 15
9: Prchl-8.75 10 492 ± 30 4.15 ± 0.25 0.71 ± 0.05 0.64 ± 0.15 2.05 ± 0.25 1.31 ± 0.21 0.28 ± 0.06 12.9 ± 1.6 22 ± 3
10: Prchl-35 6 437 ± 18# 3.69 ± 0.19 0.64 ± 0.03 0.65 ± 0.11 1.98 ± 0.20 1.31 ± 0.20 0.22 ± 0.09 10.7 ± 0.9 21 ± 2
11: Tebu-12.5 8 455 ± 27# 3.84 ± 0.41 0.69 ± 0.12 0.59 ± 0.13 1.80 ± 0.29 1.24 ± 0.16 0.17 ± 0.06 11.3 ± 0.8 21 ± 2
12: Tebu-50 8 481 ± 62 3.83 ± 0.22 0.66 ± 0.03 0.55 ± 0.11 1.92 ± 0.41 1.23 ± 0.19 0.16 ± 0.02 12.7 ± 1.9 24 ± 4
13: Procy-12.5 8 481 ± 62 4.02 ± 0.43 0.73 ± 0.09 0.52 ± 0.10 1.95 ± 0.25 1.21 ± 0.21 0.18 ± 0.06 12.3 ± 1.3 21 ± 3
14: Procy-50 6 481 ± 47 4.03 ± 0.35 0.72 ± 0.07 0.43 ± 0.19# 1.73 ± 0.25 1.16 ± 0.22 0.21 ± 0.07 11.5 ± 2.0**,# 20 ± 4
Bulbo: glandula bulbocavernosus; LABC: levator ani/bulbocavernosus muscle.
Statistically signiﬁcant differences between controls and exposed are marked with asterisks which indicate signiﬁcance levels: *indicates p<0.05; ** indicates p<0.01; *** indicates p<0.001. p values result from ANCOVA using
body weights as a covariate followed by Dunnett’s test on all 14 groups. # Indicates signiﬁcantly different from controls in a model including only control and different doses of the same compound or the mixture using Dunnett’s
post hoc test. # p<0.05, ## p<0.01, ### p<0.001. All signiﬁcant results are written in bold. Epoxiconazole (Epoxi), mancozeb (Manz), prochloraz (Prchl), tebuconazole (Tebu) or procymidone (Procy). a Data for adults in the Epoxi-15
group were left out of statistical analysis due to only 2 animals in this group.
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were seen for analyses of relative organ weights (Table S1, Supple-
mentary data).
In addition to the Dunnett’s test on 14 groups, an alternative
approachusingaDunnett’s posthoc test oneachgroupof chemicals
separately was also applied, as described in the statistics section.
Using this approach, epididymis weights were reduced in all three
mixture groups, prostate weights were reduced and paired testis
weights increased in the two highest mixture groups and semi-
nal vesicles were reduced in the highest mixture group, compared
to controls. Furthermore, statistically signiﬁcant changes in organ
weights were also seen for high doses of some of the individual
pesticides compared with controls. The high dose of epoxicona-
zole increased epididymis and prostate weights, the high dose of
prochloraz decreased epididymis and thyroid weights, the high
dose of tebuconazole increased liver weights, the high dose of pro-
cymidone reduced weights of epididymis, prostate and the bulbo
urethral gland, while the low dose procymidone increased paired
testes weights (Table 2).
Because someof the single pesticide groupswere quite small, an
additional statistical approach was used, where data from the low
and the high dose groups for each chemicalwere pooled, increasing
the number of litters per chemical group. No statistically signiﬁcant
changes could be observed between controls and individual chem-
ical groups, except for an increase in testis weight in the pooled
procymidone group (data not shown). It may be noted that in some
of these pooled chemical groups the n was still somewhat lower
than the n of 12 litters in the high dose mixture group (n=9–13, for
exact number please consult Table 2).
In female offspring no changes in absolute or relative weights of
uterus, ovary or liverwere seen. Furthermore no statistically signif-
icant changes in body weights compared to control were observed
(data not shown).
3.3. Section on PD 16, histology
No clear alterations were observed in the histological examina-
tion of testes, seminal vesicles and epididymides. Thyroid histology
of controls and all three mixture groups was evaluated in female
offspring, and no clear differences between groups were observed
with respect tomarkers of activity, i.e. epithelial height and amount
of colloid (data not shown).
3.4. Section adult offspring, organ weights
Absolute weights of male reproductive organs are listed in
Table 2 and relative weights can be found in Table S1, Supple-
mentary data. In the comparisons of absolute organ weights, body
weight was taken into consideration as this was included as a
covariate in the statistical analysis. Data from the high dose epoxi-
conazole group were omitted from the statistical analysis because
only two males were available for data analysis. Reduced absolute
weights of LABCwere seen in the highestmixture dose group, using
both statistical approaches. When the groups were analyzed sepa-
rately, signiﬁcant reductions were also seen on prostate weight in
the highest mixture group and in the highest procymidone group.
Bodyweight appeared slightly reduced inmost dose groups though
thiswas not statistically signiﬁcant in the statistical approach using
Dunnett’s test on all 14 groups. When separating the dataset into
single compound groups the reduction in body weight was statis-
tically signiﬁcant in the low mixture group, high prochloraz, and
low tebuconazole groups.
The low body weight observed in mainly the epoxiconazole
groups resulted in increased relative, but not absolute, weights
of testes in the low epoxiconazole group (Table S1, Supple-
mentary data). Statistical analysis of relative organ weights also
revealed signiﬁcantly decreased relative liver weight in the groups
Fig. 2. Numberof spermper gramcaudaepididymis in the adultmales fromthe con-
trol group, and the group dosed with the highest dose of the pesticide mix during
gestation and lactation. The control group included measurements from 15 males
(representing 13 litters) and the mixture group included data from 16 males (rep-
resenting 14 litters). Group means± standard deviations for the two dose groups
were 522.0±178 and 326.4±69.2, respectively. ***p<0.001.
exposed to the high doses of prochloraz and procymidone,whereas
absolute liver weights analyzed with body weight as a covariate
were not signiﬁcantly decreased by the high dose of prochloraz but
only by the high dose of procymidone.
Thyroid weights were not affected by treatment. One animal
from each of the mancozeb groups and one animal from the low
dose mixture group had more than double thyroid weight com-
pared to controls and to other pesticide exposed animals, but no
treatment-related effectswere observedwith orwithout these out-
liers.
No dose related effects were observed on weights of uterus,
ovary or liver in adult female offspring (data not shown).
3.5. Semen quality
The sperm count in the adult males was signiﬁcantly lowered
in the highest mixture group compared to controls (p<0.0005)
(Fig. 2). The sperm count results are shown as number of sperm
per gram cauda epididymis, and the observed reduction was not
due to effects on the weight of the cauda epididymis, as this
was unaffected by the exposure (data not shown). Sperm motil-
ity parameters were investigated in all 14 dose groups, but neither
% motile sperm nor % progressive sperm were signiﬁcantly affected
by pesticide exposure (data not shown).
3.6. Section adult offspring, histology
Testicular histology appeared normal in most animals, whereas
twoanimals had testeswith tubular degeneration in approximately
20% of seminiferous tubule cross-sections. As this ﬁnding may also
be seen in controls and as these animals were from two different
low dose groups (tebuconazole and procymidone), this was not
considered to be dose related (data not shown). Due to the ﬁnding
of reduced sperm number in the high mixture group, the histolog-
ical examination was repeated on a new set of testicular sections
(high mixture group and controls only) including the rete testis to
see if examination of the rete testis would reveal subtle changes in
histology. This examination showed no differences between dose
groups (data not shown).
Caput epididymides were examined in groups 1 and 4, and both
groups had normally appearing epithelium, equally high sperm
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content, and had no sloughed cells or cell debris in lumen (data
not shown).
In the ventral prostate, various lesions were observed in both
controls and exposed animals, and acinar epithelial atrophy was
observed less frequently in the high dose mixture compared with
the control group (Table 3). In the single compound groups, no sta-
tistically signiﬁcant differences were found with respect to scores
for epithelial atrophy (data not shown). Increasing scores for pap-
illary growth were found in a few dose groups (low dose mixture
and low dose prochloraz) compared to controls (data not shown).
No statistically signiﬁcant differenceswere seenwith respect to the
following ﬁndings: interstitial inﬂammation, intraepithelial vac-
uolation, acini with concretions in the lumen, presence of areas
with multilayering of epithelial cells, and focal acinar atrophy. The
observation of lower scores for atrophy in the high dose mixture
was followed up by an evaluation of hyperplastic lesions including
presence of atypical hyperplasia and cribriform patterns in con-
trols and the high dose mixture group. Animals in the high dose
mixture group showed higher scores for atypical hyperplasia and
cribriform pattern (p=0.011 and p=0.031, respectively, Table 3)
compared with controls.
In the seminal vesicle a large degree of variation in lumen size,
epithelial height, epithelial infolding and secretory content were
seen, and overall, no treatment-related ﬁndings were observed
(data not shown).
The activity of the thyroid was generally not very marked in
the adult female offspring. Follicles with high columnar vacuo-
lated epithelial cells indicating higher degree of secretory activity
were only observed in few animals, mainly belonging to the high
dose mancozeb group. Correspondingly, a statistically signiﬁcant
increase in the number of animals with follicles dominated by
columnar to cuboidal epithelium was seen in mancozeb exposed
animals compared to the control group (observed in 4 of 9 animals
from the high dose mancozeb group compared to 1 of 17 control
animals, p=0.03). Mild diffuse C-cell hyperplasia was observed in
thyroids of all groups with no statistically signiﬁcant differences.
No clear differences were observed in liver histopathology
between controls and the exposed groups (data not shown).
3.7. Mammary glands PD 22 and 50
Examination of mammary gland whole mounts of males and
females at PD 22 showed no statistically signiﬁcant changes in
longitudinal growth, transverse growth, glandular area, glandular
density or in the number of terminal end buds (Table S2, Supple-
mentary data). Histopathology of female mammary glands PD 50
showed a lobuloalveolar pattern in one animal from each of the 3
mixture groups (not statistically signiﬁcant) (Table S2). At PD 50,
mammary glands of both male and female rats showed higher den-
sities with increasing mixture doses (Fig. 3 and Table S2). When
evaluated using an ANOVA approach this apparent increase in den-
sity was not statistically signiﬁcant. However, when considering
the distribution of density scores, it was evident that density score
4 and 5 were only present in males of the mixture groups (Fig. 3).
This increase in the incidence of high density scores for males was
statistically signiﬁcant in a Fisher’s exact test comparing animals
with scores above 3 in exposed groups versus controls (p=0.03 in
both high mixture groups). For females, a slightly higher frequency
of scores 4 and 5 was seen in exposed animals than in controls, but
this was not statistically signiﬁcant. Male mammary glands PD 50
were also evaluated for growth and area. The longitudinal growth
was increasedwith dosing andwas statistically signiﬁcantly higher
in males PD 50 in group 3 (p=0.04) (Table S2). No changes were
found in the transverse growth and area of male mammary glands
PD 50 (data not shown). Ta
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Fig. 3. (a,b) Mammary gland whole mounts PD 50. Glandular density was evaluated
as described in Section 2 and the distribution of density scores is presented as % of
animals with a given score for each group separately. For males, scores 4 and 5 are
only present in exposed groups indicating a dose-related inﬂuence on mammary
development in some individuals. Number of animals examined PD 50; males n=14
(control), n=17 (Pestimix-14.6), n=12 (Pestimix-29.2), n=16 (Pestimix-43.8), in
femalen=18 (control),n=18 (Pestimix-14.6),n=10 (Pestimix-29.2),n=9 (Pestimix-
43.8).
3.8. Onset of puberty
No treatment related effects were observed in age or weight at
onset of puberty determined as VO or PPS in either male or female
offspring (data not shown).
3.9. Activity
In 28 day old offspring motor activity levels did not show any
effects of pesticides exposure or any differences between male and
female pups (data not shown). When the offspring were tested
again in adulthood, there was a statistically signiﬁcant sexual
dimorphism, with females showing signiﬁcantly higher activity
levels than males (p<0.0001) (Table S3, Supplementary data). The
results from the two sexes were therefore analyzed separately.
No statistically signiﬁcant effects were seen in either males or
females exposed to the pesticide mixture, compared with con-
trols (Table S3, Supplementary data). In the animals dosed with the
single pesticides, no signiﬁcant effects were seen in the male off-
spring, whereas signiﬁcantly higher activity level were observed
in females from the high dose mancozeb group (p=0.007), the
low dose prochloraz group (p=0.029) and low dose tebucona-
zole group (p=0.029) (Table S3, Supplementary data). None of
the observed effects were due to effects on habituation (data not
shown).
3.10. Spatial learning
During the last four days of the learning period (days 4–7), a
statistically signiﬁcant sexual dimorphism in Morris Maze perfor-
mancewasobserved,with females spendingmore time in thewater
and swimming further before ﬁnding the platform than males
(p<0.0001) (Table S4, Supplementary data). The results from the
two sexes were therefore analyzed separately.
InFig. 4, total swimlengthsduring the learningperiod (days1–7)
(Fig. 4a) and total latency to reach the platform during this period
(Fig. 4b), are shown for male and female offspring from controls
and the three mixture groups. In males, both endpoints showed a
dose-dependent increase, which reached signiﬁcance in the high-
est mixture dose group compared to controls, when all 14 groups
were included in the statistical analyses (p=0.03 and 0.02, for swim
length and latency respectively). When the test was performed on
just the data from the control and mixture groups, the p-values
were no longer statistically signiﬁcant but only borderline (p=0.11
and 0.07 respectively). As shown in Fig. 5, the effect of pesticide
exposure on male swim length and latency was primarily observed
at the end of the learning period (days 6 and 7) and reached signif-
icance for swim latency on day 7, with high mixture group males
spending signiﬁcantly more time to ﬁnd the platform than control
males (p=0.01). Thepicturewas similar for swimlength, butdidnot
reach signiﬁcance, even on day 7 (Table S4, Supplementary data).
The effect on swim latency on day 7 was also signiﬁcant when the
data form control and mixture groups were analyzed separately
(p=0.049). The higher group mean values in the highest mixture
groupwere primarily caused by a fewanimals still having very high
latencies and swim length values at the end of the learning period,
whereas all males in the control group had efﬁciently learned to
ﬁnd the platform at this time point. In the female offspring, there
were no statistically signiﬁcant effects of exposure to the mixture
on either swim length or latencies to reach the platform (Fig. 4a and
b), and in both sexes, no statistically signiﬁcant effects of pesticide
exposurewere observed on the animals’ swimming speed (data not
shown).
In the female animals exposed to the single pesticides, no statis-
tically signiﬁcant effectswere seen (Table S4, Supplementary data).
In the males, statistically signiﬁcant increases in total latency and
swim length were seen only in the low dose tebuconazole group
and the high dose procymidone group (see Table S4, Supplemen-
tray data). Like in the mixture groups, these increases were most
marked on day 7 of testing.
No effects of pesticide exposure were seen in neither males nor
females during reversal learning, on days 8 and 9 (data not shown).
3.11. Mating behavior
Mating behavior was assessed in 87 males (from all groups), as
one of the 88 recordings was spoiled. No statistically signiﬁcant
differences in mating behavior (assessed as frequency of mount-
ing, intromissionandejaculation, andas intromission latency)were
revealed between the control and the three mixture groups. More-
over, no statistically signiﬁcantdifferencesbetween the control and
the single pesticides groups inmating behaviorwere revealed (data
not shown).
When the animals were characterized, as belonging to either a
low (i.e. number of mounts below or equal to 5), medium (number
ofmounts between5 and30) or high (number ofmounts equal to or
above 30) group with regards to general mating activity, the males
from the highest dose of prochloraz showed signiﬁcantly increased
mating activity (p<0.001) compared to the controls. In Fig. 6, the
distribution in these different groups in relation to mounting fre-
quency is shown.
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Fig. 4. (a,b) Total latency to reach the platform (a) and total swim length (b) in adult male and female offspring exposed to 0, 14.6, 29.2 or 43.8mg/kg/day of the pesticide
mixture during fetal and neonatal life. Data is shown as group means± SEM for total latency and swim length to reach the platform in the Morris Water Maze, n=9–10.
Statistically signiﬁcant differences between controls and exposed are marked with asterisks which indicate signiﬁcance levels: *p<0.05. The results from these groups and
the 10 single pesticide exposed are shown in Table S4, Supplementary data.
3.12. Hormone levels
There were no statistically signiﬁcant effects of exposure to the
mixture on any of the measured plasma hormone levels in dams or
in male or female pups (data not shown).
Also, there were no statistically signiﬁcant effects of exposure
to the single pesticides on progesterone and testosterone levels in
adult offspring.
4. Discussion
This study generally aimed at exploring whether combined
perinatal exposure to low doses of ﬁve endocrine disrupting pes-
ticides could lead to adverse reproductive and neurobehavioral
effects, including effects observed months after ended exposure.
It was also the intention to investigate whether effects of the mix-
ture were present at dose levels where single compounds were
ineffective, i.e. at NOAELs for single compounds. However, due to
very low pregnancy rates, some dose groups were unintentionally
small, and as discussed in the following, the reader should bear this
in mind when interpreting the data on single compound effects.
Alterations in reproductive organ weights and altered histology
were seen in both young and adult offspring, and decreased sperm
count and impaired spatial learning was observed in adult male
offspring. Furthermore, reproductive organ weights changes gen-
erally showed cumulative effects, conﬁrming the mixture effects
also described by Hass et al. [28].
4.1. Mixture effects on reproductive organ weights
As can be seen in Table 2, weights of male reproductive organs
in both 16 day old and adult offspring were affected by a com-
bination of the 5 pesticides at dose levels where the individual
pesticides caused no or only small effects. Fig. 7 shows the relative
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Fig. 5. Mean daily latency to reach the platform in adult male rat offspring exposed to 0, 14.6, 29.2 or 43.8mg/kg/day of the pesticide mixture during fetal and neonatal
life. Data is shown as group means± SEM for latency in the Morris Water Maze for the ﬁrst seven days of the learning testing, n=9–10. Statistically signiﬁcant differences
between controls and exposed group on each day of testing are marked with asterisks which indicate signiﬁcance levels: *p<0.05. The results from these groups and the 10
single pesticide exposed are shown in Table S4, Supplementary data.
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Fig. 6. Mating behavior, % mounting activity and distribution in 3 groups. Low (number of mounts ≤5), medium (number of mounts >5 and <30) or high (number of mounts
≥30), during a 20min. period, shown as group means (%). The number of males is shown as n, while the number in parenthesis is the number of litters. ***p<0.001.
epididymis, prostate and seminal vesicle weight data from day 16
offspring and relative prostate and LABC weights from adult males
compared to control values. Results are shown for the highest mix-
ture group and for the individual pesticides in the low doses, which
were included in this mixture, and the ﬁgure illustrates how the
slight effects of individual compounds add up to a marked effect in
themixture group at the same dose levels. Similar results have pre-
viously been obtained in another mixture study of three similarly
acting anti-androgens, i.e. the androgen receptor (AR) antagonists
ﬂutamide, procymidone and vinclozolin [24]. For chemicals act-
ing via the same mode of action, e.g. AR antagonists, effects will
be in the same direction (e.g. decreased organ weights) and dose-
additive effects are expected when such compounds are given in
combination. Evidently, exposure to antagonists in combination
with agonists for the same receptor, may result in opposite direc-
tions of effects and thus one compound compensating the effect of
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Fig. 7. Organ weight changes compared with controls in male rat pups exposed to the low dose of epoxiconazole (Epoxi), mancozeb (Manz), prochloraz (Prchl), tebuconazole
(Tebu), procymidone (Procy) or the highest mixture dose of these pesticides (Pestimix) from GD 7 to PND 16. Values are expressed as percent of control values for relative
organ weights. Horizontal line indicates control level 100%. n=2–16 as listed in Table 2.
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another. For compounds with multiple modes of action, the effects
of each chemical may be in opposite direction (increase versus
decrease) and the effect of the mixture is more difﬁcult to predict.
In the current study, procymidone appears to be the dominating
compound in themixture asprocymidonehas the largest individual
effect reducing prostate and seminal vesicle weights at the applied
doses. In contrast, the low dose of tebuconazole slightly increased
prostate weights and the high dose of epoxiconazole signiﬁcantly
increased prostate weights at PD 16. These azole fungicides have
multiple modes of action, i.e. anti-androgenic, anti-estrogenic and
steroid synthesis disrupting actions, which may inﬂuence prostate
weight in opposing directions. However, when these azole fungi-
cideswere given in combinationwith procymidone, the joint effect
is a signiﬁcant reduction in prostate weight at a lower dose of pro-
cymidone than is effective alone. Currently, little is known about
combination effects on endpoints inﬂuenced in opposite directions
by endocrine disrupters with different modes of action and more
research is needed in this area.
It should be noted that the low doses of the individual com-
poundswere similar to thedosesused in thehighestmixture group.
As the numbers of animals in the individual chemical groups were
lower than the number of animals in the mixture groups, it could
be argued that the low “n” of the individual chemical groups might
reduce the likelihood for detecting statistically signiﬁcant changes.
However, even after pooling weight data from the low and the high
dose groups for each chemical where “n” was increased to 9–13 lit-
tersper chemical group, no statistically signiﬁcant changes couldbe
observed between controls and individual chemical groups, except
for an increase in testis weight in the pooled procymidone group.
Thus, increasing the number of litters in the individual chemical
low dose groups would not change the overall picture that effects
on male reproductive organ weights occur in mixture groups but
not in individual chemical groups using the same doses. The reduc-
tions in weights of male accessory reproductive organs on PD 16 in
only the highest mixture group indicates a cumulative effect seen
at dose levels where each compound does not have a statistically
signiﬁcant effect. Cumulative effects, in relation to mixtures tox-
icology, has previously been introduced by Silva et al. [23] who
showed that in mixture studies, every chemical in the mixture, in
proportion to its toxic unit, can contribute to the overall effect –
even when it is present at concentrations below the threshold of
statistically detectable effects. The concept has subsequently been
proven several times during the last decade in both in vivo and
in vitro studies [23,25,37–43].
A statistically signiﬁcant increase in testisweightswas observed
in animals exposed to the lowest dose of 12.5mg/kgbw/day of pro-
cymidone on PD 16 but not at 50mg/kgbw/day. Interestingly, our
own previous study on procymidone showed a statistically signif-
icant increase in testis weight at 10mg/kgbw/day, no change at
25–100mg/kgbw/day and a decrease at 150mg/kgbw/day point-
ing to a non-monotonous dose–response curve [24]. Testis weight
may be affected by chemically induced changes such as ﬂuid
accumulation or impaired proliferation/differentiation, and these
changes will likely have opposing effects on testis weight. If these
changes appear at different doses, it may be speculated that this
could result in non-monotonous dose–response curves for testis
weight.
In adult offspring, reduced absoluteweight of LABC andprostate
were seen in the highest mixture dose group compared to controls,
but not in any of the groups exposed to the pesticides alone at the
same dose levels, again conﬁrming a cumulative effect seen at dose
levels where each compound did not have a statistically signiﬁcant
effect (Table 2 and Fig. 7). The decreased weights of prostates in
the high dose mixture group corresponded well with the ﬁnding of
low weights of prostates, seminal vesicles and epididymides on PD
16 and revealed that pesticide effects on male reproductive organs
persisted into adulthood. The decreased weight of the LABC in the
adult but not prepubertal male offspring may indicate long-term
delayed mixture effects, but could also reﬂect a higher degree of
variation (biological or procedural) at PD 16 than in adulthood. No
changes in seminal vesicle or epididymis weight were observed in
adult animals, indicating that PD 16 may be a more sensitive time
point for observing impaired growth of male reproductive organs
due toanti-androgenic effects of thesepesticides.Ourownprevious
studies on perinatal exposure to other anti-androgenic chemicals
have shown that prostate weight on PD 16 is often affected at low
doses. For different anti-androgenic chemicals, it differs whether
LABC, seminal vesicle or epididymis weights are also affected at
the same doses that affect prostate weight, i.e. prostates appear to
bemost sensitive to anti-androgenswhereasweights of othermale
reproductive organs vary in their sensitivity depending on the type
of chemical exposure.
4.2. Effects on sperm count, semen quality and adult reproductive
organs
Exposure to the pesticide mixture lowered sperm counts in the
highest dose group. Control values did not differ from historical
control values and our ﬁnding therefore indicates that the low-
ered sperm counts were caused by developmental exposure to this
mixture of endocrine disrupting pesticides. This is a very important
and potentially quite alarming result in relation to the low sperm
counts and declining sperm quality in humans reported during the
last decades [6,44]. No effects on sperm motility parameters were
seen in the exposed animals in the present study, which indicates
that the mixture affected the number but not the function of the
sperm cells.
Histological evaluation of testes and caput epididymides
showed no differences between controls and the high mixture
group. The epididymis is well known to be a sensitive indica-
tor of spermatogenic disturbance showing increased numbers of
sloughed cells and cell debris in case of endocrine disruption such
as anti-androgen effects [45]. However, in this study the effects
were seen months after exposure, and any histological changes
were likely to be much more subtle than would be expected from
studies on direct exposure. It should also be noted that no histo-
logical examination of corpus or cauda epididymis was performed
and that functional and/or histological changes in these parts may
be present.
Although theweightsofprostate inadultoffspringwere reduced
in the highest mixture group compared to the control group, this
was not associated with any increase in prostate atrophy. Interest-
ingly, in the present study a higher degree of atypical hyperplasia
and cribriform patterns together with less epithelial atrophy was
observed in the highest mixture dose group compared with the
control group. In rats, epithelial atrophy is a known age-related
ﬁnding in prostate, probably caused by a decline in circulating
testosterone [46]. This apparent change from epithelial atrophy (as
a normal age-related ﬁnding) towards epithelial hyperplasia (as an
abnormal change)may be related to endocrine disruption. It is gen-
erally agreed that early exposure to endocrinedisrupting chemicals
can initiate imbalances in the prostatic cells which may contribute
to prostatic pathology with aging [47,48]. Neonatal exposure to
bisphenol A resulted in an increased susceptibility to precancer-
ous lesions in the adult rat ventral prostate [48]. An adult onset of
mainly augmented atrophic changes and to a lesser extent hyper-
plastic changes were seen in aged ventral prostates through four
generations of rats following neonatal exposure to Vinclozolin in
F0 [47]. The ﬁndings of atypical hyperplasia and cribriform pattern
in ventral prostates of thehighestmixturedose group in the current
study may similarly reﬂect alterations caused by early exposure to
this pesticide mixture. A comparable shift from atrophy towards
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hyperplasia of prostatic epithelium has been observed in another
study on aging rats exposed perinatally to anti-androgenic chemi-
cals ([47] manuscript in preparation).
4.3. Thyroid and liver effects
Since at least one (mancozeb) and possibly more of the tested
pesticides (the azole pesticides) may affect the thyroid hormone
system, several endpoints which can be used to investigate thyroid
disruption were included in the present study.
On pup day 16, reduced thyroid weights were seen in animals
exposed to the high dose of prochloraz. Similar effects have not
been described in the literature and have not been investigated in
our previous studies on prochloraz [11,13]. In adults an increase in
thenumberof ratswith folliclesdominatedbycolumnar tocuboidal
epithelium was found in group 8 compared to the control group
indicating thyroid hyperactivity. This conﬁrms previous ﬁndings
that Mancozeb produces structural and functional changes in rat
thyroids [49,50].
No thyroid weight or histological changes were seen in mixture
groups, and T4 levels were measured in male and female pups at
PD 50 in control and mixture groups, and at this age no statistically
signiﬁcant changes were seen in any dose group, indicating that
possible effects of prochloraz and mancozeb would require higher
doses than those included in the mixture. Thyroid hormones are
important to growth and mental development, and in the activity
test, a signiﬁcantly elevated activity level was seen in the high dose
Mancozeb females. This could reﬂect a real effect on activity levels,
however other studies on Mancozeb performed in our laboratory
using a larger group size did not show similar effects [19], and this
may therefore be considered a chance ﬁnding due to the relatively
low number of offspring in the mancozeb group. Also, no changes
in the learning and memory of the animals were observed in the
Mancozeb groups. All in all, no signiﬁcant changes indicating anti-
thyroid properties of the pesticide mixture were observed.
The observed increase in absolute and relative liver weight
observed at PD 16 in animals exposed to 50mg/kgbw/day of tebu-
conazolewere comparable toﬁndings ina studybyMoser et al. [51],
who described increased liver weights at PD 46 in rats following
perinatal exposure to 60mg/kgbw/day of tebuconazol.
4.4. Effects on mammary glands
Mammary glands of offspring from the three mixture groups
showed no altered growth or development on PD 22. On PD 50
increased densities of male mammary glands appeared in the high
dose mixture groups. The female form of the mammary glands in
rodents is the default morphology of the mammary glands and
testosterone is responsible for the development of the male mor-
phology of the mammary glands (Goldman et al. [52]). Hence, the
anti-androgenic effects of the mixture in the present study may
impart the virilisation of the fetalmalemammary glands. The dose-
related increase in density of the male mammary glands may thus
reﬂect the anti-androgenic properties of the mixture. In addition,
nipple retention is strongly linked to endocrine disrupting chemi-
cals [25]. More nipples were found in the male offspring exposed
to the mixtures, as reported in Hass et al. [28]. This ﬁnding may
comply with the increased density in the male mammary glands
PD 50 reﬂecting a possible permanent feminization of the mam-
mary glands. Likewise, more male mammary glands in the high
mixture group had secretory material in the ducts and more vac-
uolated epithelium, suggesting an increased secretory activity of
the glands. This may be linked to an increased feminization of the
male mammary glands. However, in some of the animals, it was
not evident if the material in the ducts were of secretory origin.
Further investigation with other staining techniques will be neces-
sary to determine the nature of the material in the ducts.
4.5. Effects on onset of puberty
No effects were seen in age or weight at onset of puberty on
male or female offspring in either the groups receiving themixtures
or the single chemicals in the present study. However, as some of
the pesticides have been shown to affect timing of sexual matu-
ration and several of the pesticides used in this study can act as
anti-androgens [14,15,17,53,54] onset of puberty could have been
affected in the tested animals [55].
4.6. Behavioral studies
In the behavioral studies ofmotor activity, no statistically signif-
icant exposure-related effects were seen in males or females from
the threemixturegroups, compared to controls. Asbehavioral stud-
ies conductedwith the small group sizeswhichwere present in the
single pesticides groups are very difﬁcult to interpret, the signiﬁ-
cantly elevated activity levels observed in female rats exposed to
the low doses of prochloraz and tebuconazole and the high dose of
mancozebwere probably randomﬁndings. No dose–response rela-
tionship was seen for the two ﬁrst groups, and a previous study of
mancozeb [19] did not show any effect on activity level usingmuch
larger group sizes and higher dose levels.
In the Morris Maze spatial learning test signiﬁcant effects of
mixed pesticide exposure were seen in the male offspring. On
the last day of the learning period (day 7), males from the high-
est mixture group spent signiﬁcantly more time in the maze and
swam signiﬁcantly longer than control males before reaching the
platform, indicating decreased learning ability in these animals.
Even though the effect was most marked on day 7, a similar dose-
dependent increase in swim length and latency was seen over the
last three days of the learning period. The fact that no effects on
activity levelswere seen in themales from three groups dosedwith
the pesticide mixture indicates that the signiﬁcant effects seen in
the Morris Water Maze were not related to alterations in the level
of general motor activity. As male rats generally perform better
than females in tests of spatial learning [56,57], a result that was
also conﬁrmed in the present study, the signs of decreased learning
ability seen in the pesticide exposed males could be interpreted as
being in the direction of female performance.
Spatial learning ability after perinatal pesticide exposure has
previously been investigated for prochloraz, mancozeb and pro-
cymidone, but none of the compounds affected learning ability
when tested alone, as a dose of 30mgprochloraz/kg/day [11], doses
of 50–100mg mancozeb/kg/day [19] and doses of 25–100mg pro-
cymidone/kg/day [27] did not result in any signiﬁcant alterations
of spatial learning ability in male or female offspring. However,
demasulinization of another sexually dimorphic behavior, sweet
preference, was seen in the males from the prochloraz study
[11]. Moreover, spatial learning ability was impaired in males
dosed perinatally with a mixture of the three anti-androgenic
chemicals vinclozolin, ﬂutamide and procymidone, as both tested
doses of the mixture resulted in impaired Morris Maze perfor-
mance in the adult male offspring [27]. The same mixture doses
caused increased nipple retention as well as decreased weights
of epididymis, ventral prostate and bulbouretral glands [24,25].
These results indicate that behavioral effects induced by com-
bined exposure to anti-androgenic chemicals may be caused by
altered sexual differentiation of the male brain. More studies
are however needed before clear conclusions on this matter can
be drawn.
For the single pesticide exposures, group sizes were gener-
ally quite small in regard to assessment of behavioral results
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(n=2–6). Therefore, conclusions on whether the statistically sig-
niﬁcant increase in swim length and latency seen in the low but
not the high dose tebuconazole males, could be involved in the
observed mixture effect in the males are only speculative.
In the behavioral studies of mating behavior, males from the
highest dose of prochloraz showed signiﬁcantly increased mating
activity compared to the controls. However, due to the limited
number of animals in the single pesticide exposure groups this
ﬁnding can only be considered as suggestive.
4.7. Overall conclusions
The study showed that a mixture of the endocrine disrupting
pesticides epoxiconazole,mancozeb, prochloraz, tebuconazole and
procymidone, was able to cause adverse developmental toxicity
effects, including long-term delayed effects, at dose levels where
the single pesticides had no effects. The adverse effects, which
included decreased weight of reproductive organs, decreased
sperm count, altered mammary gland development and decreased
spatial learning ability in male offspring, were seen after exposure
to a mixture, where the individual pesticides were present at dose
levels below their respective NOAEL values. These results imply
that risk assessment based on NOAELs for single chemicals can
underestimate the risk, and that there is a need for modiﬁcation of
risk assessment procedures for pesticides in order to take account
ofmixture effects and thepotentially serious impact ofmixedexpo-
sure on development and reproduction. This issue is discussed in
much more detail in the paper by Hass et al. [28], and is supported
by the present ﬁndings.
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Table S1. Relative male organ weights on PD 16 and in adult rats (PD 260-280), exposed to the pesticides singly 
or in mixture during fetal and neonatal life.  
Relative organ 
weights 
 (mg/100g bw) 
 
n 
Testes Epididymis Prostate Ves sem LABC Bulbo Liver Thyroid 
Male offspring PD 16 
1: Control 15 337±23 71.2±23.2 34.5±6.8 33.8±8.5 89.1±20.6 5.7±1.2 2557±114 14.5±2.8 
2: Pestimix-14.6 16 350±38 70.7±9.3 30.4±5.4 27.9±6.3 79.2±10.7 5.1±1.4 2546±105 14.0±2.0 
3: Pestimix-29.2 9 362±14 60.8±25.4 28.2±5.6 28.5±4.7 86.6±16.1 4.9±1.1 2677±68 14.8±2.6 
4: Pestimix-43.8 12 357±13 63.7±6.5**. 
## 
23.4±5.9***. 
### 
21.5±7.9**. 
## 
82.4±16.0 5.0±2.0 2645±140 14.3±4.8 
5: Epoxi-3.75 6 348±34 73.2±8.8 36.1±7.3 31.3±6.5 98.7±19.5 7.3±2.9 2548±136 15.8±5.2 
6: Epoxi-15 3 358±38 82.8±11.3 44.8±11.7 28.6±5.3 74.6±7.4 6.6±2.1 2682±152 12.9±3.3 
7: Manz-6.25 5 351±17 74.4±8.4 33.9±4.1 37.1±5.3 82.2±5.1 5.9±0.8 2525±259 15.6±2.3 
8: Manz-25 7 359±29 71.9±32.1 36.0±11.3 31.7±7.9 94.5±16.0 6.2±1.1 2540±93 15.8±3.7 
9: Prchl-8.75 9 357±23 77.4±10.2 38.0±3.5 28.4±5.9 85.4±12.1 5.3±1.3 2531±152 11.3±4.7 
10: Prchl-35 4 355±36 67.1±5.2 36.1±6.6 26.7±9.6 76.1±5.0 5.0±1.8 2520±148 11.3±1.9 
11: Tebu-12.5 8 363±29 69.6±28.5 41.8±6.0 34.7±11.5 89.6±12.5 6.1±1.5 2599±70 14.2±3.3 
12: Tebu-50 5 346±19 72.4±8.4 32.3±9.6 37.7±6.6 80.6±6.4 5.4±0.8 2749±121#
# 
17.2±3.1 
13: Procy-12.5 6 376±22*, 
## 
74.8±11.2 28.8±5.1 25.3±4.5 93.3±21.0 5.1±0.5 2636±128 14.3±3.0 
14: Procy-50 3 363±27 67.2±12.9 23.3±1.8 29.5±2.6 41.7±36.2 2.4±2.2# 2722±260 15.2±2.5 
Adult male offspring 
1: Control 16 792±63 142±15 129±31 391±71 283±36 44±14 2673±190 4.5±0.6 
2: Pestimix-14.6 18 854±78 152±16 147±39 428±76 279±43 53±17 2547±148 5.3±2.2 
3: Pestimix-29.2 12 861±143 158±21 134±25 455±99 275±43 38±13 2551±131 5.3±1.0 
4: Pestimix-43.8 16 865±63 150±17 101±43 444±75 246±44 46±12 2590±174 4.1±1.2 
5: Epoxi-3.75 10 860±65# 141±16 135±26 421±88 267±43 46±10 2549±208 4.2±0.6 
6: Epoxi-15 2 (970±65) (180±13) (155±42) (502±37) (307±4) (71±19) (2747±223) (5.6±0.7) 
7: Manz-6.25 8 833±90 153±19 114±50 390±89 280±56 48±11 2604±89 6.2±3.7 
8: Manz-25 10 817±80 151±12 126±25 405±100 259±19 43±14 2694±195 6.0±3.2 
9: Prchl-8.75 10 846±70 146±18 131±32 419±62 266±35 56±13 2610±216 4.4±0.6 
10: Prchl-35 6 844±39 147±10 148±29 447±53 287±26 52±25 2431±180# 4.6±0.4 
11: Tebu-12.5 8 860±91 154±27 131±31 407±92 278±35 39±14 2523±144 4.6±0.3 
12: Tebu-50 8 803±65 138±15 116±28 407±113 259±48 33±2 2632±176 5.1±0.9 
13: Procy-12.5 8 844±113 154±28 111±32 410±77 258±60 38±15 2567±148 4.3±0.7 
14: Procy-50 6 840±48 150±12 90±38# 363±48 241±28 42±13 2374±255# 4.2±0.7 
 
Epoxiconazole (Epoxi), mancozeb (Manz), prochloraz (Prchl), tebuconazole (Tebu) or procymidone (Procy).Ves.sem.: seminal vesicle; Bulbo: 
glandula bulbocavernosus; LABC: levator ani/bulbospongiosus muscle.  
Statistically significant differences between controls and exposed are marked with asterisks which indicate significance levels: *indicates 
p<0.05; ** indicates p<0.01; *** indicates p<0.001. P values result from  ANOVA of relative weights followed by Dunnett’s test on all 14 
groups . # indicates significantly different from controls in a model including only control and different doses of the same compound or the 
mixture using Dunnett's post hoc test. # p<0.05, ## p<0.01, ### p<0.001. All significant results are written in bold. 
Data for adults in the Epoxi-15 group are in parentheses as these are left out of statistical analysis due to only 2 animals in this group. 
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Table S2. Mammary gland whole mounts and histology PND 22 and 50, in rats exposed to the pesticide mixture 
during fetal and neonatal life.  
  1: Control  2: Pestimix-14.6 3: Pestimix-29.2  4: Pestimix-43.8  
Mammary whole 
mounts PD 22, males 
n 14 15 8 10 
Density score 2.9 ± 1.1  2.1 ± 0.8  2.6 ± 1.3  2.1 ±1.4  
Longitudinal growth, 
mm 
10.0 ± 1.3 9.8 ± 2.3  9.5 ± 1.9 10.4 ± 1.9  
Transverse growth, mm 5.5 ±1.1  5.5 ±1.4  5.7 ±1.3  5.1 ± 0.9  
Area, mm2 41.9 ± 11.9 43.5 ± 16.7  41.7 ± 13.3  43.2 ± 15.7 
TEB number 6 ± 4.5 7.6 ± 11.6 5.1 ± 2.0 6.3 ± 6.5 
Mammary whole 
mounts PD 22, females 
N 10-11 13-15 4-5 10 
Density score 3.5 ± 1.0  3.0 ± 0.9  3.2 ± 0.4  3.5 ± 0.8  
Longitudinal growth, 
mm 
11.2 ± 1.7  10.3 ± 1.5 11.0 ±1.9 11.2 ± 1.9 
Transverse growth, mm 5.7 ± 1.3  5.6 ± 1.3  6.4 ± 2.2  5.9 ± 1.0  
Area, mm2 49.4 ± 14.4  46.3 ± 13.4  54.5 ± 26.2  49.3 ± 12.2 
TEB number 24.6 ±19.5  21.0 ± 13.9  36.0 ± 15.9  20.5 ± 16.9 
Mammary whole 
mounts PD 50, male 
n litters [total number 
of examined animals] 
13 [13-14] 15 [15-16 ] 8 [9-10 ] 13 [13-14] 
Density score 2.7 ± 0.5  2.8 ± 0.9  2.9 ± 1.0  2.9 ±1.1  
Longitudinal growth, 
mm 
15.4 ± 2.9  16.3 ± 2.3  18.7* ± 4.1  16.6 ± 2.5  
Transverse growth, mm 9.9 ± 1.3  9.5 ± 2.2  10.4 ± 1.8  9.9 ± 2.9  
Area, mm2 114.7 ± 33.5  117.5 ± 35.0  138.7 ± 44.7  126.2 ± 40.4  
Mammary whole 
mounts PD 50, females 
n litters [total number 
of examined animals] 
15 [18] 16 [18 ] 8 [10] 7 [9] 
Density score 2.8 ± 0.8  3.4 ± 0.9  3.3 ± 1.0  3.4 ±1.0  
Mammary histology 
PD50, males 
Secretory material in 
ducts 
17% (1/6) - - 33% (3/9) 
Vacuolization of 
mammary epithelium 
50% (3/6) - - 67% (6/9) 
Mammary histology PD 
50, females 
Presence of 
lobuloalveolar pattern, 
% (number 
affected/total) 
0% (0/14) 8% (1/13) 11% (1/9) 8% (1/12) 
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Data on whole mounts is shown as group means ± standard deviation. At PD 22, mammary gland from one pup per litter was 
examined, n is the number of examined litters per dose group. At PD 50, one or two pups per litter were examined and values are 
based on litter means, and in brackets following the n for number of litters, the total number of examined animals is given. 
Histology data are given as % of affected animals and in parentheses are given (numbers affected of animals/total number of 
animals examined). Statistically significant differences between controls and exposed groups are marked in bold. Asterisks 
indicate significance levels: * p<0.05.  
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Table S3. Total motor activity levels in adult male and female rat offspring exposed to the pesticides singly or in 
mixture during fetal and neonatal life.  
  Male Female 
  
no. animals 
(litters) 
activity count 
+ std. dev. 
no. animals 
(litters) 
activity count 
+ std. dev. 
1:Control 16(14) 977+138 18(15) 1339+79 
2:Pestimix-14.6 18(17) 1285+97 18(17) 1591+110 
3:Pestimix-29.2 12(9) 1137+175 10(8) 1145+82 
4:Pestimix-43.8 16(14) 1142+128 12(11) 1463+65 
5:Epoxiconazol-3.75 10(6) 1210+184 10(7) 1355+164 
6:Epoxyconazol-15 2(2) 1227+374 6(4) 1460+154 
7:Mancozeb-6.25 8(5) 1153+65 8(5) 1518+264 
8:Mancozeb-25 10(7) 1068+137 10(7) 1896+193** 
9:Prochloraz-8.75 10(9) 1293+156 10(9) 1718+181* 
10:Prochloraz-35 6(4) 1522+129 6(4) 1634+184 
11:Tebuconazol-12.5 10(8) 1121+113 8(7) 1938+135** 
12:Tebuconazol-50 8(6) 980+104 8(6) 1524+221 
13:Procymidon-12.5 8(7) 1261+92 8(7) 1545+178 
14:Procymidon-50 6(4) 772+81 6(4) 1295+85 
 
Data is shown as group means + standard deviation, and for each dose group the tested number of animals and the number of 
litters they represent is shown. Statistically significant differences between controls and exposed groups are marked in bold. 
Asterisks indicate significance levels: * p<0.05, ** p<0.01. An overall significant differences between males and females was 
seen in the data (p<0.0001). Statistically significant differences between males and females from the same dose group were seen 
in groups 1, 2, 4, 7, 8, 9, 11, 12 and 14 but are not marked in the table. 
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Table S4. Swim lengths and latencies in male and female rat offspring exposed to the pesticides singly or in 
mixture during fetal and neonatal life.  
. 
MALE   Swim length  Swim latency 
  
n day 1 day 2 day 3 day 4 day 5 day 
6 
day  7 total day 
1 
day 
2 
day 
3 
day 
4 
day 
5 
day 
6 
day 
7 
total 
1: Control 10 
(10) 
1416+
319 
1411+
458 
880+ 
459 
650+ 
468 
562+ 
329 
312+
168 
273+ 
117 
5504+ 
1760 
50+ 
10.4 
45+ 
13.4 
34+ 
16.3 
26+ 
16.3 
23+ 
10.5 
15+ 
7.0 
14+ 
8.3 
206+ 
57 
2: Pestimix-
14.6 
10 
(10) 
1642+
184 
1358+
445 
867+4
85 
514+2
63 
518+2
22 
356+
175 
299+ 
129 
5553+ 
1096 
55+ 
7.2 
44+ 
14.8 
32+ 
15.9 
22+ 
9.9 
23+ 
9.6 
18+ 
7.8 
15+ 
5.8 
210+
34 
3: Pestimix-
29.2 
10 
(9) 
1481+
261 
1608+
367 
1154+
496 
829+4
02 
631+3
65 
514+
321 
448+ 
263 
6665+ 
1662 
50+ 
9.5 
50+1
0.6 
38+ 
15.8 
31+ 
12.0 
25+ 
11.6 
22+ 
10.3 
19+ 
8.2 
235+
50 
4: Pestimix-
43.8 
10 
(10) 
1571+
312 
1544+
384 
1056+
571 
911+4
34 
785+4
07 
580+
436 
627 
+604 
7074+ 
2052* 
54+ 
7.9 
50+ 
10.5 
37+ 
17.4 
36+ 
15.4 
31+ 
15.2 
25+ 
14.0 
26+ 
18.3* 
259+
63* 
5: Epoxi-3.75 
6(4) 
1561+
152 
1289+
375 
1127+
466 
625+2
76 
718+3
73 
532+
248 
366+ 
145 
6218+ 
1393 
50+ 
3.6 
40+ 
10.8 
38+ 
14.4 
27+ 
9.3 
29+ 
11.7 
25+ 
10.6 
18+ 
6.3 
227+
46 
6: Epoxi-15 
2(2) 
1450+
158 
1378+
335 
824+9
04 
492+3
53 
456+2
94 
301+
87 
259+ 
109 
5159+ 
2241 
54+ 
9.2 
46+ 
2.2 
30+ 
25.5 
20+ 
9.9 
20+ 
8.8 
15+ 
4.1 
12+ 
2.8 
196+
63 
7: Manc-6.25 
5(4) 
1351+
374 
1509+
381 
873+3
77 
668+4
15 
428+1
31 
464+
217 
296+ 
162 
5589+ 
809 
44+ 
13.5 
45+ 
11.6 
29+ 
12.8 
26+ 
13.8 
16+ 
4.0 
20+ 
10.2 
14+ 
7.7 
194+
33 
8: Manc-25 
5(5) 
1642+
273 
1254+
314 
1007+
256 
610+2
35 
557+1
86 
415+
213 
339+ 
127 
5824+ 
944 
58+ 
5.4 
41+ 
9.1 
38+ 
8.2 
26+ 
7.6 
23+ 
7.4 
21+ 
6.2 
16+ 
5.0 
222+
27 
9: Prchl-8.75 
5(5) 
1558+
207 
1353+
375 
932+4
96 
450+1
84 
514+2
71 
340+
106 
347+ 
154 
5494+ 
1164 
57+ 
4.7 
47+ 
12.5 
36+ 
16.3 
23+ 
10.1 
23+ 
12.6 
20+ 
5.0 
23+ 
10.7 
231+
51 
10: Prchl-35 
5(4) 
1626+
239 
1363+
298 
983+3
04 
559+1
21 
486+2
18 
321+
180 
298+ 
181 
5637+ 
657 
54+ 
7.4 
43+ 
9.4 
34+ 
10.4 
23+ 
5.6 
23+ 
10.1 
15+ 
8.1 
12+ 
5.9 
204+
30 
11: Tebu-12.5 
5(5) 
1778+
328 
1708+
356 
1500+
477 
1074+
620 
1024+
836 
916+
698 
756+ 
493* 
8756+ 
2924** 
56+ 
5.3 
51+ 
8.8 
50+ 
11.3 
37+ 
16.8 
37+ 
22.6 
38+ 
21.4 
31+ 
14** 
300+
78** 
12: Tebu-50 
5(5) 
1515+
129 
1536+
615 
882+6
29 
642+4
35 
718+6
83 
376+
311 
293+ 
106 
5962+ 
1868 
50+ 
3.2 
50+ 
16.7 
33+ 
18.4 
27+ 
16.0 
28+ 
23.7 
18+ 
11.8 
14+ 
5.1 
220+
54 
13: Procy-
12.5 6(6) 
1572+
396 
1478+
520 
739+2
14 
471+3
03 
563+2
22 
319+
164 
290+ 
145 
5432+ 
949 
52+ 
5.7 
48+ 
10.5 
29+ 
8.2 
20+ 
8.8 
24+ 
8.2 
18+ 
10.4 
15+ 
6.6 
204+
28 
14: Procy-50 
4(4) 
1480+
88 
1449+
280 
1190+
171 
886+1
73 
663+4
91 
573+
222 
598+ 
260 
6839+ 
1074 
55+ 
6.7 
50+ 
6.5 
46+ 
10.1 
35+ 
7.0 
30+ 
20.5 
30+ 
8.5 
31+ 
10** 
277+
26** 
 
                  FEMALE   Swim length  Swim latency  
 n day 1 day 2 day 3 day 4 day 5 day 
6 
day  7 total day 
1 
day 
2 
day 
3 
day 
4 
day 
5 
day 
6 
day 
7 
total 
1: Control 10 
(10) 
1593+
192 
1222+
357 
911+ 
346 
586+ 
235 
669+ 
398 
617+
305 
574+ 
277 
6175+ 
473 
56+ 
5.7 
45+ 
11.9 
35+ 
12.9 
26+ 
9.5 
30+ 
15.7 
28+ 
12.8 
26+ 
13.9 
249+ 
58 
2: Pestimix-
14.6 
10 
(10) 
1469+
373 
1215+
271 
891+3
39 
640+2
82 
553+3
81 
674+
416 
741+ 
355 
6184+ 
497 
52+ 
11.3 
45+ 
11.6 
35+ 
11.5 
28+ 
10.0 
25+ 
14.6 
28+ 
15.7 
30+ 
11.8 
247+ 
62 
3: Pestimix-
29.2 
10 
(8) 
1540+
233 
1413+
382 
1156+
331 
918+ 
417 
877+ 
408 
894+
419 
775+ 
425 
7578+ 
496 
53+ 
6.7 
51+ 
11.2 
50+ 
11.5 
41+ 
16.9 
43+ 
18.0 
40+ 
16.1 
34+ 
15.9 
314+ 
58 
4: Pestimix-
43.8 
10 
(10) 
1484+
257 
1246+
397 
1017+
582 
890+ 
352 
753+ 
436 
698+
502 
505+ 
299 
6597+ 
738 
51+ 
7.3 
44+ 
12.1 
36+ 
16.5 
35+ 
12.9 
29+ 
15.6 
29+ 
17.6 
23+ 
14.0 
250+ 
73 
5: Epoxi-3.75 
6(4) 
1559+
144 
1241+
419 
1041+
516 
953+ 
484 
918+ 
638 
883+
578 
868+ 
562 
7466+ 
3159 
53+ 
6.2 
46+ 
15.3 
41+ 
16.0 
38+ 
16.5 
34+ 
18.5 
34+ 
20.7 
33+ 
18.4 
283+ 
105 
6: Epoxi-15 
6(4) 
1602+
307 
1225+
398 
793+ 
291 
896+ 
283 
522+ 
85 
702+
206 
600+ 
98 
6342+ 
158 
55+ 
4.4 
44+ 
15.4 
33+ 
13.7 
37+ 
14.3 
21+ 
4.7 
29+ 
6.9 
25+ 
6.3 
248+ 
11 
7: Manc-6.25 
5(4) 
1507+
104 
1491+
275 
1187+
322 
1400+
84 
933+ 
255 
800+
253 
822+ 
201 
8143+ 
611 
52+ 
6.2 
49+ 
10.6 
43+ 
16.0 
52+ 
5.6 
35+ 
12.9 
33+ 
9.5 
34+ 
11.2 
300+ 
33 
8: Manc-25 
5(5) 
1518+
175 
1476+
402 
999+ 
779 
1049+
808 
677+ 
358 
778+
484 
500+ 
284 
7001+ 
1767 
53+ 
4.7 
47+ 
9.5 
31+ 
8.5 
33+ 
21.6 
28+ 
15.1 
28+ 
14.8 
19+ 
9.4 
243+ 
46 
9: Prchl-8.75 
5(5) 
1654+
433 
1395+
613 
569+ 
349 
405+ 
199 
433+ 
214 
766+
466 
575+ 
450 
5801+ 
1852 
51+ 
9.5 
45+ 
18.9 
24+ 
20.5 
17+ 
9.9 
18+ 
9.1 
29+ 
16.3 
24+ 
18.0 
211+ 
77 
10: Prchl-35 
5(4) 
1450+
249 
1224+
265 
789+ 
462 
633+ 
356 
639+ 
344 
470+
352 
382+ 
178 
5590+ 
1150 
55+ 
6.8 
47+ 
13.7 
33+ 
11.8 
27+ 
13.7 
31+ 
15.7 
21+ 
16.1 
17+ 
9.0 
234+ 
51 
11: Tebu-12.5 
5(4) 
1786+
194 
1511+
141 
1314+
86 
905+ 
242 
810+ 
235 
821+
232 
1043+2
81 
8191+ 
790 
59+ 
0.9 
54+ 
5.9 
50+ 
8.8 
36+ 
9.6 
33+ 
7.9 
35+ 
8.7 
41+ 
9.1 
310+ 
21 
12: Tebu-50 
5(5) 
1429+
273 
1101+
469 
1065+
312 
876+ 
466 
650+ 
560 
916+
581 
846+ 
546 
6885+ 
2832 
52+ 
11.0 
40+ 
15.2 
44+ 
13.4 
33+ 
12.6 
29+ 
19.5 
36+ 
17.0 
33+ 
17.5 
270+ 
87 
13: Procy-
12.5 6(6) 
1598+
253 
1418+
377 
1246+
436 
930+ 
634 
584+ 
124 
653+
320 
474+ 
303 
6906+ 
1761 
56+ 
4.9 
47+ 
11.4 
44+ 
15.0 
32+ 
16.6 
25+ 
6.1 
29+ 
13.1 
22+ 
13.7 
256+ 
61 
14: Procy-50 
4(4) 
1217+
435 
1501+
482 
1005+
219 
565+ 
145 
666+ 
276 
595+
281 
626+ 
93 
6179+ 
438 
44+1
7.8 
49+1
2.4 
37+ 
6.9 
36+ 
17.8 
36+ 
20.6 
33+ 
20.5 
32+ 
17.7 
270+ 
82 
 
Data is shown as group means + standard deviation. Statistically significant differences between controls and exposed animals for 
post hoc analysis with all 14 dose groups are marked in bold. Asterisks indicate significance levels: * p<0.05, ** p<0.01. An 
overall statistically significant differences between males and females was seen in the data on days 4-7 (p<0.0001). 
 
PAPER 5 
 
Karen Riiber Mandrup, Julie Boberg, Anne Stilling Pedersen, Mette Sidsel 
Mortensen, Jennifer Jørgensen, Katrine Højholt Kristensen, Ulla Hass.  
 
Mammary gland effects of perinatal exposure to environmentally relevant endocrine 
disrupting chemicals.  
 
Draft manuscript/ in preparation 
 
 
1 
 
Mammary gland effects in mixture studies with endocrine disrupting chemicals  
 
Karen Riiber Mandrup, Julie Boberg, Anne Stilling Pedersen, Mette Sidsel Mortensen, Jennifer 
Jørgensen, Katrine Højholt Kristensen, Ulla Hass.  
 
 
Keywords: endocrine disruption, mammary gland, mix, paracetamol, whole mount 
 
 
Abstract 
Endocrine disrupting chemicals (EDCs) such as estrogenic and anti-androgenic compounds may 
affect mammary gland development. Estrogenic chemicals have been shown to increase mammary 
gland development in females, however, little is known on the effects of anti-androgens and 
mixtures of EDCs with dissimilar modes of action. 
Pregnant Wistar rat dams were exposed to paracetamol or mixtures of environmentally relevant 
EDCs with estrogenic (Emix), anti-androgenic (Amix) or dissimilar modes of action (TotalMix) of 
100-, 200- or 450-fold high end human intake estimates during gestation and the lactational period. 
Mammary glands of prepubertal and adult female and male offspring were examined for endocrine 
disrupting effects.  
Emix and TotalMix were found to increase mammary outgrowth prepubertally in females. No 
effects of anti-androgens were observed. In adulthood, morphological changes of female mammary 
glands may indicate a higher prevalence of prolactin producing pituitary tumours in the TotalMix 
group compared to controls. 
The present study showed estrogenic effects on mammary glands, but no NOAEL was determined 
for changes in prepubertal female mammary glands. Further studies on dose-levels are needed for 
risk assessment of the effects of perinatal estrogenic chemicals on mammary glands. 
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Introduction 
Sexual differentiation during fetal development and infancy is highly dependent on hormonal 
influence. Disturbance of the hormonal balance by endocrine disrupting chemicals may have 
important impact on the development of a wide range of hormone sensitive organs in the young 
animal or child. In rodent studies, perinatal exposure to such chemicals has been shown to affect 
offspring and some changes are persistent in adulthood [Jacobsen et al. 2012; Soto et al. 2008]. 
During sexual differentiation in utero the mammary glands are formed. Androgens are responsible 
for the male-like differentiation, blocking the nipple formation [Kratochwil 1977; Sourla et al. 
1998] and estrogens are important for the female development of mammary glands [Borellini and 
Oka 1989; Sourla et al. 1998]. Several environmental chemicals have been demonstrated to have 
estrogenic or anti-androgenic properties and may thus interfere with mammary gland development.  
Estrogenic chemicals have been shown to affect mammary gland development in females and to 
accelerate mammary gland growth. In rat studies, an increase in the area and the number of terminal 
end buds (TEBs) have been shown in prepubertal female mammary glands when exposed to 
estrogenic compounds [Cotroneo et al. 2002; Delclos et al. 2001; Murrill et al. 1996]. Moreover, 
studies have shown increased lobular or alveolar hyperplasia [Biegel et al. 1998; Delclos et al. 
2001; Masutomi et al. 2004; Takagi et al. 2004] and secretory dilation of alveoli of adult female 
mammary glands exposed to estrogens [Biegel et al. 1998; Foster et al. 2004]. Terminal end buds 
(TEBs) are undifferentiated proliferative structures in rat mammary glands where neoplastic 
transformation primarily occurs, and an increase in the number of TEBs may be a sign of increased 
risk of mammary cancer later in life [Russo et al. 1990]. Lobules are differentiated structures and 
lobule development with alveolar or lobular hyperplasia, on the other hand, may be a sign of 
accelerated growth or increased differentiation of the mammary gland. Estrogens have also been 
shown to affect male mammary glands, increasing the area, density and branching of the gland 
[Mandrup et al. 2012; Wang et al. 2006; You et al. 2002], suggesting an enhanced growth of 
mammary glands in males.  
Anti-androgenic chemicals are well-known to affect male offspring. For example, phthalates are 
known to induce malformations of the sexual organs, change the ano-genital distance and affect 
nipple retention [Christiansen et al. 2012; Parks et al. 2000; Schultz et al. 1999]. However, the 
possible effects of anti-androgens on mammary gland development have only been described in a 
few studies. Saad et al. (2011) observed increased branching in whole mounts of pubertal female 
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mammary glands following perinatal exposure to vinclozolin [Saad et al. 2011]. In a study by 
Jacobsen et al (2012), no change in density was observed in either male or female offspring PD22 
exposed perinatally to anti-androgenic pesticides. No changes in outgrowth has been reported in 
whole mounts of prepubertal mammary glands exposed to anti-androgens [Jacobsen et al. 2012; 
Saad et al. 2011]. Histology of adult males exposed perinatally to di-n-butyl phthalate was reported 
by Lee et al (2004) to show increased incidence of vacuolar degeneration in alveolar cells and 
alveolar atrophy in the mammary glands [Lee et al. 2004]. Moreover, developmental exposure to a 
mixture of anti-androgenic pesticides in a study by Jacobsen et al (2012) showed effects indicating 
an increased feminization of adult male mammary glands [Jacobsen et al. 2012]. Thus, anti-
androgens appears to affect both female and male mammary glands, however further studies are 
needed for more insights on the influence of anti-androgens on mammary gland development. 
Humans are exposed to a wide range of chemicals with estrogenic and anti-androgenic properties. 
To mimic human exposure, an environmentally relevant mixture of EDCs with dissimilar modes of 
action was studied for effects on male and female mammary development of perinatally exposed 
rats. This paper describes the effects of a mixture of chemicals known to be mainly estrogenic 
(Emix), a mixture of chemicals known to be mainly anti-androgenic (Amix) and a total mixture of 
both the estrogenic and the anti-androgenic compounds. Additionally, paracetamol has been shown 
to have endocrine disrupting capacities and was tested alone and included in the total mixture 
(TotalMix). The TotalMix included the following 13 chemicals: the phthalates di-n-butyl phthalate 
(DBP) and di-(2-ethylhexyl) phthalate (DEHP), the pesticides vinclozolin, prochloraz, 
procymidone, linuron and epoxiconazole, the pesticide metabolite p,p’-DDE, the UV-filter 
substances octyl methoxycinnamate (OMC) and 4-methyl-benzylidene camphor (4-MBC), the 
phenolic compound bisphenol A, the preservative butyl paraben and the analgesic compound 
paracetamol. This mixture affected a range of anti-androgenic endpoints during early development 
as reported previously (Christiansen et al., 2012). 
As noted, mammary effects of endocrine disrupting chemicals have been described in both 
prepubertal and adult rats [Delclos et al. 2001; Murrill et al. 1996; Wang et al. 2006; You et al. 
2002]. In rodent studies, examination of the entire mammary gland during development is possible 
by evaluation of mammary whole mounts, i.e. mammary tissue fixed on a glass slide and stained for 
microscopic investigation.To determine the optimal age for evaluation of the mammary gland 
whole mounts, we performed an initial study (study A) comparing results of neonatal, prepubertal 
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and adult mammary whole mount evaluation following exposure to the TotalMix. Female and male 
mammary gland whole mounts of offspring were evaluated for outgrowth, density and number of 
TEBs. In the following study (Study B), whole mounts of prepubertal animals were prepared and 
the effect of each sub-component of the TotalMix (Emix, Amix, paracetamol) was compared to the 
effect of the TotalMix. Histological sections of adult mammary glands were evaluated for adult 
offspring. Other reproductive parameters will be described in another paper. 
 
 
Materials and methods 
Chemicals  
In these two studies, dose levels were selected based on human intake data. A detailed description 
of the TotalMix composition and choice of dose-levels can be found in Christiansen et al. 
[Christiansen et al. 2012]. The highest dose of the TotalMix (TotalMix-450) represented 450-fold 
“high human intake levels” of each compound. Paracetamol was present at a dose level of 360 
mg/kg bw/day in the TotalMix-450, a dose level of paracetamol that corresponds to approximately 
7-fold human intake levels in individuals consuming 6 paracetamol tablets of 500mg per day. Study 
B also included the same dose of paracetamol in the dose-group receiving paracetamol only (PM-
360). Study B also included 100- and 200- fold “high human intake levels” for the total mixture 
(TotalMix-100 and TotalMix-200), and 200-fold and 450-fold “high human intake levels” for the 
anti-androgen (Amix-200 and Amix-450) as well as the estrogen (Emix-200 and Emix-450) sub-
mixtures. The ratios and amounts of the single compounds in the mixtures are shown in table 1. 
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Table 1. Chemicals included in the mixture, mixture ratio equivalent to estimated human exposure levels and 
dose levels of the mixture used in rats for the studies A and B. Doses are in mg/kg bw/day.  
 Group and 
dosing 
1. 
Control 
 2. 
Mix-100 
3.  
Mix-200 
4.  
Mix-450 
5.  
Amix-200 
6.  
Amix-450 
7.  
Emix-200 
8. Emix-
450 
9. 
Paracetamol 
DBP 0 1 2 4.5 2 4.5 0 0 0 
DEHP 0 2 4 9 4 9 0 0 0 
Vinclozolin 0 0.9 1.8 4.05 1.8 4.05 0 0 0 
Prochloraz 0 1.4 2.8 6.3 2.8 6.3 0 0 0 
Epoxiconazole 0 1 2 4.5 2 4.5 0 0 0 
Procymidone 0 1.5 3 6.75 3 6.75 0 0 0 
Linuron 0 0.06 0.12 0.27 0.12 0.27 0 0 0 
ppDDE 0 0.1 0.2 0.45 0.2 0.45 0 0 0 
4-MBC 0 6 12 27 0 0 12 27 0 
OMC 0 12 24 54 0 0 24 54 0 
Bisphenol A 0 0.15 0.30 0.675 0 0 0.30 0.675 0 
Butyl paraben 0 6 12 27 0 0 12 27 0 
          
Paracetamol 0 80 * 160 * 360 * 0 0 0 0 360* 
*: For group 2-4, mixtures contain paracetamol on GD 13-19 and PND 14-22. Group 9 received paracetamol on GD 13-
19 and PND 14-22 and vehicle on other days. 
 
Animals and experimental design 
Two studies were performed using comparable study designs. Time-mated nulliparous female 
Wistar rats were supplied on gestation day (GD) 3 and on GD4 dams were assigned to dose groups 
with similar weight distributions in all groups. Dams were dosed by gavage from GD7 to GD21. 
The day after expected delivery was defined as pup day (PD) 1. Dosing of dams was resumed 
during lactation PD1-22. However, when animals were exposed to paracetamol, dosing of 
paracetamol was restricted to GD13-GD19 and PD14-22. Animals were administered acidified tap 
water (in glass bottles) and soy- and alfalfa free diet (Altromin 1314, GmBH, Lage Germany) ad 
libitum. Animals were housed in semi-transparent polycarbonate cages (15x27x43cm) with Aspen 
bedding (Tapvei, Brogaarden, Gentofte, Denmark) in controlled  environmental conditions with 
22°C ± 1°C, 10 air changes per hour, air humidity 55% ± 5 and 12h light-dark cycles with lights on 
from 9PM to 9AM. Until GD 17, pregnant rat dams were housed in pairs and thereafter alone. The 
animal studies were performed under conditions approved by the Danish Agency for Protection of 
Experimental Animals and by the in-house Animal Welfare Committee of the National Food 
Institute at the Technical University of Denmark. 
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The first series of studies (Study A) aimed to determine the optimal timing of mammary 
examination in whole mounts, and mammary effects were examined in neonatal (PD 6), prepubertal 
(PD 22) and post-pubertal (PD 49 or 55) offspring exposed to the mixture. In the second study 
(Study B), the same mixture was subdivided into anti-androgens, estrogens and paracetamol, and 
mammary effects at PD22 of each sub-mixture were compared with effects of the total-mixture.  
Study A was performed in two blocks. In each block 28 dams were assigned to 2 groups (n=14): 
control (0mg/kg) and TotalMix-450. In study B 152 dams were assigned to 9 groups (n=20 in 
control and TotalMix-100 groups and n=16 in each of the other groups): control (0mg), 3 TotalMix 
groups (TotalMix-100, TotalMix-200 and Totalix-450), 2 Amix groups (Amix-200 and Amix-450), 
2 Emix groups (Emix-200 and Emix-450) and PM-360. The dose-levels used in the two studies are 
described in table 1. 
 
Necropsy 
Pups were anesthetized with CO2/O2 and sacrificed by decapitation. In study A, pups were 
sacrificed at different time points: neonatally, prepubertally and post-pubertally. In the first block, 
one male and one female pup were sacrificed PD6 and one male and one female were weaned on 
PD22 for sacrifice PD49 (females) or PD55 (males). In the second block, one female and one male 
were sacrificed on PD22. In study B, one male and one female pup were sacrificed on PD22. At 
sacrifice, the 4th mammary gland was dissected from male and female pups for whole mounting. 
Furthermore, 1 male and 1 female in study B were weaned on PD22. At 10 months (males) and 13 
months (females), the weaned offspring were sacrificed in CO2/O2 anesthesia and the 4th mammary 
gland and uterus were dissected and fixed in formalin for histology. Adult females were sacrificed 
when in estrous verified by macroscopic evaluation of unstained smears (clots of vaginal material 
on glass slide) and confirmed by microscopic evaluation of uterus. 
 
Whole mounts 
Mammary glands were dissected and spread on a glass slide, covered with parafilm and pressed 
while drying for approximately 2 hours. The mammary glands were fixed in 4% formalin buffer, 
stained with alum carmine, dehydrated in alcohol and cleared with xylene before mounting with a 
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coverslip. Whole mounts were scanned in a flatbed scanner (4800dpi). Measurements were 
performed on the digital images in Image Pro Plus 7.0 software (Media Cybernetics, Bethesda, MD, 
USA). Spatial calibration was performed for each picture before measurements were made, and the 
data were collected in a Microsoft Excel spread sheet. Mammary glands PD22 were evaluated for 
outgrowth (outer area, transverse growth, longitudinal growth and distance to the lymph node, and 
in study B additionally the distance to the 5th gland), number of TEBs and density (score 1-5 
describing the level of branching and budding, where score 5 has extensively branching and 
budding). At PD6 and in males PD55, same parameters were evaluated, except the distance to the 
lymph node and the distance to the 5th gland. Female mammary glands PD49 were often incomplete 
due to the large size of the gland and only the density was scored in a triangular area defined by the 
nipple and the lymph nodes. Density score criteria were adjusted for age and gender and thus not 
directly comparable between age and gender. In study B, mammary gland whole mounts were 
evaluated for controls and the high-dose groups (TotalMix-450, Amix-450, Emix-450 and PM-
360). As effects were seen in the high-dose Emix group, the lower dose (Emix-200) was also 
evaluated.  
 
Histology 
Mammary glands from study B were sectioned and stained in haematoxylin and eosin. Histologic 
evaluation was performed on controls and the high-dose groups (TotalMix-450, Amix-450, Emix-
450 and PM-360). Female mammary glands were evaluated for lobuloalveolar pattern, dilation of 
and secretion in alveoli and ducts and hyperplasia of alveolar and duct epithelium. Histological 
slides of male mammary glands were evaluated for secretory activity (dilated lumens with secretory 
material and vacuolated alveolar epithelium) and hypertrophy of mammary epithelium. Histological 
parameters evaluated were scored on a two- or three-scaled score. The stage of estrous cycle of 
adult females at necropsy was confirmed by histological evaluation of uterus. Females not 
confirmed to be in estrous or proestrous were not examined for these changes. 
 
Statistics 
Statistical analysis was performed in the statistical software SAS Enterprise Guide 3.0 and 4.3 (SAS 
Institute Inc., Cary, NC, USA) or GraphPad Prism 5. The alpha level was set at 0.05 and the litter 
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was the statistical unit. Continuous data from males and females were pooled and gender was 
analysed for interaction with dose-groups. If no interaction was present, data were analysed with an 
analysis of variance (ANOVA) with body weight (bw) as a covariate and gender as a main factor. 
However, if an interaction was present, data for each gender were analysed separately. Data were 
evaluated for normal distribution and homogeneity of variance before performing the statistical 
tests. Data not fulfilling criteria for homogeneity of variance or normal distribution (i.e. generally 
the density data, the distance to the lymph node and the number of TEBs) were analysed using a 
non-parametric statistical test (Kruskal-Wallis) with a Dunn’s post-hoc test correcting for multiple 
comparisons when more than two groups were compared, or with a non-parametric t-test (Mann 
Whitney) if only two groups were compared. Histological data were analysed with a Fisher’s exact 
test in GraphPad Prism 5 software (GraphPad Software Inc., La Jolla, NC, USA). 
 
 
Results 
Whole mounts 
In the first study, the effects of perinatal dosing on mammary gland development were investigated 
at three different ages. No statistically significant differences between control animals and rats 
exposed to TotalMix-450 were found (data not shown).  
In the second study, a statistically significant decrease in the distance to the lymph node was 
observed in females PD22 exposed perinatally to Emix-450 compared to controls, indicating an 
increased outgrowth of the mammary gland (Figure 1A). A statistically significant decrease in the 
distance to the lymph node was additionally found for females in the TotalMix-450 group when 
data on the distance to the lymph node from females PD22 were pooled from the two studies. This 
may indicate a stronger effect of Emix-450 than of TotalMix-450 on mammary outgrowth, but there 
was no statistically significant difference between these two groups.  
Due to the finding of increased outgrowth in the high-dose Emix group, re-evaluation of these 
whole mounts was performed including the low-dose Emix group (Emix-200). This evaluation 
revealed a statistically significant decrease in the distance to the lymph node in both Emix groups 
(Figure 1B, C, D). No difference in TEB numbers for females or males was found (data not shown). 
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Figure 1. Distance to lymph node in study B. A, Distance to the lymph node in females PD22 from the 
high dose-groups compared to controls. B, Distance to the lymph node in females PD22 in the Emix groups 
compared to controls. C, Distance to the lymph node in a female whole mount from the control group PD22. 
D, Distance to the lymph node in a female whole mount from the Emix-200 group PD22. Dashed white lines 
illustrate the shortest distance from the mammary gland to the lymph nodes. Black bar in C and D represents 
1mm. *: statistically significantly different from controls in Dunn’s post-hoc test with p<0.05.  
 
 
Histology 
At 13 months of age, females with striking histological changes in parts of the mammary glands 
were observed. An increased prevalence of females showing simple cuboidal to low cuboidal 
epithelium, abundant amounts of secretory material in alveoli and extensive lobular development 
was observed in the TotalMix-450 group compared to controls (p<0.05) (Table 2). These focal 
changes resembled lactating glands and suggest an increased prevalence of prolactin producing 
pituitary tumours in exposed females compared to controls. Females not showing signs of effects 
from a prolactin producing pituitary tumour, showed no significant changes in lobuloalveolar 
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pattern, secretory activity or hyperplasia of mammary epithelium (data not shown). Male mammary 
glands showed no statistically significant changes in the prevalence of secretory activity or 
hypertrophy of the mammary epithelium at 10 months of age (data not shown). More than half of 
the animals showed hypertrophic mammary epithelium in all groups and the highest incidence 
(81%) of males with hypertrophic epithelium was present in the Emix-450 group. Some of the male 
mammary glands with hypertrophic epithelium were extensively hypertrophic with abundant 
eosinophilic cytoplasm, similar to apocrine-like changes described by Boberg et al (submitted 
2013). Apocrine-like changes were also observed in controls and the biological relevance of such 
changes are yet unknown.  
 
Table 2. Histological changes in mammary glands of adult females (13 months old) and males (10 months 
old).  
 Control TotalMix-450 Amix-450 Emix-450 Paracetamol 
Females (n) 17 16 16 16 13 
Well-developed lobules 
with dilated and 
secretion filled alveoli 
with simple cubic or 
low cubic epithelium 
1 6* 3 3 3 
Males (n) 16 15 16 16 11 
Hypertrophic 
epithelium (including 
apocrine-like changes) 
10 8 9 13 6 
Apocrine-like changes 3 3 0 5 0 
*: statistically significant in a Fisher’s exact test with p<0.05. 
 
Discussion 
Study A: Age for evaluation of mammary gland whole mounts 
Study A showed no statistically significant effects. Effects PD22 were observed in our previous 
studies on ethinyl estradiol [Mandrup et al. 2012] and other studies have shown effects of EDCs in 
mammary glands PD22 [Fritz et al. 1998; Murrill et al. 1996]. Additionally, most parameters were 
not possible to evaluate in whole mounts of adult female mammary glands and may prevent the 
detection of relevant changes in the mammary glands. Outgrowth parameters and the number of 
TEBs were not possible to evaluate and the density was measured in a defined area known to 
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belong to the 4th gland. Hence, it was decided to examine mammary glands on PD22 in study B for 
evaluation of different combinations of mixtures of endocrine disrupting chemicals. 
 
Study B: Estrogenic compounds influence mammary development   
Perinatal exposure to a mixture of endocrine disrupting chemicals gave rise to morphological 
changes in mammary gland whole mounts prepubertally, but not in histological sections of 
mammary glands in adult rats. Females PD22 exposed perinatally to the mixture of estrogenic 
chemicals or to the total mixture showed increased outgrowth whereas exposure to anti-androgens 
or paracetamol alone did not seem to affect outgrowth or differentiation of mammary glands of 
prepubertal female or male offspring. In another rat study, exposure to the estrogenic compound 
genistein similarly showed increased outgrowth of female mammary glands [Murrill et al. 1996]. 
Alteration of other parameters by estrogenic chemicals has also been reported in female mammary 
glands. Altered differentiation observed as a change in the lobule development relative to the 
number of TEBs has been observed for genistein and 17β-estradiol in rats and mice [Cabanes et al. 
2004; Hilakivi-Clarke et al. 1997; Murrill et al. 1996]. The number of TEBs was not changed by 
exposure in the present study, and a change in differentiation may not be present. Estrogens have 
also been shown to affect prepubertal male mammary glands by increasing the branching and 
density of the gland [Mandrup et al. 2012; You et al. 2002], but in the current study, estrogens did 
not influence any of the examined parameters in males, including the density.  
Previous studies have shown an increased prevalence of hypertrophy in adult male mammary 
glands exposed perinatally to phytoestrogens or genistein [Boberg et al. 2013; Delclos et al. 2001]. 
In a study by Boberg et al (2013, submitted), 80% of 6 months old males exposed to a mixture of 
phytoestrogens had hypertrophic mammary epithelium compared to 33% of controls. Similarly, 
Delclos et al. (2001) showed hypertrophic epithelium in mammary glands of 62% of 50 days old 
males exposed perinatally to genistein [Delclos et al. 2001]. In a study by Mandrup et al. (2013, 
submitted) hypertrophic epithelium was found in 88-90% of males PD90 exposed to ethinyl 
estradiol [Mandrup et al. 2013]. In the present study, the prevalence of hypertrophy in exposed 
males was 81%, however, more than half of control males displayed hypertrophic epithelium likely 
due to the higher age compared to the mentioned studies, and a change in the prevalence was not 
present. In the two previous studies in Sprague-Dawley rats, none of the 50 days old control males 
had hypertrophic epithelium [Delclos et al. 2001] and less than 30% of 6 months old control males 
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were hypertrophic [Boberg et al. 2013]. In a study with Wistar rats, 50% of controls had 
hypertrophic epithelium [Mandrup et al. 2013]. This difference in the prevalence of hypertrophy in 
control males may be due to the difference in strain or the age of the rat. The occurrence of 
hypertrophic epithelium appears to increase with age in controls and it may thus be preferable to 
evaluate male mammary glands for hypertrophy at an earlier age to detect a possible change in the 
susceptibility to develop hypertrophic mammary epithelium at an earlier age. Likewise, Lee et al. 
(2004) found age-related differences in sensitivity of mammary glands exposed to EDCs [Lee et al. 
2004]. Thus, some changes may be naturally occurring with age and a difference in exposure-
groups may not be observable after a certain age. Further studies on young post-pubertal and older 
male mammary glands may clarify this hypothesis. 
 
Based on the present findings, mixed exposure to estrogenic chemicals appear to increase mammary 
gland growth and the susceptibility to mammary cancer in females exposed perinatally to estrogens. 
This may give rise to concern for the daughters of women exposed to estrogenic chemicals from 
various sources during pregnancy and in the breast feeding period. However, further studies on 
dose-levels are needed for risk assessment of the effects of perinatal estrogenic chemicals on the 
mammary glands, as no NOAEL was determined for changes in prepubertal female mammary 
glands. 
 
No influence of anti-androgens on prepubertal mammary development 
Anti-androgens alone did not affect the examined parameters in prepubertal or adult mammary 
glands in the present study. Accordingly, effects of anti-androgens on female and male mammary 
glands from prepubertal rodents have not been observed in previous studies [Jacobsen et al. 2012; 
Peters et al. 2011; Skarda 2003]. However, effects of anti-androgens have been described in rodents 
at puberty or older [Jacobsen et al. 2012; Lee et al. 2004; Peters et al. 2011; Saad et al. 2011]. In 
pubertal female mammary glands, perinatal exposure to anti-androgens has been found to increase 
branching and ductal hyperplasia [Saad et al. 2011]. In sexually mature rodents, anti-androgens 
have been described to increase branching [Peters et al. 2011] and increase the number of TEBs 
[Saad et al. 2011] in females. In adult males, anti-androgens were found to have feminising effects 
[Jacobsen et al. 2012] or to increase atrophy and degeneration of the mammary gland epithelium 
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[Lee et al. 2004]. However, histological evaluation of adult male mammary glands in the present 
study did not show effects of feminisation. This may be explained by different dose-levels of the 
anti-androgens studied with relatively high exposure levels applied in the study by Jacobsen et al. 
(2012).  
Androgens have been described to be responsible for the male-like lobuloalveolar development of 
the male mammary glands [Sourla et al. 1998], but this morphology is only apparent in adulthood 
[Ahren and Etienne 1957; Cardy 1991; Sourla et al. 1998]. Thus the effects of anti-androgens on 
mammary glands may not be observable morphologically in males before a lobuloalveolar pattern 
can be expected and effects of anti-androgens are not observed morphologically in prepubertal male 
mammary glands.  
The findings reported by Jacobsen et al (2012) suggests that early exposure to anti-androgens in 
male offspring can lead to changes in the mammary glands influencing the development of 
mammary glands later in life after sexual maturation, although the exposure is not continuing to 
adulthood. Saad et al. showed changes in the gene expression of estrogen receptors (ERs) and 
androgen receptors (ARs) in prepubertal and adult mammary glands of female Wistar rats exposed 
perinatally to the estrogenic compound genistein or the anti-androgenic compound vinclozolin 
[Saad et al. 2011]. The presence of ARs have been shown to be of importance for prepubertal, 
pubertal and adult mammary gland development in female mice [Yeh et al. 2003]. Changes in the 
levels of ARs and ERs before sexual maturation may thus influence mammary gland development 
in adult females and males. Further histological evaluation or gene expression of adult mammary 
glands of offspring exposed perinatally to EDCs may help to confirm or dismiss this hypothesis.  
 
Mixture considerations 
The combined exposure to estrogens and anti-androgens affected growth in female mammary 
glands to the same extent as the estrogens alone. Thus, the effect in the TotalMix-450 group is 
considered to be due to the estrogenic compounds present in the mixture, and the anti-androgenic 
compounds did not appear to influence this effect, i.e. no combination effects could be detected. 
Saad et al (2011) found an increased ductal proliferation and branching of the female mammary 
glands of female offspring exposed concomitantly to an estrogenic and an anti-androgenic 
chemical. However, this increase was similar to the changes seen in females exposed to the single 
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compounds genistein and vinclozolin [Saad et al. 2011]. This is in accordance with the findings in 
the present study, in which the increased outgrowth of the female mammary gland was comparable 
for estrogenic chemicals alone and for mixed exposure to estrogenic and anti-androgenic chemicals.  
Histological examination of female mammary glands in 1-year old offspring showed an increased 
prevalence in the number of females showing lobular development with dilated and secretion filled 
alveoli and ducts in the TotalMix-450 group. Such changes may be related to high levels of 
prolactin [Neville et al. 2002]. Female rats are known to develop spontaneous pituitary tumours 
with age [Poteracki and Walsh 1998] and such changes in the mammary glands may be associated 
with the development of prolactin producing pituitary tumours. The changes observed in the 
TotalMix-450 group may indicate an increase in the prevalence of animals with signs of prolactin 
producing pituitary tumours in the mixture group. This may be attributed to estrogens and anti-
androgens jointly.  
 
 
Conclusion 
Perinatal exposure to estrogenic chemicals increased outgrowth in mammary glands of prepubertal 
female offspring. The effect on outgrowth of estrogenic chemicals was retrieved in the TotalMix. In 
contrast, anti-androgenic effects on mammary gland morphology were not present in prepubertal 
mammary glands; however, changes may be observed in sexually mature male mammary glands. 
Histological examination of 13 months old females exposed to TotalMix-450 suggested an 
increased prevalence of pituitary tumours in this exposure-group, but this is yet to be confirmed. No 
other changes in adult mammary glands were found, and this may be explained by the age at 
examination. Changes observed around PD50 may not be detectable in 1-year old rats, if such 
changes are naturally occurring with age.  
The present study showed estrogenic effects on mammary glands, but no NOAEL was determined 
for changes in prepubertal female mammary glands. Further studies on dose-levels are needed for 
risk assessment of the effects of perinatal estrogenic chemicals on mammary glands. 
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Appendix 1 
Historical control data in whole mounts – differences in strains and sub-
strains  
 
Introduction 
The number of TEBs in Wistar females in the study with ethinyl estradiol (mean number of 
TEBs=10) appeared smaller compared to the number of TEBs reported in Sprague-Dawley females 
in other studies (mean TEBs=30-43) [Cotroneo et al. 2002; Moral et al. 2008; Tan et al. 2004]. 
Control values for some parameters evaluated in whole mounts in mammary glands may not be 
comparable between studies due to differences in methods, strains or sub-strains. This appendix 
looks into the differences between strains and sub-strains (from another supplier) used in our 
studies. Control values of the same parameters evaluated in a Wistar rat strain from a different 
supplier and in Sprague-Dawley rats used in studies in our laboratory were investigated. Moreover, 
the present appendix looks into the differences in control values for the parameters area, distance to 
the lymph node, density and number of TEBs evaluated in whole mounts of mammary glands from 
the Wistar rat strain routinely used in our laboratory.  
 
 
Methods 
Animals 
Data from historical controls from studies performed on female and male mammary gland whole 
mounts pup day 22 were collected. Most control values were from Wistar rats from a Danish 
supplier, Taconic. A single set of control values was from another sub-strain of Wistar rats from a 
Swedish supplier, Scanbur, and another set was from Sprague-Dawley rats, a different strain than 
Wistar. The mammary glands were processed in similar conditions (in the same laboratory and by 
the same technician), yet, one important step in the processing of the glands was changed in two 
studies with Wistar rats from Taconic. Clamps were used to squeeze mammary glands before 
fixation of the whole mounts in most studies (referred to as the clamp method) (Figure 1A). In two 
studies, mammary glands were pressed with two Plexiglas blocks of equal weight (referred to as the 
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weight method) (Figure 1B), resulting in less pressure than the clamp method before fixation of the 
whole mounts. Values for the area, distance to the lymph node, density and number of terminal end 
buds (TEBs) were assembled for control animals in tables 1 and 2. In the following, Wistar rats 
from Taconic will be referred to as Taconic rats and Wistar rats from Scanbur will be referred to as 
Scanbur rats. 
 
  
Figure 1. Different methods used for squeezing mammary glands before fixation in formalin. A, 
Mammary gland whole mount was placed between two plexiglass blocks and squeezed with clamps 
(referred to as the clamp method). B, Two plexiglass blocks were placed as weight on the mammary 
gland whole mount (referred to as the weight method).  
 
 
Statistics 
Statistical analysis was performed in SAS Enterprise Guide 4.3 statistical software (SAS Institute 
Inc, Cary, NC, USA) or GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). The 
level of significance was set at p=0.05. A t-test was used to analyse pairwise comparisons of area, 
distance to the lymph node and density between sub-strains of Wistar rats (from Scanbur and 
Taconic), between the two strains (Wistar and Sprague-Dawley) and between two methods (weight- 
and clamp methods). For these pairwise analyses the number of TEBs was analysed with a non-
parametric Mann Whitney test. For the evaluation of the differences within Wistar Taconic rats, 
control values for the area, distance to the lymph node and density were analysed with an ANOVA 
with a post hoc Tukey test to correct for multiple comparison of the difference in LS Means. The 
number of TEBs were analysed using a non-parametric Kruskal-Wallis test followed by a Dunn’s 
A B 
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post hoc test to correct for multiple comparisons. The density was furthermore analysed in a non-
parametric test similarly as the number of TEBs in all the comparisons. The area in Taconic rats 
was analysed for correlation with body weight with a two-tailed Pearson analysis. 
 
 
Results and discussion 
Control means for area, distance to the lymph node, density and number of TEBs for female and 
male mammary glands on PD22 are shown in table 1 and 2. Results from the statistical analysis are 
shown in table 3.  
 
Table 1. Control data (mean ±SD) from mammary gland whole mounts from females PD22. Data included 
are from studies performed in the present thesis or historical control data from previous studies. Data from 
Wistar and Sprague-Dawley rats are included. Wistar rats were from either Taconic in Denmark or Scanbur 
in Sweden. Two different methods were used for the whole mount procedure, the clamp method or the 
weight method. Bw: body weight. Lnn: lymph nodes. P:paper. H: historical data. 
Paper/ study Strain – supplier N 
(litter) 
Bw 
 
area Distance 
to lnn 
density TEBs 
Clamp method 
P1: Ethinyl 
estradiol 
Wistar – Taconic 7 42±5 41±13 1.4±0.7 2.6±1.1 10±11 
P3: Phyto-
estrogens 
Sprague-Dawley 14 50±6 93±22  2.9±1.8  
P4: Pesticides Wistar – Taconic 11  49±14  3.5±1.0 25±19 
P5a: Mix study Wistar – Taconic 16 47±5 49±15 1.1±1.0 3.4±1.2 42±14 
P5b: pre-study  Wistar – Taconic 10 55±6 79±16 1.2±1.1 2.5±1.1 6±9 
H1: Historical 
data 1  
Wistar – Taconic 17 44±5 64±19 1.0±1.1 3.9±0.6 8±7 
H2: Historical 
data 2  
Wistar – Scanbur 8 50±7 69±11 1.6±1.5 3.9±0.6 47±20 
Weight method 
H3: Historical 
data 3  
Wistar – Taconic 14 41±5 28±9 0.5±0.6   
H4: Historical 
data 4  
Wistar – Taconic 14 46±6 30±11 0.4±0.6   
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Table 2. Control data (mean ±SD) from mammary gland whole mounts from males PD21/22. Data included 
are from studies performed in the present thesis or historical control data from previous studies. Data from 
Wistar and Sprague-Dawley rats are included. Wistar rats were from either Taconic in Denmark or Scanbur 
in Sweden. Two different methods were used for the whole mount procedure, the clamp method or the 
weight method. Bw: body weight. Lnn: lymph nodes. P: paper. H: historical data. 
Paper/ study Strain N 
(litter) 
Bw 
 
Area Distance 
to lnn 
Density TEBs 
Clamp method 
P1: Ethinyl 
estradiol 
Wistar – Taconic 8 39±4 46±9 2.4±1.4 1.9±0.6 0.6±0.4 
P4: Pesticides Wistar – Taconic 14  42±12  2.9±1.1 6±5 
P5a: Mix study  Wistar – Taconic 12 51±15 47±23 1.8±1.4 2.6±1.0 4±6 
P5b: pre-study  Wistar – Taconic 10 56±6 67±18 1.7±1.8 2.6±0.5 1±1 
H1: Historical 
data 1  
Wistar – Taconic 17 46±5 49±16 2.6±2.0 2.7±1.1 0.5±1.1 
H2: Historical 
data 2  
Wistar – Scanbur 8 51±7 59±22 3.1±1.8 4.3±0.7 31±12 
Weight method 
H3: Historical 
data 3  
Wistar – Taconic 17 44±4 21±10 1.1±0.9   
H4: Historical 
data 4  
Wistar – Taconic 10 47±6 28±10 0.6±0.3   
 
Table 3. Statistically significant differences found in control values from evaluation of whole mounts of 
female and male mammary glands. P-numbers refer to paper numbers and H-numbers refer to historic data 
numbers from tables 1 and 2. 
Groups compared Gender  Differences found 
Strain differences:  
Sprague-Dawley vs. Wistar Taconic 
Females  Area: Sprague-Dawley > Taconic 
Sub-strain differences:  
Scanbur vs. Taconic Wistar rats 
Females Terminal end buds: Scanbur > Taconic 
Males Density: Scanbur > Taconic 
Terminal end buds: Scanbur > Taconic 
Differences within a Wistar sub-
strain:  
Taconic Wistar rats 
Females Area: P5b > P1, P4 and P5a; H1 > P1  
Density: H1 > P5b  
Terminal end buds: P5a > P1, P5b, H1 
Males Area: P5b > P4, P5a. 
Differences in methods:  
Weight vs. clamps 
Females  Area: clamp s> weight 
Distance to the lymph nodes: clamps > weight 
Males Area: clamps > weight 
Distance to the lymph nodes: clamps > weight 
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Mammary glands of Sprague-Dawley rats were only studied in females. The area of Sprague-
Dawley rats was statistically significantly larger compared to mammary glands of Taconic rats 
(p<0.0001). The body weight of Sprague-Dawley females was comparable to Taconic rats. 
Similarly, the mean density of Sprague-Dawley rats was within the range of mean densities in 
Taconic rats. The distance to the lymph nodes and the number of TEBs was not assessed for 
Sprague-Dawley rats and a difference between strains could not be investigated for that parameter.  
Scanbur males differed from Taconic males. Males from Scanbur had higher densities compared to 
Taconic males (p<0.001). Moreover, Scanbur rats had more TEBs than Taconic rats in females as 
well as males (p<0.01 in females and p<0.0001 in males). No differences were observed between 
Scanbur and Taconic females, except for the difference in the number of TEBs.  
Taconic rats had equal means for the distance to the lymph node in females and males and the 
number of terminal end buds in males. Additionally, the densities were equal in means; however, 
females in the pre-study in paper 5 had lower mean density compared to controls from the historical 
study 1 (H1). The number of TEBs in females was higher for the study in paper 5 compared to other 
Taconic females. Statistically significant difference in the area in female and male mammary glands 
was observed in Taconic rats. A Pearson analysis showed more marked correlation between area 
and body weight in Taconic females compared to males (r2= 0.4 in females and r2= 0.1 in males) 
and a variation in the area may reflect a variation in body weight in females (Figure 2). 
Accordingly, rats from the pre-study in paper 5 were generally larger compared to other Taconic 
rats (55g compared to 42-47g in other Taconic rats) and mammary glands from these animals were 
in general larger than other Taconic mammary glands (mean area=79 compared to 41-49 in female 
Taconic rats with significantly smaller mammary glands).  
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Figure 2. Correlation between area and body weight (bw) in Wistar rats from Taconic. 
 
The two different methods used showed effects on the mammary outgrowth. The area (p<0.0001) 
and the distance to the lymph node (p<0.01) were increased in mammary glands squeezed by 
clamps. The density and the number of TEBs were not determined for the studies using the weight 
method.  
 
 
Discussion 
Rat strains, sub-strains and rats from the same sub-strain can differ substantially in mammary gland 
size, density and number of TEBs in controls, although parameters are measured at the same age, 
animals are housed under the same conditions and glands are processed in the same laboratory.  
Strain differences were apparent in the area. Sprague-Dawley (S-D) mammary glands were larger 
prepubertally than Wistar Taconic mammary glands in our studies, whereas female Long Evans 
(LE) rats have been reported to have mammary glands about the size of our Wistar rats PND 21 
(area in female LE rats: 25.1±2.1; mean±SEM) [Hovey et al. 2010]. The number of TEBs was not 
possible to count in the whole mounts from Sprague-Dawley rats in the present studies, but several 
studies have reported a larger number of TEBs in female Sprague-Dawley rats PND21 (TEBs in S-
D rats: 30±5 - 43±5; mean±SEM) compared to our Wistar Taconic mammary glands [Cotroneo et 
al. 2002; Moral et al. 2008; Tan et al. 2004]. Female Long Evans rats were reported to have a 
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number of TEBs closer to the number reported in Sprague-Dawley females than in Wistar females 
from our studies, although the mammary gland area of Long Evans rats appeared to be similar to 
our female Wistar rats (TEBs in LE rats: 48.3±7.8; mean±SEM) [Hovey et al. 2010]. It appears that 
mammary glands have strain-specific morphologic features.  
Differences were also observable within the same strain, between sub-strains, i.e. in Wistar rats 
purchased from different suppliers. Control values on outgrowth parameters evaluated in whole 
mounts from Scanbur rats were not significantly different from Taconic rats. However, control data 
revealed differences between the two sub-strains of Wistar rats for the number of TEBs in females 
and males and the density in males. These parameters in Scanbur rats were significantly higher 
compared to Taconic rats. Thus, Scanbur rats had more developed mammary glands compared to 
Taconic rats, although the glands were of similar sizes.  
Within the same sub-strain, differences were also observed in mean control values between 
different studies. The distance to the lymph node and the number of TEBs for each gender and the 
density in males were found to be similar between studies for prepubertal Wistar Taconic rats. Area 
correlated with body weight and the gland area in rats from one study was generally larger than in 
other Taconic rats, likely due to the larger size of the animals. Moreover, the number of TEBs 
varied largely between the study in paper 5 and the other studies. This may be due to the different 
persons counting TEBs, as this procedure is somewhat subjective. Especially females have many 
TEBs and the number of TEBs may increase substantially if the borders of zone C are assessed 
differently or if the criteria used for defining a TEB are different.   
Moreover, differences may also be seen between different studies using different techniques in the 
processing of mammary gland whole mounts. Statistically significant differences in the area and the 
distance to the lymph node were observed comparing the clamp method and the weight method. 
The area and distance to the lymph node measured in historical controls (from recent, unpublished 
studies) using the weight method were smaller than the areas and distances to the lymph node 
observed in other studies on Taconic rats using the clamp method. These differences may indicate a 
large variation in the size of female and male mammary glands in Wistar rats from Taconic. 
However, this could also be explained by the novel technique used with less pressure (weight 
method) spreading the mammary glands on the glass slides to a lesser extent compared to the clamp 
method.  
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Overall, area varied greatly from study to study and between Wistar and Sprague-Dawley strains. In 
contrast, the distance to the lymph node was only affected by the processing method used in the 
present studies, but was not different within Wistar Taconic rats or between Wistar sub-strains. 
Thus, less variation between studies was observed in the distance to the lymph node compared to 
the area. The number of TEBs was comparable for most Taconic rats; however, it appears that 
technical differences lead to a high number in a single study. Also sub-strain differences in the 
number of TEBs were observed. Further studies are needed to investigate the strain differences in 
the number of TEBs, although the literature suggests a higher number of TEBs in Sprague-Dawley 
rats compared to the Wistar rats studied in the present studies. Density was comparable for all 
strains and sub-strains except for Scanbur males, in which densities were higher compared to 
Taconic males. 
 
 
Conclusion 
Some parameters evaluated in whole mounts in mammary glands are not comparable between 
studies due to differences in strains, sub-strains or methods. Even within the same sub-strain, 
variation is seen in control means from study to study. 
In Sprague-Dawley rats, only females and only the density and area were assessed, and the area of 
mammary glands was larger compared to Wistar rats. Further investigation of other parameters in 
Sprague-Dawley and other strains is needed to elaborate on strain differences. Differences in 
morphologic parameters in mammary glands in Wistar sub-strains were also found. Wistar rats from 
Scanbur had more developed mammary glands compared to Wistar rats from Taconic. However, 
outgrowth was similar between sub-strains.  
Within the same sub-strain of Wistar rats differences were apparent in parameters like area, density 
and number of TEBs. Differences in area may be related to the different sizes of the animals with 
larger gland area in larger animals, especially in females. Another outgrowth parameter, the 
distance to the lymph node, appeared to be more consistent within the Wistar sub-strain. This 
parameter was, however, affected by the amount of pressure used for squeezing the gland.  
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Several parameters evaluated in whole mounts of prepubertal mammary glands vary greatly 
between strains, sub-strains and methods used in different studies and comparison of crude means 
between studies of such endpoints should be avoided.  
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Appendix 2  
Study report presenting evaluation of female external genital malformations 
 
Introduction 
The objective was to investigate whether the development of female external genitals is sensitive to 
exposure to endocrine disrupting chemicals (EDCs). The goals were (i) to define a sensitive 
parameter in female external genitals and (ii) to evaluate if female external genital malformation is 
a sensitive endpoint to environmentally relevant EDCs. 
Based on findings reported in studies investigating the effects of EDCs on female external genital 
malformations [Flaws et al. 1997; Gray et al. 1997; Gray and Ostby 1995; Sawaki et al. 2003a; 
Sawaki et al. 2003b; Wolf et al. 2002; Yamasaki et al. 2005], four different methods for evaluation 
of the genitals were evaluated in the present studies in female offspring after exposure to a potent 
estrogenic chemical, ethinyl estradiol. The urethral slit length was assessed to be the most reliable 
measurement sensitive to ethinyl estradiol and was then studied in offspring exposed perinatally to 
environmentally relevant EDCs.  
 
Materials and methods 
Animals, chemicals and study design 
Animals, environmental conditions and diet are described in papers 2 and 5. Details on these 
parameters are similar for all studies performed. A study with a potent estrogenic compound, 
ethinyl estradiol, was performed as a positive control study. Details on study design of the positive 
control study are described in paper 2. Furthermore, studies with the environmentally relevant 
EDCs bisphenol A (estrogenic), epoxiconazole (anti-estrogenic), and mixtures with either 
estrogenic (Emix), anti-androgenic (Amix) or EDCs with dissimilar modes of action (TotalMix) 
were performed. The study design on the mixture studies is described in paper 5. The study designs 
of the studies on bisphenol A and epoxiconazole are similar to the studies described in paper 2 and 
5. Chemicals, doses, number of litters, ages for the evaluation of female external genital 
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malformations and papers describing the study in details are shown in Table 1. The day of expected 
delivery was defined as pup day (PD) 0. 
 
Table 1. Studies performed for evaluation of the female external genital malformations. Chemicals, doses, 
ages evaluated for genital malformations and papers where the study is described are shown.  
Chemical Doses n Ages evaluated Paper 
Ethinyl estradiol 5, 15 and 50 µg/kg 10 PD 22, 50 and 90 2 
Bisphenol A 0.025, 0.25, 5, 50 mg/kg 22 PD22 and 90 NA 
Epoxiconazole 15, 30 mg/kg 18 PD22 and 90 NA 
Paracetamol 350x 16-20 PD22, 50, and 400 5 
Emix 200, 450x 16-20 PD22, 50, and 400 5 
Amix 200, 450x 16-20 PD22, 50, and 400 5 
TotalMix 100, 200, 450x 16-20 PD22, 50, and 400 5 
n: number of litters. Paper: study design described in one of the five papers of this PhD. NA: not applicable – not 
described in a paper. x: fold high human exposure.  
 
 
Evaluation of a sensitive endpoint 
Several measurements were performed on female external genitals at PD22, 50 and 90 in the 
positive control study. For each age, the urethral slit length, the urethral-vaginal distance, the 
relative length of the urethral slit compared to the length of the genital papilla and an evaluation of 
the presence or absence of a clefted genital papilla were evaluated. All measurements were 
performed in a stereomicroscope with a scale. The measurement of the urethral slit length was 
performed as described in paper 2. The urethral-vaginal distance was measured as the distance 
between the bottom of the cleft and the vaginal opening. To calculate the relative urethral slit length 
(𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑢𝑟𝑒𝑡ℎ𝑟𝑎𝑙 𝑠𝑙𝑖𝑡 𝑙𝑒𝑛𝑔𝑡ℎ = 𝑢𝑟𝑒𝑡ℎ𝑟𝑎𝑙 𝑠𝑙𝑖𝑡 𝑙𝑒𝑛𝑔𝑡ℎ
𝑙𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑔𝑒𝑛𝑖𝑡𝑎𝑙 𝑝𝑎𝑝𝑖𝑙𝑙𝑎 ∗ 100), the length of the genital papilla 
was calculated as the sum of the urethral slit length and the urethral-vaginal distance. The presence 
or absence of a clefted genital papilla was evaluated by determining a threshold for the normal cleft 
(urethral slit length in controls). The sides of the urethral slit were separated manually and the 
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measurements were performed with triple repetition to avoid false negative results from the sides of 
the urethral slit sticking together. 
 
Evaluation of endocrine disrupting chemicals 
The urethral slit length was measured in female offspring exposed perinatally to single compounds 
with endocrine disrupting activity – epoxiconazole, bisphenol A or paracetamol – or mixtures of 
estrogenic chemicals (Emix), anti-androgenic chemicals (Amix), or a mixture of EDCs with 
dissimilar modes of action (TotalMix). Female external genitals were evaluated at PD22, 50 and in 
13 months old (PD400) offspring.  
 
Statistics 
The statistical programmes SAS Enterprise Guide 4.3 (SAS Institute Inc., Cary, NC, USA) and 
GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA) were used for the statistical 
analyses. Quantitative data (urethral slit length, relative urethral slit length, urethral-vaginal distance 
and genital papilla length) were analysed using an analysis of variance (ANOVA) with body weight 
as a covariate and a Dunnett’s post-hoc test. If several pups per litter were evaluated, the litter was 
included as a random factor. The presence or absence of a clefted genital papilla was analysed with 
a Fisher’s exact test.  
 
 
Results 
Evaluation of a sensitive endpoint 
In the study with ethinyl estradiol, no statistically significant changes were seen for the urethral slit 
length or the relative urethral slit length on PD22 and PD50, nor for the qualitative evaluation of the 
presence of a clefted papilla on PD22 and PD90 (Table 2). The urethral slit length and the relative 
urethral slit length were statistically significantly increased on PD90 at 50 µg/kg. The urethral-
vaginal distance was decreased in all ages evaluated. The prevalence of females with a clefted 
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genital papilla was increased in the highest dose-group PD50. Results for the urethral slit length in 
the positive control study are also described in paper 2.  
 
Table 2. Results of measurements in female external genitals after perinatal exposure to ethinyl estradiol. 
Arrows: statistically significant increase or decrease. Parentheses specifies at which dose level a statistically 
significant change was observed. 
 PD22 PD50 PD90 
Urethral slit length - - ↑ (50 µg/kg) 
Length of genital papilla ↓ (50 µg/kg) ↓ (15 µg/kg) ↓ (50 µg/kg) 
Realtive urethral slit length - - ↑ (50 µg/kg) 
Urethral-vaginal distance ↓ (50 µg/kg) ↓ (15 µg/kg) ↓ (50 µg/kg) 
Clefted genital papilla - ↑ (50 µg/kg) - 
 
 
The distances to the vaginal opening were difficult to assess. Thus, the urethral slit length was 
measured in studies on EDCs. 
 
Evaluation of endocrine disrupting chemicals 
No statistically significant effects were found in the urethral slit length in offspring exposed to 
environmentally relevant EDCs in utero and during the lactation period (data not shown). 
 
 
Discussion 
Evaluation of female external genital malformations 
Measurement of the parameters in the female external genitals was somewhat complicated. The 
parts of the papilla that form the urethral slit can stick together and a urethral slit may not be visible. 
To evaluate the urethral slit length and other parameters measured for the evaluation of genital 
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malformations, these parts must be separated by digital manipulation. If such manipulation is not 
performed, false negative results may follow showing small urethral slits, although a deep urethral 
slit is present. Moreover, digital manipulation of the genital papilla can provoke excretion of 
secretory material (probably from the glandulae preputiales) at the tip of the genital papilla. The 
urethral slit length may appear longer due to this secretion and may lead to false positive results. 
Secretory material should be wiped off before measurement. It is thus imperative to be aware of 
these difficulties to secure proper measurement of the urethral slit length. 
A decrease in the length of the papilla was accompanied by a decrease in the urethral-vaginal 
distance. The boundary of the vaginal opening is difficult to decide and the distance to the vaginal 
opening is difficult to assess. This measurement is very dependent on the person measuring. To 
assess these parameters, the person must be trained and the same person must perform the 
measurements throughout the study. Effects on the distance to the vaginal opening may be a chance 
finding. Thus, this method was not used in following studies although effects were observed at all 
ages. The relative urethral slit length was also dependent on the length of the genital papilla and was 
accordingly not used in the following studies either.  
The urethral slit length was not dependent on the length of the genital papilla and was the most 
precise measurement and thus the most credible parameter reflecting the genital malformations of 
the urethral slit. The urethral slit length was used to determine the presence or absence of a clefted 
genital papilla and both these parameters were evaluated in the following studies on EDCs. 
 
Sensitivity of the urethral slit length to EDCs 
The urethral slit length was increased in 90 days-old female offspring exposed perinatally to 50 
μg/kg ethinyl estradiol. The parameter was not changed in 22 or 50 days old offspring compared to 
controls. EDCs with estrogenic, anti-androgenic or mixtures of EDCs with dissimilar modes of 
action did not show effects on the urethral slit length.  
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Conclusion 
The urethral slit length was sensitive to ethinyl estradiol and was the most reliable measurement 
used for evaluation of female genital malformations. In the present studies, the urethral slit length 
did not appear to be sensitive to environmentally relevant EDCs. 
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